window.__IS_SSR__=true
window.__INITIAL_STATE__={
"attachmentsReducer": {
"audio_0": {
"type": "attachments",
"id": "audio_0",
"imgSizes": {
"kqedFullSize": {
"file": "https://ww2.kqed.org/news/wp-content/themes/KQED-unified/img/audio_bgs/background0.jpg"
}
}
},
"audio_1": {
"type": "attachments",
"id": "audio_1",
"imgSizes": {
"kqedFullSize": {
"file": "https://ww2.kqed.org/news/wp-content/themes/KQED-unified/img/audio_bgs/background1.jpg"
}
}
},
"audio_2": {
"type": "attachments",
"id": "audio_2",
"imgSizes": {
"kqedFullSize": {
"file": "https://ww2.kqed.org/news/wp-content/themes/KQED-unified/img/audio_bgs/background2.jpg"
}
}
},
"audio_3": {
"type": "attachments",
"id": "audio_3",
"imgSizes": {
"kqedFullSize": {
"file": "https://ww2.kqed.org/news/wp-content/themes/KQED-unified/img/audio_bgs/background3.jpg"
}
}
},
"audio_4": {
"type": "attachments",
"id": "audio_4",
"imgSizes": {
"kqedFullSize": {
"file": "https://ww2.kqed.org/news/wp-content/themes/KQED-unified/img/audio_bgs/background4.jpg"
}
}
},
"placeholder": {
"type": "attachments",
"id": "placeholder",
"imgSizes": {
"thumbnail": {
"file": "https://cdn.kqed.org/wp-content/uploads/2024/12/KQED-Default-Image-816638274-2000x1333-1-160x107.jpg",
"width": 160,
"height": 107,
"mimeType": "image/jpeg"
},
"medium": {
"file": "https://cdn.kqed.org/wp-content/uploads/2024/12/KQED-Default-Image-816638274-2000x1333-1-800x533.jpg",
"width": 800,
"height": 533,
"mimeType": "image/jpeg"
},
"medium_large": {
"file": "https://cdn.kqed.org/wp-content/uploads/2024/12/KQED-Default-Image-816638274-2000x1333-1-768x512.jpg",
"width": 768,
"height": 512,
"mimeType": "image/jpeg"
},
"large": {
"file": "https://cdn.kqed.org/wp-content/uploads/2024/12/KQED-Default-Image-816638274-2000x1333-1-1020x680.jpg",
"width": 1020,
"height": 680,
"mimeType": "image/jpeg"
},
"1536x1536": {
"file": "https://cdn.kqed.org/wp-content/uploads/2024/12/KQED-Default-Image-816638274-2000x1333-1-1536x1024.jpg",
"width": 1536,
"height": 1024,
"mimeType": "image/jpeg"
},
"fd-lrg": {
"file": "https://cdn.kqed.org/wp-content/uploads/2024/12/KQED-Default-Image-816638274-2000x1333-1-1536x1024.jpg",
"width": 1536,
"height": 1024,
"mimeType": "image/jpeg"
},
"fd-med": {
"file": "https://cdn.kqed.org/wp-content/uploads/2024/12/KQED-Default-Image-816638274-2000x1333-1-1020x680.jpg",
"width": 1020,
"height": 680,
"mimeType": "image/jpeg"
},
"fd-sm": {
"file": "https://cdn.kqed.org/wp-content/uploads/2024/12/KQED-Default-Image-816638274-2000x1333-1-800x533.jpg",
"width": 800,
"height": 533,
"mimeType": "image/jpeg"
},
"post-thumbnail": {
"file": "https://cdn.kqed.org/wp-content/uploads/2024/12/KQED-Default-Image-816638274-2000x1333-1-672x372.jpg",
"width": 672,
"height": 372,
"mimeType": "image/jpeg"
},
"twentyfourteen-full-width": {
"file": "https://cdn.kqed.org/wp-content/uploads/2024/12/KQED-Default-Image-816638274-2000x1333-1-1038x576.jpg",
"width": 1038,
"height": 576,
"mimeType": "image/jpeg"
},
"xxsmall": {
"file": "https://cdn.kqed.org/wp-content/uploads/2024/12/KQED-Default-Image-816638274-2000x1333-1-160x107.jpg",
"width": 160,
"height": 107,
"mimeType": "image/jpeg"
},
"xsmall": {
"file": "https://cdn.kqed.org/wp-content/uploads/2024/12/KQED-Default-Image-816638274-2000x1333-1-672x372.jpg",
"width": 672,
"height": 372,
"mimeType": "image/jpeg"
},
"small": {
"file": "https://cdn.kqed.org/wp-content/uploads/2024/12/KQED-Default-Image-816638274-2000x1333-1-672x372.jpg",
"width": 672,
"height": 372,
"mimeType": "image/jpeg"
},
"xlarge": {
"file": "https://cdn.kqed.org/wp-content/uploads/2024/12/KQED-Default-Image-816638274-2000x1333-1-1020x680.jpg",
"width": 1020,
"height": 680,
"mimeType": "image/jpeg"
},
"full-width": {
"file": "https://cdn.kqed.org/wp-content/uploads/2024/12/KQED-Default-Image-816638274-2000x1333-1-1920x1280.jpg",
"width": 1920,
"height": 1280,
"mimeType": "image/jpeg"
},
"guest-author-32": {
"file": "https://cdn.kqed.org/wp-content/uploads/2025/01/KQED-Default-Image-816638274-1333x1333-1-160x160.jpg",
"width": 32,
"height": 32,
"mimeType": "image/jpeg"
},
"guest-author-50": {
"file": "https://cdn.kqed.org/wp-content/uploads/2025/01/KQED-Default-Image-816638274-1333x1333-1-160x160.jpg",
"width": 50,
"height": 50,
"mimeType": "image/jpeg"
},
"guest-author-64": {
"file": "https://cdn.kqed.org/wp-content/uploads/2025/01/KQED-Default-Image-816638274-1333x1333-1-160x160.jpg",
"width": 64,
"height": 64,
"mimeType": "image/jpeg"
},
"guest-author-96": {
"file": "https://cdn.kqed.org/wp-content/uploads/2025/01/KQED-Default-Image-816638274-1333x1333-1-160x160.jpg",
"width": 96,
"height": 96,
"mimeType": "image/jpeg"
},
"guest-author-128": {
"file": "https://cdn.kqed.org/wp-content/uploads/2025/01/KQED-Default-Image-816638274-1333x1333-1-160x160.jpg",
"width": 128,
"height": 128,
"mimeType": "image/jpeg"
},
"detail": {
"file": "https://cdn.kqed.org/wp-content/uploads/2025/01/KQED-Default-Image-816638274-1333x1333-1-160x160.jpg",
"width": 160,
"height": 160,
"mimeType": "image/jpeg"
},
"kqedFullSize": {
"file": "https://cdn.kqed.org/wp-content/uploads/2024/12/KQED-Default-Image-816638274-2000x1333-1.jpg",
"width": 2000,
"height": 1333
}
}
},
"news_11291236": {
"type": "attachments",
"id": "news_11291236",
"meta": {
"index": "attachments_1716263798",
"site": "news",
"id": "11291236",
"found": true
},
"parent": 11291235,
"imgSizes": {
"small": {
"file": "https://ww2.kqed.org/app/uploads/sites/10/2017/01/GettyImages-632935736-520x347.jpg",
"width": 520,
"mimeType": "image/jpeg",
"height": 347
},
"twentyfourteen-full-width": {
"file": "https://ww2.kqed.org/app/uploads/sites/10/2017/01/GettyImages-632935736-1038x576.jpg",
"width": 1038,
"mimeType": "image/jpeg",
"height": 576
},
"thumbnail": {
"file": "https://ww2.kqed.org/app/uploads/sites/10/2017/01/GettyImages-632935736-160x107.jpg",
"width": 160,
"mimeType": "image/jpeg",
"height": 107
},
"fd-sm": {
"file": "https://ww2.kqed.org/app/uploads/sites/10/2017/01/GettyImages-632935736-960x640.jpg",
"width": 960,
"mimeType": "image/jpeg",
"height": 640
},
"post-thumbnail": {
"file": "https://ww2.kqed.org/app/uploads/sites/10/2017/01/GettyImages-632935736-672x372.jpg",
"width": 672,
"mimeType": "image/jpeg",
"height": 372
},
"xsmall": {
"file": "https://ww2.kqed.org/app/uploads/sites/10/2017/01/GettyImages-632935736-375x250.jpg",
"width": 375,
"mimeType": "image/jpeg",
"height": 250
},
"kqedFullSize": {
"file": "https://ww2.kqed.org/app/uploads/sites/10/2017/01/GettyImages-632935736-e1485668712291.jpg",
"width": 1920,
"height": 1280
},
"large": {
"file": "https://ww2.kqed.org/app/uploads/sites/10/2017/01/GettyImages-632935736-1020x680.jpg",
"width": 1020,
"mimeType": "image/jpeg",
"height": 680
},
"xlarge": {
"file": "https://ww2.kqed.org/app/uploads/sites/10/2017/01/GettyImages-632935736-1180x787.jpg",
"width": 1180,
"mimeType": "image/jpeg",
"height": 787
},
"guest-author-50": {
"file": "https://ww2.kqed.org/app/uploads/sites/10/2017/01/GettyImages-632935736-50x50.jpg",
"width": 50,
"mimeType": "image/jpeg",
"height": 50
},
"guest-author-96": {
"file": "https://ww2.kqed.org/app/uploads/sites/10/2017/01/GettyImages-632935736-96x96.jpg",
"width": 96,
"mimeType": "image/jpeg",
"height": 96
},
"medium": {
"file": "https://ww2.kqed.org/app/uploads/sites/10/2017/01/GettyImages-632935736-800x533.jpg",
"width": 800,
"mimeType": "image/jpeg",
"height": 533
},
"guest-author-64": {
"file": "https://ww2.kqed.org/app/uploads/sites/10/2017/01/GettyImages-632935736-64x64.jpg",
"width": 64,
"mimeType": "image/jpeg",
"height": 64
},
"guest-author-32": {
"file": "https://ww2.kqed.org/app/uploads/sites/10/2017/01/GettyImages-632935736-32x32.jpg",
"width": 32,
"mimeType": "image/jpeg",
"height": 32
},
"jmtc-small-thumb": {
"file": "https://ww2.kqed.org/app/uploads/sites/10/2017/01/GettyImages-632935736-280x150.jpg",
"width": 280,
"mimeType": "image/jpeg",
"height": 150
},
"fd-lrg": {
"file": "https://ww2.kqed.org/app/uploads/sites/10/2017/01/GettyImages-632935736-1920x1280.jpg",
"width": 1920,
"mimeType": "image/jpeg",
"height": 1280
},
"fd-med": {
"file": "https://ww2.kqed.org/app/uploads/sites/10/2017/01/GettyImages-632935736-1180x787.jpg",
"width": 1180,
"mimeType": "image/jpeg",
"height": 787
},
"full-width": {
"file": "https://ww2.kqed.org/app/uploads/sites/10/2017/01/GettyImages-632935736-1920x1280.jpg",
"width": 1920,
"mimeType": "image/jpeg",
"height": 1280
},
"detail": {
"file": "https://ww2.kqed.org/app/uploads/sites/10/2017/01/GettyImages-632935736-150x150.jpg",
"width": 150,
"mimeType": "image/jpeg",
"height": 150
},
"guest-author-128": {
"file": "https://ww2.kqed.org/app/uploads/sites/10/2017/01/GettyImages-632935736-128x128.jpg",
"width": 128,
"mimeType": "image/jpeg",
"height": 128
},
"xxsmall": {
"file": "https://ww2.kqed.org/app/uploads/sites/10/2017/01/GettyImages-632935736-240x160.jpg",
"width": 240,
"mimeType": "image/jpeg",
"height": 160
}
},
"publishDate": 1485668556,
"modified": 1485668705,
"caption": "President Trump holds up one of his latest round of executive actions on Saturday in the Oval Office. ",
"description": null,
"title": "Donald Trump-Executive Orders",
"credit": "Pete Marovich/Pool-Getty Ima",
"status": "inherit",
"isLoading": false,
"fetchFailed": false
},
"news_11220335": {
"type": "attachments",
"id": "news_11220335",
"meta": {
"index": "attachments_1716263798",
"site": "news",
"id": "11220335",
"found": true
},
"parent": 11219853,
"imgSizes": {
"small": {
"file": "https://ww2.kqed.org/app/uploads/sites/10/2016/12/ucsf-1920-520x347.jpg",
"width": 520,
"mimeType": "image/jpeg",
"height": 347
},
"twentyfourteen-full-width": {
"file": "https://ww2.kqed.org/app/uploads/sites/10/2016/12/ucsf-1920-1038x576.jpg",
"width": 1038,
"mimeType": "image/jpeg",
"height": 576
},
"thumbnail": {
"file": "https://ww2.kqed.org/app/uploads/sites/10/2016/12/ucsf-1920-160x107.jpg",
"width": 160,
"mimeType": "image/jpeg",
"height": 107
},
"fd-sm": {
"file": "https://ww2.kqed.org/app/uploads/sites/10/2016/12/ucsf-1920-960x640.jpg",
"width": 960,
"mimeType": "image/jpeg",
"height": 640
},
"post-thumbnail": {
"file": "https://ww2.kqed.org/app/uploads/sites/10/2016/12/ucsf-1920-672x372.jpg",
"width": 672,
"mimeType": "image/jpeg",
"height": 372
},
"xsmall": {
"file": "https://ww2.kqed.org/app/uploads/sites/10/2016/12/ucsf-1920-375x250.jpg",
"width": 375,
"mimeType": "image/jpeg",
"height": 250
},
"kqedFullSize": {
"file": "https://ww2.kqed.org/app/uploads/sites/10/2016/12/ucsf-1920.jpg",
"width": 1920,
"height": 1280
},
"large": {
"file": "https://ww2.kqed.org/app/uploads/sites/10/2016/12/ucsf-1920-1020x680.jpg",
"width": 1020,
"mimeType": "image/jpeg",
"height": 680
},
"xlarge": {
"file": "https://ww2.kqed.org/app/uploads/sites/10/2016/12/ucsf-1920-1180x787.jpg",
"width": 1180,
"mimeType": "image/jpeg",
"height": 787
},
"guest-author-50": {
"file": "https://ww2.kqed.org/app/uploads/sites/10/2016/12/ucsf-1920-50x50.jpg",
"width": 50,
"mimeType": "image/jpeg",
"height": 50
},
"guest-author-96": {
"file": "https://ww2.kqed.org/app/uploads/sites/10/2016/12/ucsf-1920-96x96.jpg",
"width": 96,
"mimeType": "image/jpeg",
"height": 96
},
"medium": {
"file": "https://ww2.kqed.org/app/uploads/sites/10/2016/12/ucsf-1920-800x533.jpg",
"width": 800,
"mimeType": "image/jpeg",
"height": 533
},
"guest-author-64": {
"file": "https://ww2.kqed.org/app/uploads/sites/10/2016/12/ucsf-1920-64x64.jpg",
"width": 64,
"mimeType": "image/jpeg",
"height": 64
},
"guest-author-32": {
"file": "https://ww2.kqed.org/app/uploads/sites/10/2016/12/ucsf-1920-32x32.jpg",
"width": 32,
"mimeType": "image/jpeg",
"height": 32
},
"jmtc-small-thumb": {
"file": "https://ww2.kqed.org/app/uploads/sites/10/2016/12/ucsf-1920-280x150.jpg",
"width": 280,
"mimeType": "image/jpeg",
"height": 150
},
"fd-lrg": {
"file": "https://ww2.kqed.org/app/uploads/sites/10/2016/12/ucsf-1920-1920x1280.jpg",
"width": 1920,
"mimeType": "image/jpeg",
"height": 1280
},
"fd-med": {
"file": "https://ww2.kqed.org/app/uploads/sites/10/2016/12/ucsf-1920-1180x787.jpg",
"width": 1180,
"mimeType": "image/jpeg",
"height": 787
},
"full-width": {
"file": "https://ww2.kqed.org/app/uploads/sites/10/2016/12/ucsf-1920-1920x1280.jpg",
"width": 1920,
"mimeType": "image/jpeg",
"height": 1280
},
"detail": {
"file": "https://ww2.kqed.org/app/uploads/sites/10/2016/12/ucsf-1920-150x150.jpg",
"width": 150,
"mimeType": "image/jpeg",
"height": 150
},
"guest-author-128": {
"file": "https://ww2.kqed.org/app/uploads/sites/10/2016/12/ucsf-1920-128x128.jpg",
"width": 128,
"mimeType": "image/jpeg",
"height": 128
},
"xxsmall": {
"file": "https://ww2.kqed.org/app/uploads/sites/10/2016/12/ucsf-1920-240x160.jpg",
"width": 240,
"mimeType": "image/jpeg",
"height": 160
}
},
"publishDate": 1481763069,
"modified": 1481763114,
"caption": "A view of UC San Francisco.",
"description": null,
"title": "ucsf-1920",
"credit": "Niall Kennedy/Flickr",
"status": "inherit",
"isLoading": false,
"fetchFailed": false
},
"futureofyou_325331": {
"type": "attachments",
"id": "futureofyou_325331",
"meta": {
"index": "attachments_1716263798",
"site": "futureofyou",
"id": "325331",
"found": true
},
"parent": 322609,
"imgSizes": {
"small": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2017/01/ezekielemanuel-520x345.jpg",
"width": 520,
"mimeType": "image/jpeg",
"height": 345
},
"thumbnail": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2017/01/ezekielemanuel-160x106.jpg",
"width": 160,
"mimeType": "image/jpeg",
"height": 106
},
"post-thumbnail": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2017/01/ezekielemanuel-672x372.jpg",
"width": 672,
"mimeType": "image/jpeg",
"height": 372
},
"xsmall": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2017/01/ezekielemanuel-375x249.jpg",
"width": 375,
"mimeType": "image/jpeg",
"height": 249
},
"kqedFullSize": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2017/01/ezekielemanuel.jpg",
"width": 800,
"height": 531
},
"guest-author-50": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2017/01/ezekielemanuel-50x50.jpg",
"width": 50,
"mimeType": "image/jpeg",
"height": 50
},
"guest-author-96": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2017/01/ezekielemanuel-96x96.jpg",
"width": 96,
"mimeType": "image/jpeg",
"height": 96
},
"medium": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2017/01/ezekielemanuel-800x531.jpg",
"width": 800,
"mimeType": "image/jpeg",
"height": 531
},
"guest-author-64": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2017/01/ezekielemanuel-64x64.jpg",
"width": 64,
"mimeType": "image/jpeg",
"height": 64
},
"guest-author-32": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2017/01/ezekielemanuel-32x32.jpg",
"width": 32,
"mimeType": "image/jpeg",
"height": 32
},
"detail": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2017/01/ezekielemanuel-150x150.jpg",
"width": 150,
"mimeType": "image/jpeg",
"height": 150
},
"medium_large": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2017/01/ezekielemanuel-768x510.jpg",
"width": 768,
"mimeType": "image/jpeg",
"height": 510
},
"guest-author-128": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2017/01/ezekielemanuel-128x128.jpg",
"width": 128,
"mimeType": "image/jpeg",
"height": 128
},
"xxsmall": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2017/01/ezekielemanuel-240x159.jpg",
"width": 240,
"mimeType": "image/jpeg",
"height": 159
}
},
"publishDate": 1485290320,
"modified": 1485290451,
"caption": "Ezekiel Emanuel, in 2010. Emanuel is one of the main policy experts to help shape the Affordable Care Act.",
"description": null,
"title": "ezekielemanuel",
"credit": null,
"status": "inherit",
"isLoading": false,
"fetchFailed": false
},
"futureofyou_323235": {
"type": "attachments",
"id": "futureofyou_323235",
"meta": {
"index": "attachments_1716263798",
"site": "futureofyou",
"id": "323235",
"found": true
},
"parent": 323092,
"imgSizes": {
"small": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2017/01/Laufer-holding-Epi-Pencil.-Photo-credit-Four-Thieves-Vinegar-Collective-2016-520x347.jpg",
"width": 520,
"mimeType": "image/jpeg",
"height": 347
},
"twentyfourteen-full-width": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2017/01/Laufer-holding-Epi-Pencil.-Photo-credit-Four-Thieves-Vinegar-Collective-2016-1038x576.jpg",
"width": 1038,
"mimeType": "image/jpeg",
"height": 576
},
"thumbnail": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2017/01/Laufer-holding-Epi-Pencil.-Photo-credit-Four-Thieves-Vinegar-Collective-2016-160x107.jpg",
"width": 160,
"mimeType": "image/jpeg",
"height": 107
},
"fd-sm": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2017/01/Laufer-holding-Epi-Pencil.-Photo-credit-Four-Thieves-Vinegar-Collective-2016-960x640.jpg",
"width": 960,
"mimeType": "image/jpeg",
"height": 640
},
"post-thumbnail": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2017/01/Laufer-holding-Epi-Pencil.-Photo-credit-Four-Thieves-Vinegar-Collective-2016-672x372.jpg",
"width": 672,
"mimeType": "image/jpeg",
"height": 372
},
"xsmall": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2017/01/Laufer-holding-Epi-Pencil.-Photo-credit-Four-Thieves-Vinegar-Collective-2016-375x250.jpg",
"width": 375,
"mimeType": "image/jpeg",
"height": 250
},
"kqedFullSize": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2017/01/Laufer-holding-Epi-Pencil.-Photo-credit-Four-Thieves-Vinegar-Collective-2016.jpg",
"width": 1080,
"height": 720
},
"large": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2017/01/Laufer-holding-Epi-Pencil.-Photo-credit-Four-Thieves-Vinegar-Collective-2016-1020x680.jpg",
"width": 1020,
"mimeType": "image/jpeg",
"height": 680
},
"guest-author-50": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2017/01/Laufer-holding-Epi-Pencil.-Photo-credit-Four-Thieves-Vinegar-Collective-2016-50x50.jpg",
"width": 50,
"mimeType": "image/jpeg",
"height": 50
},
"guest-author-96": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2017/01/Laufer-holding-Epi-Pencil.-Photo-credit-Four-Thieves-Vinegar-Collective-2016-96x96.jpg",
"width": 96,
"mimeType": "image/jpeg",
"height": 96
},
"medium": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2017/01/Laufer-holding-Epi-Pencil.-Photo-credit-Four-Thieves-Vinegar-Collective-2016-800x533.jpg",
"width": 800,
"mimeType": "image/jpeg",
"height": 533
},
"guest-author-64": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2017/01/Laufer-holding-Epi-Pencil.-Photo-credit-Four-Thieves-Vinegar-Collective-2016-64x64.jpg",
"width": 64,
"mimeType": "image/jpeg",
"height": 64
},
"guest-author-32": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2017/01/Laufer-holding-Epi-Pencil.-Photo-credit-Four-Thieves-Vinegar-Collective-2016-32x32.jpg",
"width": 32,
"mimeType": "image/jpeg",
"height": 32
},
"detail": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2017/01/Laufer-holding-Epi-Pencil.-Photo-credit-Four-Thieves-Vinegar-Collective-2016-150x150.jpg",
"width": 150,
"mimeType": "image/jpeg",
"height": 150
},
"medium_large": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2017/01/Laufer-holding-Epi-Pencil.-Photo-credit-Four-Thieves-Vinegar-Collective-2016-768x512.jpg",
"width": 768,
"mimeType": "image/jpeg",
"height": 512
},
"guest-author-128": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2017/01/Laufer-holding-Epi-Pencil.-Photo-credit-Four-Thieves-Vinegar-Collective-2016-128x128.jpg",
"width": 128,
"mimeType": "image/jpeg",
"height": 128
},
"xxsmall": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2017/01/Laufer-holding-Epi-Pencil.-Photo-credit-Four-Thieves-Vinegar-Collective-2016-240x160.jpg",
"width": 240,
"mimeType": "image/jpeg",
"height": 160
}
},
"publishDate": 1484962141,
"modified": 1484962191,
"caption": "Michael Laufer holding his Epi-Pencil.",
"description": "Michael Laufer holding his Epi-Pencil.",
"title": "Laufer holding Epi-Pencil. Photo credit Four Thieves Vinegar Collective 2016",
"credit": "Four Thieves Vinegar Collective",
"status": "inherit",
"isLoading": false,
"fetchFailed": false
},
"futureofyou_188656": {
"type": "attachments",
"id": "futureofyou_188656",
"meta": {
"index": "attachments_1716263798",
"site": "futureofyou",
"id": "188656",
"found": true
},
"parent": 187778,
"imgSizes": {
"twentyfourteen-full-width": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2016/06/StemCells-1038x576.jpg",
"width": 1038,
"mimeType": "image/jpeg",
"height": 576
},
"thumbnail": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2016/06/StemCells-400x267.jpg",
"width": 400,
"mimeType": "image/jpeg",
"height": 267
},
"fd-sm": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2016/06/StemCells-960x641.jpg",
"width": 960,
"mimeType": "image/jpeg",
"height": 641
},
"post-thumbnail": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2016/06/StemCells-672x372.jpg",
"width": 672,
"mimeType": "image/jpeg",
"height": 372
},
"kqedFullSize": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2016/06/StemCells-e1466538458286.jpg",
"width": 1920,
"height": 1282
},
"large": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2016/06/StemCells-1180x788.jpg",
"width": 1180,
"mimeType": "image/jpeg",
"height": 788
},
"guest-author-50": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2016/06/StemCells-50x50.jpg",
"width": 50,
"mimeType": "image/jpeg",
"height": 50
},
"guest-author-96": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2016/06/StemCells-96x96.jpg",
"width": 96,
"mimeType": "image/jpeg",
"height": 96
},
"medium": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2016/06/StemCells-800x534.jpg",
"width": 800,
"mimeType": "image/jpeg",
"height": 534
},
"guest-author-64": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2016/06/StemCells-64x64.jpg",
"width": 64,
"mimeType": "image/jpeg",
"height": 64
},
"guest-author-32": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2016/06/StemCells-32x32.jpg",
"width": 32,
"mimeType": "image/jpeg",
"height": 32
},
"fd-lrg": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2016/06/StemCells-1920x1282.jpg",
"width": 1920,
"mimeType": "image/jpeg",
"height": 1282
},
"fd-med": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2016/06/StemCells-1180x788.jpg",
"width": 1180,
"mimeType": "image/jpeg",
"height": 788
},
"detail": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2016/06/StemCells-150x150.jpg",
"width": 150,
"mimeType": "image/jpeg",
"height": 150
},
"medium_large": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2016/06/StemCells-768x513.jpg",
"width": 768,
"mimeType": "image/jpeg",
"height": 513
},
"guest-author-128": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2016/06/StemCells-128x128.jpg",
"width": 128,
"mimeType": "image/jpeg",
"height": 128
}
},
"publishDate": 1466538329,
"modified": 1515539971,
"caption": "Buttons with the slogan 'Save Lives With Stem Cells,' in support of Prop. 71 at the Stem Cell Research Proposition Party at the Biltmore Hotel Nov. 2, 2004 in Los Angeles, California.",
"description": "Buttons with the slogan 'Save Lives With Stem Cells,' in support of Prop. 71 at the Stem Cell Research Proposition Party at the Biltmore Hotel Nov. 2, 2004 in Los Angeles, California.",
"title": "Stem Cell Research Proposition Party",
"credit": "Frazer Harrison/Getty Images",
"status": "inherit",
"isLoading": false,
"fetchFailed": false
},
"science_1338618": {
"type": "attachments",
"id": "science_1338618",
"meta": {
"index": "attachments_1716263798",
"site": "science",
"id": "1338618",
"found": true
},
"parent": 1338482,
"imgSizes": {
"small": {
"file": "https://ww2.kqed.org/app/uploads/sites/35/2017/01/Screen-Shot-2017-01-20-at-12.55.05-PM-520x254.png",
"width": 520,
"mimeType": "image/png",
"height": 254
},
"thumbnail": {
"file": "https://ww2.kqed.org/app/uploads/sites/35/2017/01/Screen-Shot-2017-01-20-at-12.55.05-PM-160x78.png",
"width": 160,
"mimeType": "image/png",
"height": 78
},
"xsmall": {
"file": "https://ww2.kqed.org/app/uploads/sites/35/2017/01/Screen-Shot-2017-01-20-at-12.55.05-PM-375x183.png",
"width": 375,
"mimeType": "image/png",
"height": 183
},
"kqedFullSize": {
"file": "https://ww2.kqed.org/app/uploads/sites/35/2017/01/Screen-Shot-2017-01-20-at-12.55.05-PM.png",
"width": 648,
"height": 317
},
"guest-author-50": {
"file": "https://ww2.kqed.org/app/uploads/sites/35/2017/01/Screen-Shot-2017-01-20-at-12.55.05-PM-50x50.png",
"width": 50,
"mimeType": "image/png",
"height": 50
},
"guest-author-96": {
"file": "https://ww2.kqed.org/app/uploads/sites/35/2017/01/Screen-Shot-2017-01-20-at-12.55.05-PM-96x96.png",
"width": 96,
"mimeType": "image/png",
"height": 96
},
"guest-author-64": {
"file": "https://ww2.kqed.org/app/uploads/sites/35/2017/01/Screen-Shot-2017-01-20-at-12.55.05-PM-64x64.png",
"width": 64,
"mimeType": "image/png",
"height": 64
},
"detail": {
"file": "https://ww2.kqed.org/app/uploads/sites/35/2017/01/Screen-Shot-2017-01-20-at-12.55.05-PM-150x150.png",
"width": 150,
"mimeType": "image/png",
"height": 150
},
"guest-author-32": {
"file": "https://ww2.kqed.org/app/uploads/sites/35/2017/01/Screen-Shot-2017-01-20-at-12.55.05-PM-32x32.png",
"width": 32,
"mimeType": "image/png",
"height": 32
},
"guest-author-128": {
"file": "https://ww2.kqed.org/app/uploads/sites/35/2017/01/Screen-Shot-2017-01-20-at-12.55.05-PM-128x128.png",
"width": 128,
"mimeType": "image/png",
"height": 128
},
"xxsmall": {
"file": "https://ww2.kqed.org/app/uploads/sites/35/2017/01/Screen-Shot-2017-01-20-at-12.55.05-PM-240x117.png",
"width": 240,
"mimeType": "image/png",
"height": 117
}
},
"publishDate": 1484945736,
"modified": 1484945750,
"caption": "Website accessed at 12:40 p.m. PST, Jan. 20, 2017.",
"description": null,
"title": "Screen Shot 2017-01-20 at 12.55.05 PM",
"credit": null,
"status": "inherit",
"isLoading": false,
"fetchFailed": false
},
"news_11277001": {
"type": "attachments",
"id": "news_11277001",
"meta": {
"index": "attachments_1716263798",
"site": "news",
"id": "11277001",
"found": true
},
"parent": 11276919,
"imgSizes": {
"small": {
"file": "https://ww2.kqed.org/app/uploads/sites/10/2017/01/GettyImages-629845080-520x347.jpg",
"width": 520,
"mimeType": "image/jpeg",
"height": 347
},
"twentyfourteen-full-width": {
"file": "https://ww2.kqed.org/app/uploads/sites/10/2017/01/GettyImages-629845080-1038x576.jpg",
"width": 1038,
"mimeType": "image/jpeg",
"height": 576
},
"thumbnail": {
"file": "https://ww2.kqed.org/app/uploads/sites/10/2017/01/GettyImages-629845080-160x107.jpg",
"width": 160,
"mimeType": "image/jpeg",
"height": 107
},
"fd-sm": {
"file": "https://ww2.kqed.org/app/uploads/sites/10/2017/01/GettyImages-629845080-960x640.jpg",
"width": 960,
"mimeType": "image/jpeg",
"height": 640
},
"post-thumbnail": {
"file": "https://ww2.kqed.org/app/uploads/sites/10/2017/01/GettyImages-629845080-672x372.jpg",
"width": 672,
"mimeType": "image/jpeg",
"height": 372
},
"xsmall": {
"file": "https://ww2.kqed.org/app/uploads/sites/10/2017/01/GettyImages-629845080-375x250.jpg",
"width": 375,
"mimeType": "image/jpeg",
"height": 250
},
"kqedFullSize": {
"file": "https://ww2.kqed.org/app/uploads/sites/10/2017/01/GettyImages-629845080.jpg",
"width": 4529,
"height": 3019
},
"large": {
"file": "https://ww2.kqed.org/app/uploads/sites/10/2017/01/GettyImages-629845080-1020x680.jpg",
"width": 1020,
"mimeType": "image/jpeg",
"height": 680
},
"xlarge": {
"file": "https://ww2.kqed.org/app/uploads/sites/10/2017/01/GettyImages-629845080-1180x787.jpg",
"width": 1180,
"mimeType": "image/jpeg",
"height": 787
},
"guest-author-50": {
"file": "https://ww2.kqed.org/app/uploads/sites/10/2017/01/GettyImages-629845080-50x50.jpg",
"width": 50,
"mimeType": "image/jpeg",
"height": 50
},
"guest-author-96": {
"file": "https://ww2.kqed.org/app/uploads/sites/10/2017/01/GettyImages-629845080-96x96.jpg",
"width": 96,
"mimeType": "image/jpeg",
"height": 96
},
"medium": {
"file": "https://ww2.kqed.org/app/uploads/sites/10/2017/01/GettyImages-629845080-800x533.jpg",
"width": 800,
"mimeType": "image/jpeg",
"height": 533
},
"guest-author-64": {
"file": "https://ww2.kqed.org/app/uploads/sites/10/2017/01/GettyImages-629845080-64x64.jpg",
"width": 64,
"mimeType": "image/jpeg",
"height": 64
},
"guest-author-32": {
"file": "https://ww2.kqed.org/app/uploads/sites/10/2017/01/GettyImages-629845080-32x32.jpg",
"width": 32,
"mimeType": "image/jpeg",
"height": 32
},
"jmtc-small-thumb": {
"file": "https://ww2.kqed.org/app/uploads/sites/10/2017/01/GettyImages-629845080-280x150.jpg",
"width": 280,
"mimeType": "image/jpeg",
"height": 150
},
"fd-lrg": {
"file": "https://ww2.kqed.org/app/uploads/sites/10/2017/01/GettyImages-629845080-1920x1280.jpg",
"width": 1920,
"mimeType": "image/jpeg",
"height": 1280
},
"fd-med": {
"file": "https://ww2.kqed.org/app/uploads/sites/10/2017/01/GettyImages-629845080-1180x787.jpg",
"width": 1180,
"mimeType": "image/jpeg",
"height": 787
},
"full-width": {
"file": "https://ww2.kqed.org/app/uploads/sites/10/2017/01/GettyImages-629845080-1920x1280.jpg",
"width": 1920,
"mimeType": "image/jpeg",
"height": 1280
},
"detail": {
"file": "https://ww2.kqed.org/app/uploads/sites/10/2017/01/GettyImages-629845080-150x150.jpg",
"width": 150,
"mimeType": "image/jpeg",
"height": 150
},
"guest-author-128": {
"file": "https://ww2.kqed.org/app/uploads/sites/10/2017/01/GettyImages-629845080-128x128.jpg",
"width": 128,
"mimeType": "image/jpeg",
"height": 128
},
"xxsmall": {
"file": "https://ww2.kqed.org/app/uploads/sites/10/2017/01/GettyImages-629845080-240x160.jpg",
"width": 240,
"mimeType": "image/jpeg",
"height": 160
}
},
"publishDate": 1484851163,
"modified": 1484873132,
"caption": "Tech industry leaders meet with President-elect Donald Trump at Trump Tower. Like the industry at large, the group is mostly white and male. ",
"description": null,
"title": "Trump Holds Summit With Technology Industry Leaders",
"credit": "Drew Angerer/Getty Images",
"status": "inherit",
"isLoading": false,
"fetchFailed": false
},
"news_11276988": {
"type": "attachments",
"id": "news_11276988",
"meta": {
"index": "attachments_1716263798",
"site": "news",
"id": "11276988",
"found": true
},
"parent": 11275664,
"imgSizes": {
"small": {
"file": "https://ww2.kqed.org/app/uploads/sites/10/2017/01/DSC01590-520x347.jpg",
"width": 520,
"mimeType": "image/jpeg",
"height": 347
},
"twentyfourteen-full-width": {
"file": "https://ww2.kqed.org/app/uploads/sites/10/2017/01/DSC01590-1038x576.jpg",
"width": 1038,
"mimeType": "image/jpeg",
"height": 576
},
"thumbnail": {
"file": "https://ww2.kqed.org/app/uploads/sites/10/2017/01/DSC01590-160x107.jpg",
"width": 160,
"mimeType": "image/jpeg",
"height": 107
},
"fd-sm": {
"file": "https://ww2.kqed.org/app/uploads/sites/10/2017/01/DSC01590-960x640.jpg",
"width": 960,
"mimeType": "image/jpeg",
"height": 640
},
"post-thumbnail": {
"file": "https://ww2.kqed.org/app/uploads/sites/10/2017/01/DSC01590-672x372.jpg",
"width": 672,
"mimeType": "image/jpeg",
"height": 372
},
"xsmall": {
"file": "https://ww2.kqed.org/app/uploads/sites/10/2017/01/DSC01590-375x250.jpg",
"width": 375,
"mimeType": "image/jpeg",
"height": 250
},
"kqedFullSize": {
"file": "https://ww2.kqed.org/app/uploads/sites/10/2017/01/DSC01590-e1484858500295.jpg",
"width": 1920,
"height": 1280
},
"large": {
"file": "https://ww2.kqed.org/app/uploads/sites/10/2017/01/DSC01590-1020x680.jpg",
"width": 1020,
"mimeType": "image/jpeg",
"height": 680
},
"xlarge": {
"file": "https://ww2.kqed.org/app/uploads/sites/10/2017/01/DSC01590-1180x787.jpg",
"width": 1180,
"mimeType": "image/jpeg",
"height": 787
},
"guest-author-50": {
"file": "https://ww2.kqed.org/app/uploads/sites/10/2017/01/DSC01590-50x50.jpg",
"width": 50,
"mimeType": "image/jpeg",
"height": 50
},
"guest-author-96": {
"file": "https://ww2.kqed.org/app/uploads/sites/10/2017/01/DSC01590-96x96.jpg",
"width": 96,
"mimeType": "image/jpeg",
"height": 96
},
"medium": {
"file": "https://ww2.kqed.org/app/uploads/sites/10/2017/01/DSC01590-800x534.jpg",
"width": 800,
"mimeType": "image/jpeg",
"height": 534
},
"guest-author-64": {
"file": "https://ww2.kqed.org/app/uploads/sites/10/2017/01/DSC01590-64x64.jpg",
"width": 64,
"mimeType": "image/jpeg",
"height": 64
},
"guest-author-32": {
"file": "https://ww2.kqed.org/app/uploads/sites/10/2017/01/DSC01590-32x32.jpg",
"width": 32,
"mimeType": "image/jpeg",
"height": 32
},
"jmtc-small-thumb": {
"file": "https://ww2.kqed.org/app/uploads/sites/10/2017/01/DSC01590-280x150.jpg",
"width": 280,
"mimeType": "image/jpeg",
"height": 150
},
"fd-lrg": {
"file": "https://ww2.kqed.org/app/uploads/sites/10/2017/01/DSC01590-1920x1280.jpg",
"width": 1920,
"mimeType": "image/jpeg",
"height": 1280
},
"fd-med": {
"file": "https://ww2.kqed.org/app/uploads/sites/10/2017/01/DSC01590-1180x787.jpg",
"width": 1180,
"mimeType": "image/jpeg",
"height": 787
},
"full-width": {
"file": "https://ww2.kqed.org/app/uploads/sites/10/2017/01/DSC01590-1920x1280.jpg",
"width": 1920,
"mimeType": "image/jpeg",
"height": 1280
},
"detail": {
"file": "https://ww2.kqed.org/app/uploads/sites/10/2017/01/DSC01590-150x150.jpg",
"width": 150,
"mimeType": "image/jpeg",
"height": 150
},
"guest-author-128": {
"file": "https://ww2.kqed.org/app/uploads/sites/10/2017/01/DSC01590-128x128.jpg",
"width": 128,
"mimeType": "image/jpeg",
"height": 128
},
"xxsmall": {
"file": "https://ww2.kqed.org/app/uploads/sites/10/2017/01/DSC01590-240x160.jpg",
"width": 240,
"mimeType": "image/jpeg",
"height": 160
}
},
"publishDate": 1484849292,
"modified": 1484858572,
"caption": "Bluegogo says it will place its bikes in locations where it's legal to park a bicycle.",
"description": null,
"title": "Bluegogo Bike Share",
"credit": "Bluegogo ",
"status": "inherit",
"isLoading": false,
"fetchFailed": false
},
"futureofyou_319194": {
"type": "attachments",
"id": "futureofyou_319194",
"meta": {
"index": "attachments_1716263798",
"site": "futureofyou",
"id": "319194",
"found": true
},
"parent": 319192,
"imgSizes": {
"small": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2017/01/wearable-520x346.jpg",
"width": 520,
"mimeType": "image/jpeg",
"height": 346
},
"thumbnail": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2017/01/wearable-160x107.jpg",
"width": 160,
"mimeType": "image/jpeg",
"height": 107
},
"post-thumbnail": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2017/01/wearable-620x372.jpg",
"width": 620,
"mimeType": "image/jpeg",
"height": 372
},
"xsmall": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2017/01/wearable-375x250.jpg",
"width": 375,
"mimeType": "image/jpeg",
"height": 250
},
"kqedFullSize": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2017/01/wearable.jpg",
"width": 620,
"height": 413
},
"guest-author-50": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2017/01/wearable-50x50.jpg",
"width": 50,
"mimeType": "image/jpeg",
"height": 50
},
"guest-author-96": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2017/01/wearable-96x96.jpg",
"width": 96,
"mimeType": "image/jpeg",
"height": 96
},
"guest-author-64": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2017/01/wearable-64x64.jpg",
"width": 64,
"mimeType": "image/jpeg",
"height": 64
},
"detail": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2017/01/wearable-150x150.jpg",
"width": 150,
"mimeType": "image/jpeg",
"height": 150
},
"guest-author-32": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2017/01/wearable-32x32.jpg",
"width": 32,
"mimeType": "image/jpeg",
"height": 32
},
"guest-author-128": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2017/01/wearable-128x128.jpg",
"width": 128,
"mimeType": "image/jpeg",
"height": 128
},
"xxsmall": {
"file": "https://ww2.kqed.org/app/uploads/sites/13/2017/01/wearable-240x160.jpg",
"width": 240,
"mimeType": "image/jpeg",
"height": 160
}
},
"publishDate": 1484328187,
"modified": 1484328205,
"caption": "Geneticist Michael Snyder was wearing seven biosensors collecting data about his health when he noticed changes in his heart rate and oxygen level during a flight. When he later developed a fever, he suspected he had been infected with Lyme disease. Subsequent tests confirmed his suspicion.",
"description": null,
"title": "wearable",
"credit": "Steve Fisch/Stanford",
"status": "inherit",
"isLoading": false,
"fetchFailed": false
},
"news_11263475": {
"type": "attachments",
"id": "news_11263475",
"meta": {
"index": "attachments_1716263798",
"site": "news",
"id": "11263475",
"found": true
},
"parent": 11263472,
"imgSizes": {
"small": {
"file": "https://ww2.kqed.org/app/uploads/sites/10/2017/01/Yahoo-520x349.jpg",
"width": 520,
"mimeType": "image/jpeg",
"height": 349
},
"twentyfourteen-full-width": {
"file": "https://ww2.kqed.org/app/uploads/sites/10/2017/01/Yahoo-1038x576.jpg",
"width": 1038,
"mimeType": "image/jpeg",
"height": 576
},
"thumbnail": {
"file": "https://ww2.kqed.org/app/uploads/sites/10/2017/01/Yahoo-160x108.jpg",
"width": 160,
"mimeType": "image/jpeg",
"height": 108
},
"fd-sm": {
"file": "https://ww2.kqed.org/app/uploads/sites/10/2017/01/Yahoo-960x645.jpg",
"width": 960,
"mimeType": "image/jpeg",
"height": 645
},
"post-thumbnail": {
"file": "https://ww2.kqed.org/app/uploads/sites/10/2017/01/Yahoo-672x372.jpg",
"width": 672,
"mimeType": "image/jpeg",
"height": 372
},
"xsmall": {
"file": "https://ww2.kqed.org/app/uploads/sites/10/2017/01/Yahoo-375x252.jpg",
"width": 375,
"mimeType": "image/jpeg",
"height": 252
},
"kqedFullSize": {
"file": "https://ww2.kqed.org/app/uploads/sites/10/2017/01/Yahoo.jpg",
"width": 1920,
"height": 1290
},
"large": {
"file": "https://ww2.kqed.org/app/uploads/sites/10/2017/01/Yahoo-1020x685.jpg",
"width": 1020,
"mimeType": "image/jpeg",
"height": 685
},
"xlarge": {
"file": "https://ww2.kqed.org/app/uploads/sites/10/2017/01/Yahoo-1180x793.jpg",
"width": 1180,
"mimeType": "image/jpeg",
"height": 793
},
"guest-author-50": {
"file": "https://ww2.kqed.org/app/uploads/sites/10/2017/01/Yahoo-50x50.jpg",
"width": 50,
"mimeType": "image/jpeg",
"height": 50
},
"guest-author-96": {
"file": "https://ww2.kqed.org/app/uploads/sites/10/2017/01/Yahoo-96x96.jpg",
"width": 96,
"mimeType": "image/jpeg",
"height": 96
},
"medium": {
"file": "https://ww2.kqed.org/app/uploads/sites/10/2017/01/Yahoo-800x538.jpg",
"width": 800,
"mimeType": "image/jpeg",
"height": 538
},
"guest-author-64": {
"file": "https://ww2.kqed.org/app/uploads/sites/10/2017/01/Yahoo-64x64.jpg",
"width": 64,
"mimeType": "image/jpeg",
"height": 64
},
"guest-author-32": {
"file": "https://ww2.kqed.org/app/uploads/sites/10/2017/01/Yahoo-32x32.jpg",
"width": 32,
"mimeType": "image/jpeg",
"height": 32
},
"jmtc-small-thumb": {
"file": "https://ww2.kqed.org/app/uploads/sites/10/2017/01/Yahoo-280x150.jpg",
"width": 280,
"mimeType": "image/jpeg",
"height": 150
},
"fd-lrg": {
"file": "https://ww2.kqed.org/app/uploads/sites/10/2017/01/Yahoo-1920x1290.jpg",
"width": 1920,
"mimeType": "image/jpeg",
"height": 1290
},
"fd-med": {
"file": "https://ww2.kqed.org/app/uploads/sites/10/2017/01/Yahoo-1180x793.jpg",
"width": 1180,
"mimeType": "image/jpeg",
"height": 793
},
"full-width": {
"file": "https://ww2.kqed.org/app/uploads/sites/10/2017/01/Yahoo-1920x1290.jpg",
"width": 1920,
"mimeType": "image/jpeg",
"height": 1290
},
"detail": {
"file": "https://ww2.kqed.org/app/uploads/sites/10/2017/01/Yahoo-150x150.jpg",
"width": 150,
"mimeType": "image/jpeg",
"height": 150
},
"guest-author-128": {
"file": "https://ww2.kqed.org/app/uploads/sites/10/2017/01/Yahoo-128x128.jpg",
"width": 128,
"mimeType": "image/jpeg",
"height": 128
},
"xxsmall": {
"file": "https://ww2.kqed.org/app/uploads/sites/10/2017/01/Yahoo-240x161.jpg",
"width": 240,
"mimeType": "image/jpeg",
"height": 161
}
},
"publishDate": 1484075642,
"modified": 1484075722,
"caption": "Yahoo's headquarters in Sunnyvale.",
"description": "The Yahoo logo outside Yahoo headquarters in Sunnyvale.",
"title": "yahoo",
"credit": "Justin Sullivan/Getty Images",
"status": "inherit",
"isLoading": false,
"fetchFailed": false
},
"news_11257448": {
"type": "attachments",
"id": "news_11257448",
"meta": {
"index": "attachments_1716263798",
"site": "news",
"id": "11257448",
"found": true
},
"parent": 11257442,
"imgSizes": {
"small": {
"file": "https://ww2.kqed.org/app/uploads/sites/10/2017/01/PootPoot-520x365.jpg",
"width": 520,
"mimeType": "image/jpeg",
"height": 365
},
"twentyfourteen-full-width": {
"file": "https://ww2.kqed.org/app/uploads/sites/10/2017/01/PootPoot-1038x576.jpg",
"width": 1038,
"mimeType": "image/jpeg",
"height": 576
},
"thumbnail": {
"file": "https://ww2.kqed.org/app/uploads/sites/10/2017/01/PootPoot-160x112.jpg",
"width": 160,
"mimeType": "image/jpeg",
"height": 112
},
"fd-sm": {
"file": "https://ww2.kqed.org/app/uploads/sites/10/2017/01/PootPoot-960x674.jpg",
"width": 960,
"mimeType": "image/jpeg",
"height": 674
},
"post-thumbnail": {
"file": "https://ww2.kqed.org/app/uploads/sites/10/2017/01/PootPoot-672x372.jpg",
"width": 672,
"mimeType": "image/jpeg",
"height": 372
},
"xsmall": {
"file": "https://ww2.kqed.org/app/uploads/sites/10/2017/01/PootPoot-375x263.jpg",
"width": 375,
"mimeType": "image/jpeg",
"height": 263
},
"kqedFullSize": {
"file": "https://ww2.kqed.org/app/uploads/sites/10/2017/01/PootPoot.jpg",
"width": 1920,
"height": 1348
},
"large": {
"file": "https://ww2.kqed.org/app/uploads/sites/10/2017/01/PootPoot-1020x716.jpg",
"width": 1020,
"mimeType": "image/jpeg",
"height": 716
},
"xlarge": {
"file": "https://ww2.kqed.org/app/uploads/sites/10/2017/01/PootPoot-1180x828.jpg",
"width": 1180,
"mimeType": "image/jpeg",
"height": 828
},
"guest-author-50": {
"file": "https://ww2.kqed.org/app/uploads/sites/10/2017/01/PootPoot-50x50.jpg",
"width": 50,
"mimeType": "image/jpeg",
"height": 50
},
"guest-author-96": {
"file": "https://ww2.kqed.org/app/uploads/sites/10/2017/01/PootPoot-96x96.jpg",
"width": 96,
"mimeType": "image/jpeg",
"height": 96
},
"medium": {
"file": "https://ww2.kqed.org/app/uploads/sites/10/2017/01/PootPoot-800x562.jpg",
"width": 800,
"mimeType": "image/jpeg",
"height": 562
},
"guest-author-64": {
"file": "https://ww2.kqed.org/app/uploads/sites/10/2017/01/PootPoot-64x64.jpg",
"width": 64,
"mimeType": "image/jpeg",
"height": 64
},
"guest-author-32": {
"file": "https://ww2.kqed.org/app/uploads/sites/10/2017/01/PootPoot-32x32.jpg",
"width": 32,
"mimeType": "image/jpeg",
"height": 32
},
"jmtc-small-thumb": {
"file": "https://ww2.kqed.org/app/uploads/sites/10/2017/01/PootPoot-280x150.jpg",
"width": 280,
"mimeType": "image/jpeg",
"height": 150
},
"fd-lrg": {
"file": "https://ww2.kqed.org/app/uploads/sites/10/2017/01/PootPoot-1920x1348.jpg",
"width": 1920,
"mimeType": "image/jpeg",
"height": 1348
},
"fd-med": {
"file": "https://ww2.kqed.org/app/uploads/sites/10/2017/01/PootPoot-1180x828.jpg",
"width": 1180,
"mimeType": "image/jpeg",
"height": 828
},
"full-width": {
"file": "https://ww2.kqed.org/app/uploads/sites/10/2017/01/PootPoot-1920x1348.jpg",
"width": 1920,
"mimeType": "image/jpeg",
"height": 1348
},
"detail": {
"file": "https://ww2.kqed.org/app/uploads/sites/10/2017/01/PootPoot-150x150.jpg",
"width": 150,
"mimeType": "image/jpeg",
"height": 150
},
"guest-author-128": {
"file": "https://ww2.kqed.org/app/uploads/sites/10/2017/01/PootPoot-128x128.jpg",
"width": 128,
"mimeType": "image/jpeg",
"height": 128
},
"xxsmall": {
"file": "https://ww2.kqed.org/app/uploads/sites/10/2017/01/PootPoot-240x169.jpg",
"width": 240,
"mimeType": "image/jpeg",
"height": 169
}
},
"publishDate": 1483748357,
"modified": 1483748397,
"caption": "Russian President Vladimir Putin makes his New Year's address to the nation in Moscow's Kremlin, December 31, 2016.",
"description": "Russian President Vladimir Putin makes his New Year's address to the nation in Moscow's Kremlin, December 31, 2016.",
"title": "pootpoot",
"credit": "MIKHAIL KLIMENTIEV/AFP/Getty Images",
"status": "inherit",
"isLoading": false,
"fetchFailed": false
}
},
"audioPlayerReducer": {
"postId": "stream_live",
"isPaused": true,
"isPlaying": false,
"pfsActive": false,
"pledgeModalIsOpen": true,
"playerDrawerIsOpen": false,
"liveAudioPlayStartedAt": 0,
"liveAudioPlayContext": ""
},
"authorsReducer": {
"byline_news_11291235": {
"type": "authors",
"id": "byline_news_11291235",
"meta": {
"override": true
},
"slug": "byline_news_11291235",
"name": "\u003cstrong>Mae Anderson\u003cbr />Associated Press\u003c/strong>",
"isLoading": false
},
"byline_futureofyou_323092": {
"type": "authors",
"id": "byline_futureofyou_323092",
"meta": {
"override": true
},
"slug": "byline_futureofyou_323092",
"name": "Anne-christine d'Adesky",
"isLoading": false
},
"byline_futureofyou_322634": {
"type": "authors",
"id": "byline_futureofyou_322634",
"meta": {
"override": true
},
"slug": "byline_futureofyou_322634",
"name": "Charles Piller\u003cbr />\u003cA HREF=\"https://www.statnews.com/\">STAT\u003c/A>",
"isLoading": false
},
"byline_futureofyou_319192": {
"type": "authors",
"id": "byline_futureofyou_319192",
"meta": {
"override": true
},
"slug": "byline_futureofyou_319192",
"name": "Lauran Neergard\u003cbr />Associated Press",
"isLoading": false
},
"byline_news_11263472": {
"type": "authors",
"id": "byline_news_11263472",
"meta": {
"override": true
},
"slug": "byline_news_11263472",
"name": "Rebecca Hersher",
"isLoading": false
},
"byline_news_11257442": {
"type": "authors",
"id": "byline_news_11257442",
"meta": {
"override": true
},
"slug": "byline_news_11257442",
"name": "Merrit Kennedy",
"isLoading": false
},
"jbrooks": {
"type": "authors",
"id": "80",
"meta": {
"index": "authors_1716337520",
"id": "80",
"found": true
},
"name": "Jon Brooks",
"firstName": "Jon",
"lastName": "Brooks",
"slug": "jbrooks",
"email": "jbrooks@kqed.org",
"display_author_email": true,
"staff_mastheads": [
"science"
],
"title": "Digital Editor",
"bio": "Jon Brooks is a former Digital Editor for KQED Science. He is the former editor of KQED’s daily news blog, News Fix. In 2014, he won a California Journalism Award for his coverage of ride services like Uber and Lyft and the taxi industry. A veteran blogger, he previously worked for Yahoo! in various news writing and editing roles. Jon is also a playwright whose work has been produced in San Francisco, New York, Italy, and around the U.S. He has written about film for his own blog and studied film at Boston University.",
"avatar": "https://secure.gravatar.com/avatar/98887f7ed1c876ed414d4c915e969584?s=600&d=blank&r=g",
"twitter": "jbrooksfoy",
"facebook": null,
"instagram": null,
"linkedin": null,
"sites": [
{
"site": "arts",
"roles": [
"Contributor",
"editor"
]
},
{
"site": "news",
"roles": [
"author"
]
},
{
"site": "futureofyou",
"roles": [
"administrator"
]
},
{
"site": "mindshift",
"roles": [
"editor"
]
},
{
"site": "stateofhealth",
"roles": [
"editor"
]
},
{
"site": "science",
"roles": [
"administrator"
]
},
{
"site": "quest",
"roles": [
"editor"
]
}
],
"headData": {
"title": "Jon Brooks | KQED",
"description": "Digital Editor",
"ogImgSrc": "https://secure.gravatar.com/avatar/98887f7ed1c876ed414d4c915e969584?s=600&d=blank&r=g",
"twImgSrc": "https://secure.gravatar.com/avatar/98887f7ed1c876ed414d4c915e969584?s=600&d=blank&r=g"
},
"isLoading": false,
"link": "/author/jbrooks"
},
"lisapickoffwhite-2": {
"type": "authors",
"id": "199",
"meta": {
"index": "authors_1716337520",
"id": "199",
"found": true
},
"name": "Lisa Pickoff-White",
"firstName": "Lisa",
"lastName": "Pickoff-White",
"slug": "lisapickoffwhite-2",
"email": "lpickoffwhite@kqed.org",
"display_author_email": false,
"staff_mastheads": [
"news"
],
"title": "Data Journalist, Senior Producer",
"bio": "Lisa Pickoff-White is KQED's data reporter. Lisa specializes in simplifying complex topics and bringing them to life through compelling visuals, including photography and data visualizations. She previously has worked at the Center for Investigative Reporting and other national outlets. Her work has been honored with awards from the Online News Association, Investigative Reporters and Editors, the Society of Professional Journalists and SXSW Interactive. \u003cstrong> \u003c/strong>",
"avatar": "https://secure.gravatar.com/avatar/5513c5f3967df792aa65bee2501e84d6?s=600&d=blank&r=g",
"twitter": "pickoffwhite",
"facebook": null,
"instagram": null,
"linkedin": null,
"sites": [
{
"site": "",
"roles": [
"editor"
]
},
{
"site": "arts",
"roles": []
},
{
"site": "news",
"roles": [
"administrator"
]
},
{
"site": "about",
"roles": [
"editor"
]
},
{
"site": "stateofhealth",
"roles": [
"administrator"
]
},
{
"site": "science",
"roles": [
"editor"
]
},
{
"site": "quest",
"roles": [
"editor"
]
},
{
"site": "forum",
"roles": [
"editor"
]
}
],
"headData": {
"title": "Lisa Pickoff-White | KQED",
"description": "Data Journalist, Senior Producer",
"ogImgSrc": "https://secure.gravatar.com/avatar/5513c5f3967df792aa65bee2501e84d6?s=600&d=blank&r=g",
"twImgSrc": "https://secure.gravatar.com/avatar/5513c5f3967df792aa65bee2501e84d6?s=600&d=blank&r=g"
},
"isLoading": false,
"link": "/author/lisapickoffwhite-2"
},
"bgoebel": {
"type": "authors",
"id": "214",
"meta": {
"index": "authors_1716337520",
"id": "214",
"found": true
},
"name": "Bryan Goebel",
"firstName": "Bryan",
"lastName": "Goebel",
"slug": "bgoebel",
"email": "bgoebel@kqed.org",
"display_author_email": false,
"staff_mastheads": [],
"title": null,
"bio": "Bryan Goebel is a reporter focused on transportation and housing issues. He was previously the editor of Streetsblog San Francisco, and an anchor/editor at KCBS Radio. He's a lifelong Californian and has also worked at radio stations in Barstow, Redding and Sacramento.",
"avatar": "https://secure.gravatar.com/avatar/7fdd6b065bfe9a23a71bcfa80848df88?s=600&d=blank&r=g",
"twitter": "velobry",
"facebook": null,
"instagram": null,
"linkedin": null,
"sites": [
{
"site": "news",
"roles": [
"subscriber"
]
},
{
"site": "stateofhealth",
"roles": [
"subscriber"
]
}
],
"headData": {
"title": "Bryan Goebel | KQED",
"description": null,
"ogImgSrc": "https://secure.gravatar.com/avatar/7fdd6b065bfe9a23a71bcfa80848df88?s=600&d=blank&r=g",
"twImgSrc": "https://secure.gravatar.com/avatar/7fdd6b065bfe9a23a71bcfa80848df88?s=600&d=blank&r=g"
},
"isLoading": false,
"link": "/author/bgoebel"
},
"samharnett": {
"type": "authors",
"id": "253",
"meta": {
"index": "authors_1716337520",
"id": "253",
"found": true
},
"name": "Sam Harnett",
"firstName": "Sam",
"lastName": "Harnett",
"slug": "samharnett",
"email": "samharnett@gmail.com",
"display_author_email": false,
"staff_mastheads": [],
"title": "KQED Contributor",
"bio": "Sam Harnett covered tech and work at KQED. He is the co-creator of \u003cem>\u003ca href=\"http://www.theworldaccordingtosound.org\">The World According to Sound\u003c/a>,\u003c/em> a 90-second podcast that features different sounds and the stories behind them.\r\n\r\nBefore coming to KQED, Sam worked as an independent reporter who contributed regularly to \u003cem>The California Report, Marketplace,\u003c/em> \u003cem>The World \u003c/em>and NPR.",
"avatar": "https://secure.gravatar.com/avatar/2538b972ac02f2b9546c7a6c59a0f3d0?s=600&d=blank&r=g",
"twitter": "Samwharnett",
"facebook": null,
"instagram": null,
"linkedin": null,
"sites": [
{
"site": "news",
"roles": [
"edit_others_posts",
"subscriber"
]
},
{
"site": "stateofhealth",
"roles": [
"author"
]
},
{
"site": "science",
"roles": [
"editor"
]
},
{
"site": "quest",
"roles": [
"subscriber"
]
}
],
"headData": {
"title": "Sam Harnett | KQED",
"description": "KQED Contributor",
"ogImgSrc": "https://secure.gravatar.com/avatar/2538b972ac02f2b9546c7a6c59a0f3d0?s=600&d=blank&r=g",
"twImgSrc": "https://secure.gravatar.com/avatar/2538b972ac02f2b9546c7a6c59a0f3d0?s=600&d=blank&r=g"
},
"isLoading": false,
"link": "/author/samharnett"
},
"lindseyhoshaw": {
"type": "authors",
"id": "5432",
"meta": {
"index": "authors_1716337520",
"id": "5432",
"found": true
},
"name": "Lindsey Hoshaw",
"firstName": "Lindsey",
"lastName": "Hoshaw",
"slug": "lindseyhoshaw",
"email": "lhoshaw@kqed.org",
"display_author_email": false,
"staff_mastheads": [],
"title": "KQED Contributor",
"bio": "Lindsey Hoshaw is a former interactive producer for KQED Science. Before joining KQED, Lindsey was a science correspondent for The New York Times, The Boston Globe, Forbes and Scientific American. On Twitter @lindseyhoshaw",
"avatar": "https://secure.gravatar.com/avatar/274b07694c998eaa8f26cfabaa941186?s=600&d=mm&r=g",
"twitter": "lindseyhoshaw",
"facebook": "lindsey.hoshaw.9",
"instagram": null,
"linkedin": null,
"sites": [
{
"site": "arts",
"roles": [
"author"
]
},
{
"site": "news",
"roles": [
"subscriber"
]
},
{
"site": "futureofyou",
"roles": [
"editor"
]
},
{
"site": "bayareabites",
"roles": [
"contributor"
]
},
{
"site": "stateofhealth",
"roles": [
"author"
]
},
{
"site": "science",
"roles": [
"edit_theme_options",
"subscriber"
]
},
{
"site": "quest",
"roles": [
"edit_post_subscriptions",
"edit_usergroups",
"unfiltered_html",
"unfiltered_upload",
"leadcoordinator",
"editor"
]
},
{
"site": "food",
"roles": []
}
],
"headData": {
"title": "Lindsey Hoshaw | KQED",
"description": "KQED Contributor",
"ogImgSrc": "https://secure.gravatar.com/avatar/274b07694c998eaa8f26cfabaa941186?s=600&d=mm&r=g",
"twImgSrc": "https://secure.gravatar.com/avatar/274b07694c998eaa8f26cfabaa941186?s=600&d=mm&r=g"
},
"isLoading": false,
"link": "/author/lindseyhoshaw"
},
"qkim": {
"type": "authors",
"id": "11099",
"meta": {
"index": "authors_1716337520",
"id": "11099",
"found": true
},
"name": "Queena Sook Kim",
"firstName": "Queena",
"lastName": "Kim",
"slug": "qkim",
"email": "qkim@kqed.org",
"display_author_email": false,
"staff_mastheads": [
"news"
],
"title": "Senior Editor",
"bio": "\u003cspan style=\"font-weight: 400;\">Queena Sook Kim is a former senior editor of the weekend desk at KQED. Before taking on that post, she was the Senior Editor of the Silicon Valley Desk and was the \u003c/span>\u003cspan style=\"font-weight: 400;\">host of The California Report. The daily morning show airs on KQED in San Francisco, one of the nation’s largest NPR affiliates, and on 30 stations across the state. In that role, she produces and reports on news, politics and life in the Golden State. Queena likes to take sideways look at the larger trends changing the state. One of her favorite stories asked\u003c/span>\u003ca href=\"https://ww2.kqed.org/news/2015/02/15/why-the-heck-do-mexican-reporters-on-public-radio-say-their-names-that-way\"> \u003cspan style=\"font-weight: 400;\">why Latino journalists “over’pronounce” their Spanish surnames\u003c/span>\u003c/a>\u003cspan style=\"font-weight: 400;\"> as a way of looking at how immigration is creating a culture shift in California.\u003c/span>\r\n\r\n\u003cspan style=\"font-weight: 400;\">Before joining The California Report, Queena was a \u003ca href=\"http://www.marketplace.org/people/queena-kim\">Senior Reporter covering technology for Marketplace\u003c/a>, the daily business show that airs on public radio. Queena covered daily tech business stories and reported on larger technology trends. She did a series of stories looking at role of social engineering in hacking and on a start-up in Silicon Valley that’s trying to use technology, instead of animals, to make meat that bleeds.\u003c/span>\r\n\r\n\u003cspan style=\"font-weight: 400;\">Queena started her career as a business journalist at the Wall Street Journal, where she spent four years covering the paper, home building and toy industries. She wrote A1 stories about the unusually aggressive tactics KB Home took against its home buyers. and the resurgence of “Cracker” architecture in Florida. She also wrote section front stories on marketing trends and\u003c/span>\r\n\r\n\u003cspan style=\"font-weight: 400;\">As a journalist, Queena has spent much of her career helping start-up editorial products. She was on the founding editorial team of The Bay Citizen, an experimental, online news site in San Francisco that was funded by the late hillbilly billionaire Warren Hellman. In 2009, Queena received a grant from the Corporation of Public Broadcasting to start-up a podcast called \u003ca href=\"https://soundcloud.com/cyberfrequencies\">CyberFrequencies\u003c/a>, which reported on the culture of technology. She also helped start-up two radio shows - Off-Ramp and Pacific Drift - for KPCC, the NPR-affiliate in Los Angeles. Off-Ramp was awarded 1st Place for news and Public Affairs programming by the PRINDI and the L.A. Press club. \u003ca href=\"https://soundcloud.com/queena-sook-kim\">Queena’s stories have appeared \u003c/a>on NPR’s Day to Day, Hearing Voices, WNYC’s Studio 360, WBUR’s Here and Now, BBC’s Global Perspectives and New York Times’ multimedia page.\u003c/span>\r\n\r\n\u003cspan style=\"font-weight: 400;\">In 1994, Queena won a Fulbright Grant to teach and study in Seoul, South Korea. She was also selected to be a Teach For America Corps Member in 1991 and taught elementary school in the Inglewood Unified School District in Southern California.\u003c/span>\r\n\r\n\u003cspan style=\"font-weight: 400;\">Queena is a frequent public speaker and has given talks at UC Berkeley, Stanford University, San Francisco State University, PRINDI conference and the Craigslist Foundation Boot Camp. Queena went to UC Berkeley’s Graduate School of Journalism and graduated cum laude from New York University with a B.A. in Politics. She grew up in Southern California and lives in Berkeley, Ca in a big fixer on which she spends most weekends, well, fixing.\u003c/span>",
"avatar": "https://secure.gravatar.com/avatar/b72382fd0db351b99f8a31939f4853fc?s=600&d=blank&r=g",
"twitter": "queenasookkim",
"facebook": null,
"instagram": null,
"linkedin": null,
"sites": [
{
"site": "news",
"roles": [
"subscriber"
]
},
{
"site": "forum",
"roles": [
"author"
]
},
{
"site": "breakingnews",
"roles": [
"editor"
]
}
],
"headData": {
"title": "Queena Sook Kim | KQED",
"description": "Senior Editor",
"ogImgSrc": "https://secure.gravatar.com/avatar/b72382fd0db351b99f8a31939f4853fc?s=600&d=blank&r=g",
"twImgSrc": "https://secure.gravatar.com/avatar/b72382fd0db351b99f8a31939f4853fc?s=600&d=blank&r=g"
},
"isLoading": false,
"link": "/author/qkim"
}
},
"pagesReducer": {
"news_category_technology": {
"type": "terms",
"id": "news_248",
"meta": {
"index": "terms_1716263798",
"site": "news",
"id": "248",
"score": 10.947765
},
"featImg": null,
"name": "Technology",
"description": null,
"taxonomy": "category",
"headData": {
"twImgId": null,
"twTitle": null,
"ogTitle": null,
"ogImgId": null,
"twDescription": null,
"description": null,
"title": "Technology Archives | KQED News",
"ogDescription": null
},
"ttid": 256,
"slug": "technology",
"isLoading": false,
"title": "Technology",
"pageMeta": {
"site": "news",
"WpPageTemplate": "page-topic-editorial",
"currentPage": 121
},
"blocks": [
{
"blockName": "kqed/post-list",
"attrs": {
"layout": "cardArticle2",
"query": "posts/news?category=technology",
"seeMore": false,
"paginated": true,
"page": 121
}
},
{
"blockName": "kqed/ad"
}
]
}
},
"pfsSessionReducer": {},
"postsReducer": {
"stream_live": {
"type": "live",
"id": "stream_live",
"audioUrl": "https://streams.kqed.org/kqedradio",
"title": "Live Stream",
"excerpt": "Live Stream information currently unavailable.",
"link": "/radio",
"featImg": "",
"label": {
"name": "KQED Live",
"link": "/"
}
},
"stream_kqedNewscast": {
"type": "posts",
"id": "stream_kqedNewscast",
"audioUrl": "https://www.kqed.org/.stream/anon/radio/RDnews/newscast.mp3?_=1",
"title": "KQED Newscast",
"featImg": "",
"label": {
"name": "88.5 FM",
"link": "/"
}
},
"news_11291235": {
"type": "posts",
"id": "news_11291235",
"meta": {
"index": "posts_1716263798",
"site": "news",
"id": "11291235",
"score": null,
"sort": [
1485668747000
]
},
"guestAuthors": [],
"slug": "some-silicon-valley-heavyweights-denounce-trump-order",
"title": "Some Silicon Valley Heavyweights Denounce Trump Order",
"publishDate": 1485668747,
"format": "standard",
"headTitle": "Some Silicon Valley Heavyweights Denounce Trump Order | KQED",
"labelTerm": {
"term": 72,
"site": "news"
},
"content": "\u003cp>\u003cem>Updated 10:35 a.m. Sunday\u003c/em>\u003c/p>\n\u003cp>Google, Apple and other tech giants expressed dismay over Friday’s executive order on immigration from President Trump that bars nationals of seven Muslim-majority countries from entering the United States\u003c/p>\n\u003cp>The U.S tech industry relies on foreign engineers and other technical experts for a sizable percentage of its workforce. The order bars entry to the U.S. for anyone from Iran, Iraq, Libya, Somalia, Sudan, Syria and Yemen for 90 days.\u003c/p>\n\u003caside class=\"pullquote alignright\">‘Trump’s actions are hurting Netflix employees around the world, and are so un-American it pains us all. Worse, these actions will make America less safe (through hatred and loss of allies) rather than more safe.’\u003ccite>Reed Hastings,\u003cbr>Netflix CEO\u003c/cite>\u003c/aside>\n\u003cp>The move, ostensibly intended to prevent extremists from carrying out attacks in the U.S., could now also heighten tensions between the Trump administration and one of the nation’s most economically and culturally important industries. That’s especially true if Trump goes on to revamp the industry’s temporary worker permits known as H-1B visas, as some fear.\u003c/p>\n\u003cp>“I share your concerns” about Trump’s immigration order, Apple CEO Tim Cook wrote in a memo to employees obtained by The Associated Press. “It is not a policy we support.”\u003c/p>\n\u003cp>[ad fullwidth]\u003c/p>\n\u003cp>“We have reached out to the White House to explain the negative effect on our coworkers and our company,” he added.\u003c/p>\n\u003cp>Cook didn’t say how many Apple employees are directly affected by the order, but said the company’s HR, legal and security teams are in contact to support them. \u003c/p>\n\u003cp>“Apple would not exist without immigration, let alone thrive and innovate the way we do,” Cook wrote — an apparent reference not only to the company’s foreign-born employees, but to Apple co-founder Steve Jobs, the son of a Syrian immigrant.\u003c/p>\n\u003cp>Netflix CEO Reed Hastings was forcefully blunt.\u003c/p>\n\u003cp>“Trump’s actions are hurting Netflix employees around the world, and are so un-American it pains us all,” he wrote on Facebook . “Worse, these actions will make America less safe (through hatred and loss of allies) rather than more safe.”\u003c/p>\n\u003cp>“It is time to link arms together to protect American values of freedom and opportunity,” he continued.\u003c/p>\n\u003cp>Facebook founder Mark Zuckerberg criticized the order in similar, though more carefully couched, terms on Friday.\u003c/p>\n\u003cp>On Sunday, Lyft cofounders John Zimmer and Logan Green announced they would donate $1 million to the American Civil Liberties Union over the next four years “to defend our Constitution.”\u003c/p>\n\u003cp>“Banning people of a particular faith or creed, race or identity, sexuality or ethnicity, from entering the U.S. is antithetical to both Lyft’s and our nation’s core values,” Zimmer and Green said in a statement. “We stand firmly against these actions, and will not be silent on issues that threaten the values of our community.”\u003c/p>\n\u003cp>Uber CEO Travis Kalanick, one of 19 corporate leaders chosen to serve as business advisors to Trump, stopped short of criticizing the president’s order. But he noted in \u003ca href=\"https://newsroom.uber.com/standing-up-for-whats-right/\" target=\"_blank\" rel=\"noopener\">a blog post published Saturday\u003c/a> that the travel ban will affect thousands of Uber drivers.\u003c/p>\n\u003cp>“This ban will impact many innocent people,” Kalanick said, “an issue that I will raise this coming Friday when I go to Washington for President Trump’s first business advisory group meeting.” \u003c/p>\n\u003cp>Technology investor Chris Sacca, an early backer of Uber and Instagram, said on Twitter that he would match ACLU donations up to $75,000 after the organization sued over the ban — and then decided to donate another $75,000 , for a total of $150,000. \u003c/p>\n\u003cp>EBay founder Pierre Omidyar, the child of Iranians, complained that the order was “simple bigotry .”\u003c/p>\n\u003cp>Tesla Motors and SpaceX founder Elon Musk, who has recently appeared to be cultivating a relationship with Trump, tweeted that “many people negatively affected by this policy are strong supporters of the U.S.” who don’t “deserve to be rejected.” Musk is an immigrant from South Africa.\u003c/p>\n\u003cp>Google told its employees from those countries to cancel any travel plans outside the U.S. and to consult with the company’s human resources department if they’re not currently in the U.S., according to a companywide note described to The Associated Press. That memo was first reported by Bloomberg and the Wall Street Journal.\u003c/p>\n\u003cp>Google CEO Sundar Pichai told employees in the note that at least 187 Google workers could be affected by Trump’s order. It is not clear how many of those workers are currently traveling outside the U.S. “We’ve always made our views on immigration known publicly and will continue to do so,” Pichai said in the memo.\u003c/p>\n\u003cp>Company representatives declined to discuss the memo or to answer questions about the affected employees. In an official statement, Google said: “We’re concerned about the impact of this order and any proposals that could impose restrictions on Googlers and their families, or that could create barriers to bringing great talent to the U.S.”\u003c/p>\n\u003cp>Microsoft also said it is providing legal advice and assistance to its employees from the banned countries, noting they are all working in the U.S. lawfully.\u003c/p>\n\u003cp>The tech industry may be bracing for further immigration-related hits. Leaks of draft executive orders, still unverified, suggest that Trump might also revamp the H1-B program that lets Silicon Valley bring foreigners with technical skills to the U.S. for three to six years.\u003c/p>\n\u003cp>While the tech industry insists the H1-B program is vital, it has drawn fire for allegedly disadvantaging American programmers and engineers, especially given that the visas are widely used by outsourcing firms. Trump’s attorney general nominee, Sen. Jeff Sessions, is a long-time critic of the program.\u003c/p>\n\u003cp>Venky Ganesan, a managing director at venture capitalist firm Menlo Ventures, acknowledged that the program is “not perfect” and subject to some abuse, but noted that it provides an invaluable source of skilled workers and plays a “pivotal” role in the tech industry.\u003c/p>\n\u003cp>“If we want to buy American and hire American, we do that best by creating companies in America,” he said. :Having the best and brightest from all over the world come and create companies in America is better than them creating companies in India, Israel or China.”\u003c/p>\n\u003cp>[ad floatright]\u003c/p>\n\u003cp>\u003cem>AP Auto Writer Dee-Ann Durbin contributed to this article from Detroit. AP Technology Editor David Hamilton contributed from San Francisco.\u003c/em>\u003c/p>\n\n",
"blocks": [],
"excerpt": "Netflix, eBay, Tesla, Apple and Google among firms voicing criticism of ban on refugees and travelers from seven Muslim-majority nations.",
"status": "publish",
"parent": 0,
"modified": 1729029618,
"stats": {
"hasAudio": false,
"hasVideo": false,
"hasChartOrMap": false,
"iframeSrcs": [],
"hasGoogleForm": false,
"hasGallery": false,
"hasHearkenModule": false,
"hasPolis": false,
"paragraphCount": 30,
"wordCount": 1131
},
"headData": {
"title": "Some Silicon Valley Heavyweights Denounce Trump Order | KQED",
"description": "Netflix, eBay, Tesla, Apple and Google among firms voicing criticism of ban on refugees and travelers from seven Muslim-majority nations.",
"ogTitle": "",
"ogDescription": "",
"ogImgId": "",
"twTitle": "",
"twDescription": "",
"twImgId": "",
"schema": {
"@context": "https://schema.org",
"@type": "NewsArticle",
"headline": "Some Silicon Valley Heavyweights Denounce Trump Order",
"datePublished": "2017-01-28T21:45:47-08:00",
"dateModified": "2024-10-15T15:00:18-07:00",
"image": "https://cdn.kqed.org/wp-content/uploads/2020/02/KQED-OG-Image@1x.png",
"isAccessibleForFree": "True",
"publisher": {
"@type": "NewsMediaOrganization",
"@id": "https://www.kqed.org/#organization",
"name": "KQED",
"logo": "https://cdn.kqed.org/wp-content/uploads/2020/02/KQED-OG-Image@1x.png",
"url": "https://www.kqed.org",
"sameAs": [
"https://www.facebook.com/KQED",
"https://twitter.com/KQED",
"https://www.instagram.com/kqed/",
"https://www.tiktok.com/@kqedofficial",
"https://www.linkedin.com/company/kqed",
"https://www.youtube.com/channel/UCeC0IOo7i1P_61zVUWbJ4nw"
]
}
}
},
"sticky": false,
"nprByline": "\u003cstrong>Mae Anderson\u003cbr />Associated Press\u003c/strong>",
"path": "/news/11291235/some-silicon-valley-heavyweights-denounce-trump-order",
"audioTrackLength": null,
"parsedContent": [
{
"type": "contentString",
"content": "\u003cdiv class=\"post-body\">\u003cp>\u003cp>\u003cem>Updated 10:35 a.m. Sunday\u003c/em>\u003c/p>\n\u003cp>Google, Apple and other tech giants expressed dismay over Friday’s executive order on immigration from President Trump that bars nationals of seven Muslim-majority countries from entering the United States\u003c/p>\n\u003cp>The U.S tech industry relies on foreign engineers and other technical experts for a sizable percentage of its workforce. The order bars entry to the U.S. for anyone from Iran, Iraq, Libya, Somalia, Sudan, Syria and Yemen for 90 days.\u003c/p>\n\u003caside class=\"pullquote alignright\">‘Trump’s actions are hurting Netflix employees around the world, and are so un-American it pains us all. Worse, these actions will make America less safe (through hatred and loss of allies) rather than more safe.’\u003ccite>Reed Hastings,\u003cbr>Netflix CEO\u003c/cite>\u003c/aside>\n\u003cp>The move, ostensibly intended to prevent extremists from carrying out attacks in the U.S., could now also heighten tensions between the Trump administration and one of the nation’s most economically and culturally important industries. That’s especially true if Trump goes on to revamp the industry’s temporary worker permits known as H-1B visas, as some fear.\u003c/p>\n\u003cp>“I share your concerns” about Trump’s immigration order, Apple CEO Tim Cook wrote in a memo to employees obtained by The Associated Press. “It is not a policy we support.”\u003c/p>\n\u003cp>\u003c/p>\u003c/div>",
"attributes": {
"named": {},
"numeric": []
}
},
{
"type": "component",
"content": "",
"name": "ad",
"attributes": {
"named": {
"label": "fullwidth"
},
"numeric": [
"fullwidth"
]
}
},
{
"type": "contentString",
"content": "\u003cdiv class=\"post-body\">\u003cp>\u003c/p>\n\u003cp>“We have reached out to the White House to explain the negative effect on our coworkers and our company,” he added.\u003c/p>\n\u003cp>Cook didn’t say how many Apple employees are directly affected by the order, but said the company’s HR, legal and security teams are in contact to support them. \u003c/p>\n\u003cp>“Apple would not exist without immigration, let alone thrive and innovate the way we do,” Cook wrote — an apparent reference not only to the company’s foreign-born employees, but to Apple co-founder Steve Jobs, the son of a Syrian immigrant.\u003c/p>\n\u003cp>Netflix CEO Reed Hastings was forcefully blunt.\u003c/p>\n\u003cp>“Trump’s actions are hurting Netflix employees around the world, and are so un-American it pains us all,” he wrote on Facebook . “Worse, these actions will make America less safe (through hatred and loss of allies) rather than more safe.”\u003c/p>\n\u003cp>“It is time to link arms together to protect American values of freedom and opportunity,” he continued.\u003c/p>\n\u003cp>Facebook founder Mark Zuckerberg criticized the order in similar, though more carefully couched, terms on Friday.\u003c/p>\n\u003cp>On Sunday, Lyft cofounders John Zimmer and Logan Green announced they would donate $1 million to the American Civil Liberties Union over the next four years “to defend our Constitution.”\u003c/p>\n\u003cp>“Banning people of a particular faith or creed, race or identity, sexuality or ethnicity, from entering the U.S. is antithetical to both Lyft’s and our nation’s core values,” Zimmer and Green said in a statement. “We stand firmly against these actions, and will not be silent on issues that threaten the values of our community.”\u003c/p>\n\u003cp>Uber CEO Travis Kalanick, one of 19 corporate leaders chosen to serve as business advisors to Trump, stopped short of criticizing the president’s order. But he noted in \u003ca href=\"https://newsroom.uber.com/standing-up-for-whats-right/\" target=\"_blank\" rel=\"noopener\">a blog post published Saturday\u003c/a> that the travel ban will affect thousands of Uber drivers.\u003c/p>\n\u003cp>“This ban will impact many innocent people,” Kalanick said, “an issue that I will raise this coming Friday when I go to Washington for President Trump’s first business advisory group meeting.” \u003c/p>\n\u003cp>Technology investor Chris Sacca, an early backer of Uber and Instagram, said on Twitter that he would match ACLU donations up to $75,000 after the organization sued over the ban — and then decided to donate another $75,000 , for a total of $150,000. \u003c/p>\n\u003cp>EBay founder Pierre Omidyar, the child of Iranians, complained that the order was “simple bigotry .”\u003c/p>\n\u003cp>Tesla Motors and SpaceX founder Elon Musk, who has recently appeared to be cultivating a relationship with Trump, tweeted that “many people negatively affected by this policy are strong supporters of the U.S.” who don’t “deserve to be rejected.” Musk is an immigrant from South Africa.\u003c/p>\n\u003cp>Google told its employees from those countries to cancel any travel plans outside the U.S. and to consult with the company’s human resources department if they’re not currently in the U.S., according to a companywide note described to The Associated Press. That memo was first reported by Bloomberg and the Wall Street Journal.\u003c/p>\n\u003cp>Google CEO Sundar Pichai told employees in the note that at least 187 Google workers could be affected by Trump’s order. It is not clear how many of those workers are currently traveling outside the U.S. “We’ve always made our views on immigration known publicly and will continue to do so,” Pichai said in the memo.\u003c/p>\n\u003cp>Company representatives declined to discuss the memo or to answer questions about the affected employees. In an official statement, Google said: “We’re concerned about the impact of this order and any proposals that could impose restrictions on Googlers and their families, or that could create barriers to bringing great talent to the U.S.”\u003c/p>\n\u003cp>Microsoft also said it is providing legal advice and assistance to its employees from the banned countries, noting they are all working in the U.S. lawfully.\u003c/p>\n\u003cp>The tech industry may be bracing for further immigration-related hits. Leaks of draft executive orders, still unverified, suggest that Trump might also revamp the H1-B program that lets Silicon Valley bring foreigners with technical skills to the U.S. for three to six years.\u003c/p>\n\u003cp>While the tech industry insists the H1-B program is vital, it has drawn fire for allegedly disadvantaging American programmers and engineers, especially given that the visas are widely used by outsourcing firms. Trump’s attorney general nominee, Sen. Jeff Sessions, is a long-time critic of the program.\u003c/p>\n\u003cp>Venky Ganesan, a managing director at venture capitalist firm Menlo Ventures, acknowledged that the program is “not perfect” and subject to some abuse, but noted that it provides an invaluable source of skilled workers and plays a “pivotal” role in the tech industry.\u003c/p>\n\u003cp>“If we want to buy American and hire American, we do that best by creating companies in America,” he said. :Having the best and brightest from all over the world come and create companies in America is better than them creating companies in India, Israel or China.”\u003c/p>\n\u003cp>\u003c/p>\u003c/div>",
"attributes": {
"named": {},
"numeric": []
}
},
{
"type": "component",
"content": "",
"name": "ad",
"attributes": {
"named": {
"label": "floatright"
},
"numeric": [
"floatright"
]
}
},
{
"type": "contentString",
"content": "\u003cdiv class=\"post-body\">\u003cp>\u003c/p>\n\u003cp>\u003cem>AP Auto Writer Dee-Ann Durbin contributed to this article from Detroit. AP Technology Editor David Hamilton contributed from San Francisco.\u003c/em>\u003c/p>\n\n\u003c/div>\u003c/p>",
"attributes": {
"named": {},
"numeric": []
}
}
],
"link": "/news/11291235/some-silicon-valley-heavyweights-denounce-trump-order",
"authors": [
"byline_news_11291235"
],
"programs": [
"news_6944",
"news_72"
],
"categories": [
"news_1169",
"news_6188",
"news_33520",
"news_13",
"news_356",
"news_248"
],
"tags": [
"news_1323",
"news_17286",
"news_1631"
],
"featImg": "news_11291236",
"label": "news_72"
},
"news_11286563": {
"type": "posts",
"id": "news_11286563",
"meta": {
"index": "posts_1716263798",
"site": "news",
"id": "11286563",
"score": null,
"sort": [
1485474104000
]
},
"guestAuthors": [],
"slug": "another-lawmaker-asks-uc-president-to-halt-ucsf-layoffs",
"title": "Another Lawmaker Asks UC President to Halt UCSF Layoffs",
"publishDate": 1485474104,
"format": "standard",
"headTitle": "Another Lawmaker Asks UC President to Halt UCSF Layoffs | KQED",
"labelTerm": {
"term": 72,
"site": "news"
},
"content": "\u003cp>This time the letter came from Democratic Rep. Jared Huffman.\u003c/p>\n\u003cp>In his letter to UC President Janet Napolitano on Wednesday, Huffman of San Rafael denounced UCSF’s decision to send nearly 100 IT jobs to a multinational contractor overseas. IT employees at UCSF began training their replacements in October, and if Napolitano does not step in, several dozen of the IT workers will lose their jobs by the end of February. The employees had received layoff notices in July 2016.\u003c/p>\n\u003cp>[contextly_sidebar id=”6jOiXgMFR0BFdRWWv2H0418FHZcizQ2g”]\u003c/p>\n\u003cp>Lawmakers, academics and unions have sent almost a dozen letters to Napolitano criticizing the outsourcing. At the UC Regents meeting Thursday, UCSF employee Keith Pavlik read off the names of all the letter writers to board members, hoping to get their attention.\u003c/p>\n\u003cp>Those who have sent letters include UCSF’s Faculty Association, Sen. Dianne Feinstein and House Minority Leader Nancy Pelosi. But Napolitano has not budged on the issue. Her office has not yet responded to a request for comment.\u003c/p>\n\u003cp>[ad fullwidth]\u003c/p>\n\u003cp>Here are some of the letters sent to her office so far.\u003c/p>\n\u003cp>[scribd id=337641404 key=key-9WdX8YAx4bxyzaCchYzc mode=scroll]\u003c/p>\n\u003cp>[scribd id=337642212 key=key-nNkCG2ZX13sINYIHuY8m mode=scroll]\u003c/p>\n\u003cp>[scribd id=337642315 key=key-1a4MoVGdMuBNoPly3DpD mode=scroll]\u003c/p>\n\u003cp>[scribd id=337642429 key=key-pzmzi9OVBZVg77ab3J3K mode=scroll]\u003c/p>\n\u003cp>[scribd id=337642508 key=key-zpFByUwKOe410vPQEIhL mode=scroll]\u003c/p>\n\u003cp>[scribd id=337642611 key=key-Pp2tQBr5BTe2C7lJPNXx mode=scroll]\u003c/p>\n\u003cp>[scribd id=337646119 key=key-0kc5eZyJw9v91LWhKmw7 mode=scroll]\u003c/p>\n\u003cp>[scribd id=337646397 key=key-gFH5a5USrMEeHwLBICQg mode=scroll]\u003c/p>\n\u003cp>[scribd id=337642810 key=key-yT4wEUl8div9ItsTUAbt mode=scroll]\u003c/p>\n\u003cp>\u003c/p>\n\u003cp>[scribd id=337642941 key=key-AtrcVpvzOnmuRHoEqQWb mode=scroll]\u003c/p>\n\n",
"blocks": [],
"excerpt": "Democratic Rep. Jared Huffman of San Rafael denounces UCSF’s decision to send nearly 100 IT jobs to a multinational contractor overseas.",
"status": "publish",
"parent": 0,
"modified": 1721151649,
"stats": {
"hasAudio": false,
"hasVideo": false,
"hasChartOrMap": false,
"iframeSrcs": [],
"hasGoogleForm": false,
"hasGallery": false,
"hasHearkenModule": false,
"hasPolis": false,
"paragraphCount": 18,
"wordCount": 266
},
"headData": {
"title": "Another Lawmaker Asks UC President to Halt UCSF Layoffs | KQED",
"description": "Democratic Rep. Jared Huffman of San Rafael denounces UCSF’s decision to send nearly 100 IT jobs to a multinational contractor overseas.",
"ogTitle": "",
"ogDescription": "",
"ogImgId": "",
"twTitle": "",
"twDescription": "",
"twImgId": "",
"schema": {
"@context": "https://schema.org",
"@type": "NewsArticle",
"headline": "Another Lawmaker Asks UC President to Halt UCSF Layoffs",
"datePublished": "2017-01-26T15:41:44-08:00",
"dateModified": "2024-07-16T10:40:49-07:00",
"image": "https://cdn.kqed.org/wp-content/uploads/2020/02/KQED-OG-Image@1x.png",
"isAccessibleForFree": "True",
"publisher": {
"@type": "NewsMediaOrganization",
"@id": "https://www.kqed.org/#organization",
"name": "KQED",
"logo": "https://cdn.kqed.org/wp-content/uploads/2020/02/KQED-OG-Image@1x.png",
"url": "https://www.kqed.org",
"sameAs": [
"https://www.facebook.com/KQED",
"https://twitter.com/KQED",
"https://www.instagram.com/kqed/",
"https://www.tiktok.com/@kqedofficial",
"https://www.linkedin.com/company/kqed",
"https://www.youtube.com/channel/UCeC0IOo7i1P_61zVUWbJ4nw"
]
}
}
},
"sticky": false,
"path": "/news/11286563/another-lawmaker-asks-uc-president-to-halt-ucsf-layoffs",
"audioTrackLength": null,
"parsedContent": [
{
"type": "contentString",
"content": "\u003cdiv class=\"post-body\">\u003cp>\u003cp>This time the letter came from Democratic Rep. Jared Huffman.\u003c/p>\n\u003cp>In his letter to UC President Janet Napolitano on Wednesday, Huffman of San Rafael denounced UCSF’s decision to send nearly 100 IT jobs to a multinational contractor overseas. IT employees at UCSF began training their replacements in October, and if Napolitano does not step in, several dozen of the IT workers will lose their jobs by the end of February. The employees had received layoff notices in July 2016.\u003c/p>\n\u003cp>\u003c/p>\u003cp>\u003c/p>\u003cp>\u003c/p>\n\u003cp>Lawmakers, academics and unions have sent almost a dozen letters to Napolitano criticizing the outsourcing. At the UC Regents meeting Thursday, UCSF employee Keith Pavlik read off the names of all the letter writers to board members, hoping to get their attention.\u003c/p>\n\u003cp>Those who have sent letters include UCSF’s Faculty Association, Sen. Dianne Feinstein and House Minority Leader Nancy Pelosi. But Napolitano has not budged on the issue. Her office has not yet responded to a request for comment.\u003c/p>\n\u003cp>\u003c/p>\u003c/div>",
"attributes": {
"named": {},
"numeric": []
}
},
{
"type": "component",
"content": "",
"name": "ad",
"attributes": {
"named": {
"label": "fullwidth"
},
"numeric": [
"fullwidth"
]
}
},
{
"type": "contentString",
"content": "\u003cdiv class=\"post-body\">\u003cp>\u003c/p>\n\u003cp>Here are some of the letters sent to her office so far.\u003c/p>\n\u003cp>\u003c/p>\u003cp>\u003ciframe\n class=\"scribd_iframe_embed\"\n src=\"//www.scribd.com/embeds/337641404/content?start_page=1&view_mode=&access_key=key-9WdX8YAx4bxyzaCchYzc\"\n title=\"http://www.scribd.com/doc/337641404\"\n data-auto-height=\"true\" scrolling=\"no\" id=\"scribd_337641404\"\n width=\"100%\" height=\"500\" frameborder=\"0\">\u003c/iframe>\n \u003ca class=\"utils-parseShortcode-shortcodes-__scribdShortcode__scribd_footer\"\n href=\"http://www.scribd.com/doc/337641404\"\n target=\"_blank\" rel=\"noopener noreferrer\">View this document on Scribd\u003c/a>\u003c/p>\u003cp>\u003c/p>\n\u003cp>\u003c/p>\u003cp>\u003ciframe\n class=\"scribd_iframe_embed\"\n src=\"//www.scribd.com/embeds/337642212/content?start_page=1&view_mode=&access_key=key-nNkCG2ZX13sINYIHuY8m\"\n title=\"http://www.scribd.com/doc/337642212\"\n data-auto-height=\"true\" scrolling=\"no\" id=\"scribd_337642212\"\n width=\"100%\" height=\"500\" frameborder=\"0\">\u003c/iframe>\n \u003ca class=\"utils-parseShortcode-shortcodes-__scribdShortcode__scribd_footer\"\n href=\"http://www.scribd.com/doc/337642212\"\n target=\"_blank\" rel=\"noopener noreferrer\">View this document on Scribd\u003c/a>\u003c/p>\u003cp>\u003c/p>\n\u003cp>\u003c/p>\u003cp>\u003ciframe\n class=\"scribd_iframe_embed\"\n src=\"//www.scribd.com/embeds/337642315/content?start_page=1&view_mode=&access_key=key-1a4MoVGdMuBNoPly3DpD\"\n title=\"http://www.scribd.com/doc/337642315\"\n data-auto-height=\"true\" scrolling=\"no\" id=\"scribd_337642315\"\n width=\"100%\" height=\"500\" frameborder=\"0\">\u003c/iframe>\n \u003ca class=\"utils-parseShortcode-shortcodes-__scribdShortcode__scribd_footer\"\n href=\"http://www.scribd.com/doc/337642315\"\n target=\"_blank\" rel=\"noopener noreferrer\">View this document on Scribd\u003c/a>\u003c/p>\u003cp>\u003c/p>\n\u003cp>\u003c/p>\u003cp>\u003ciframe\n class=\"scribd_iframe_embed\"\n src=\"//www.scribd.com/embeds/337642429/content?start_page=1&view_mode=&access_key=key-pzmzi9OVBZVg77ab3J3K\"\n title=\"http://www.scribd.com/doc/337642429\"\n data-auto-height=\"true\" scrolling=\"no\" id=\"scribd_337642429\"\n width=\"100%\" height=\"500\" frameborder=\"0\">\u003c/iframe>\n \u003ca class=\"utils-parseShortcode-shortcodes-__scribdShortcode__scribd_footer\"\n href=\"http://www.scribd.com/doc/337642429\"\n target=\"_blank\" rel=\"noopener noreferrer\">View this document on Scribd\u003c/a>\u003c/p>\u003cp>\u003c/p>\n\u003cp>\u003c/p>\u003cp>\u003ciframe\n class=\"scribd_iframe_embed\"\n src=\"//www.scribd.com/embeds/337642508/content?start_page=1&view_mode=&access_key=key-zpFByUwKOe410vPQEIhL\"\n title=\"http://www.scribd.com/doc/337642508\"\n data-auto-height=\"true\" scrolling=\"no\" id=\"scribd_337642508\"\n width=\"100%\" height=\"500\" frameborder=\"0\">\u003c/iframe>\n \u003ca class=\"utils-parseShortcode-shortcodes-__scribdShortcode__scribd_footer\"\n href=\"http://www.scribd.com/doc/337642508\"\n target=\"_blank\" rel=\"noopener noreferrer\">View this document on Scribd\u003c/a>\u003c/p>\u003cp>\u003c/p>\n\u003cp>\u003c/p>\u003cp>\u003ciframe\n class=\"scribd_iframe_embed\"\n src=\"//www.scribd.com/embeds/337642611/content?start_page=1&view_mode=&access_key=key-Pp2tQBr5BTe2C7lJPNXx\"\n title=\"http://www.scribd.com/doc/337642611\"\n data-auto-height=\"true\" scrolling=\"no\" id=\"scribd_337642611\"\n width=\"100%\" height=\"500\" frameborder=\"0\">\u003c/iframe>\n \u003ca class=\"utils-parseShortcode-shortcodes-__scribdShortcode__scribd_footer\"\n href=\"http://www.scribd.com/doc/337642611\"\n target=\"_blank\" rel=\"noopener noreferrer\">View this document on Scribd\u003c/a>\u003c/p>\u003cp>\u003c/p>\n\u003cp>\u003c/p>\u003cp>\u003ciframe\n class=\"scribd_iframe_embed\"\n src=\"//www.scribd.com/embeds/337646119/content?start_page=1&view_mode=&access_key=key-0kc5eZyJw9v91LWhKmw7\"\n title=\"http://www.scribd.com/doc/337646119\"\n data-auto-height=\"true\" scrolling=\"no\" id=\"scribd_337646119\"\n width=\"100%\" height=\"500\" frameborder=\"0\">\u003c/iframe>\n \u003ca class=\"utils-parseShortcode-shortcodes-__scribdShortcode__scribd_footer\"\n href=\"http://www.scribd.com/doc/337646119\"\n target=\"_blank\" rel=\"noopener noreferrer\">View this document on Scribd\u003c/a>\u003c/p>\u003cp>\u003c/p>\n\u003cp>\u003c/p>\u003cp>\u003ciframe\n class=\"scribd_iframe_embed\"\n src=\"//www.scribd.com/embeds/337646397/content?start_page=1&view_mode=&access_key=key-gFH5a5USrMEeHwLBICQg\"\n title=\"http://www.scribd.com/doc/337646397\"\n data-auto-height=\"true\" scrolling=\"no\" id=\"scribd_337646397\"\n width=\"100%\" height=\"500\" frameborder=\"0\">\u003c/iframe>\n \u003ca class=\"utils-parseShortcode-shortcodes-__scribdShortcode__scribd_footer\"\n href=\"http://www.scribd.com/doc/337646397\"\n target=\"_blank\" rel=\"noopener noreferrer\">View this document on Scribd\u003c/a>\u003c/p>\u003cp>\u003c/p>\n\u003cp>\u003c/p>\u003cp>\u003ciframe\n class=\"scribd_iframe_embed\"\n src=\"//www.scribd.com/embeds/337642810/content?start_page=1&view_mode=&access_key=key-yT4wEUl8div9ItsTUAbt\"\n title=\"http://www.scribd.com/doc/337642810\"\n data-auto-height=\"true\" scrolling=\"no\" id=\"scribd_337642810\"\n width=\"100%\" height=\"500\" frameborder=\"0\">\u003c/iframe>\n \u003ca class=\"utils-parseShortcode-shortcodes-__scribdShortcode__scribd_footer\"\n href=\"http://www.scribd.com/doc/337642810\"\n target=\"_blank\" rel=\"noopener noreferrer\">View this document on Scribd\u003c/a>\u003c/p>\u003cp>\u003c/p>\n\u003cp>\u003c/p>\n\u003cp>\u003c/p>\u003cp>\u003ciframe\n class=\"scribd_iframe_embed\"\n src=\"//www.scribd.com/embeds/337642941/content?start_page=1&view_mode=&access_key=key-AtrcVpvzOnmuRHoEqQWb\"\n title=\"http://www.scribd.com/doc/337642941\"\n data-auto-height=\"true\" scrolling=\"no\" id=\"scribd_337642941\"\n width=\"100%\" height=\"500\" frameborder=\"0\">\u003c/iframe>\n \u003ca class=\"utils-parseShortcode-shortcodes-__scribdShortcode__scribd_footer\"\n href=\"http://www.scribd.com/doc/337642941\"\n target=\"_blank\" rel=\"noopener noreferrer\">View this document on Scribd\u003c/a>\u003c/p>\u003cp>\u003c/p>\n\n\u003c/div>\u003c/p>",
"attributes": {
"named": {},
"numeric": []
}
}
],
"link": "/news/11286563/another-lawmaker-asks-uc-president-to-halt-ucsf-layoffs",
"authors": [
"253"
],
"programs": [
"news_6944",
"news_72"
],
"categories": [
"news_18540",
"news_8",
"news_248"
],
"tags": [
"news_206"
],
"featImg": "news_11220335",
"label": "news_72"
},
"futureofyou_322609": {
"type": "posts",
"id": "futureofyou_322609",
"meta": {
"index": "posts_1716263798",
"site": "futureofyou",
"id": "322609",
"score": null,
"sort": [
1485371139000
]
},
"parent": 0,
"labelTerm": {},
"blocks": [],
"publishDate": 1485371139,
"format": "standard",
"disqusTitle": "Obamacare Architect Says Silicon Valley Tech Won't Steer Health Care",
"title": "Obamacare Architect Says Silicon Valley Tech Won't Steer Health Care",
"headTitle": "KQED Future of You | KQED Science",
"content": "\u003cp>Ezekiel Emanuel is one of the architects of the Affordable Care Act, aka Obamacare, aka \u003ca href=\"http://www.npr.org/sections/thetwo-way/2017/01/17/510281627/18-million-people-could-lose-insurance-in-first-year-after-partial-obamacare-rep\" target=\"_blank\" rel=\"noopener\">dead-plan-walking\u003c/a>.\u003c/p>\n\u003cp>He's also a \"techno-skeptic,\" as he called himself the other day during an \u003ca href=\"http://audio.californiareport.org/archive/R201701170850/b\" target=\"_blank\" rel=\"noopener\">interview\u003c/a> with KQED health editor Carrie Feibel. When Feibel asked him if there should be any role to play for the \"data gurus of Silicon Valley\" in whatever comes after the ACA, he literally laughed.\u003c/p>\n\u003caside class=\"pullquote alignright\">'I do think there is an important role for tech, but I think the role is probably not what many of the startup companies around here are thinking of.'\u003ccite>Ezekiel Emanuel\u003c/cite>\u003c/aside>\n\u003cp>\"I do think there is an important role for tech, but I think the role is probably not what many of the startup companies around here are thinking of,\" he said, \"around here\" meaning San Francisco and Silicon Valley. Emanuel said tech should play a support role that \"augments\" what health care providers do, providing better data about the patient and where health care funds are spent.\u003c/p>\n\u003cp>\"I am much more skeptical that the computer is going to replace a doctor,\" he said. \"That a computer is going to interface with the patient and take care of them. Not gonna happen.\" (See our posts \"\u003ca href=\"https://ww2.kqed.org/futureofyou/2016/11/07/AI-computers-diagnosis-watson/\" target=\"_blank\" rel=\"noopener\">Will Computers Ever Be as Good as Physicians at Diagnosing Patients\u003c/a>\" and \"\u003ca href=\"https://ww2.kqed.org/futureofyou/2016/02/03/virtual_care_clinic_usc/\" target=\"_blank\" rel=\"noopener\">Would You See a Holographic Doctor?\" \u003c/a>for high hopes surrounding digital docs.)\u003c/p>\n\u003cp>Emanuel said he's also not big on efforts to achieve continuous patient monitoring for health indicators like glucose level and blood pressure. He cited the \u003ca href=\"https://ww2.kqed.org/futureofyou/2016/10/10/fitbit-study/\" target=\"_blank\" rel=\"noopener\">failure of Fitbits and other wearable tech\u003c/a> to improve health outcomes in research studies.\u003c/p>\n\u003cp>[ad fullwidth]\u003c/p>\n\u003cp>\"It’s not that we don’t have information,\" he said. \"The problem is what do you do once you have the information. And there, tech is not going to be the key thing. Medicine fundamentally is about human interaction. That is really the most important challenge, and I don’t think the tech sector has locked onto that part of it.\"\u003c/p>\n\u003cp>This sort of digital contrarianism is not unheard of in the health care biz, even at events and panels where tech-oriented medicine is the focus. Last September, for instance, at the Stanford Medicine X conference, Stephen Downs, the chief technical officer at the Robert Wood Johnson Foundation, said digital health companies\u003ca href=\"https://ww2.kqed.org/futureofyou/2016/09/29/analysis-digital-health-companies-arent-solving-the-right-problems/\" target=\"_blank\" rel=\"noopener\"> weren't focused on solving the right problems\u003c/a>. From a report by KQED's Lesley McClurg:\u003c/p>\n\u003cblockquote>\u003cp>In this age of the Fitbit, Downs said, digital health companies are focused on monitoring the consequences of our \u003ca href=\"http://stateofobesity.org/physical-inactivity/\" target=\"_blank\" rel=\"noopener\">notoriously sedentary lifestyles. \u003c/a>But what is really called for from innovators is to stop treating symptoms and start remedying the roots of the problem.\u003c/p>\n\u003cp>“The system needs to be re-engineered,” said Downs. ... “We don’t need an app that counts steps, because that really just tells you that your day doesn’t naturally incorporate the time and space to walk.”\u003c/p>\u003c/blockquote>\n\u003cp>Instead of a focus on monitoring, he said, engineers and designers need to incorporate solutions --such as enabling urban farming --to core health problems like obesity and heart disease. \u003cstrong>\u003cbr>\n\u003c/strong>\u003c/p>\n\u003cp>\u003cstrong>Policy Versus Scientific Advances\u003c/strong>\u003c/p>\n\u003cp>Several times now at conferences I've witnessed one expert or another--in the midst of a coterie of big data boosters and monitoring mavens, no less--offer up a kind of indirect scolding by cautioning that the best way to improve health is not via smartphones, but smart policy.\u003c/p>\n\u003cp>That dichotomy to some degree echoes a conversation I once had with a longtime health journalist who thought even something as institutionally sanctioned and evidence-based as \u003ca href=\"https://ww2.kqed.org/futureofyou/2017/01/20/time-running-out-california-stem-cell-agency-yet-to-produce-big-results/\" target=\"_blank\" rel=\"noopener\">California's stem cell initiative\u003c/a> was a waste of money, because the funds would have been better directed toward policy prescriptions that address basic health needs.\u003c/p>\n\u003cp>I asked Emanuel to comment on this point, specifically mentioning stem cells.\u003c/p>\n\u003cp>\"Here's a thought experiment,\" he said. \"You know how many lives stem cells have saved? A tiny number compared to the 2.7 million people [in the U.S.] who die each year.\u003c/p>\n\u003cp>\"Now, how many lives have been saved by the ACA?\" he said. \"I don’t know, but it ain’t zero. I intersect with people all the time who happen to recognize me on the street and say I or a family friend got diagnosed with cancer and got therapy or got a heart transplant or something like that.\u003c/p>\n\u003cp>\"In the future, even under a rosy projection, stem cells will not save tons of people,\" he said. \"If you were to cure every single cancer in the U.S.-- no one in America ever dies again of cancer--we add three years to the average life expectancy. It’s a big improvement but it is not anything close to [gains achieved by] doing the basics.\"\u003c/p>\n\u003cp>The two most effective goals for increasing longevity, he said, would be to reduce smoking even further and to control blood pressure.\u003c/p>\n\u003cp>\"We’re not talking high tech,\" he said. \"There is nothing you can do that is going to come close to those two interventions.\"\u003c/p>\n\u003cp>Of course, medical value depends on your perspective, and Emanuel's is a public health view. Someone suffering from any number of horrendous diseases that stem cell research is targeting is not going to be thinking: \"Boy, what a waste to be chasing stem cell cures. I sure wish they'd divert that money to anti-smoking programs.\"\u003c/p>\n\u003cp>And even on the health tech front, some doctors have come around to viewing digital monitoring devices like \u003ca href=\"https://ww2.kqed.org/futureofyou/2016/03/17/mobile-ekg-on-a-watchband-is-useful-for-some-say-docs/\" target=\"_blank\" rel=\"noopener\">mobile EKGs\u003c/a> as useful.\u003c/p>\n\u003cp>\u003c/p>\n\u003cp>As for computers versus doctors, physician and author Bob Wachter, has written that radiology may be the \u003ca href=\"https://ww2.kqed.org/futureofyou/2016/10/25/technology-radiology/\" target=\"_blank\" rel=\"noopener\">canary in the coal mine\u003c/a> in terms of algorithms replacing humans.\u003c/p>\n\n",
"disqusIdentifier": "322609 https://ww2.kqed.org/futureofyou/?p=322609",
"disqusUrl": "https://ww2.kqed.org/futureofyou/2017/01/25/obamacare-architect-says-policy-not-tech-should-steer-health-care/",
"stats": {
"hasVideo": false,
"hasChartOrMap": false,
"hasAudio": false,
"hasPolis": false,
"wordCount": 993,
"hasGoogleForm": false,
"hasGallery": false,
"hasHearkenModule": false,
"iframeSrcs": [],
"paragraphCount": 24
},
"modified": 1510187555,
"excerpt": "In interviews, Ezekiel Emanuel, a former adviser on health care to President Obama, disses digital health monitoring and even stem cell research. ",
"headData": {
"twImgId": "",
"twTitle": "",
"ogTitle": "",
"ogImgId": "",
"twDescription": "",
"description": "In interviews, Ezekiel Emanuel, a former adviser on health care to President Obama, disses digital health monitoring and even stem cell research. ",
"title": "Obamacare Architect Says Silicon Valley Tech Won't Steer Health Care | KQED",
"ogDescription": "",
"schema": {
"@context": "https://schema.org",
"@type": "Article",
"headline": "Obamacare Architect Says Silicon Valley Tech Won't Steer Health Care",
"datePublished": "2017-01-25T11:05:39-08:00",
"dateModified": "2017-11-08T16:32:35-08:00",
"image": "https://cdn.kqed.org/wp-content/uploads/2020/02/KQED-OG-Image@1x.png"
}
},
"guestAuthors": [],
"slug": "obamacare-architect-says-policy-not-tech-should-steer-health-care",
"status": "publish",
"source": "KQED Future of You",
"path": "/futureofyou/322609/obamacare-architect-says-policy-not-tech-should-steer-health-care",
"audioTrackLength": null,
"parsedContent": [
{
"type": "contentString",
"content": "\u003cdiv class=\"post-body\">\u003cp>\u003cp>Ezekiel Emanuel is one of the architects of the Affordable Care Act, aka Obamacare, aka \u003ca href=\"http://www.npr.org/sections/thetwo-way/2017/01/17/510281627/18-million-people-could-lose-insurance-in-first-year-after-partial-obamacare-rep\" target=\"_blank\" rel=\"noopener\">dead-plan-walking\u003c/a>.\u003c/p>\n\u003cp>He's also a \"techno-skeptic,\" as he called himself the other day during an \u003ca href=\"http://audio.californiareport.org/archive/R201701170850/b\" target=\"_blank\" rel=\"noopener\">interview\u003c/a> with KQED health editor Carrie Feibel. When Feibel asked him if there should be any role to play for the \"data gurus of Silicon Valley\" in whatever comes after the ACA, he literally laughed.\u003c/p>\n\u003caside class=\"pullquote alignright\">'I do think there is an important role for tech, but I think the role is probably not what many of the startup companies around here are thinking of.'\u003ccite>Ezekiel Emanuel\u003c/cite>\u003c/aside>\n\u003cp>\"I do think there is an important role for tech, but I think the role is probably not what many of the startup companies around here are thinking of,\" he said, \"around here\" meaning San Francisco and Silicon Valley. Emanuel said tech should play a support role that \"augments\" what health care providers do, providing better data about the patient and where health care funds are spent.\u003c/p>\n\u003cp>\"I am much more skeptical that the computer is going to replace a doctor,\" he said. \"That a computer is going to interface with the patient and take care of them. Not gonna happen.\" (See our posts \"\u003ca href=\"https://ww2.kqed.org/futureofyou/2016/11/07/AI-computers-diagnosis-watson/\" target=\"_blank\" rel=\"noopener\">Will Computers Ever Be as Good as Physicians at Diagnosing Patients\u003c/a>\" and \"\u003ca href=\"https://ww2.kqed.org/futureofyou/2016/02/03/virtual_care_clinic_usc/\" target=\"_blank\" rel=\"noopener\">Would You See a Holographic Doctor?\" \u003c/a>for high hopes surrounding digital docs.)\u003c/p>\n\u003cp>Emanuel said he's also not big on efforts to achieve continuous patient monitoring for health indicators like glucose level and blood pressure. He cited the \u003ca href=\"https://ww2.kqed.org/futureofyou/2016/10/10/fitbit-study/\" target=\"_blank\" rel=\"noopener\">failure of Fitbits and other wearable tech\u003c/a> to improve health outcomes in research studies.\u003c/p>\n\u003cp>\u003c/p>\u003c/div>",
"attributes": {
"named": {},
"numeric": []
}
},
{
"type": "component",
"content": "",
"name": "ad",
"attributes": {
"named": {
"label": "fullwidth"
},
"numeric": [
"fullwidth"
]
}
},
{
"type": "contentString",
"content": "\u003cdiv class=\"post-body\">\u003cp>\u003c/p>\n\u003cp>\"It’s not that we don’t have information,\" he said. \"The problem is what do you do once you have the information. And there, tech is not going to be the key thing. Medicine fundamentally is about human interaction. That is really the most important challenge, and I don’t think the tech sector has locked onto that part of it.\"\u003c/p>\n\u003cp>This sort of digital contrarianism is not unheard of in the health care biz, even at events and panels where tech-oriented medicine is the focus. Last September, for instance, at the Stanford Medicine X conference, Stephen Downs, the chief technical officer at the Robert Wood Johnson Foundation, said digital health companies\u003ca href=\"https://ww2.kqed.org/futureofyou/2016/09/29/analysis-digital-health-companies-arent-solving-the-right-problems/\" target=\"_blank\" rel=\"noopener\"> weren't focused on solving the right problems\u003c/a>. From a report by KQED's Lesley McClurg:\u003c/p>\n\u003cblockquote>\u003cp>In this age of the Fitbit, Downs said, digital health companies are focused on monitoring the consequences of our \u003ca href=\"http://stateofobesity.org/physical-inactivity/\" target=\"_blank\" rel=\"noopener\">notoriously sedentary lifestyles. \u003c/a>But what is really called for from innovators is to stop treating symptoms and start remedying the roots of the problem.\u003c/p>\n\u003cp>“The system needs to be re-engineered,” said Downs. ... “We don’t need an app that counts steps, because that really just tells you that your day doesn’t naturally incorporate the time and space to walk.”\u003c/p>\u003c/blockquote>\n\u003cp>Instead of a focus on monitoring, he said, engineers and designers need to incorporate solutions --such as enabling urban farming --to core health problems like obesity and heart disease. \u003cstrong>\u003cbr>\n\u003c/strong>\u003c/p>\n\u003cp>\u003cstrong>Policy Versus Scientific Advances\u003c/strong>\u003c/p>\n\u003cp>Several times now at conferences I've witnessed one expert or another--in the midst of a coterie of big data boosters and monitoring mavens, no less--offer up a kind of indirect scolding by cautioning that the best way to improve health is not via smartphones, but smart policy.\u003c/p>\n\u003cp>That dichotomy to some degree echoes a conversation I once had with a longtime health journalist who thought even something as institutionally sanctioned and evidence-based as \u003ca href=\"https://ww2.kqed.org/futureofyou/2017/01/20/time-running-out-california-stem-cell-agency-yet-to-produce-big-results/\" target=\"_blank\" rel=\"noopener\">California's stem cell initiative\u003c/a> was a waste of money, because the funds would have been better directed toward policy prescriptions that address basic health needs.\u003c/p>\n\u003cp>I asked Emanuel to comment on this point, specifically mentioning stem cells.\u003c/p>\n\u003cp>\"Here's a thought experiment,\" he said. \"You know how many lives stem cells have saved? A tiny number compared to the 2.7 million people [in the U.S.] who die each year.\u003c/p>\n\u003cp>\"Now, how many lives have been saved by the ACA?\" he said. \"I don’t know, but it ain’t zero. I intersect with people all the time who happen to recognize me on the street and say I or a family friend got diagnosed with cancer and got therapy or got a heart transplant or something like that.\u003c/p>\n\u003cp>\"In the future, even under a rosy projection, stem cells will not save tons of people,\" he said. \"If you were to cure every single cancer in the U.S.-- no one in America ever dies again of cancer--we add three years to the average life expectancy. It’s a big improvement but it is not anything close to [gains achieved by] doing the basics.\"\u003c/p>\n\u003cp>The two most effective goals for increasing longevity, he said, would be to reduce smoking even further and to control blood pressure.\u003c/p>\n\u003cp>\"We’re not talking high tech,\" he said. \"There is nothing you can do that is going to come close to those two interventions.\"\u003c/p>\n\u003cp>Of course, medical value depends on your perspective, and Emanuel's is a public health view. Someone suffering from any number of horrendous diseases that stem cell research is targeting is not going to be thinking: \"Boy, what a waste to be chasing stem cell cures. I sure wish they'd divert that money to anti-smoking programs.\"\u003c/p>\n\u003cp>And even on the health tech front, some doctors have come around to viewing digital monitoring devices like \u003ca href=\"https://ww2.kqed.org/futureofyou/2016/03/17/mobile-ekg-on-a-watchband-is-useful-for-some-say-docs/\" target=\"_blank\" rel=\"noopener\">mobile EKGs\u003c/a> as useful.\u003c/p>\n\u003cp>\u003c/p>\n\u003cp>As for computers versus doctors, physician and author Bob Wachter, has written that radiology may be the \u003ca href=\"https://ww2.kqed.org/futureofyou/2016/10/25/technology-radiology/\" target=\"_blank\" rel=\"noopener\">canary in the coal mine\u003c/a> in terms of algorithms replacing humans.\u003c/p>\n\n\u003c/div>\u003c/p>",
"attributes": {
"named": {},
"numeric": []
}
}
],
"link": "/futureofyou/322609/obamacare-architect-says-policy-not-tech-should-steer-health-care",
"authors": [
"80"
],
"categories": [
"futureofyou_1060",
"futureofyou_452",
"futureofyou_1062",
"futureofyou_1",
"futureofyou_73"
],
"tags": [
"futureofyou_1171",
"futureofyou_1173",
"futureofyou_1172",
"futureofyou_680"
],
"featImg": "futureofyou_325331",
"label": "source_futureofyou_322609"
},
"futureofyou_323092": {
"type": "posts",
"id": "futureofyou_323092",
"meta": {
"index": "posts_1716263798",
"site": "futureofyou",
"id": "323092",
"score": null,
"sort": [
1496675063000
]
},
"parent": 0,
"labelTerm": {
"site": "futureofyou",
"term": 1093
},
"blocks": [],
"publishDate": 1496675063,
"format": "standard",
"disqusTitle": "Was the EpiPen Hack Ethical?",
"title": "Was the EpiPen Hack Ethical?",
"headTitle": "KQED Future of You | KQED Science",
"content": "\u003cp>\u003cstrong>Update June 5, 2017 \u003c/strong>\u003c/p>\n\u003cp>From The New York Times Sunday: Charles Duhigg \u003ca href=\"https://www.nytimes.com/2017/06/04/business/angry-about-epipen-prices-executive-dont-care-much.html\" target=\"_blank\" rel=\"noopener noreferrer\">writes\u003c/a> that last year's outrage over Mylan ratcheting up the price of the EpiPen, so that patients\u003ca href=\"http://www.reuters.com/article/us-health-epipen-costs-idUSKBN16Y24O\" target=\"_blank\" rel=\"noopener noreferrer\"> out-of-pocket costs\u003c/a> increased by over 500 percent in a few years, has not resulted in the company lowering the price of the product. Duhigg writes:\u003c/p>\n\u003cblockquote>\u003cp>Mylan has been called out again and again over the years — by the company’s own employees, regulators, patients, politicians and the press — and hasn’t changed, even as revenue has skyrocketed, hitting $11 billion last year. The firm is a case study in the limits of what consumer and employee activism, as well as government oversight, can achieve.\u003c/p>\u003c/blockquote>\n\u003cp>Meanwhile last week, Iowa Republican Sen. Charles Grassley\u003ca href=\"https://www.grassley.senate.gov/news/news-releases/grassley-latest-estimate-taxpayers-overpaid-127-billion-epipen\" target=\"_blank\" rel=\"noopener noreferrer\"> announced\u003c/a> that the government has estimated Mylan may have overcharged Medicaid by as much as $1.27 billion for the EpiPen under the agency's drug rebate program.\u003c/p>\n\u003cp>\u003cstrong>Original post from Jan. 23, 2017\u003c/strong>\u003c/p>\n\u003cp>Should we be free, as individuals, to make and take our own medicine at home? Who’s responsible if we get hurt or die? Do we have to right to do what we wish with our bodies in the interests of survival, healing and self-care? For years, such questions have been at the heart of public health debates over euthanasia – the right to die – and even drug addiction.\u003c/p>\n\u003cp>[ad fullwidth]\u003c/p>\n\u003cp>They also lie at the center of the infamous Mylan EpiPen pricing scandal. Last fall, Mylan CEO Heather Bresch appeared before the House Oversight Committee to explain the company’s 548 percent price hike for a simple device that injects a lifesaving anti-allergy hormone, FDA-approved epinephrine.\u003c/p>\n\u003cp>The cost drove desperate allergy patients to seek alternatives, including \u003ca href=\"http://www.thedailybeast.com/articles/2016/09/22/please-do-not-hack-your-own-epipen.html\">the dangerous practice\u003c/a> of shooting epinephrine straight from a vial into a muscle.\u003c/p>\n\u003cp>Enter a new challenger: the pharmaceutical hacking collective \u003ca href=\"https://fourthievesvinegar.org/\">Four Thieves Vinegar.\u003c/a> The group is led by Michael Laufer, a math professor by day at Menlo College in Atherton, California, who shot to internet fame overnight last August when he uploaded a DIY instructional video that went viral, showcasing his homemade version of a copycat EpiPen he called the EpiPencil. \u003ca href=\"https://www.the-parallax.com/2016/09/19/epipencil-hack-costs-fraction-epipen-exclusive/\">His device costs around $35 to construct\u003c/a>– a fraction of Mylan’s $600 brand name dual-pack EpiPen. Anyone can make it at home for personal use, he claims.\u003c/p>\n\u003cp>Laufer isn’t a medical doctor and doesn’t pretend to be. But he’s a numbers guy, well versed in computer science, and has dipped into biology and chemistry. It took him two weeks to research and assemble the plastic components of the EpiPen, an auto injector created by a NASA researcher and marketed in 1980 for $20. Mylan later picked up the patent and has benefited from a monopoly.\u003c/p>\n\u003cfigure id=\"attachment_323237\" class=\"wp-caption aligncenter\" style=\"max-width: 800px\">\u003cimg class=\"size-medium wp-image-323237\" src=\"https://ww2.kqed.org/futureofyou/wp-content/uploads/sites/13/2017/01/Epi-Pencil-packaging-sent-by-Laufer-800x1013.jpg\" alt=\"Close-up of packaging used in the Epi-Pencil. \" width=\"800\" height=\"1013\" srcset=\"https://ww2.kqed.org/app/uploads/sites/13/2017/01/Epi-Pencil-packaging-sent-by-Laufer-800x1013.jpg 800w, https://ww2.kqed.org/app/uploads/sites/13/2017/01/Epi-Pencil-packaging-sent-by-Laufer-160x203.jpg 160w, https://ww2.kqed.org/app/uploads/sites/13/2017/01/Epi-Pencil-packaging-sent-by-Laufer-768x973.jpg 768w, https://ww2.kqed.org/app/uploads/sites/13/2017/01/Epi-Pencil-packaging-sent-by-Laufer-1020x1292.jpg 1020w, https://ww2.kqed.org/app/uploads/sites/13/2017/01/Epi-Pencil-packaging-sent-by-Laufer-1920x2432.jpg 1920w, https://ww2.kqed.org/app/uploads/sites/13/2017/01/Epi-Pencil-packaging-sent-by-Laufer-1180x1495.jpg 1180w, https://ww2.kqed.org/app/uploads/sites/13/2017/01/Epi-Pencil-packaging-sent-by-Laufer-960x1216.jpg 960w, https://ww2.kqed.org/app/uploads/sites/13/2017/01/Epi-Pencil-packaging-sent-by-Laufer-240x304.jpg 240w, https://ww2.kqed.org/app/uploads/sites/13/2017/01/Epi-Pencil-packaging-sent-by-Laufer-375x475.jpg 375w, https://ww2.kqed.org/app/uploads/sites/13/2017/01/Epi-Pencil-packaging-sent-by-Laufer-520x659.jpg 520w\" sizes=\"(max-width: 800px) 100vw, 800px\">\u003cfigcaption class=\"wp-caption-text\">Close-up of packaging used in the EpiPencil. \u003ccite>(Four Thieves Vinegar Collective)\u003c/cite>\u003c/figcaption>\u003c/figure>\n\u003cp>Four Thieves Vinegar is named after a folk remedy made from vinegar and spices to ward off bubonic plague. The collective is part of the fast-growing DIY Biology movement, a subculture in which tech meets pharma--a Maker Faire for bio-geeks. In the video, Laufer carefully demonstrates how anyone can do what he did: combine a cheap off-the-shelf needle injector made for diabetics that is easy to buy on the internet, and combine it with a syringe that can be preloaded with a $1 dose of epinephrine.\u003c/p>\n\u003cp>Under fire, Mylan soon released\u003ca href=\"http://newsroom.mylan.com/2016-12-16-Mylan-Launches-the-First-Generic-for-EpiPen-epinephrine-injection-USP-Auto-Injector-as-an-Authorized-Generic\"> a $300 generic of its EpiPen\u003c/a>, but that did little to quiet critics. Georgia Congressman Buddy Carter accused the company of failing to disclose the truth about its profiteering. “There is no transparency, that's the problem here,\" he declared.\u003c/p>\n\u003cp>Leaders also criticized the FDA for its slow-paced approval of generic rivals. Teva Pharmaceutical Industries failed to get approval \u003ca href=\"https://consumerist.com/2016/09/12/teva-will-try-again-to-get-fda-approval-on-epipen-competitor-by-2018/\">for its generic EpiPen\u003c/a> in late 2016, but expects approval by 2018. Meanwhile, CVS Pharmacy has just released a $109.99 generic \u003ca href=\"http://www.pharmacytimes.com/sap-news/cvs-offers-2pack-adrenaclick-for-fraction-of-epipen-price\">two-pack EpiPen called Adrenaclick\u003c/a>. At $55 a pen, it’s close to Laufer’s DIY price -- and provides consumers with a safe, FDA-approved product.\u003c/p>\n\u003cp>That’s exactly what Laufer hoped might happen. As he sees it, his EpiPencil hack was a classic example of The Emperor Has No Clothes: It revealed the actual cost of the plastic auto injector – and showed others how they could make such a device cheaply.\u003c/p>\n\u003cp>It’s a mixed victory, though. The media spotlight gained supporters for Laufer's collective, but also opened him up to criticism. “I get a lot more fan mail then hate mail,” he says, including from parents. But others sharply condemn his actions, and his hacking group’s broader mission: making medicine at home.\u003c/p>\n\u003cp>\u003cstrong>Home Pharma Hacks Raise Safety Questions\u003c/strong>\u003c/p>\n\u003cp>Shortly after Laufer’s hack, the FDA issued a strongly worded warning against its use: “Using unapproved prescription drugs for personal use is a potentially dangerous practice,” an FDA spokesperson \u003ca href=\"http://www.in-pharmatechnologist.com/Regulatory-Safety/US-FDA-warns-against-30-alternative-to-Mylan-s-EpiPen\">told\u003c/a> the website in-PharmaTechnologist. “Unapproved drugs may be contaminated, sub-potent, super-potent or counterfeit.”\u003c/p>\n\u003cp>Critics agree. Yvette d’Entremont, known as SciBabe, is a former chemist-cum-blogger who quickly labeled the EpiPen hack a potential major fail if misused. “It seems like such a bad idea,” she told the Daily Beast. “It’s all fun and games until your product gets contaminated and you get a giant abscess in your muscle.”\u003c/p>\n\u003caside class=\"pullquote alignright\">'I believe in empowering people, in sharing information. We need to talk about alternatives to expensive medication regimens.’\u003ccite>Michael Laufer\u003c/cite>\u003c/aside>\n\u003cp>Contamination and improper dosing can happen with approved drugs too. Epinephrine is a serious drug, used to shock the heart. Laufer defends his device as safe. “In most ways it is equivalent” to Mylan’s EpiPen, he argues, pointing out that it features a safety cap like approved EpiPens, and only carries a single dose.\u003c/p>\n\u003cp>But it’s still untested. And as the father of toxicology himself, Paracelsus, famously warned: all medicine is poison at a certain dose.\u003c/p>\n\u003cp>Oncologist Ezekiel Emanuel, a bioethicist and senior fellow at the Center for American Progress, adds to the chorus of concern, cautioning strongly against using the device.\u003c/p>\n\u003cp>“We have the FDA for a reason. We want to protect the American public from dangerous drugs, which they have no ability to evaluate independently,” he says. “So now we’re going to have some guy who’s going to make a drug and a drug delivery device, put it out there -- no testing, no evaluation of whether it’s safe or effective -- and who the hell knows how many people are going to be hurt -- or not.”\u003c/p>\n\u003cfigure id=\"attachment_323239\" class=\"wp-caption aligncenter\" style=\"max-width: 678px\">\u003cimg class=\"size-full wp-image-323239\" src=\"https://ww2.kqed.org/futureofyou/wp-content/uploads/sites/13/2017/01/RESEND-capture-of-screenshot-of-Daraprim-chemical-breakdown.jpg\" alt=\"Michael Laufer demonstrates how to lead the Epi-Pencil in a DIY video posted to YouTube.\" width=\"678\" height=\"487\" srcset=\"https://ww2.kqed.org/app/uploads/sites/13/2017/01/RESEND-capture-of-screenshot-of-Daraprim-chemical-breakdown.jpg 678w, https://ww2.kqed.org/app/uploads/sites/13/2017/01/RESEND-capture-of-screenshot-of-Daraprim-chemical-breakdown-160x115.jpg 160w, https://ww2.kqed.org/app/uploads/sites/13/2017/01/RESEND-capture-of-screenshot-of-Daraprim-chemical-breakdown-240x172.jpg 240w, https://ww2.kqed.org/app/uploads/sites/13/2017/01/RESEND-capture-of-screenshot-of-Daraprim-chemical-breakdown-375x269.jpg 375w, https://ww2.kqed.org/app/uploads/sites/13/2017/01/RESEND-capture-of-screenshot-of-Daraprim-chemical-breakdown-520x374.jpg 520w\" sizes=\"(max-width: 678px) 100vw, 678px\">\u003cfigcaption class=\"wp-caption-text\">Michael Laufer demonstrates the EpiPencil in a DIY video posted to YouTube. \u003ccite>(Anne-christine d'Adesky/KQED)\u003c/cite>\u003c/figcaption>\u003c/figure>\n\u003cp>Adds Emanuel: “In this case he may turn out to be lucky and no one’s hurt. But we don’t want that regime.”\u003c/p>\n\u003cp>He said the solution to high pharmaceutical prices was \"not this cockamamie 'let people throw drugs out there untested,'\" but to reduce the market power that drug companies rely on to set prices.\u003c/p>\n\u003cp>\"We give drug companies monopolies through the patent law, and marketing exclusivity,\" he said. \"No other country gives a monopoly and then expects good behavior on pricing.\u003c/p>\n\u003cp>\"So what we’ve done is say, 'Oh we’re giving drug companies monopoly pricing power and then we’re like shocked, shocked they're raising prices.\"\u003c/p>\n\u003cp>Margaret McLean, director of bioethics at the\u003ca href=\"https://www.scu.edu/ethics/focus-areas/bioethics/\"> Markkula Center for Applied Ethics\u003c/a> in Santa Clara, also agrees using Laufer's device could be dangerous. She herself, carries an EpiPen. It carries a higher copay than her other medicines, so she sympathizes with parents who can’t afford even generic versions. But the safety risks remain serious.\u003c/p>\n\u003cp>“There is always user error,” says McLean, citing incorrect dosing as a concern. “That is true with FDA-approved drugs too. But the error is less if I don’t have to draw up the right amount of epinephrine myself. I’m grateful for the standardization and check on the injector itself, and that the dose in there is appropriate for me.” She doesn’t want to worry about bubbles in the syringe, which are very dangerous. “There are a lot of steps here,” she says of Laufer’s DIY epinephrine device, “where sitting at home in your kitchen, never having done this before, it puts you in a higher risk category then buying it from the pharmacy.”\u003c/p>\n\u003cp>Still, she understands the urgent unmet need for affordable EpiPens. “The FDA is not able to move things through in an expeditious way, so people rightly get antsy.”\u003c/p>\n\u003cp>Perhaps surprisingly, Laufer agrees about the warnings on safety. “Chemistry is science. So, yes, it’s a concern. You have to think immediately, ‘What if it’s misused?’ But that’s a first-order reaction,” he says. “Ideologically, I believe that more access to more information is inherently better for everyone.” He supports FDA safety reviews and clinical trial tests for new drugs and devices that are marketed to consumers. But he stresses, he’s not marketing anything.\u003c/p>\n\u003caside class=\"pullquote alignright\">'We have the FDA for a reason. We want to protect the American public from dangerous drugs which they have no ability to evaluate independently.'\u003ccite>Ezekiel Emanuel, Center for American Progress\u003c/cite>\u003c/aside>\n\u003cp>Where Laufer draws a hard line – and marks his battleground -- is the domain of the private individual. “What I’m saying is, here is something you can think about... If you decide you’d like to adopt it, then that’s the whole ethic: Here is an idea, play with it, if you like -- no strings attached.”\u003c/p>\n\u003cp>\u003cstrong>More Drug Hacks On the Horizon\u003c/strong>\u003c/p>\n\u003cp>In his cramped faculty office, Laufer greets visitors with a warm smile, eager to share his mission and rebut critics who, he feels, have misperceptions about the true goals and the impact of his hacking action. Online, he looks like a steampunk rebel hero in a metal-studded leather jacket, rimless glasses shoved high on his forehead. Offline, he’s natty in a dark suit, purple tie and tie pin, and fancy abacus-shaped cuff links befitting a math geek.\u003c/p>\n\u003cp>“I believe in empowering people, in sharing information,” Laufer says, citing his hacker creed. “We need to talk about alternatives to expensive medication regimens.” He compares the need for a cheap drug delivery device like his EpiPencil to IKEA furniture: something that should be easy to make, with simple instructions for the average consumer.\u003c/p>\n\u003cp>What people do with that information is not his business, he declares. “I don’t know if anyone has built it besides me,” he says of the EpiPencil. “I don’t want to know. I believe in giving people information they can use to make important decisions about their self-care. That’s what I can offer.”[contextly_sidebar id=\"ucdOGkeG5JNKwxC6hhmw4jS3XUbH2VRU\"]\u003c/p>\n\u003cp>Anyone who copies a patented device risks running afoul of patent law. It's a form of civil disobedience with life-or-death stakes. That make it easy to justify, according to Laufer's group, whose \u003ca href=\"https://fourthievesvinegar.org/faq\">website asks\u003c/a>, \"If the choices presented to you are to die, because you cannot afford medication, or violate a copyright, which would you choose?\"\u003c/p>\n\u003cp>Four Thieves Vinegar is presently focused on “small batch” chemistry--medicines that are easy to make with at-home equipment. Laufer’s first successful hack was pyrimethamine (brand name Daraprim), a decades-old drug used to treat toxoplasmosis in AIDS, cancer and malaria patients. Turing Pharmaceuticals purchased the patent in August 2015 and, a month later, \u003ca href=\"http://www.cbsnews.com/news/generic-drug-price-increases-5000-percent-overnight/\">hiked the price for a single Daraprim pill overnight\u003c/a> by 5,000 percent, from $13.50 to $750. Turing CEO Martin Shkreli became a Big Pharma pariah. In response, Laufer made a batch of DIY Daraprim for $2 a pill. So did a group of \u003ca href=\"https://qz.com/851416/why-martin-shkreli-and-turings-daraprim-still-costs-750-in-the-us-when-australian-schoolkids-can-make-it-for-2/\">Australian high school students\u003c/a>.\u003c/p>\n\u003cp>Laufer has now set his sights on several drugs he feels urgently merit greater public access, including the\u003ca href=\"http://www.rawstory.com/2016/05/american-women-increasingly-turn-to-diy-abortion-drugs-after-gop-laws-shut-down-health-clinics/\"> abortion drugs RU-486 (Mifepristone) and Misoprostol\u003c/a>; Solvadi, a hepatitis C drug; and Glaxo’s HIV prevention pill, GSK-744. He’s keenly aware his choices remain controversial and politically charged.\u003c/p>\n\u003cp>[ad floatright]\u003c/p>\n\u003cp>Looking ahead, Laufer foresees a future of medicine more like Socrates, less like Big Pharma: “Maybe in not too long, the idea of doing chemistry on a personal and individual level and applying it to medicine will be more commonplace. I like dreaming about that.”\u003c/p>\n\n",
"disqusIdentifier": "323092 https://ww2.kqed.org/futureofyou/?p=323092",
"disqusUrl": "https://ww2.kqed.org/futureofyou/2017/06/05/was-the-epipen-hack-ethical/",
"stats": {
"hasVideo": false,
"hasChartOrMap": false,
"hasAudio": false,
"hasPolis": false,
"wordCount": 2163,
"hasGoogleForm": false,
"hasGallery": false,
"hasHearkenModule": false,
"iframeSrcs": [],
"paragraphCount": 41
},
"modified": 1496685066,
"excerpt": "Their work may skirt the law, but pharma hacking collective Four Thieves Vinegar says their DIY medicine demos serve a greater good. ",
"headData": {
"twImgId": "",
"twTitle": "",
"ogTitle": "",
"ogImgId": "",
"twDescription": "",
"description": "Their work may skirt the law, but pharma hacking collective Four Thieves Vinegar says their DIY medicine demos serve a greater good. ",
"title": "Was the EpiPen Hack Ethical? | KQED",
"ogDescription": "",
"schema": {
"@context": "https://schema.org",
"@type": "Article",
"headline": "Was the EpiPen Hack Ethical?",
"datePublished": "2017-06-05T08:04:23-07:00",
"dateModified": "2017-06-05T10:51:06-07:00",
"image": "https://cdn.kqed.org/wp-content/uploads/2020/02/KQED-OG-Image@1x.png"
}
},
"guestAuthors": [],
"slug": "was-the-epipen-hack-ethical",
"status": "publish",
"customPermalink": "2017/01/23/was-the-epipen-hack-ethical/",
"nprByline": "Anne-christine d'Adesky",
"path": "/futureofyou/323092/was-the-epipen-hack-ethical",
"audioTrackLength": null,
"parsedContent": [
{
"type": "contentString",
"content": "\u003cdiv class=\"post-body\">\u003cp>\u003cp>\u003cstrong>Update June 5, 2017 \u003c/strong>\u003c/p>\n\u003cp>From The New York Times Sunday: Charles Duhigg \u003ca href=\"https://www.nytimes.com/2017/06/04/business/angry-about-epipen-prices-executive-dont-care-much.html\" target=\"_blank\" rel=\"noopener noreferrer\">writes\u003c/a> that last year's outrage over Mylan ratcheting up the price of the EpiPen, so that patients\u003ca href=\"http://www.reuters.com/article/us-health-epipen-costs-idUSKBN16Y24O\" target=\"_blank\" rel=\"noopener noreferrer\"> out-of-pocket costs\u003c/a> increased by over 500 percent in a few years, has not resulted in the company lowering the price of the product. Duhigg writes:\u003c/p>\n\u003cblockquote>\u003cp>Mylan has been called out again and again over the years — by the company’s own employees, regulators, patients, politicians and the press — and hasn’t changed, even as revenue has skyrocketed, hitting $11 billion last year. The firm is a case study in the limits of what consumer and employee activism, as well as government oversight, can achieve.\u003c/p>\u003c/blockquote>\n\u003cp>Meanwhile last week, Iowa Republican Sen. Charles Grassley\u003ca href=\"https://www.grassley.senate.gov/news/news-releases/grassley-latest-estimate-taxpayers-overpaid-127-billion-epipen\" target=\"_blank\" rel=\"noopener noreferrer\"> announced\u003c/a> that the government has estimated Mylan may have overcharged Medicaid by as much as $1.27 billion for the EpiPen under the agency's drug rebate program.\u003c/p>\n\u003cp>\u003cstrong>Original post from Jan. 23, 2017\u003c/strong>\u003c/p>\n\u003cp>Should we be free, as individuals, to make and take our own medicine at home? Who’s responsible if we get hurt or die? Do we have to right to do what we wish with our bodies in the interests of survival, healing and self-care? For years, such questions have been at the heart of public health debates over euthanasia – the right to die – and even drug addiction.\u003c/p>\n\u003cp>\u003c/p>\u003c/div>",
"attributes": {
"named": {},
"numeric": []
}
},
{
"type": "component",
"content": "",
"name": "ad",
"attributes": {
"named": {
"label": "fullwidth"
},
"numeric": [
"fullwidth"
]
}
},
{
"type": "contentString",
"content": "\u003cdiv class=\"post-body\">\u003cp>\u003c/p>\n\u003cp>They also lie at the center of the infamous Mylan EpiPen pricing scandal. Last fall, Mylan CEO Heather Bresch appeared before the House Oversight Committee to explain the company’s 548 percent price hike for a simple device that injects a lifesaving anti-allergy hormone, FDA-approved epinephrine.\u003c/p>\n\u003cp>The cost drove desperate allergy patients to seek alternatives, including \u003ca href=\"http://www.thedailybeast.com/articles/2016/09/22/please-do-not-hack-your-own-epipen.html\">the dangerous practice\u003c/a> of shooting epinephrine straight from a vial into a muscle.\u003c/p>\n\u003cp>Enter a new challenger: the pharmaceutical hacking collective \u003ca href=\"https://fourthievesvinegar.org/\">Four Thieves Vinegar.\u003c/a> The group is led by Michael Laufer, a math professor by day at Menlo College in Atherton, California, who shot to internet fame overnight last August when he uploaded a DIY instructional video that went viral, showcasing his homemade version of a copycat EpiPen he called the EpiPencil. \u003ca href=\"https://www.the-parallax.com/2016/09/19/epipencil-hack-costs-fraction-epipen-exclusive/\">His device costs around $35 to construct\u003c/a>– a fraction of Mylan’s $600 brand name dual-pack EpiPen. Anyone can make it at home for personal use, he claims.\u003c/p>\n\u003cp>Laufer isn’t a medical doctor and doesn’t pretend to be. But he’s a numbers guy, well versed in computer science, and has dipped into biology and chemistry. It took him two weeks to research and assemble the plastic components of the EpiPen, an auto injector created by a NASA researcher and marketed in 1980 for $20. Mylan later picked up the patent and has benefited from a monopoly.\u003c/p>\n\u003cfigure id=\"attachment_323237\" class=\"wp-caption aligncenter\" style=\"max-width: 800px\">\u003cimg class=\"size-medium wp-image-323237\" src=\"https://ww2.kqed.org/futureofyou/wp-content/uploads/sites/13/2017/01/Epi-Pencil-packaging-sent-by-Laufer-800x1013.jpg\" alt=\"Close-up of packaging used in the Epi-Pencil. \" width=\"800\" height=\"1013\" srcset=\"https://ww2.kqed.org/app/uploads/sites/13/2017/01/Epi-Pencil-packaging-sent-by-Laufer-800x1013.jpg 800w, https://ww2.kqed.org/app/uploads/sites/13/2017/01/Epi-Pencil-packaging-sent-by-Laufer-160x203.jpg 160w, https://ww2.kqed.org/app/uploads/sites/13/2017/01/Epi-Pencil-packaging-sent-by-Laufer-768x973.jpg 768w, https://ww2.kqed.org/app/uploads/sites/13/2017/01/Epi-Pencil-packaging-sent-by-Laufer-1020x1292.jpg 1020w, https://ww2.kqed.org/app/uploads/sites/13/2017/01/Epi-Pencil-packaging-sent-by-Laufer-1920x2432.jpg 1920w, https://ww2.kqed.org/app/uploads/sites/13/2017/01/Epi-Pencil-packaging-sent-by-Laufer-1180x1495.jpg 1180w, https://ww2.kqed.org/app/uploads/sites/13/2017/01/Epi-Pencil-packaging-sent-by-Laufer-960x1216.jpg 960w, https://ww2.kqed.org/app/uploads/sites/13/2017/01/Epi-Pencil-packaging-sent-by-Laufer-240x304.jpg 240w, https://ww2.kqed.org/app/uploads/sites/13/2017/01/Epi-Pencil-packaging-sent-by-Laufer-375x475.jpg 375w, https://ww2.kqed.org/app/uploads/sites/13/2017/01/Epi-Pencil-packaging-sent-by-Laufer-520x659.jpg 520w\" sizes=\"(max-width: 800px) 100vw, 800px\">\u003cfigcaption class=\"wp-caption-text\">Close-up of packaging used in the EpiPencil. \u003ccite>(Four Thieves Vinegar Collective)\u003c/cite>\u003c/figcaption>\u003c/figure>\n\u003cp>Four Thieves Vinegar is named after a folk remedy made from vinegar and spices to ward off bubonic plague. The collective is part of the fast-growing DIY Biology movement, a subculture in which tech meets pharma--a Maker Faire for bio-geeks. In the video, Laufer carefully demonstrates how anyone can do what he did: combine a cheap off-the-shelf needle injector made for diabetics that is easy to buy on the internet, and combine it with a syringe that can be preloaded with a $1 dose of epinephrine.\u003c/p>\n\u003cp>Under fire, Mylan soon released\u003ca href=\"http://newsroom.mylan.com/2016-12-16-Mylan-Launches-the-First-Generic-for-EpiPen-epinephrine-injection-USP-Auto-Injector-as-an-Authorized-Generic\"> a $300 generic of its EpiPen\u003c/a>, but that did little to quiet critics. Georgia Congressman Buddy Carter accused the company of failing to disclose the truth about its profiteering. “There is no transparency, that's the problem here,\" he declared.\u003c/p>\n\u003cp>Leaders also criticized the FDA for its slow-paced approval of generic rivals. Teva Pharmaceutical Industries failed to get approval \u003ca href=\"https://consumerist.com/2016/09/12/teva-will-try-again-to-get-fda-approval-on-epipen-competitor-by-2018/\">for its generic EpiPen\u003c/a> in late 2016, but expects approval by 2018. Meanwhile, CVS Pharmacy has just released a $109.99 generic \u003ca href=\"http://www.pharmacytimes.com/sap-news/cvs-offers-2pack-adrenaclick-for-fraction-of-epipen-price\">two-pack EpiPen called Adrenaclick\u003c/a>. At $55 a pen, it’s close to Laufer’s DIY price -- and provides consumers with a safe, FDA-approved product.\u003c/p>\n\u003cp>That’s exactly what Laufer hoped might happen. As he sees it, his EpiPencil hack was a classic example of The Emperor Has No Clothes: It revealed the actual cost of the plastic auto injector – and showed others how they could make such a device cheaply.\u003c/p>\n\u003cp>It’s a mixed victory, though. The media spotlight gained supporters for Laufer's collective, but also opened him up to criticism. “I get a lot more fan mail then hate mail,” he says, including from parents. But others sharply condemn his actions, and his hacking group’s broader mission: making medicine at home.\u003c/p>\n\u003cp>\u003cstrong>Home Pharma Hacks Raise Safety Questions\u003c/strong>\u003c/p>\n\u003cp>Shortly after Laufer’s hack, the FDA issued a strongly worded warning against its use: “Using unapproved prescription drugs for personal use is a potentially dangerous practice,” an FDA spokesperson \u003ca href=\"http://www.in-pharmatechnologist.com/Regulatory-Safety/US-FDA-warns-against-30-alternative-to-Mylan-s-EpiPen\">told\u003c/a> the website in-PharmaTechnologist. “Unapproved drugs may be contaminated, sub-potent, super-potent or counterfeit.”\u003c/p>\n\u003cp>Critics agree. Yvette d’Entremont, known as SciBabe, is a former chemist-cum-blogger who quickly labeled the EpiPen hack a potential major fail if misused. “It seems like such a bad idea,” she told the Daily Beast. “It’s all fun and games until your product gets contaminated and you get a giant abscess in your muscle.”\u003c/p>\n\u003caside class=\"pullquote alignright\">'I believe in empowering people, in sharing information. We need to talk about alternatives to expensive medication regimens.’\u003ccite>Michael Laufer\u003c/cite>\u003c/aside>\n\u003cp>Contamination and improper dosing can happen with approved drugs too. Epinephrine is a serious drug, used to shock the heart. Laufer defends his device as safe. “In most ways it is equivalent” to Mylan’s EpiPen, he argues, pointing out that it features a safety cap like approved EpiPens, and only carries a single dose.\u003c/p>\n\u003cp>But it’s still untested. And as the father of toxicology himself, Paracelsus, famously warned: all medicine is poison at a certain dose.\u003c/p>\n\u003cp>Oncologist Ezekiel Emanuel, a bioethicist and senior fellow at the Center for American Progress, adds to the chorus of concern, cautioning strongly against using the device.\u003c/p>\n\u003cp>“We have the FDA for a reason. We want to protect the American public from dangerous drugs, which they have no ability to evaluate independently,” he says. “So now we’re going to have some guy who’s going to make a drug and a drug delivery device, put it out there -- no testing, no evaluation of whether it’s safe or effective -- and who the hell knows how many people are going to be hurt -- or not.”\u003c/p>\n\u003cfigure id=\"attachment_323239\" class=\"wp-caption aligncenter\" style=\"max-width: 678px\">\u003cimg class=\"size-full wp-image-323239\" src=\"https://ww2.kqed.org/futureofyou/wp-content/uploads/sites/13/2017/01/RESEND-capture-of-screenshot-of-Daraprim-chemical-breakdown.jpg\" alt=\"Michael Laufer demonstrates how to lead the Epi-Pencil in a DIY video posted to YouTube.\" width=\"678\" height=\"487\" srcset=\"https://ww2.kqed.org/app/uploads/sites/13/2017/01/RESEND-capture-of-screenshot-of-Daraprim-chemical-breakdown.jpg 678w, https://ww2.kqed.org/app/uploads/sites/13/2017/01/RESEND-capture-of-screenshot-of-Daraprim-chemical-breakdown-160x115.jpg 160w, https://ww2.kqed.org/app/uploads/sites/13/2017/01/RESEND-capture-of-screenshot-of-Daraprim-chemical-breakdown-240x172.jpg 240w, https://ww2.kqed.org/app/uploads/sites/13/2017/01/RESEND-capture-of-screenshot-of-Daraprim-chemical-breakdown-375x269.jpg 375w, https://ww2.kqed.org/app/uploads/sites/13/2017/01/RESEND-capture-of-screenshot-of-Daraprim-chemical-breakdown-520x374.jpg 520w\" sizes=\"(max-width: 678px) 100vw, 678px\">\u003cfigcaption class=\"wp-caption-text\">Michael Laufer demonstrates the EpiPencil in a DIY video posted to YouTube. \u003ccite>(Anne-christine d'Adesky/KQED)\u003c/cite>\u003c/figcaption>\u003c/figure>\n\u003cp>Adds Emanuel: “In this case he may turn out to be lucky and no one’s hurt. But we don’t want that regime.”\u003c/p>\n\u003cp>He said the solution to high pharmaceutical prices was \"not this cockamamie 'let people throw drugs out there untested,'\" but to reduce the market power that drug companies rely on to set prices.\u003c/p>\n\u003cp>\"We give drug companies monopolies through the patent law, and marketing exclusivity,\" he said. \"No other country gives a monopoly and then expects good behavior on pricing.\u003c/p>\n\u003cp>\"So what we’ve done is say, 'Oh we’re giving drug companies monopoly pricing power and then we’re like shocked, shocked they're raising prices.\"\u003c/p>\n\u003cp>Margaret McLean, director of bioethics at the\u003ca href=\"https://www.scu.edu/ethics/focus-areas/bioethics/\"> Markkula Center for Applied Ethics\u003c/a> in Santa Clara, also agrees using Laufer's device could be dangerous. She herself, carries an EpiPen. It carries a higher copay than her other medicines, so she sympathizes with parents who can’t afford even generic versions. But the safety risks remain serious.\u003c/p>\n\u003cp>“There is always user error,” says McLean, citing incorrect dosing as a concern. “That is true with FDA-approved drugs too. But the error is less if I don’t have to draw up the right amount of epinephrine myself. I’m grateful for the standardization and check on the injector itself, and that the dose in there is appropriate for me.” She doesn’t want to worry about bubbles in the syringe, which are very dangerous. “There are a lot of steps here,” she says of Laufer’s DIY epinephrine device, “where sitting at home in your kitchen, never having done this before, it puts you in a higher risk category then buying it from the pharmacy.”\u003c/p>\n\u003cp>Still, she understands the urgent unmet need for affordable EpiPens. “The FDA is not able to move things through in an expeditious way, so people rightly get antsy.”\u003c/p>\n\u003cp>Perhaps surprisingly, Laufer agrees about the warnings on safety. “Chemistry is science. So, yes, it’s a concern. You have to think immediately, ‘What if it’s misused?’ But that’s a first-order reaction,” he says. “Ideologically, I believe that more access to more information is inherently better for everyone.” He supports FDA safety reviews and clinical trial tests for new drugs and devices that are marketed to consumers. But he stresses, he’s not marketing anything.\u003c/p>\n\u003caside class=\"pullquote alignright\">'We have the FDA for a reason. We want to protect the American public from dangerous drugs which they have no ability to evaluate independently.'\u003ccite>Ezekiel Emanuel, Center for American Progress\u003c/cite>\u003c/aside>\n\u003cp>Where Laufer draws a hard line – and marks his battleground -- is the domain of the private individual. “What I’m saying is, here is something you can think about... If you decide you’d like to adopt it, then that’s the whole ethic: Here is an idea, play with it, if you like -- no strings attached.”\u003c/p>\n\u003cp>\u003cstrong>More Drug Hacks On the Horizon\u003c/strong>\u003c/p>\n\u003cp>In his cramped faculty office, Laufer greets visitors with a warm smile, eager to share his mission and rebut critics who, he feels, have misperceptions about the true goals and the impact of his hacking action. Online, he looks like a steampunk rebel hero in a metal-studded leather jacket, rimless glasses shoved high on his forehead. Offline, he’s natty in a dark suit, purple tie and tie pin, and fancy abacus-shaped cuff links befitting a math geek.\u003c/p>\n\u003cp>“I believe in empowering people, in sharing information,” Laufer says, citing his hacker creed. “We need to talk about alternatives to expensive medication regimens.” He compares the need for a cheap drug delivery device like his EpiPencil to IKEA furniture: something that should be easy to make, with simple instructions for the average consumer.\u003c/p>\n\u003cp>What people do with that information is not his business, he declares. “I don’t know if anyone has built it besides me,” he says of the EpiPencil. “I don’t want to know. I believe in giving people information they can use to make important decisions about their self-care. That’s what I can offer.”\u003c/p>\u003cp>\u003c/p>\u003cp>\u003c/p>\n\u003cp>Anyone who copies a patented device risks running afoul of patent law. It's a form of civil disobedience with life-or-death stakes. That make it easy to justify, according to Laufer's group, whose \u003ca href=\"https://fourthievesvinegar.org/faq\">website asks\u003c/a>, \"If the choices presented to you are to die, because you cannot afford medication, or violate a copyright, which would you choose?\"\u003c/p>\n\u003cp>Four Thieves Vinegar is presently focused on “small batch” chemistry--medicines that are easy to make with at-home equipment. Laufer’s first successful hack was pyrimethamine (brand name Daraprim), a decades-old drug used to treat toxoplasmosis in AIDS, cancer and malaria patients. Turing Pharmaceuticals purchased the patent in August 2015 and, a month later, \u003ca href=\"http://www.cbsnews.com/news/generic-drug-price-increases-5000-percent-overnight/\">hiked the price for a single Daraprim pill overnight\u003c/a> by 5,000 percent, from $13.50 to $750. Turing CEO Martin Shkreli became a Big Pharma pariah. In response, Laufer made a batch of DIY Daraprim for $2 a pill. So did a group of \u003ca href=\"https://qz.com/851416/why-martin-shkreli-and-turings-daraprim-still-costs-750-in-the-us-when-australian-schoolkids-can-make-it-for-2/\">Australian high school students\u003c/a>.\u003c/p>\n\u003cp>Laufer has now set his sights on several drugs he feels urgently merit greater public access, including the\u003ca href=\"http://www.rawstory.com/2016/05/american-women-increasingly-turn-to-diy-abortion-drugs-after-gop-laws-shut-down-health-clinics/\"> abortion drugs RU-486 (Mifepristone) and Misoprostol\u003c/a>; Solvadi, a hepatitis C drug; and Glaxo’s HIV prevention pill, GSK-744. He’s keenly aware his choices remain controversial and politically charged.\u003c/p>\n\u003cp>\u003c/p>\u003c/div>",
"attributes": {
"named": {},
"numeric": []
}
},
{
"type": "component",
"content": "",
"name": "ad",
"attributes": {
"named": {
"label": "floatright"
},
"numeric": [
"floatright"
]
}
},
{
"type": "contentString",
"content": "\u003cdiv class=\"post-body\">\u003cp>\u003c/p>\n\u003cp>Looking ahead, Laufer foresees a future of medicine more like Socrates, less like Big Pharma: “Maybe in not too long, the idea of doing chemistry on a personal and individual level and applying it to medicine will be more commonplace. I like dreaming about that.”\u003c/p>\n\n\u003c/div>\u003c/p>",
"attributes": {
"named": {},
"numeric": []
}
}
],
"link": "/futureofyou/323092/was-the-epipen-hack-ethical",
"authors": [
"byline_futureofyou_323092"
],
"categories": [
"futureofyou_1060",
"futureofyou_452",
"futureofyou_1",
"futureofyou_73"
],
"tags": [
"futureofyou_1167",
"futureofyou_1164",
"futureofyou_38",
"futureofyou_1275",
"futureofyou_1168"
],
"collections": [
"futureofyou_1093"
],
"featImg": "futureofyou_323235",
"label": "futureofyou_1093"
},
"futureofyou_322634": {
"type": "posts",
"id": "futureofyou_322634",
"meta": {
"index": "posts_1716263798",
"site": "futureofyou",
"id": "322634",
"score": null,
"sort": [
1484930860000
]
},
"parent": 0,
"labelTerm": {},
"blocks": [],
"publishDate": 1484930860,
"format": "standard",
"disqusTitle": "Time Running Out, California Stem Cell Agency Yet to Produce Big Results",
"title": "Time Running Out, California Stem Cell Agency Yet to Produce Big Results",
"headTitle": "KQED Future of You | KQED Science",
"content": "\u003cp>It’s been more than a decade since California launched an unprecedented experiment in medical research by direct democracy, when voters created a $3 billion fund to kick-start the hunt for stem cell therapies.\u003c/p>\n\u003cp>The bold plan, a response to federal funding limits for embryonic stem cell research, was sold with a simple pitch: The money would rapidly yield cures for devastating human diseases such as Parkinson’s and ALS.\u003c/p>\n\u003cp>That hasn’t happened.\u003c/p>\n\u003cp>[contextly_sidebar id=\"wiA2OMIATARmkALimTVF9L5bJoRR3eQd\"]A major reason, a STAT examination found, is that the \u003ca href=\"https://www.cirm.ca.gov/\" target=\"_blank\">California Institute for Regenerative Medicine\u003c/a> has been slow to move promising experimental therapies into clinical trials. The National Institutes of Health has supported three and a half times as many human trials of stem cell therapies, dollar for dollar, as the California agency has funded since it started making grants in 2006. Just two of its clinical trials have been completed.\u003c/p>\n\u003cp>“I am floored by the disparity,” said Jim Lott, a health care consultant and member of the state board that monitors the agency, known as CIRM. If the numbers are correct, he told STAT, “that doesn’t settle well with me as a voter. That doesn’t settle well with me as a taxpayer. That doesn’t settle well with me as a member of the oversight committee.”\u003c/p>\n\u003cp>[ad fullwidth]\u003c/p>\n\u003cp>CIRM has used most of the $2.2 billion in grants it has distributed so far to build labs and pay for basic research at public and private universities, such as Stanford and the University of Southern California, and private companies.\u003c/p>\n\u003cp>It has given more than $300 million to 27 projects that include clinical trials — though much of that funding also supported preclinical work. Meanwhile, the agency has committed about $540 million to new labs and buildings.\u003c/p>\n\u003cp>In part, that’s because its directors chose to focus on infrastructure early on, as well as bench experiments and animal studies given that the biology of embryonic stem cells was not well-understood and there are formidable roadblocks to moving into human studies. Much more is known about the bone marrow stem cells that are the focus of many NIH-funded clinical trials.\u003c/p>\n\u003cp>But critics have noted that many top grantees come from institutions that hold seats on CIRM’s governing board. The respected Institute of Medicine, in a 2013 \u003ca href=\"https://www.nap.edu/catalog/13523/the-california-institute-for-regenerative-medicine-science-governance-and-the\" target=\"_blank\">review\u003c/a>, said institutionalized conflicts of interest have raised questions about “the integrity and independence of some of CIRM’s decisions.” CIRM later enacted reforms that barred board members from voting directly on grants for their institutions. But the changes didn’t prevent other financial \u003ca href=\"http://www.latimes.com/business/hiltzik/la-fi-hiltzik-20140720-column.html\" target=\"_blank\">conflicts\u003c/a> involving \u003ca href=\"http://californiastemcellreport.blogspot.com/2016/09/alan-trounson-former-ceo-of-california.html\" target=\"_blank\">CIRM officers and grantees\u003c/a>, and the flow of funds to board members’ institutions continued unabated.\u003c/p>\n\u003cfigure id=\"attachment_322983\" class=\"wp-caption aligncenter\" style=\"max-width: 979px\">\u003ca href=\"https://ww2.kqed.org/futureofyou/wp-content/uploads/sites/13/2017/01/CIRM.jpg\">\u003cimg class=\"wp-image-322983 size-full\" src=\"https://ww2.kqed.org/futureofyou/wp-content/uploads/sites/13/2017/01/CIRM.jpg\" alt=\"CIRM\" width=\"979\" height=\"462\" srcset=\"https://ww2.kqed.org/app/uploads/sites/13/2017/01/CIRM.jpg 979w, https://ww2.kqed.org/app/uploads/sites/13/2017/01/CIRM-160x76.jpg 160w, https://ww2.kqed.org/app/uploads/sites/13/2017/01/CIRM-800x378.jpg 800w, https://ww2.kqed.org/app/uploads/sites/13/2017/01/CIRM-768x362.jpg 768w, https://ww2.kqed.org/app/uploads/sites/13/2017/01/CIRM-960x453.jpg 960w, https://ww2.kqed.org/app/uploads/sites/13/2017/01/CIRM-240x113.jpg 240w, https://ww2.kqed.org/app/uploads/sites/13/2017/01/CIRM-375x177.jpg 375w, https://ww2.kqed.org/app/uploads/sites/13/2017/01/CIRM-520x245.jpg 520w\" sizes=\"(max-width: 979px) 100vw, 979px\">\u003c/a>\u003cfigcaption class=\"wp-caption-text\">Sources: California Institute for Regenerative Medicine, National Institutes of Health. \u003cspan class=\"media-source\">*Several CIRM trials included here were announced shortly after Sept. 30, 2016, the cut-off for the NIH data. **NIH spending for 2006 and 2007 is estimated because exact figures were unavailable.\u003c/span>NATALIA BRONSHTEIN/STAT\u003c/figcaption>\u003c/figure>\n\u003cp>“You could make an argument that California taxpayer money should go to build new facilities on state university campuses,” said Marcy Darnovsky, who directs the Berkeley-based Center for Genetics and Society, a public affairs nonprofit. “But I don’t see an argument for Stanford getting fancy new buildings from California taxpayer money.”\u003c/p>\n\u003cp>Stanford, whose endowment is among the top five nationally, and USC have received more than $70\u003cstrong> \u003c/strong>million for major building projects, and hundreds of millions more for labs and research. Stanford alone has been favored with $1 out of every $7 CIRM has approved.\u003c/p>\n\u003cp>But scientists outside California said CIRM’s record is a strong one. CIRM-funded researchers have published nearly 2,000 scholarly papers. That output has helped vault California into the top ranks of stem cell science, said Dr. George Daley, the new dean of Harvard Medical School and a leading stem cell scientist who describes himself as an informal adviser and cheerleader for CIRM. “When I look at the progress my colleagues have made in California, I am duly awed,” he said.\u003c/p>\n\u003cp>The institute announced a year ago that it would reinvent itself to emphasize clinical research until it runs out of money in 2020 — unless voters grant a new infusion of cash. CIRM plans to fund 50 new trials with its remaining $692 million, of which 10 were announced in 2016. Just 17 trials were funded in its first decade of grants.\u003c/p>\n\u003cp>C. Randal Mills, CIRM’s CEO since 2014 and architect of its new strategy, said he welcomed comparisons that help benchmark CIRM’s progress. Mills, former head of Osiris Therapeutics, the first company to commercialize an approved stem cell treatment, declined to comment on STAT’s specific findings, but defended the initial emphasis on labs and basic science as underpinning future clinical work.\u003c/p>\n\u003cp>“We’re running our own race. … What we have to do is just continually get better” to benefit patients, Mills said in an interview. “If we’re behind [NIH], we’re going to get better.”\u003c/p>\n\u003cp>Lott’s teenage daughter was paralyzed in an automobile crash and he hopes for a stem cell cure. He supports the goals of CIRM and applauds much of its work, but he now has second thoughts about the governance structure, which allows board members’ institutions to benefit from CIRM grants, as well as its financing. The ballot question that created CIRM, Proposition 71, authorized bond sales to pay for the agency’s budget, raising the total cost for taxpayers to $6 billion including interest. Financial experts, however, said that relatively low interest rates paid on long-term bonds can offer advantages over funding so large a venture directly from state coffers.\u003c/p>\n\u003cp>Asked whether he would support a similar ballot measure today, Lott said, “We were all caught up in the time, and the events were different when we first looked at this. But not today. Not at all.”\u003c/p>\n\u003cp>\u003cstrong>'Lives Will Be Saved'\u003c/strong>\u003c/p>\n\u003cp>Californians emphatically supported CIRM, creating the stem cell colossus with 59 percent of the vote in 2004. Many were upset that President George W. Bush had sharply limited federal funding for work with embryonic stem cells, which are derived from early human embryos and able to develop into any type of tissue or organ.\u003c/p>\n\u003cp>But Proposition 71 also won because it was shamelessly oversold, consumer advocates and science policy experts said. Desperate patients, Nobel laureates, and A-list celebrities such as \u003ca href=\"https://www.statnews.com/2016/08/30/parkinsons-study-fox-foundation-feud/\" target=\"_blank\">Michael J. Fox\u003c/a> — the Hollywood star and Parkinson’s sufferer — predicted “cures” that would “save millions of lives.”\u003c/p>\n\u003cp>“There are more Americans than … we can count who are sick now, or are going to be sick in the future, whose lives will be saved by Prop 71,” patient advocate Joan Samuelson said in another ad. The sponsors of the measure also predicted that CIRM-generated cures would drastically reduce health care spending. No one made specific promises for the 10-year timeframe initially planned for CIRM’s work, but miracles seemed just around the corner.\u003c/p>\n\u003cp>“You can support embryonic stem cell research, which we do and did, and still be pretty appalled by what was going down,” said Darnovsky. “The airwaves were swamped with guys in white coats who were identified with their academic affiliation even though they were principals of private companies (some of which later got CIRM grants), and basically saying, ‘We’re going to have cures by Christmas.’”\u003c/p>\n\u003cp>Mills, who was not involved at the agency’s genesis, called the idea sold to voters — impending, sweeping breakthroughs — “naïve.” Radical medical change usually takes decades from idea to cure.\u003c/p>\n\u003cp>“But here we are,” he said. “My sole mission is to create as much value for the resources we have left, for the people of California, that I can.”\u003c/p>\n\u003cp>\u003cstrong>California vs. NIH\u003c/strong>\u003c/p>\n\u003cp>Even under Bush-era restrictions — rescinded after President Barack Obama took office — the NIH continued to support substantial stem cell research.\u003c/p>\n\u003cp>Since 2006, it has spent $13.4 billion on stem cell science, six times CIRM’s budget during that period. But NIH fully or partly funded 571 clinical trials, according to STAT’s review — more than 20 times the number backed by California.\u003c/p>\n\u003cp>While NIH in that period funded 50 Phase 3 clinical trials of stem cell therapies — generally the last step before seeking approval to market a product — CIRM has supported just three.\u003c/p>\n\u003cp>One, the study of a treatment for skin cancer involving immune system cells, was terminated by Caladrius Biosciences, the grantee, when it determined that existing treatments had overtaken its approach. The others — testing altered immune cells to treat brain cancer and bioengineered veins to manage vascular problems — show promise, but are still recruiting patients and will not be completed for several years, according to the NIH website, ClinicalTrials.gov.\u003c/p>\n\u003cp>Daley called the NIH comparison “a little unfair,” because that agency emphasized hematopoietic stem cells — blood-forming cells from bone marrow, which had been studied for decades — unlike CIRM’s sharper focus on cutting-edge embryonic stem cells. A little more than half of CIRM’s awards have gone to support research on embryonic or induced pluripotent stem cells, which are created by modifying adult stem cells to act like embryonic ones. It gave about a quarter of its awards to support adult stem cell work, and the rest for other research areas.\u003c/p>\n\u003cp>“In the early days of CIRM, the feeling was that the field needed deep and direct investments in the … fundamental foundation of stem cell biology, because the translational opportunities were not yet mature, certainly not using embryonic or induced pluripotent stem cells,” Daley said.\u003c/p>\n\u003cp>\u003ca href=\"https://www.statnews.com/2016/01/30/paul-knoepfler/\" target=\"_blank\">Paul Knoepfler\u003c/a>, a University of California, Davis, researcher and CIRM grantee who writes a popular \u003ca href=\"http://www.ipscell.com/\" target=\"_blank\">stem cell blog\u003c/a>, agreed. “One almost had to invent a system for figuring out what would be a safe way to proceed with embryonic stem cell clinical trials because those cells are really much more powerful and also have different kinds of risks,” he said.\u003c/p>\n\u003cp>Knoepfler said he expected the basic science to spark clinical breakthroughs in time, citing, for example, promising early work on reversing paralysis from Asterias Biotherapeutics, located in Fremont, southeast of San Francisco. Jake Javier, a patient in a CIRM-supported Asterias trial, lost almost all use of his limbs in an accident diving into a swimming pool. He recently received an injection of a type of cell derived from embryonic stem cells that can help protect nerve cells damaged in spinal cord injuries. Javier has since regained some\u003cstrong> \u003c/strong>use of his arms — one of five patients in early trials who have shown improvement that CIRM and the researchers attribute to the treatment. The results have not yet been published in a peer-reviewed journal.\u003c/p>\n\u003cp>In addition, Mills noted that grants for new labs included provisions that required grantees to raise other funds — to “leverage” economic benefits to taxpayers — and to assist future trials. The institute, for example, gave $30 million to the contract research firm Quintiles to create facilities that will conduct preclinical research, manage regulatory issues, and provide clinical support for CIRM-supported stem cell trials, all at a steep discount.\u003c/p>\n\u003cp>“There is no iPhone 4 without an iPhone 3 or a 2 or a 1,” Mills said. But in a world where technology advances rapidly — Apple is already selling the iPhone 7, after all — voters are still waiting for the promised cures.\u003c/p>\n\u003cfigure id=\"attachment_322991\" class=\"wp-caption alignright\" style=\"max-width: 384px\">\u003ca href=\"https://ww2.kqed.org/futureofyou/wp-content/uploads/sites/13/2017/01/evangelina.jpg\">\u003cimg class=\"size-full wp-image-322991\" src=\"https://ww2.kqed.org/futureofyou/wp-content/uploads/sites/13/2017/01/evangelina.jpg\" alt=\"Evangelina Padilla Vaccaro in November 2016.\" width=\"384\" height=\"576\" srcset=\"https://ww2.kqed.org/app/uploads/sites/13/2017/01/evangelina.jpg 384w, https://ww2.kqed.org/app/uploads/sites/13/2017/01/evangelina-160x240.jpg 160w, https://ww2.kqed.org/app/uploads/sites/13/2017/01/evangelina-240x360.jpg 240w, https://ww2.kqed.org/app/uploads/sites/13/2017/01/evangelina-375x563.jpg 375w\" sizes=\"(max-width: 384px) 100vw, 384px\">\u003c/a>\u003cfigcaption class=\"wp-caption-text\">Evangelina Padilla Vaccaro in November 2016. \u003ccite>(Nancy Ramos)\u003c/cite>\u003c/figcaption>\u003c/figure>\n\u003cp>So far, CIRM has one literal poster child to show it can deliver. Four-year-old Evangelina Padilla Vaccaro, featured on the cover of CIRM’s recent \u003ca href=\"https://www.cirm.ca.gov/about-cirm/2016-annual-report\" target=\"_blank\">annual report\u003c/a>, was born with severe combined immunodeficiency. She had no operating immune system. Some such children have been kept alive in sterile isolation tents for a time — hence the term, “bubble baby” — but most have died from infections within a few years. A lucky few who received matching bone-marrow transplants survived.\u003c/p>\n\u003cp>UCLA’s Dr. Donald Kohn, supported by CIRM, cured Evangelina by extracting some of her blood stem cells, altering them to correct the genetic defect, and returning them to her body. She’s now thriving with a robust immune system.\u003c/p>\n\u003cp>That little girl, and 29 children like her, “are getting immunizations, they’re going to school, they’re swimming in public swimming pools, they’re eating dirt, they’re doing all the things that little kids are supposed to do,” said Steven Peckman, associate director of UCLA’s Broad Center of Regenerative Medicine and Stem Cell Research. “They get sick and their own bodies attack those viruses and bacteria. And they survive. If there’s going to be something that’s called a cure, this is it.”\u003c/p>\n\u003cp>That inspiring triumph was partly funded by CIRM, but Kohn’s work took three decades, was well underway long before CIRM existed, and didn’t involve embryonic stem cells — the key gap CIRM was founded to fill. Evangelina was saved by hematopoietic stem cells, the type that NIH has been more focused on.\u003c/p>\n\u003cp>\u003cstrong>Racing the Clock\u003c/strong>\u003c/p>\n\u003cp>As much as Mills defends the old CIRM, last year he announced “CIRM 2.0” — a drastic shift to speed up clinical trials before the organization’s clock runs out.\u003c/p>\n\u003cp>Asked whether Californians are getting good value for their money from CIRM, Mills cited economic gains to the state, then added: “I focus a lot more on the return in relief of human suffering. We’re just starting to lift off the ground on that. I hope in history, in time, the record shows CIRM was a great deal.”\u003c/p>\n\u003cp>To that end, CIRM has said it will focus in 2017 primarily on clinical trials and work it hopes will lay the foundation for such studies.\u003c/p>\n\u003cp>If the studies show clear results, Mills said, “I think it will be self-evident that CIRM should be continued” with new funding.\u003c/p>\n\u003cp>Lott, the state overseer, called CIRM 2.0 long overdue. “They needed to at least create something a little more tangible, more specifically measurable, for the billions of dollars that they’ve allocated,” he said. “But it may be a little too late,” he added, to convince taxpayers that CIRM should get a new infusion of funds, given its governance structure.\u003c/p>\n\u003cp>Even Daley — unbridled in his enthusiasm for CIRM’s work — hesitated when asked if it was a model to emulate, though for a different reason. “I reluctantly endorse it,” he said, “in part because I think it’s another argument that allows the federal government and the NIH to abdicate its responsibility for investments in biomedical research, which benefits us all.”\u003c/p>\n\u003cp>Yet, just as President Bush’s policy on stem cells led to CIRM’s creation, the incoming Trump administration might bail out the institute just in time. The president-elect has not weighed in on federal funding, but Representative Tom Price, his nominee for Health and Human Services secretary, has long opposed federal funding of embryonic stem cell research — a view shared by Vice President-elect Mike Pence.\u003c/p>\n\u003cp>“If the Trump administration takes a hostile mind toward embryonic stem cell research, and perhaps some kinds of important fetal research are restricted as well, it may give another source of energy to CIRM,” said Knoepfler. “I don’t think Californians like to be told what we can or cannot do, research-wise.”\u003c/p>\n\u003cp>[ad floatright]\u003c/p>\n\u003cp>\u003cem>This \u003ca href=\"https://www.statnews.com/2017/01/19/california-stem-cell-agency-cirm/\" target=\"_blank\">story\u003c/a> was originally published by STAT, an online publication of Boston Globe Media that covers health, medicine and scientific discovery.\u003c/em>\u003c/p>\n\n",
"disqusIdentifier": "322634 https://ww2.kqed.org/futureofyou/?p=322634",
"disqusUrl": "https://ww2.kqed.org/futureofyou/2017/01/20/time-running-out-california-stem-cell-agency-yet-to-produce-big-results/",
"stats": {
"hasVideo": false,
"hasChartOrMap": false,
"hasAudio": false,
"hasPolis": false,
"wordCount": 2723,
"hasGoogleForm": false,
"hasGallery": false,
"hasHearkenModule": false,
"iframeSrcs": [],
"paragraphCount": 51
},
"modified": 1484950180,
"excerpt": "California's $3 billion stem cell initiative was sold to voters with the pitch that the investment would rapidly yield cures for devastating diseases like Parkinson’s and ALS. That hasn’t happened.",
"headData": {
"twImgId": "",
"twTitle": "",
"ogTitle": "",
"ogImgId": "",
"twDescription": "",
"description": "California's $3 billion stem cell initiative was sold to voters with the pitch that the investment would rapidly yield cures for devastating diseases like Parkinson’s and ALS. That hasn’t happened.",
"title": "Time Running Out, California Stem Cell Agency Yet to Produce Big Results | KQED",
"ogDescription": "",
"schema": {
"@context": "https://schema.org",
"@type": "Article",
"headline": "Time Running Out, California Stem Cell Agency Yet to Produce Big Results",
"datePublished": "2017-01-20T08:47:40-08:00",
"dateModified": "2017-01-20T14:09:40-08:00",
"image": "https://cdn.kqed.org/wp-content/uploads/2020/02/KQED-OG-Image@1x.png"
}
},
"guestAuthors": [],
"slug": "time-running-out-california-stem-cell-agency-yet-to-produce-big-results",
"status": "publish",
"nprByline": "Charles Piller\u003cbr />\u003cA HREF=\"https://www.statnews.com/\">STAT\u003c/A>",
"source": "\u003ca href=\"https://www.statnews.com/2017/01/19/california-stem-cell-agency-cirm/\">STAT\u003c/a>",
"path": "/futureofyou/322634/time-running-out-california-stem-cell-agency-yet-to-produce-big-results",
"audioTrackLength": null,
"parsedContent": [
{
"type": "contentString",
"content": "\u003cdiv class=\"post-body\">\u003cp>\u003cp>It’s been more than a decade since California launched an unprecedented experiment in medical research by direct democracy, when voters created a $3 billion fund to kick-start the hunt for stem cell therapies.\u003c/p>\n\u003cp>The bold plan, a response to federal funding limits for embryonic stem cell research, was sold with a simple pitch: The money would rapidly yield cures for devastating human diseases such as Parkinson’s and ALS.\u003c/p>\n\u003cp>That hasn’t happened.\u003c/p>\n\u003cp>\u003c/p>\u003cp>\u003c/p>\u003cp>A major reason, a STAT examination found, is that the \u003ca href=\"https://www.cirm.ca.gov/\" target=\"_blank\">California Institute for Regenerative Medicine\u003c/a> has been slow to move promising experimental therapies into clinical trials. The National Institutes of Health has supported three and a half times as many human trials of stem cell therapies, dollar for dollar, as the California agency has funded since it started making grants in 2006. Just two of its clinical trials have been completed.\u003c/p>\n\u003cp>“I am floored by the disparity,” said Jim Lott, a health care consultant and member of the state board that monitors the agency, known as CIRM. If the numbers are correct, he told STAT, “that doesn’t settle well with me as a voter. That doesn’t settle well with me as a taxpayer. That doesn’t settle well with me as a member of the oversight committee.”\u003c/p>\n\u003cp>\u003c/p>\u003c/div>",
"attributes": {
"named": {},
"numeric": []
}
},
{
"type": "component",
"content": "",
"name": "ad",
"attributes": {
"named": {
"label": "fullwidth"
},
"numeric": [
"fullwidth"
]
}
},
{
"type": "contentString",
"content": "\u003cdiv class=\"post-body\">\u003cp>\u003c/p>\n\u003cp>CIRM has used most of the $2.2 billion in grants it has distributed so far to build labs and pay for basic research at public and private universities, such as Stanford and the University of Southern California, and private companies.\u003c/p>\n\u003cp>It has given more than $300 million to 27 projects that include clinical trials — though much of that funding also supported preclinical work. Meanwhile, the agency has committed about $540 million to new labs and buildings.\u003c/p>\n\u003cp>In part, that’s because its directors chose to focus on infrastructure early on, as well as bench experiments and animal studies given that the biology of embryonic stem cells was not well-understood and there are formidable roadblocks to moving into human studies. Much more is known about the bone marrow stem cells that are the focus of many NIH-funded clinical trials.\u003c/p>\n\u003cp>But critics have noted that many top grantees come from institutions that hold seats on CIRM’s governing board. The respected Institute of Medicine, in a 2013 \u003ca href=\"https://www.nap.edu/catalog/13523/the-california-institute-for-regenerative-medicine-science-governance-and-the\" target=\"_blank\">review\u003c/a>, said institutionalized conflicts of interest have raised questions about “the integrity and independence of some of CIRM’s decisions.” CIRM later enacted reforms that barred board members from voting directly on grants for their institutions. But the changes didn’t prevent other financial \u003ca href=\"http://www.latimes.com/business/hiltzik/la-fi-hiltzik-20140720-column.html\" target=\"_blank\">conflicts\u003c/a> involving \u003ca href=\"http://californiastemcellreport.blogspot.com/2016/09/alan-trounson-former-ceo-of-california.html\" target=\"_blank\">CIRM officers and grantees\u003c/a>, and the flow of funds to board members’ institutions continued unabated.\u003c/p>\n\u003cfigure id=\"attachment_322983\" class=\"wp-caption aligncenter\" style=\"max-width: 979px\">\u003ca href=\"https://ww2.kqed.org/futureofyou/wp-content/uploads/sites/13/2017/01/CIRM.jpg\">\u003cimg class=\"wp-image-322983 size-full\" src=\"https://ww2.kqed.org/futureofyou/wp-content/uploads/sites/13/2017/01/CIRM.jpg\" alt=\"CIRM\" width=\"979\" height=\"462\" srcset=\"https://ww2.kqed.org/app/uploads/sites/13/2017/01/CIRM.jpg 979w, https://ww2.kqed.org/app/uploads/sites/13/2017/01/CIRM-160x76.jpg 160w, https://ww2.kqed.org/app/uploads/sites/13/2017/01/CIRM-800x378.jpg 800w, https://ww2.kqed.org/app/uploads/sites/13/2017/01/CIRM-768x362.jpg 768w, https://ww2.kqed.org/app/uploads/sites/13/2017/01/CIRM-960x453.jpg 960w, https://ww2.kqed.org/app/uploads/sites/13/2017/01/CIRM-240x113.jpg 240w, https://ww2.kqed.org/app/uploads/sites/13/2017/01/CIRM-375x177.jpg 375w, https://ww2.kqed.org/app/uploads/sites/13/2017/01/CIRM-520x245.jpg 520w\" sizes=\"(max-width: 979px) 100vw, 979px\">\u003c/a>\u003cfigcaption class=\"wp-caption-text\">Sources: California Institute for Regenerative Medicine, National Institutes of Health. \u003cspan class=\"media-source\">*Several CIRM trials included here were announced shortly after Sept. 30, 2016, the cut-off for the NIH data. **NIH spending for 2006 and 2007 is estimated because exact figures were unavailable.\u003c/span>NATALIA BRONSHTEIN/STAT\u003c/figcaption>\u003c/figure>\n\u003cp>“You could make an argument that California taxpayer money should go to build new facilities on state university campuses,” said Marcy Darnovsky, who directs the Berkeley-based Center for Genetics and Society, a public affairs nonprofit. “But I don’t see an argument for Stanford getting fancy new buildings from California taxpayer money.”\u003c/p>\n\u003cp>Stanford, whose endowment is among the top five nationally, and USC have received more than $70\u003cstrong> \u003c/strong>million for major building projects, and hundreds of millions more for labs and research. Stanford alone has been favored with $1 out of every $7 CIRM has approved.\u003c/p>\n\u003cp>But scientists outside California said CIRM’s record is a strong one. CIRM-funded researchers have published nearly 2,000 scholarly papers. That output has helped vault California into the top ranks of stem cell science, said Dr. George Daley, the new dean of Harvard Medical School and a leading stem cell scientist who describes himself as an informal adviser and cheerleader for CIRM. “When I look at the progress my colleagues have made in California, I am duly awed,” he said.\u003c/p>\n\u003cp>The institute announced a year ago that it would reinvent itself to emphasize clinical research until it runs out of money in 2020 — unless voters grant a new infusion of cash. CIRM plans to fund 50 new trials with its remaining $692 million, of which 10 were announced in 2016. Just 17 trials were funded in its first decade of grants.\u003c/p>\n\u003cp>C. Randal Mills, CIRM’s CEO since 2014 and architect of its new strategy, said he welcomed comparisons that help benchmark CIRM’s progress. Mills, former head of Osiris Therapeutics, the first company to commercialize an approved stem cell treatment, declined to comment on STAT’s specific findings, but defended the initial emphasis on labs and basic science as underpinning future clinical work.\u003c/p>\n\u003cp>“We’re running our own race. … What we have to do is just continually get better” to benefit patients, Mills said in an interview. “If we’re behind [NIH], we’re going to get better.”\u003c/p>\n\u003cp>Lott’s teenage daughter was paralyzed in an automobile crash and he hopes for a stem cell cure. He supports the goals of CIRM and applauds much of its work, but he now has second thoughts about the governance structure, which allows board members’ institutions to benefit from CIRM grants, as well as its financing. The ballot question that created CIRM, Proposition 71, authorized bond sales to pay for the agency’s budget, raising the total cost for taxpayers to $6 billion including interest. Financial experts, however, said that relatively low interest rates paid on long-term bonds can offer advantages over funding so large a venture directly from state coffers.\u003c/p>\n\u003cp>Asked whether he would support a similar ballot measure today, Lott said, “We were all caught up in the time, and the events were different when we first looked at this. But not today. Not at all.”\u003c/p>\n\u003cp>\u003cstrong>'Lives Will Be Saved'\u003c/strong>\u003c/p>\n\u003cp>Californians emphatically supported CIRM, creating the stem cell colossus with 59 percent of the vote in 2004. Many were upset that President George W. Bush had sharply limited federal funding for work with embryonic stem cells, which are derived from early human embryos and able to develop into any type of tissue or organ.\u003c/p>\n\u003cp>But Proposition 71 also won because it was shamelessly oversold, consumer advocates and science policy experts said. Desperate patients, Nobel laureates, and A-list celebrities such as \u003ca href=\"https://www.statnews.com/2016/08/30/parkinsons-study-fox-foundation-feud/\" target=\"_blank\">Michael J. Fox\u003c/a> — the Hollywood star and Parkinson’s sufferer — predicted “cures” that would “save millions of lives.”\u003c/p>\n\u003cp>“There are more Americans than … we can count who are sick now, or are going to be sick in the future, whose lives will be saved by Prop 71,” patient advocate Joan Samuelson said in another ad. The sponsors of the measure also predicted that CIRM-generated cures would drastically reduce health care spending. No one made specific promises for the 10-year timeframe initially planned for CIRM’s work, but miracles seemed just around the corner.\u003c/p>\n\u003cp>“You can support embryonic stem cell research, which we do and did, and still be pretty appalled by what was going down,” said Darnovsky. “The airwaves were swamped with guys in white coats who were identified with their academic affiliation even though they were principals of private companies (some of which later got CIRM grants), and basically saying, ‘We’re going to have cures by Christmas.’”\u003c/p>\n\u003cp>Mills, who was not involved at the agency’s genesis, called the idea sold to voters — impending, sweeping breakthroughs — “naïve.” Radical medical change usually takes decades from idea to cure.\u003c/p>\n\u003cp>“But here we are,” he said. “My sole mission is to create as much value for the resources we have left, for the people of California, that I can.”\u003c/p>\n\u003cp>\u003cstrong>California vs. NIH\u003c/strong>\u003c/p>\n\u003cp>Even under Bush-era restrictions — rescinded after President Barack Obama took office — the NIH continued to support substantial stem cell research.\u003c/p>\n\u003cp>Since 2006, it has spent $13.4 billion on stem cell science, six times CIRM’s budget during that period. But NIH fully or partly funded 571 clinical trials, according to STAT’s review — more than 20 times the number backed by California.\u003c/p>\n\u003cp>While NIH in that period funded 50 Phase 3 clinical trials of stem cell therapies — generally the last step before seeking approval to market a product — CIRM has supported just three.\u003c/p>\n\u003cp>One, the study of a treatment for skin cancer involving immune system cells, was terminated by Caladrius Biosciences, the grantee, when it determined that existing treatments had overtaken its approach. The others — testing altered immune cells to treat brain cancer and bioengineered veins to manage vascular problems — show promise, but are still recruiting patients and will not be completed for several years, according to the NIH website, ClinicalTrials.gov.\u003c/p>\n\u003cp>Daley called the NIH comparison “a little unfair,” because that agency emphasized hematopoietic stem cells — blood-forming cells from bone marrow, which had been studied for decades — unlike CIRM’s sharper focus on cutting-edge embryonic stem cells. A little more than half of CIRM’s awards have gone to support research on embryonic or induced pluripotent stem cells, which are created by modifying adult stem cells to act like embryonic ones. It gave about a quarter of its awards to support adult stem cell work, and the rest for other research areas.\u003c/p>\n\u003cp>“In the early days of CIRM, the feeling was that the field needed deep and direct investments in the … fundamental foundation of stem cell biology, because the translational opportunities were not yet mature, certainly not using embryonic or induced pluripotent stem cells,” Daley said.\u003c/p>\n\u003cp>\u003ca href=\"https://www.statnews.com/2016/01/30/paul-knoepfler/\" target=\"_blank\">Paul Knoepfler\u003c/a>, a University of California, Davis, researcher and CIRM grantee who writes a popular \u003ca href=\"http://www.ipscell.com/\" target=\"_blank\">stem cell blog\u003c/a>, agreed. “One almost had to invent a system for figuring out what would be a safe way to proceed with embryonic stem cell clinical trials because those cells are really much more powerful and also have different kinds of risks,” he said.\u003c/p>\n\u003cp>Knoepfler said he expected the basic science to spark clinical breakthroughs in time, citing, for example, promising early work on reversing paralysis from Asterias Biotherapeutics, located in Fremont, southeast of San Francisco. Jake Javier, a patient in a CIRM-supported Asterias trial, lost almost all use of his limbs in an accident diving into a swimming pool. He recently received an injection of a type of cell derived from embryonic stem cells that can help protect nerve cells damaged in spinal cord injuries. Javier has since regained some\u003cstrong> \u003c/strong>use of his arms — one of five patients in early trials who have shown improvement that CIRM and the researchers attribute to the treatment. The results have not yet been published in a peer-reviewed journal.\u003c/p>\n\u003cp>In addition, Mills noted that grants for new labs included provisions that required grantees to raise other funds — to “leverage” economic benefits to taxpayers — and to assist future trials. The institute, for example, gave $30 million to the contract research firm Quintiles to create facilities that will conduct preclinical research, manage regulatory issues, and provide clinical support for CIRM-supported stem cell trials, all at a steep discount.\u003c/p>\n\u003cp>“There is no iPhone 4 without an iPhone 3 or a 2 or a 1,” Mills said. But in a world where technology advances rapidly — Apple is already selling the iPhone 7, after all — voters are still waiting for the promised cures.\u003c/p>\n\u003cfigure id=\"attachment_322991\" class=\"wp-caption alignright\" style=\"max-width: 384px\">\u003ca href=\"https://ww2.kqed.org/futureofyou/wp-content/uploads/sites/13/2017/01/evangelina.jpg\">\u003cimg class=\"size-full wp-image-322991\" src=\"https://ww2.kqed.org/futureofyou/wp-content/uploads/sites/13/2017/01/evangelina.jpg\" alt=\"Evangelina Padilla Vaccaro in November 2016.\" width=\"384\" height=\"576\" srcset=\"https://ww2.kqed.org/app/uploads/sites/13/2017/01/evangelina.jpg 384w, https://ww2.kqed.org/app/uploads/sites/13/2017/01/evangelina-160x240.jpg 160w, https://ww2.kqed.org/app/uploads/sites/13/2017/01/evangelina-240x360.jpg 240w, https://ww2.kqed.org/app/uploads/sites/13/2017/01/evangelina-375x563.jpg 375w\" sizes=\"(max-width: 384px) 100vw, 384px\">\u003c/a>\u003cfigcaption class=\"wp-caption-text\">Evangelina Padilla Vaccaro in November 2016. \u003ccite>(Nancy Ramos)\u003c/cite>\u003c/figcaption>\u003c/figure>\n\u003cp>So far, CIRM has one literal poster child to show it can deliver. Four-year-old Evangelina Padilla Vaccaro, featured on the cover of CIRM’s recent \u003ca href=\"https://www.cirm.ca.gov/about-cirm/2016-annual-report\" target=\"_blank\">annual report\u003c/a>, was born with severe combined immunodeficiency. She had no operating immune system. Some such children have been kept alive in sterile isolation tents for a time — hence the term, “bubble baby” — but most have died from infections within a few years. A lucky few who received matching bone-marrow transplants survived.\u003c/p>\n\u003cp>UCLA’s Dr. Donald Kohn, supported by CIRM, cured Evangelina by extracting some of her blood stem cells, altering them to correct the genetic defect, and returning them to her body. She’s now thriving with a robust immune system.\u003c/p>\n\u003cp>That little girl, and 29 children like her, “are getting immunizations, they’re going to school, they’re swimming in public swimming pools, they’re eating dirt, they’re doing all the things that little kids are supposed to do,” said Steven Peckman, associate director of UCLA’s Broad Center of Regenerative Medicine and Stem Cell Research. “They get sick and their own bodies attack those viruses and bacteria. And they survive. If there’s going to be something that’s called a cure, this is it.”\u003c/p>\n\u003cp>That inspiring triumph was partly funded by CIRM, but Kohn’s work took three decades, was well underway long before CIRM existed, and didn’t involve embryonic stem cells — the key gap CIRM was founded to fill. Evangelina was saved by hematopoietic stem cells, the type that NIH has been more focused on.\u003c/p>\n\u003cp>\u003cstrong>Racing the Clock\u003c/strong>\u003c/p>\n\u003cp>As much as Mills defends the old CIRM, last year he announced “CIRM 2.0” — a drastic shift to speed up clinical trials before the organization’s clock runs out.\u003c/p>\n\u003cp>Asked whether Californians are getting good value for their money from CIRM, Mills cited economic gains to the state, then added: “I focus a lot more on the return in relief of human suffering. We’re just starting to lift off the ground on that. I hope in history, in time, the record shows CIRM was a great deal.”\u003c/p>\n\u003cp>To that end, CIRM has said it will focus in 2017 primarily on clinical trials and work it hopes will lay the foundation for such studies.\u003c/p>\n\u003cp>If the studies show clear results, Mills said, “I think it will be self-evident that CIRM should be continued” with new funding.\u003c/p>\n\u003cp>Lott, the state overseer, called CIRM 2.0 long overdue. “They needed to at least create something a little more tangible, more specifically measurable, for the billions of dollars that they’ve allocated,” he said. “But it may be a little too late,” he added, to convince taxpayers that CIRM should get a new infusion of funds, given its governance structure.\u003c/p>\n\u003cp>Even Daley — unbridled in his enthusiasm for CIRM’s work — hesitated when asked if it was a model to emulate, though for a different reason. “I reluctantly endorse it,” he said, “in part because I think it’s another argument that allows the federal government and the NIH to abdicate its responsibility for investments in biomedical research, which benefits us all.”\u003c/p>\n\u003cp>Yet, just as President Bush’s policy on stem cells led to CIRM’s creation, the incoming Trump administration might bail out the institute just in time. The president-elect has not weighed in on federal funding, but Representative Tom Price, his nominee for Health and Human Services secretary, has long opposed federal funding of embryonic stem cell research — a view shared by Vice President-elect Mike Pence.\u003c/p>\n\u003cp>“If the Trump administration takes a hostile mind toward embryonic stem cell research, and perhaps some kinds of important fetal research are restricted as well, it may give another source of energy to CIRM,” said Knoepfler. “I don’t think Californians like to be told what we can or cannot do, research-wise.”\u003c/p>\n\u003cp>\u003c/p>\u003c/div>",
"attributes": {
"named": {},
"numeric": []
}
},
{
"type": "component",
"content": "",
"name": "ad",
"attributes": {
"named": {
"label": "floatright"
},
"numeric": [
"floatright"
]
}
},
{
"type": "contentString",
"content": "\u003cdiv class=\"post-body\">\u003cp>\u003c/p>\n\u003cp>\u003cem>This \u003ca href=\"https://www.statnews.com/2017/01/19/california-stem-cell-agency-cirm/\" target=\"_blank\">story\u003c/a> was originally published by STAT, an online publication of Boston Globe Media that covers health, medicine and scientific discovery.\u003c/em>\u003c/p>\n\n\u003c/div>\u003c/p>",
"attributes": {
"named": {},
"numeric": []
}
}
],
"link": "/futureofyou/322634/time-running-out-california-stem-cell-agency-yet-to-produce-big-results",
"authors": [
"byline_futureofyou_322634"
],
"categories": [
"futureofyou_1062",
"futureofyou_1",
"futureofyou_73"
],
"tags": [
"futureofyou_961",
"futureofyou_80",
"futureofyou_680"
],
"featImg": "futureofyou_188656",
"label": "source_futureofyou_322634"
},
"science_1338482": {
"type": "posts",
"id": "science_1338482",
"meta": {
"index": "posts_1716263798",
"site": "science",
"id": "1338482",
"score": null,
"sort": [
1484947644000
]
},
"parent": 0,
"labelTerm": {
"site": "science"
},
"blocks": [],
"publishDate": 1484947644,
"format": "standard",
"title": "White House Removes Climate Change Webpage After Trump's Inauguration",
"headTitle": "White House Removes Climate Change Webpage After Trump’s Inauguration | KQED",
"content": "\u003cp>Well, that didn’t take long.\u003c/p>\n\u003cp>The morning of President Trump’s inauguration, several \u003ca href=\"https://www.whitehouse.gov/\">webpages outlining official policy and priorities on the White House website \u003c/a>were removed or replaced with new text. Those pages include information about LGBT rights, civil rights, law enforcement and climate change.\u003c/p>\n\u003cp>It’s not unusual for an incoming administration to change material on the whitehouse.gov site. But it’s also a window into the new president’s priorities and how he might frame various solutions to the nation’s problems.\u003c/p>\n\u003cp>According to a javascript program run by KQED, the climate change page on the White House website kicked the bucket at 11:52 a.m. EST.\u003c/p>\n\u003cfigure id=\"attachment_1338617\" class=\"wp-caption aligncenter\" style=\"max-width: 800px\">\u003ca href=\"https://ww2.kqed.org/science/wp-content/uploads/sites/35/2017/01/whitehousechange.jpg\">\u003cimg loading=\"lazy\" decoding=\"async\" class=\"size-medium wp-image-1338617\" src=\"https://ww2.kqed.org/science/wp-content/uploads/sites/35/2017/01/whitehousechange-800x608.jpg\" alt=\"Websites accessed at 12:40 p.m. PST, Jan. 20, 2017.\" width=\"800\" height=\"608\" srcset=\"https://cdn.kqed.org/wp-content/uploads/sites/35/2017/01/whitehousechange.jpg 800w, https://cdn.kqed.org/wp-content/uploads/sites/35/2017/01/whitehousechange-160x122.jpg 160w, https://cdn.kqed.org/wp-content/uploads/sites/35/2017/01/whitehousechange-768x584.jpg 768w, https://cdn.kqed.org/wp-content/uploads/sites/35/2017/01/whitehousechange-240x182.jpg 240w, https://cdn.kqed.org/wp-content/uploads/sites/35/2017/01/whitehousechange-375x285.jpg 375w, https://cdn.kqed.org/wp-content/uploads/sites/35/2017/01/whitehousechange-520x395.jpg 520w\" sizes=\"(max-width: 800px) 100vw, 800px\">\u003c/a>\u003cfigcaption class=\"wp-caption-text\">Websites accessed at 12:40 p.m. PST, Jan. 20, 2017.\u003c/figcaption>\u003c/figure>\n\u003cp>Following the page’s removal, a new energy website appeared with the title “\u003ca href=\"https://www.whitehouse.gov/america-first-energy\" target=\"_blank\" rel=\"noopener\">An America First Energy Plan\u003c/a>.” It outlines the administration’s goals to exploit oil and gas reserves and to revive the coal industry.\u003c/p>\n\u003cp>[ad fullwidth]\u003c/p>\n\u003cp>Ironically — or not — the page change comes during the same week \u003ca href=\"https://www.nasa.gov/\" target=\"_blank\" rel=\"noopener\">NASA\u003c/a> and \u003ca href=\"http://www.noaa.gov/\" target=\"_blank\" rel=\"noopener\">NOAA\u003c/a> reported that global warming contributed to 2016 being \u003ca href=\"https://ww2.kqed.org/science/2017/01/18/global-warming-drives-record-heat-for-third-straight-year/\" target=\"_blank\" rel=\"noopener\">the hottest year since modern record keeping began\u003c/a> in 1880. (The main contributor to global warming is the burning of fossil fuels.) Scientists have been fearful that the Trump administration would destroy climate change data, and have begun \u003ca href=\"http://www.npr.org/2016/12/14/505592206/scientists-race-to-preserve-climate-change-data-before-trump-takes-office\" target=\"_blank\" rel=\"noopener\">archiving and saving historical climate records\u003c/a>.\u003c/p>\n\u003cp>On Twitter many reacted to removal of the White House climate change site. The Wall Street Journal’s energy policy reporter, Amy Harder, for instance eulogized:\u003c/p>\n\u003cp>https://twitter.com/AmyAHarder/status/822495092367884290\u003c/p>\n\u003cp>You can find the old Obama administration\u003ca href=\"https://obamawhitehouse.archives.gov/\"> whitehouse.gov page here. \u003c/a>\u003c/p>\n\u003cp>\u003cstrong>Trump administration website accessed at 12:40 p.m.:\u003c/strong>\u003cbr>\n\u003ca href=\"https://ww2.kqed.org/science/wp-content/uploads/sites/35/2017/01/Screen-Shot-2017-01-20-at-12.42.15-PM.png\">\u003cimg loading=\"lazy\" decoding=\"async\" class=\"aligncenter size-medium wp-image-1338616\" src=\"https://ww2.kqed.org/science/wp-content/uploads/sites/35/2017/01/Screen-Shot-2017-01-20-at-12.42.15-PM-800x1106.png\" alt=\"Screen Shot 2017-01-20 at 12.42.15 PM\" width=\"800\" height=\"1106\" srcset=\"https://cdn.kqed.org/wp-content/uploads/sites/35/2017/01/Screen-Shot-2017-01-20-at-12.42.15-PM-800x1106.png 800w, https://cdn.kqed.org/wp-content/uploads/sites/35/2017/01/Screen-Shot-2017-01-20-at-12.42.15-PM-160x221.png 160w, https://cdn.kqed.org/wp-content/uploads/sites/35/2017/01/Screen-Shot-2017-01-20-at-12.42.15-PM-768x1062.png 768w, https://cdn.kqed.org/wp-content/uploads/sites/35/2017/01/Screen-Shot-2017-01-20-at-12.42.15-PM-240x332.png 240w, https://cdn.kqed.org/wp-content/uploads/sites/35/2017/01/Screen-Shot-2017-01-20-at-12.42.15-PM-375x518.png 375w, https://cdn.kqed.org/wp-content/uploads/sites/35/2017/01/Screen-Shot-2017-01-20-at-12.42.15-PM-520x719.png 520w, https://cdn.kqed.org/wp-content/uploads/sites/35/2017/01/Screen-Shot-2017-01-20-at-12.42.15-PM.png 847w\" sizes=\"(max-width: 800px) 100vw, 800px\">\u003c/a>\u003c/p>\n\u003cp>\u003c/p>\n\u003cp>\u003cstrong>Obama administration website accessed at 12:40 p.m.:\u003c/strong>\u003cbr>\n\u003ca href=\"https://ww2.kqed.org/science/wp-content/uploads/sites/35/2017/01/Screen-Shot-2017-01-20-at-12.41.47-PM.png\">\u003cimg loading=\"lazy\" decoding=\"async\" class=\"aligncenter size-medium wp-image-1338615\" src=\"https://ww2.kqed.org/science/wp-content/uploads/sites/35/2017/01/Screen-Shot-2017-01-20-at-12.41.47-PM-800x1156.png\" alt=\"Screen Shot 2017-01-20 at 12.41.47 PM\" width=\"800\" height=\"1156\" srcset=\"https://cdn.kqed.org/wp-content/uploads/sites/35/2017/01/Screen-Shot-2017-01-20-at-12.41.47-PM-800x1156.png 800w, https://cdn.kqed.org/wp-content/uploads/sites/35/2017/01/Screen-Shot-2017-01-20-at-12.41.47-PM-160x231.png 160w, https://cdn.kqed.org/wp-content/uploads/sites/35/2017/01/Screen-Shot-2017-01-20-at-12.41.47-PM-768x1109.png 768w, https://cdn.kqed.org/wp-content/uploads/sites/35/2017/01/Screen-Shot-2017-01-20-at-12.41.47-PM-240x347.png 240w, https://cdn.kqed.org/wp-content/uploads/sites/35/2017/01/Screen-Shot-2017-01-20-at-12.41.47-PM-375x542.png 375w, https://cdn.kqed.org/wp-content/uploads/sites/35/2017/01/Screen-Shot-2017-01-20-at-12.41.47-PM-520x751.png 520w, https://cdn.kqed.org/wp-content/uploads/sites/35/2017/01/Screen-Shot-2017-01-20-at-12.41.47-PM.png 846w\" sizes=\"(max-width: 800px) 100vw, 800px\">\u003c/a>\u003c/p>\n\n",
"stats": {
"hasVideo": false,
"hasChartOrMap": false,
"hasAudio": false,
"hasPolis": false,
"wordCount": 314,
"hasGoogleForm": false,
"hasGallery": false,
"hasHearkenModule": false,
"iframeSrcs": [],
"paragraphCount": 12
},
"modified": 1704929169,
"excerpt": "The government's climate change page, like the Obama administration, is gone. ",
"headData": {
"twImgId": "",
"twTitle": "",
"ogTitle": "",
"ogImgId": "",
"twDescription": "",
"description": "The government's climate change page, like the Obama administration, is gone. ",
"title": "White House Removes Climate Change Webpage After Trump's Inauguration | KQED",
"ogDescription": "",
"schema": {
"@context": "https://schema.org",
"@type": "Article",
"headline": "White House Removes Climate Change Webpage After Trump's Inauguration",
"datePublished": "2017-01-20T13:27:24-08:00",
"dateModified": "2024-01-10T15:26:09-08:00",
"image": "https://cdn.kqed.org/wp-content/uploads/2020/02/KQED-OG-Image@1x.png"
}
},
"guestAuthors": [],
"slug": "white-house-removes-climate-change-webpage-after-trumps-inauguration",
"status": "publish",
"sticky": false,
"path": "/science/1338482/white-house-removes-climate-change-webpage-after-trumps-inauguration",
"audioTrackLength": null,
"parsedContent": [
{
"type": "contentString",
"content": "\u003cdiv class=\"post-body\">\u003cp>\u003cp>Well, that didn’t take long.\u003c/p>\n\u003cp>The morning of President Trump’s inauguration, several \u003ca href=\"https://www.whitehouse.gov/\">webpages outlining official policy and priorities on the White House website \u003c/a>were removed or replaced with new text. Those pages include information about LGBT rights, civil rights, law enforcement and climate change.\u003c/p>\n\u003cp>It’s not unusual for an incoming administration to change material on the whitehouse.gov site. But it’s also a window into the new president’s priorities and how he might frame various solutions to the nation’s problems.\u003c/p>\n\u003cp>According to a javascript program run by KQED, the climate change page on the White House website kicked the bucket at 11:52 a.m. EST.\u003c/p>\n\u003cfigure id=\"attachment_1338617\" class=\"wp-caption aligncenter\" style=\"max-width: 800px\">\u003ca href=\"https://ww2.kqed.org/science/wp-content/uploads/sites/35/2017/01/whitehousechange.jpg\">\u003cimg loading=\"lazy\" decoding=\"async\" class=\"size-medium wp-image-1338617\" src=\"https://ww2.kqed.org/science/wp-content/uploads/sites/35/2017/01/whitehousechange-800x608.jpg\" alt=\"Websites accessed at 12:40 p.m. PST, Jan. 20, 2017.\" width=\"800\" height=\"608\" srcset=\"https://cdn.kqed.org/wp-content/uploads/sites/35/2017/01/whitehousechange.jpg 800w, https://cdn.kqed.org/wp-content/uploads/sites/35/2017/01/whitehousechange-160x122.jpg 160w, https://cdn.kqed.org/wp-content/uploads/sites/35/2017/01/whitehousechange-768x584.jpg 768w, https://cdn.kqed.org/wp-content/uploads/sites/35/2017/01/whitehousechange-240x182.jpg 240w, https://cdn.kqed.org/wp-content/uploads/sites/35/2017/01/whitehousechange-375x285.jpg 375w, https://cdn.kqed.org/wp-content/uploads/sites/35/2017/01/whitehousechange-520x395.jpg 520w\" sizes=\"(max-width: 800px) 100vw, 800px\">\u003c/a>\u003cfigcaption class=\"wp-caption-text\">Websites accessed at 12:40 p.m. PST, Jan. 20, 2017.\u003c/figcaption>\u003c/figure>\n\u003cp>Following the page’s removal, a new energy website appeared with the title “\u003ca href=\"https://www.whitehouse.gov/america-first-energy\" target=\"_blank\" rel=\"noopener\">An America First Energy Plan\u003c/a>.” It outlines the administration’s goals to exploit oil and gas reserves and to revive the coal industry.\u003c/p>\n\u003cp>\u003c/p>\u003c/div>",
"attributes": {
"named": {},
"numeric": []
}
},
{
"type": "component",
"content": "",
"name": "ad",
"attributes": {
"named": {
"label": "fullwidth"
},
"numeric": [
"fullwidth"
]
}
},
{
"type": "contentString",
"content": "\u003cdiv class=\"post-body\">\u003cp>\u003c/p>\n\u003cp>Ironically — or not — the page change comes during the same week \u003ca href=\"https://www.nasa.gov/\" target=\"_blank\" rel=\"noopener\">NASA\u003c/a> and \u003ca href=\"http://www.noaa.gov/\" target=\"_blank\" rel=\"noopener\">NOAA\u003c/a> reported that global warming contributed to 2016 being \u003ca href=\"https://ww2.kqed.org/science/2017/01/18/global-warming-drives-record-heat-for-third-straight-year/\" target=\"_blank\" rel=\"noopener\">the hottest year since modern record keeping began\u003c/a> in 1880. (The main contributor to global warming is the burning of fossil fuels.) Scientists have been fearful that the Trump administration would destroy climate change data, and have begun \u003ca href=\"http://www.npr.org/2016/12/14/505592206/scientists-race-to-preserve-climate-change-data-before-trump-takes-office\" target=\"_blank\" rel=\"noopener\">archiving and saving historical climate records\u003c/a>.\u003c/p>\n\u003cp>On Twitter many reacted to removal of the White House climate change site. The Wall Street Journal’s energy policy reporter, Amy Harder, for instance eulogized:\u003c/p>\u003c/p>\u003c/div>",
"attributes": {
"named": {},
"numeric": []
}
},
{
"type": "component",
"content": "",
"name": "singleTwitterStatus",
"attributes": {
"named": {
"id": "822495092367884290"
},
"numeric": []
}
},
{
"type": "contentString",
"content": "\u003cdiv class=\"post-body\">\u003cp>\n\u003cp>You can find the old Obama administration\u003ca href=\"https://obamawhitehouse.archives.gov/\"> whitehouse.gov page here. \u003c/a>\u003c/p>\n\u003cp>\u003cstrong>Trump administration website accessed at 12:40 p.m.:\u003c/strong>\u003cbr>\n\u003ca href=\"https://ww2.kqed.org/science/wp-content/uploads/sites/35/2017/01/Screen-Shot-2017-01-20-at-12.42.15-PM.png\">\u003cimg loading=\"lazy\" decoding=\"async\" class=\"aligncenter size-medium wp-image-1338616\" src=\"https://ww2.kqed.org/science/wp-content/uploads/sites/35/2017/01/Screen-Shot-2017-01-20-at-12.42.15-PM-800x1106.png\" alt=\"Screen Shot 2017-01-20 at 12.42.15 PM\" width=\"800\" height=\"1106\" srcset=\"https://cdn.kqed.org/wp-content/uploads/sites/35/2017/01/Screen-Shot-2017-01-20-at-12.42.15-PM-800x1106.png 800w, https://cdn.kqed.org/wp-content/uploads/sites/35/2017/01/Screen-Shot-2017-01-20-at-12.42.15-PM-160x221.png 160w, https://cdn.kqed.org/wp-content/uploads/sites/35/2017/01/Screen-Shot-2017-01-20-at-12.42.15-PM-768x1062.png 768w, https://cdn.kqed.org/wp-content/uploads/sites/35/2017/01/Screen-Shot-2017-01-20-at-12.42.15-PM-240x332.png 240w, https://cdn.kqed.org/wp-content/uploads/sites/35/2017/01/Screen-Shot-2017-01-20-at-12.42.15-PM-375x518.png 375w, https://cdn.kqed.org/wp-content/uploads/sites/35/2017/01/Screen-Shot-2017-01-20-at-12.42.15-PM-520x719.png 520w, https://cdn.kqed.org/wp-content/uploads/sites/35/2017/01/Screen-Shot-2017-01-20-at-12.42.15-PM.png 847w\" sizes=\"(max-width: 800px) 100vw, 800px\">\u003c/a>\u003c/p>\n\u003cp>\u003c/p>\n\u003cp>\u003cstrong>Obama administration website accessed at 12:40 p.m.:\u003c/strong>\u003cbr>\n\u003ca href=\"https://ww2.kqed.org/science/wp-content/uploads/sites/35/2017/01/Screen-Shot-2017-01-20-at-12.41.47-PM.png\">\u003cimg loading=\"lazy\" decoding=\"async\" class=\"aligncenter size-medium wp-image-1338615\" src=\"https://ww2.kqed.org/science/wp-content/uploads/sites/35/2017/01/Screen-Shot-2017-01-20-at-12.41.47-PM-800x1156.png\" alt=\"Screen Shot 2017-01-20 at 12.41.47 PM\" width=\"800\" height=\"1156\" srcset=\"https://cdn.kqed.org/wp-content/uploads/sites/35/2017/01/Screen-Shot-2017-01-20-at-12.41.47-PM-800x1156.png 800w, https://cdn.kqed.org/wp-content/uploads/sites/35/2017/01/Screen-Shot-2017-01-20-at-12.41.47-PM-160x231.png 160w, https://cdn.kqed.org/wp-content/uploads/sites/35/2017/01/Screen-Shot-2017-01-20-at-12.41.47-PM-768x1109.png 768w, https://cdn.kqed.org/wp-content/uploads/sites/35/2017/01/Screen-Shot-2017-01-20-at-12.41.47-PM-240x347.png 240w, https://cdn.kqed.org/wp-content/uploads/sites/35/2017/01/Screen-Shot-2017-01-20-at-12.41.47-PM-375x542.png 375w, https://cdn.kqed.org/wp-content/uploads/sites/35/2017/01/Screen-Shot-2017-01-20-at-12.41.47-PM-520x751.png 520w, https://cdn.kqed.org/wp-content/uploads/sites/35/2017/01/Screen-Shot-2017-01-20-at-12.41.47-PM.png 846w\" sizes=\"(max-width: 800px) 100vw, 800px\">\u003c/a>\u003c/p>\n\n\u003c/div>\u003c/p>",
"attributes": {
"named": {},
"numeric": []
}
}
],
"link": "/science/1338482/white-house-removes-climate-change-webpage-after-trumps-inauguration",
"authors": [
"5432",
"199"
],
"categories": [
"science_31",
"science_40"
],
"featImg": "science_1338618",
"label": "science"
},
"news_11276919": {
"type": "posts",
"id": "news_11276919",
"meta": {
"index": "posts_1716263798",
"site": "news",
"id": "11276919",
"score": null,
"sort": [
1484875812000
]
},
"guestAuthors": [],
"slug": "in-trump-era-where-are-diversity-efforts-in-silicon-valley-headed",
"title": "In Trump Era, Where Are Diversity Efforts in Silicon Valley Headed?",
"publishDate": 1484875812,
"format": "standard",
"headTitle": "In Trump Era, Where Are Diversity Efforts in Silicon Valley Headed? | KQED",
"labelTerm": {
"term": 72,
"site": "news"
},
"content": "\u003cp>With high-profile companies from \u003ca href=\"https://www.wired.com/2014/10/maxine-williams/\" target=\"_blank\" rel=\"noopener noreferrer\">Facebook\u003c/a> to Airbnb making pronouncements in support of diversity, you’d think that the very people hired to address the problems inside tech companies would feel comfortable talking about the challenges of their job. Not necessarily.\u003c/p>\n\u003cp>“I don’t feel comfortable speaking freely,” said “Elizabeth” with a nervous laugh.\u003c/p>\n\u003cp>Elizabeth is African-American and works at a tech company in Silicon Valley. We’re not using her real name because she’s concerned her job could be in jeopardy if she’s identified.\u003c/p>\n\u003cp>“One of the things I consistently feel is that I’m not taken seriously because of my race,” Elizabeth said.\u003c/p>\n\u003cp>What she means is that whenever she brings up issues about diversity or raises concerns that people might be treated unfairly, the response she senses from colleagues and management is: Of course she’s gonna bring that up, she’s African-American. Then, the eye roll.\u003c/p>\n\u003cp>[ad fullwidth]\u003c/p>\n\u003cp>Elizabeth’s company makes software for industries ranging from retail to banking. As a diversity and inclusion specialist, she pushes to make sure product focus groups are diverse.\u003c/p>\n\u003cp>“Even that gets an eye roll,” she said. “Just asking for an audience that is representative of the population as opposed to who we can get now, who are the easiest people to access.”\u003c/p>\n\u003cp>[soundcloud url=”https://api.soundcloud.com/tracks/303519185″ params=”auto_play=false&hide_related=false&show_comments=true&show_user=true&show_reposts=false&visual=true” width=”100%” height=”250″ iframe=”true” /]\u003c/p>\n\u003cp>Tech companies have acknowledged the need to diversify their workforce, but despite these high-profile commitments, the road has been slow going. Diversity numbers at many tech companies have barely \u003ca href=\"http://time.com/4391031/google-diversity-statistics-2016/\" target=\"_blank\" rel=\"noopener noreferrer\">budged\u003c/a>. And people of color say while the industry talks a lot about diversity, in general it’s not a top priority and initiatives to bring about change are met with \u003ca href=\"https://www.bloomberg.com/news/articles/2017-01-09/facebook-s-hiring-process-hinders-its-effort-to-create-a-diverse-workforce\" target=\"_blank\" rel=\"noopener noreferrer\">resistance\u003c/a>.\u003c/p>\n\u003cp>Elizabeth says one important ally has been President Obama. For one thing, she says, Obama was beloved by many in Silicon Valley and so had influence. Another reason?\u003c/p>\n\u003cp>“These companies do government work, and so to be on the good side of the administration there was pressure to really commit to diversity and inclusion,” Elizabeth said.\u003c/p>\n\u003cp>Obama urged tech executives to be more inclusive of women and people of color. And in response, the CEOs of Airbnb, Lyft and Intel, among others, initiated an “\u003ca href=\"https://www.google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=2&cad=rja&uact=8&ved=0ahUKEwi-x_755s7RAhVhqlQKHQUnAxoQFggjMAE&url=https%3A%2F%2Fwww.whitehouse.gov%2Fsites%2Fwhitehouse.gov%2Ffiles%2Fimages%2FBlog%2FTech-Inclusion-Pledge-Letter-6-22-16.pdf&usg=AFQjCNEwUvITCJY6FglWsP-sW5dMYd2L8w&sig2=-QwLrC2wa_BSs1cY_XRvcw\" target=\"_blank\" rel=\"noopener noreferrer\">Inclusion Pledge\u003c/a>.”\u003c/p>\n\u003cp>To date, some \u003ca href=\"https://www.tech-inclusion.org/participants\" target=\"_blank\" rel=\"noopener noreferrer\">80\u003c/a> companies have pledged to publish annual reports on the makeup of their workforce and to put in place policies and resources to train, recruit and retain more women, blacks and Latinos.\u003c/p>\n\u003cp>Elizabeth said the pledge created a tiny bit of leverage.\u003c/p>\n\u003cp>“Signing a pledge isn’t the thing that makes companies change,” she said. “But for the people doing diversity and inclusion work, you can say, ‘Hey, this is what you stated to do and your actions better line up.’ ”\u003c/p>\n\u003cp>If Obama played good cop by cajoling and flattering tech leaders to change, the Department of Labor has been bad cop.\u003c/p>\n\u003cp>\u003ca href=\"https://www.orrick.com/People/8/F/3/Erin-M-Connell\" target=\"_blank\" rel=\"noopener noreferrer\">Erin Connell\u003c/a> practices employment law at Orrick in San Francisco and represents companies that do business with the federal government.\u003c/p>\n\u003cp>“There definitely has been a focus on the technology sector within the Department of Labor,” Connell said.\u003c/p>\n\u003cp>She says federal compliance officers have taken a tougher, more adversarial tone with tech companies. And for the first time in recent memory, the Department of Labor sued three Silicon Valley companies — \u003ca href=\"http://www.reuters.com/article/us-palantir-tech-discrimination-lawsuit-idUSKCN11W2DA\" target=\"_blank\" rel=\"noopener noreferrer\">Palantir\u003c/a>, Google and Oracle — for alleged violations of equal employment opportunity laws.\u003c/p>\n\u003cp>The companies deny wrongdoing.\u003c/p>\n\u003cp>Connell speculates that the lawsuits are the Obama administration’s last-ditch effort to try to shore up its legacy.\u003c/p>\n\u003cp>“With the inauguration right around the corner, I think they’re running out of runway,” Connell said.\u003c/p>\n\u003cp>She believes the lawsuits will continue under a Trump administration but said “hypothetically, at any time the Department of Labor could choose to no longer pursue these lawsuits.”\u003c/p>\n\u003cp>Advocates believe that’s exactly what will happen under a Trump administration and fear they’ll lose another pressure point.\u003c/p>\n\u003cp>But \u003ca href=\"http://www.kaporcapital.com/who-we-are/ellen-pao/\" target=\"_blank\" rel=\"noopener noreferrer\">Ellen Pao\u003c/a>, the chief diversity and inclusion officer at \u003ca href=\"http://www.kaporcapital.com/\" target=\"_blank\" rel=\"noopener noreferrer\">Kapor Capital\u003c/a>, is more optimistic. Pao emerged as a vocal advocate for diversity after losing a high-profile gender discrimination lawsuit against the venture capital firm Kleiner Perkins Caufield & Byers in 2015.\u003c/p>\n\u003cp>Pao says that in reaction to the election, she’s seen some tech leaders, especially at up-and-coming companies, become even more committed to diversity.\u003c/p>\n\u003cp>“I’m excited because I think these startups are going to be the next wave of successful startups,” Pao said.\u003c/p>\n\u003cp>As a co-founder of \u003ca href=\"http://projectinclude.org/\" target=\"_blank\" rel=\"noopener noreferrer\">Project Include\u003c/a>, Pao works with CEOs of early-stage startups to try to build a culture of diversity from the start.\u003c/p>\n\u003cp>“You know in tech there is still very much a herd mentality,” Pao said.\u003c/p>\n\u003cp>When these new companies become successful with a diverse and inclusive workforce, she said, Trump or no Trump, it will be that success that paves the way for real change in Silicon Valley.\u003c/p>\n\u003cp>\u003c/p>\n\u003cp>\u003cem>This story is part of our ongoing series on Techquity: Diversity, Inclusion and Equity in Silicon Valley. \u003c/em>\u003c/p>\n\n",
"blocks": [],
"excerpt": "With the departure of President Obama, diversity advocates in the tech sector are concerned that efforts will stall.",
"status": "publish",
"parent": 0,
"modified": 1721109223,
"stats": {
"hasAudio": false,
"hasVideo": false,
"hasChartOrMap": false,
"iframeSrcs": [],
"hasGoogleForm": false,
"hasGallery": false,
"hasHearkenModule": false,
"hasPolis": false,
"paragraphCount": 33,
"wordCount": 913
},
"headData": {
"title": "In Trump Era, Where Are Diversity Efforts in Silicon Valley Headed? | KQED",
"description": "With the departure of President Obama, diversity advocates in the tech sector are concerned that efforts will stall.",
"ogTitle": "",
"ogDescription": "",
"ogImgId": "",
"twTitle": "",
"twDescription": "",
"twImgId": "",
"schema": {
"@context": "https://schema.org",
"@type": "NewsArticle",
"headline": "In Trump Era, Where Are Diversity Efforts in Silicon Valley Headed?",
"datePublished": "2017-01-19T17:30:12-08:00",
"dateModified": "2024-07-15T22:53:43-07:00",
"image": "https://cdn.kqed.org/wp-content/uploads/2020/02/KQED-OG-Image@1x.png",
"isAccessibleForFree": "True",
"publisher": {
"@type": "NewsMediaOrganization",
"@id": "https://www.kqed.org/#organization",
"name": "KQED",
"logo": "https://cdn.kqed.org/wp-content/uploads/2020/02/KQED-OG-Image@1x.png",
"url": "https://www.kqed.org",
"sameAs": [
"https://www.facebook.com/KQED",
"https://twitter.com/KQED",
"https://www.instagram.com/kqed/",
"https://www.tiktok.com/@kqedofficial",
"https://www.linkedin.com/company/kqed",
"https://www.youtube.com/channel/UCeC0IOo7i1P_61zVUWbJ4nw"
]
}
}
},
"sticky": false,
"path": "/news/11276919/in-trump-era-where-are-diversity-efforts-in-silicon-valley-headed",
"audioTrackLength": null,
"parsedContent": [
{
"type": "contentString",
"content": "\u003cdiv class=\"post-body\">\u003cp>\u003cp>With high-profile companies from \u003ca href=\"https://www.wired.com/2014/10/maxine-williams/\" target=\"_blank\" rel=\"noopener noreferrer\">Facebook\u003c/a> to Airbnb making pronouncements in support of diversity, you’d think that the very people hired to address the problems inside tech companies would feel comfortable talking about the challenges of their job. Not necessarily.\u003c/p>\n\u003cp>“I don’t feel comfortable speaking freely,” said “Elizabeth” with a nervous laugh.\u003c/p>\n\u003cp>Elizabeth is African-American and works at a tech company in Silicon Valley. We’re not using her real name because she’s concerned her job could be in jeopardy if she’s identified.\u003c/p>\n\u003cp>“One of the things I consistently feel is that I’m not taken seriously because of my race,” Elizabeth said.\u003c/p>\n\u003cp>What she means is that whenever she brings up issues about diversity or raises concerns that people might be treated unfairly, the response she senses from colleagues and management is: Of course she’s gonna bring that up, she’s African-American. Then, the eye roll.\u003c/p>\n\u003cp>\u003c/p>\u003c/div>",
"attributes": {
"named": {},
"numeric": []
}
},
{
"type": "component",
"content": "",
"name": "ad",
"attributes": {
"named": {
"label": "fullwidth"
},
"numeric": [
"fullwidth"
]
}
},
{
"type": "contentString",
"content": "\u003cdiv class=\"post-body\">\u003cp>\u003c/p>\n\u003cp>Elizabeth’s company makes software for industries ranging from retail to banking. As a diversity and inclusion specialist, she pushes to make sure product focus groups are diverse.\u003c/p>\n\u003cp>“Even that gets an eye roll,” she said. “Just asking for an audience that is representative of the population as opposed to who we can get now, who are the easiest people to access.”\u003c/p>\n\u003cp>\u003c/p>\u003cp>\u003cdiv class='utils-parseShortcode-shortcodes-__shortcodes__shortcodeWrapper'>\n \u003ciframe width='”100%”' height='”250″'\n scrolling='no' frameborder='no'\n src='https://w.soundcloud.com/player/?url=”https://api.soundcloud.com/tracks/303519185″&visual=true&”auto_play=false&hide_related=false&show_comments=true&show_user=true&show_reposts=false&visual=true”'\n title='”https://api.soundcloud.com/tracks/303519185″'>\n \u003c/iframe>\n \u003c/div>\u003c/p>\u003cp>\u003c/p>\n\u003cp>Tech companies have acknowledged the need to diversify their workforce, but despite these high-profile commitments, the road has been slow going. Diversity numbers at many tech companies have barely \u003ca href=\"http://time.com/4391031/google-diversity-statistics-2016/\" target=\"_blank\" rel=\"noopener noreferrer\">budged\u003c/a>. And people of color say while the industry talks a lot about diversity, in general it’s not a top priority and initiatives to bring about change are met with \u003ca href=\"https://www.bloomberg.com/news/articles/2017-01-09/facebook-s-hiring-process-hinders-its-effort-to-create-a-diverse-workforce\" target=\"_blank\" rel=\"noopener noreferrer\">resistance\u003c/a>.\u003c/p>\n\u003cp>Elizabeth says one important ally has been President Obama. For one thing, she says, Obama was beloved by many in Silicon Valley and so had influence. Another reason?\u003c/p>\n\u003cp>“These companies do government work, and so to be on the good side of the administration there was pressure to really commit to diversity and inclusion,” Elizabeth said.\u003c/p>\n\u003cp>Obama urged tech executives to be more inclusive of women and people of color. And in response, the CEOs of Airbnb, Lyft and Intel, among others, initiated an “\u003ca href=\"https://www.google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=2&cad=rja&uact=8&ved=0ahUKEwi-x_755s7RAhVhqlQKHQUnAxoQFggjMAE&url=https%3A%2F%2Fwww.whitehouse.gov%2Fsites%2Fwhitehouse.gov%2Ffiles%2Fimages%2FBlog%2FTech-Inclusion-Pledge-Letter-6-22-16.pdf&usg=AFQjCNEwUvITCJY6FglWsP-sW5dMYd2L8w&sig2=-QwLrC2wa_BSs1cY_XRvcw\" target=\"_blank\" rel=\"noopener noreferrer\">Inclusion Pledge\u003c/a>.”\u003c/p>\n\u003cp>To date, some \u003ca href=\"https://www.tech-inclusion.org/participants\" target=\"_blank\" rel=\"noopener noreferrer\">80\u003c/a> companies have pledged to publish annual reports on the makeup of their workforce and to put in place policies and resources to train, recruit and retain more women, blacks and Latinos.\u003c/p>\n\u003cp>Elizabeth said the pledge created a tiny bit of leverage.\u003c/p>\n\u003cp>“Signing a pledge isn’t the thing that makes companies change,” she said. “But for the people doing diversity and inclusion work, you can say, ‘Hey, this is what you stated to do and your actions better line up.’ ”\u003c/p>\n\u003cp>If Obama played good cop by cajoling and flattering tech leaders to change, the Department of Labor has been bad cop.\u003c/p>\n\u003cp>\u003ca href=\"https://www.orrick.com/People/8/F/3/Erin-M-Connell\" target=\"_blank\" rel=\"noopener noreferrer\">Erin Connell\u003c/a> practices employment law at Orrick in San Francisco and represents companies that do business with the federal government.\u003c/p>\n\u003cp>“There definitely has been a focus on the technology sector within the Department of Labor,” Connell said.\u003c/p>\n\u003cp>She says federal compliance officers have taken a tougher, more adversarial tone with tech companies. And for the first time in recent memory, the Department of Labor sued three Silicon Valley companies — \u003ca href=\"http://www.reuters.com/article/us-palantir-tech-discrimination-lawsuit-idUSKCN11W2DA\" target=\"_blank\" rel=\"noopener noreferrer\">Palantir\u003c/a>, Google and Oracle — for alleged violations of equal employment opportunity laws.\u003c/p>\n\u003cp>The companies deny wrongdoing.\u003c/p>\n\u003cp>Connell speculates that the lawsuits are the Obama administration’s last-ditch effort to try to shore up its legacy.\u003c/p>\n\u003cp>“With the inauguration right around the corner, I think they’re running out of runway,” Connell said.\u003c/p>\n\u003cp>She believes the lawsuits will continue under a Trump administration but said “hypothetically, at any time the Department of Labor could choose to no longer pursue these lawsuits.”\u003c/p>\n\u003cp>Advocates believe that’s exactly what will happen under a Trump administration and fear they’ll lose another pressure point.\u003c/p>\n\u003cp>But \u003ca href=\"http://www.kaporcapital.com/who-we-are/ellen-pao/\" target=\"_blank\" rel=\"noopener noreferrer\">Ellen Pao\u003c/a>, the chief diversity and inclusion officer at \u003ca href=\"http://www.kaporcapital.com/\" target=\"_blank\" rel=\"noopener noreferrer\">Kapor Capital\u003c/a>, is more optimistic. Pao emerged as a vocal advocate for diversity after losing a high-profile gender discrimination lawsuit against the venture capital firm Kleiner Perkins Caufield & Byers in 2015.\u003c/p>\n\u003cp>Pao says that in reaction to the election, she’s seen some tech leaders, especially at up-and-coming companies, become even more committed to diversity.\u003c/p>\n\u003cp>“I’m excited because I think these startups are going to be the next wave of successful startups,” Pao said.\u003c/p>\n\u003cp>As a co-founder of \u003ca href=\"http://projectinclude.org/\" target=\"_blank\" rel=\"noopener noreferrer\">Project Include\u003c/a>, Pao works with CEOs of early-stage startups to try to build a culture of diversity from the start.\u003c/p>\n\u003cp>“You know in tech there is still very much a herd mentality,” Pao said.\u003c/p>\n\u003cp>When these new companies become successful with a diverse and inclusive workforce, she said, Trump or no Trump, it will be that success that paves the way for real change in Silicon Valley.\u003c/p>\n\u003cp>\u003c/p>\n\u003cp>\u003cem>This story is part of our ongoing series on Techquity: Diversity, Inclusion and Equity in Silicon Valley. \u003c/em>\u003c/p>\n\n\u003c/div>\u003c/p>",
"attributes": {
"named": {},
"numeric": []
}
}
],
"link": "/news/11276919/in-trump-era-where-are-diversity-efforts-in-silicon-valley-headed",
"authors": [
"11099"
],
"programs": [
"news_6944",
"news_72"
],
"categories": [
"news_8",
"news_13",
"news_248"
],
"tags": [
"news_21114",
"news_17687",
"news_1323",
"news_21405",
"news_17041"
],
"featImg": "news_11277001",
"label": "news_72"
},
"news_11275664": {
"type": "posts",
"id": "news_11275664",
"meta": {
"index": "posts_1716263798",
"site": "news",
"id": "11275664",
"score": null,
"sort": [
1484869386000
]
},
"guestAuthors": [],
"slug": "chinese-companys-plan-to-disrupt-bike-share-in-san-francisco-faces-pushback",
"title": "Chinese Company's Plan for Bike Sharing in San Francisco Faces Pushback",
"publishDate": 1484869386,
"format": "standard",
"headTitle": "Chinese Company’s Plan for Bike Sharing in San Francisco Faces Pushback | KQED",
"labelTerm": {
"term": 6944,
"site": "news"
},
"content": "\u003cp>What could go wrong with a tech company’s plan to place hundreds or perhaps thousands of shared bikes around San Francisco, the nation’s \u003ca href=\"http://www.bicycling.com/culture/news/the-50-best-bike-cities-of-2016/slide/2\">second-most-bike-friendly city\u003c/a>?\u003c/p>\n\u003cp>China-based \u003ca href=\"https://www.bluegogo.com/us/\" target=\"_blank\" rel=\"noopener\">Bluegogo\u003c/a>, which \u003ca href=\"http://www.bizjournals.com/sanfrancisco/news/2017/01/18/sf-supervisors-bluegogo-bike-sharing.html\">has reportedly\u003c/a> scooped up $34 million in startup funds, appears ready to begin deploying its blue aluminum bikes in popular neighborhoods around San Francisco.\u003c/p>\n\u003cp>Unlike the Bay Area’s public bike-share system — which \u003ca href=\"http://www.bizjournals.com/sanfrancisco/news/2017/01/18/sf-supervisors-bluegogo-bike-sharing.html\" target=\"_blank\" rel=\"noopener\">plans to begin expanding this year\u003c/a> from 700 to 7,000 bikes — Bluegogo’s bikes don’t need docking stations. Bluegogo says it will place its bikes only where bicycles may be legally parked and that users will be instructed to do the same.\u003c/p>\n\u003cp>But San Francisco city officials, led by Supervisor Aaron Peskin, have painted a scenario in which abandoned Bluegogo bikes could wind up piled on city sidewalks and other public spaces. At a \u003ca href=\"https://twitter.com/akrazia/status/821793340861489152\">City Hall press conference on Wednesday\u003c/a>, blow-up photos showing \u003ca href=\"https://www.theguardian.com/world/2017/jan/17/chinese-discard-hundreds-of-cycles-for-hire-in-giant-pile\">a mess of abandoned shared bikes\u003c/a> in China were displayed.\u003c/p>\n\u003cp>“Bluegogo is just another example of the tech arrogance that has gotten everybody from Airbnb to Uber in trouble,” said Peskin. “San Francisco has historically been known for its welcome mat, but in recent years we’ve let ourselves become a doormat. It’s time to put the public’s interests first, even if that means disrupting the disrupters.”\u003c/p>\n\u003cp>[ad fullwidth]\u003c/p>\n\u003cp>Peskin, joined by Supervisor Mark Farrell and Brian Wiedenmeier, the executive director of the San Francisco Bicycle Coalition, vowed to introduce legislation “prohibiting the unpermitted use of the public realm as a distribution platform for private bike-share corporations and other unregulated ‘sharing economy’ schemes.”\u003c/p>\n\u003cp>A Jan. 16 letter to Bluegogo from Ed Reiskin, head of the Municipal Transportation Agency, and Mohammed Nuru, director of Public Works, asked the company to provide its business plan, show it has obtained a city business license, and confirm that its operations would not interfere with the city’s exclusive contract with Bay Area Motivate LLC, which operates Bay Area BikeShare, soon to become Ford GoBike.\u003c/p>\n\u003cp>The exclusive bike-share contract contains just three exceptions: traditional bike-rental operations, electric scooter sharing, and automated round-trip bike sharing — systems that require users to return bicycles to the site where they’re rented.\u003c/p>\n\u003cp>The city letter warns that if Bluegogo’s business violated that contract provision, the city may withhold permits and could take legal action against the company.\u003c/p>\n\u003cp>Of equal concern, the letter said, was the company’s use of public sidewalks and streets.\u003c/p>\n\u003cp>“To the extent that your shared bicycles will occupy the public right of way, we require they do so in compliance with local law and in a manner that does not constitute a public nuisance or public safety hazard,” the letter said.\u003c/p>\n\u003cp>Rachel Gordon, a spokeswoman for San Francisco Public Works, said the department has the authority to remove the bikes if they become a hazard.\u003c/p>\n\u003cfigure id=\"attachment_11276996\" class=\"wp-caption aligncenter\" style=\"max-width: 640px\">\u003cimg loading=\"lazy\" decoding=\"async\" class=\"size-large wp-image-11276996\" src=\"https://ww2.kqed.org/news/wp-content/uploads/sites/10/2017/01/Screen-Shot-2017-01-19-at-10.24.04-AM-1020x532.png\" alt=\"Bluegogo insists its bikes will be placed only where its legal to park a bicycle, and that its users will be instructed to do the same.\" width=\"640\" height=\"334\" srcset=\"https://cdn.kqed.org/wp-content/uploads/sites/10/2017/01/Screen-Shot-2017-01-19-at-10.24.04-AM-1020x532.png 1020w, https://cdn.kqed.org/wp-content/uploads/sites/10/2017/01/Screen-Shot-2017-01-19-at-10.24.04-AM-160x83.png 160w, https://cdn.kqed.org/wp-content/uploads/sites/10/2017/01/Screen-Shot-2017-01-19-at-10.24.04-AM-800x417.png 800w, https://cdn.kqed.org/wp-content/uploads/sites/10/2017/01/Screen-Shot-2017-01-19-at-10.24.04-AM-1180x616.png 1180w, https://cdn.kqed.org/wp-content/uploads/sites/10/2017/01/Screen-Shot-2017-01-19-at-10.24.04-AM-960x501.png 960w, https://cdn.kqed.org/wp-content/uploads/sites/10/2017/01/Screen-Shot-2017-01-19-at-10.24.04-AM-240x125.png 240w, https://cdn.kqed.org/wp-content/uploads/sites/10/2017/01/Screen-Shot-2017-01-19-at-10.24.04-AM-375x196.png 375w, https://cdn.kqed.org/wp-content/uploads/sites/10/2017/01/Screen-Shot-2017-01-19-at-10.24.04-AM-520x271.png 520w, https://cdn.kqed.org/wp-content/uploads/sites/10/2017/01/Screen-Shot-2017-01-19-at-10.24.04-AM.png 1221w\" sizes=\"(max-width: 640px) 100vw, 640px\">\u003cfigcaption class=\"wp-caption-text\">Bluegogo’s bikes have locking clamps on the back wheels, and an alarm sounds when the bikes move without being unlocked. \u003ccite>(Photo courtesy of Bluegogo)\u003c/cite>\u003c/figcaption>\u003c/figure>\n\u003cp>In an interview, Ilya Movshovich, Bluegogo’s vice president of U.S. operations, said considering that San Francisco is “a bike city,” Bluegogo was shocked to see the pushback from city officials.\u003c/p>\n\u003cp>“We’re still happy to be cooperative and collaborative,” he said.\u003c/p>\n\u003cp>In an email to SFMTA officials dated Jan. 2 and provided by Bluegogo, Movshovich wrote to Luis Montoya, the head of the SFMTA’s livable streets program. He inquired about what permits the company might need and shared some general information about the company’s planned operation.\u003c/p>\n\u003cp>“I understand that according to California law, we can’t drop our bikes in positions that would disrupt an adequate path for pedestrian traffic. We don’t intend to do that. We also have a system in place to monitor, review and reward/penalize users for bicycle placement behavior.”\u003c/p>\n\u003cp>Movshovich wrote that the company would charge a $99 deposit that “would hedge against damaged bikes or if the user is irresponsible with bike placement or any actions that would jeopardize the safety of others — they would get assessed a warning, and possibly a fine.”\u003c/p>\n\u003cp>Bluegogo says it plans to charge 99 cents for every 30 minutes, along with the $99 deposit. The cheapest Bay Area BikeShare membership is $9 for 24 hours, a charge that provides unlimited rides up to 30 minutes each; rides of 30 to 60 minutes incur a $4 overage fee; rides over 60 minutes cost $7 for each additional half-hour.\u003c/p>\n\u003cp>Users can locate a bike with the Bluegogo app, reserve it and have about 15 minutes to pick it up before the reservation expires. The bikes weigh 33 pounds and come equipped with airless tires, so users don’t have to worry about flats.\u003c/p>\n\u003cp>“The beauty is the fact that we don’t have docking stations, which makes us special and unique in this market,” said Movshovich, who is also co-founder of the shared-parking startup \u003ca href=\"https://www.carmanation.com/\" target=\"_blank\" rel=\"noopener\">CARMAnation\u003c/a>. “It’s more likely that people are going to be using the bikes when it’s a couple of steps from them as opposed to a couple of blocks. We bring easier access.”\u003c/p>\n\u003cp>\u003c/p>\n\u003cp>Movshovich wouldn’t talk numbers, neither confirming the amount of funding the company has raised nor the number of bikes the company plans to deploy around the city. But he said it’s nowhere near 10,000 to 20,000, as some have speculated. The company can scale up or down depending on the demand, he said.\u003c/p>\n\n",
"blocks": [],
"excerpt": "Bluegogo plans to place an undetermined number of shared bikes around the city.",
"status": "publish",
"parent": 0,
"modified": 1721105331,
"stats": {
"hasAudio": false,
"hasVideo": false,
"hasChartOrMap": false,
"iframeSrcs": [],
"hasGoogleForm": false,
"hasGallery": false,
"hasHearkenModule": false,
"hasPolis": false,
"paragraphCount": 23,
"wordCount": 970
},
"headData": {
"title": "Chinese Company's Plan for Bike Sharing in San Francisco Faces Pushback | KQED",
"description": "Bluegogo plans to place an undetermined number of shared bikes around the city.",
"ogTitle": "",
"ogDescription": "",
"ogImgId": "",
"twTitle": "",
"twDescription": "",
"twImgId": "",
"schema": {
"@context": "https://schema.org",
"@type": "NewsArticle",
"headline": "Chinese Company's Plan for Bike Sharing in San Francisco Faces Pushback",
"datePublished": "2017-01-19T15:43:06-08:00",
"dateModified": "2024-07-15T21:48:51-07:00",
"image": "https://cdn.kqed.org/wp-content/uploads/2020/02/KQED-OG-Image@1x.png",
"isAccessibleForFree": "True",
"publisher": {
"@type": "NewsMediaOrganization",
"@id": "https://www.kqed.org/#organization",
"name": "KQED",
"logo": "https://cdn.kqed.org/wp-content/uploads/2020/02/KQED-OG-Image@1x.png",
"url": "https://www.kqed.org",
"sameAs": [
"https://www.facebook.com/KQED",
"https://twitter.com/KQED",
"https://www.instagram.com/kqed/",
"https://www.tiktok.com/@kqedofficial",
"https://www.linkedin.com/company/kqed",
"https://www.youtube.com/channel/UCeC0IOo7i1P_61zVUWbJ4nw"
]
}
}
},
"sticky": false,
"customPermalink": "2017/01/19/chinese-companys-plan-for-bike-sharing-in-san-francisco-faces-pushback/",
"path": "/news/11275664/chinese-companys-plan-to-disrupt-bike-share-in-san-francisco-faces-pushback",
"audioTrackLength": null,
"parsedContent": [
{
"type": "contentString",
"content": "\u003cdiv class=\"post-body\">\u003cp>\u003cp>What could go wrong with a tech company’s plan to place hundreds or perhaps thousands of shared bikes around San Francisco, the nation’s \u003ca href=\"http://www.bicycling.com/culture/news/the-50-best-bike-cities-of-2016/slide/2\">second-most-bike-friendly city\u003c/a>?\u003c/p>\n\u003cp>China-based \u003ca href=\"https://www.bluegogo.com/us/\" target=\"_blank\" rel=\"noopener\">Bluegogo\u003c/a>, which \u003ca href=\"http://www.bizjournals.com/sanfrancisco/news/2017/01/18/sf-supervisors-bluegogo-bike-sharing.html\">has reportedly\u003c/a> scooped up $34 million in startup funds, appears ready to begin deploying its blue aluminum bikes in popular neighborhoods around San Francisco.\u003c/p>\n\u003cp>Unlike the Bay Area’s public bike-share system — which \u003ca href=\"http://www.bizjournals.com/sanfrancisco/news/2017/01/18/sf-supervisors-bluegogo-bike-sharing.html\" target=\"_blank\" rel=\"noopener\">plans to begin expanding this year\u003c/a> from 700 to 7,000 bikes — Bluegogo’s bikes don’t need docking stations. Bluegogo says it will place its bikes only where bicycles may be legally parked and that users will be instructed to do the same.\u003c/p>\n\u003cp>But San Francisco city officials, led by Supervisor Aaron Peskin, have painted a scenario in which abandoned Bluegogo bikes could wind up piled on city sidewalks and other public spaces. At a \u003ca href=\"https://twitter.com/akrazia/status/821793340861489152\">City Hall press conference on Wednesday\u003c/a>, blow-up photos showing \u003ca href=\"https://www.theguardian.com/world/2017/jan/17/chinese-discard-hundreds-of-cycles-for-hire-in-giant-pile\">a mess of abandoned shared bikes\u003c/a> in China were displayed.\u003c/p>\n\u003cp>“Bluegogo is just another example of the tech arrogance that has gotten everybody from Airbnb to Uber in trouble,” said Peskin. “San Francisco has historically been known for its welcome mat, but in recent years we’ve let ourselves become a doormat. It’s time to put the public’s interests first, even if that means disrupting the disrupters.”\u003c/p>\n\u003cp>\u003c/p>\u003c/div>",
"attributes": {
"named": {},
"numeric": []
}
},
{
"type": "component",
"content": "",
"name": "ad",
"attributes": {
"named": {
"label": "fullwidth"
},
"numeric": [
"fullwidth"
]
}
},
{
"type": "contentString",
"content": "\u003cdiv class=\"post-body\">\u003cp>\u003c/p>\n\u003cp>Peskin, joined by Supervisor Mark Farrell and Brian Wiedenmeier, the executive director of the San Francisco Bicycle Coalition, vowed to introduce legislation “prohibiting the unpermitted use of the public realm as a distribution platform for private bike-share corporations and other unregulated ‘sharing economy’ schemes.”\u003c/p>\n\u003cp>A Jan. 16 letter to Bluegogo from Ed Reiskin, head of the Municipal Transportation Agency, and Mohammed Nuru, director of Public Works, asked the company to provide its business plan, show it has obtained a city business license, and confirm that its operations would not interfere with the city’s exclusive contract with Bay Area Motivate LLC, which operates Bay Area BikeShare, soon to become Ford GoBike.\u003c/p>\n\u003cp>The exclusive bike-share contract contains just three exceptions: traditional bike-rental operations, electric scooter sharing, and automated round-trip bike sharing — systems that require users to return bicycles to the site where they’re rented.\u003c/p>\n\u003cp>The city letter warns that if Bluegogo’s business violated that contract provision, the city may withhold permits and could take legal action against the company.\u003c/p>\n\u003cp>Of equal concern, the letter said, was the company’s use of public sidewalks and streets.\u003c/p>\n\u003cp>“To the extent that your shared bicycles will occupy the public right of way, we require they do so in compliance with local law and in a manner that does not constitute a public nuisance or public safety hazard,” the letter said.\u003c/p>\n\u003cp>Rachel Gordon, a spokeswoman for San Francisco Public Works, said the department has the authority to remove the bikes if they become a hazard.\u003c/p>\n\u003cfigure id=\"attachment_11276996\" class=\"wp-caption aligncenter\" style=\"max-width: 640px\">\u003cimg loading=\"lazy\" decoding=\"async\" class=\"size-large wp-image-11276996\" src=\"https://ww2.kqed.org/news/wp-content/uploads/sites/10/2017/01/Screen-Shot-2017-01-19-at-10.24.04-AM-1020x532.png\" alt=\"Bluegogo insists its bikes will be placed only where its legal to park a bicycle, and that its users will be instructed to do the same.\" width=\"640\" height=\"334\" srcset=\"https://cdn.kqed.org/wp-content/uploads/sites/10/2017/01/Screen-Shot-2017-01-19-at-10.24.04-AM-1020x532.png 1020w, https://cdn.kqed.org/wp-content/uploads/sites/10/2017/01/Screen-Shot-2017-01-19-at-10.24.04-AM-160x83.png 160w, https://cdn.kqed.org/wp-content/uploads/sites/10/2017/01/Screen-Shot-2017-01-19-at-10.24.04-AM-800x417.png 800w, https://cdn.kqed.org/wp-content/uploads/sites/10/2017/01/Screen-Shot-2017-01-19-at-10.24.04-AM-1180x616.png 1180w, https://cdn.kqed.org/wp-content/uploads/sites/10/2017/01/Screen-Shot-2017-01-19-at-10.24.04-AM-960x501.png 960w, https://cdn.kqed.org/wp-content/uploads/sites/10/2017/01/Screen-Shot-2017-01-19-at-10.24.04-AM-240x125.png 240w, https://cdn.kqed.org/wp-content/uploads/sites/10/2017/01/Screen-Shot-2017-01-19-at-10.24.04-AM-375x196.png 375w, https://cdn.kqed.org/wp-content/uploads/sites/10/2017/01/Screen-Shot-2017-01-19-at-10.24.04-AM-520x271.png 520w, https://cdn.kqed.org/wp-content/uploads/sites/10/2017/01/Screen-Shot-2017-01-19-at-10.24.04-AM.png 1221w\" sizes=\"(max-width: 640px) 100vw, 640px\">\u003cfigcaption class=\"wp-caption-text\">Bluegogo’s bikes have locking clamps on the back wheels, and an alarm sounds when the bikes move without being unlocked. \u003ccite>(Photo courtesy of Bluegogo)\u003c/cite>\u003c/figcaption>\u003c/figure>\n\u003cp>In an interview, Ilya Movshovich, Bluegogo’s vice president of U.S. operations, said considering that San Francisco is “a bike city,” Bluegogo was shocked to see the pushback from city officials.\u003c/p>\n\u003cp>“We’re still happy to be cooperative and collaborative,” he said.\u003c/p>\n\u003cp>In an email to SFMTA officials dated Jan. 2 and provided by Bluegogo, Movshovich wrote to Luis Montoya, the head of the SFMTA’s livable streets program. He inquired about what permits the company might need and shared some general information about the company’s planned operation.\u003c/p>\n\u003cp>“I understand that according to California law, we can’t drop our bikes in positions that would disrupt an adequate path for pedestrian traffic. We don’t intend to do that. We also have a system in place to monitor, review and reward/penalize users for bicycle placement behavior.”\u003c/p>\n\u003cp>Movshovich wrote that the company would charge a $99 deposit that “would hedge against damaged bikes or if the user is irresponsible with bike placement or any actions that would jeopardize the safety of others — they would get assessed a warning, and possibly a fine.”\u003c/p>\n\u003cp>Bluegogo says it plans to charge 99 cents for every 30 minutes, along with the $99 deposit. The cheapest Bay Area BikeShare membership is $9 for 24 hours, a charge that provides unlimited rides up to 30 minutes each; rides of 30 to 60 minutes incur a $4 overage fee; rides over 60 minutes cost $7 for each additional half-hour.\u003c/p>\n\u003cp>Users can locate a bike with the Bluegogo app, reserve it and have about 15 minutes to pick it up before the reservation expires. The bikes weigh 33 pounds and come equipped with airless tires, so users don’t have to worry about flats.\u003c/p>\n\u003cp>“The beauty is the fact that we don’t have docking stations, which makes us special and unique in this market,” said Movshovich, who is also co-founder of the shared-parking startup \u003ca href=\"https://www.carmanation.com/\" target=\"_blank\" rel=\"noopener\">CARMAnation\u003c/a>. “It’s more likely that people are going to be using the bikes when it’s a couple of steps from them as opposed to a couple of blocks. We bring easier access.”\u003c/p>\n\u003cp>\u003c/p>\n\u003cp>Movshovich wouldn’t talk numbers, neither confirming the amount of funding the company has raised nor the number of bikes the company plans to deploy around the city. But he said it’s nowhere near 10,000 to 20,000, as some have speculated. The company can scale up or down depending on the demand, he said.\u003c/p>\n\n\u003c/div>\u003c/p>",
"attributes": {
"named": {},
"numeric": []
}
}
],
"link": "/news/11275664/chinese-companys-plan-to-disrupt-bike-share-in-san-francisco-faces-pushback",
"authors": [
"214"
],
"programs": [
"news_6944"
],
"categories": [
"news_248",
"news_1397"
],
"tags": [
"news_578",
"news_18555",
"news_38"
],
"featImg": "news_11276988",
"label": "news_6944"
},
"futureofyou_319192": {
"type": "posts",
"id": "futureofyou_319192",
"meta": {
"index": "posts_1716263798",
"site": "futureofyou",
"id": "319192",
"score": null,
"sort": [
1484329014000
]
},
"parent": 0,
"labelTerm": {},
"blocks": [],
"publishDate": 1484329014,
"format": "standard",
"disqusTitle": "Wearable Sensors Help Diagnose Lyme Disease in Stanford Study",
"title": "Wearable Sensors Help Diagnose Lyme Disease in Stanford Study",
"headTitle": "KQED Future of You | KQED Science",
"content": "\u003cp>A next step for smart watches and fitness trackers? Wearable gadgets gave a Stanford University professor an early warning that he was getting sick before he ever felt any symptoms of Lyme disease.\u003c/p>\n\u003cp>Geneticist Michael Snyder never had Lyme's characteristic bulls-eye rash. But a smart watch and other sensors charted changes in Snyder's heart rate and oxygen levels during a family vacation. Eventually a fever struck that led to his diagnosis.\u003c/p>\n\u003cp>Say \"wearables,\" and step-counting fitness trackers spring to mind. It's not clear if they really make a difference in users' health. Now Snyder's team at Stanford is starting to find out, tracking the everyday lives of several dozen volunteers wearing devices that monitor more than mere activity.\u003c/p>\n\u003cp>He envisions one day having wearables that act as a sort of \"check engine\" light indicating it's time to see the doctor.\u003c/p>\n\u003cp>\"One way to look at this is, these are the equivalent of oral thermometers but you're measuring yourself all the time,\" said Snyder, senior author of a report released Thursday on the project.\u003c/p>\n\u003cp>[ad fullwidth]\u003c/p>\n\u003cp>Among the earliest hints: Changes in people's day-to-day physiology may flag when certain ailments are brewing, from colds to Lyme to Type 2 diabetes, researchers reported in the journal PLOS Biology.\u003c/p>\n\u003cp>Interest in wearable sensors is growing along with efforts to personalize medicine, as scientists learn how to tailor treatments and preventive care to people's genes, environment and lifestyle. The sensors are expected to be a part of the National Institutes of Health's huge \"precision medicine\" study, planned to begin later this year.\u003c/p>\n\u003cp>But a first step is learning what's normal for different people under different conditions.\u003c/p>\n\u003cp>The Stanford team is collecting reams of data — as many as 250,000 daily measurements — from volunteers who wear up to eight activity monitors or other sensors of varying sizes that measure heart rate, blood oxygen, skin temperature, sleep, calories expended, exercise and even exposure to radiation. That's paired with occasional laboratory tests to measure blood chemistry and some genetic information.\u003c/p>\n\u003cp>An initial finding: Blood oxygen levels decrease with rising altitudes during plane flights, in turn triggering fatigue. But toward the end of long flights, oxygen begins rising again, possibly as bodies adapt, the researchers reported.\u003c/p>\n\u003cp>It was that phenomenon that alerted Snyder, the longest-tested participant, \"that something wasn't quite right\" on one of his frequent long flights.\u003c/p>\n\u003cp>Landing in Norway for a family vacation, Snyder noticed his oxygen levels didn't return to normal like they always had before. Plus his heart rate was much higher than normal, which sometimes signals infection.\u003c/p>\n\u003cp>Sure enough, soon a low-grade fever left him dragging. He feared Lyme because two weeks before going abroad, Snyder had helped his brother build a fence in a tick-infested rural area in Massachusetts. He persuaded a Norwegian doctor to prescribe the appropriate antibiotic, and post-vacation testing back home confirmed the diagnosis.\u003c/p>\n\u003cp>Also during the study's first two years, Snyder and several other volunteers had minor cold-like illnesses that began with higher-than-normal readings for heart rate and skin temperature — and correlated with blood tests showing inflammation was on the rise before any sniffling.\u003c/p>\n\u003cp>In addition, the Stanford team detected variations in heart rate patterns that could tell the difference between study participants with what's called insulin resistance — a risk factor for Type 2 diabetes — and healthy people.\u003c/p>\n\u003cp>No, don't try to self-diagnose with your fitness tracker any time soon. The findings in Thursday's report are intriguing but the study is highly experimental, cautioned medical technology specialist Dr. Atul Butte of the University of California, San Francisco, who wasn't involved with the research.\u003c/p>\n\u003cp>\u003c/p>\n\u003cp>\"This kind of approach is going to help science more than the general public\" until there's better data about what's normal or not, Butte said. \"Remember, the baseline is always in motion. We're always getting older. We're always exposed to things. Just because there's a deviation doesn't mean it's abnormal.\"\u003c/p>\n\n",
"disqusIdentifier": "319192 http://ww2.kqed.org/futureofyou/?p=319192",
"disqusUrl": "https://ww2.kqed.org/futureofyou/2017/01/13/wearable-sensors-help-diagnose-lyme-disease-in-stanford-study/",
"stats": {
"hasVideo": false,
"hasChartOrMap": false,
"hasAudio": false,
"hasPolis": false,
"wordCount": 687,
"hasGoogleForm": false,
"hasGallery": false,
"hasHearkenModule": false,
"iframeSrcs": [],
"paragraphCount": 19
},
"modified": 1517014364,
"excerpt": "A Stanford team is collecting as many as 250,000 daily measurements from volunteers who wear up to eight activity monitors or other sensors. One set of measurements helped diagnose Lyme disease. ",
"headData": {
"twImgId": "",
"twTitle": "",
"ogTitle": "",
"ogImgId": "",
"twDescription": "",
"description": "A Stanford team is collecting as many as 250,000 daily measurements from volunteers who wear up to eight activity monitors or other sensors. One set of measurements helped diagnose Lyme disease. ",
"title": "Wearable Sensors Help Diagnose Lyme Disease in Stanford Study | KQED",
"ogDescription": "",
"schema": {
"@context": "https://schema.org",
"@type": "Article",
"headline": "Wearable Sensors Help Diagnose Lyme Disease in Stanford Study",
"datePublished": "2017-01-13T09:36:54-08:00",
"dateModified": "2018-01-26T16:52:44-08:00",
"image": "https://cdn.kqed.org/wp-content/uploads/2020/02/KQED-OG-Image@1x.png"
}
},
"guestAuthors": [],
"slug": "wearable-sensors-help-diagnose-lyme-disease-in-stanford-study",
"status": "publish",
"nprByline": "Lauran Neergard\u003cbr />Associated Press",
"source": "KQED Future of You",
"path": "/futureofyou/319192/wearable-sensors-help-diagnose-lyme-disease-in-stanford-study",
"audioTrackLength": null,
"parsedContent": [
{
"type": "contentString",
"content": "\u003cdiv class=\"post-body\">\u003cp>\u003cp>A next step for smart watches and fitness trackers? Wearable gadgets gave a Stanford University professor an early warning that he was getting sick before he ever felt any symptoms of Lyme disease.\u003c/p>\n\u003cp>Geneticist Michael Snyder never had Lyme's characteristic bulls-eye rash. But a smart watch and other sensors charted changes in Snyder's heart rate and oxygen levels during a family vacation. Eventually a fever struck that led to his diagnosis.\u003c/p>\n\u003cp>Say \"wearables,\" and step-counting fitness trackers spring to mind. It's not clear if they really make a difference in users' health. Now Snyder's team at Stanford is starting to find out, tracking the everyday lives of several dozen volunteers wearing devices that monitor more than mere activity.\u003c/p>\n\u003cp>He envisions one day having wearables that act as a sort of \"check engine\" light indicating it's time to see the doctor.\u003c/p>\n\u003cp>\"One way to look at this is, these are the equivalent of oral thermometers but you're measuring yourself all the time,\" said Snyder, senior author of a report released Thursday on the project.\u003c/p>\n\u003cp>\u003c/p>\u003c/div>",
"attributes": {
"named": {},
"numeric": []
}
},
{
"type": "component",
"content": "",
"name": "ad",
"attributes": {
"named": {
"label": "fullwidth"
},
"numeric": [
"fullwidth"
]
}
},
{
"type": "contentString",
"content": "\u003cdiv class=\"post-body\">\u003cp>\u003c/p>\n\u003cp>Among the earliest hints: Changes in people's day-to-day physiology may flag when certain ailments are brewing, from colds to Lyme to Type 2 diabetes, researchers reported in the journal PLOS Biology.\u003c/p>\n\u003cp>Interest in wearable sensors is growing along with efforts to personalize medicine, as scientists learn how to tailor treatments and preventive care to people's genes, environment and lifestyle. The sensors are expected to be a part of the National Institutes of Health's huge \"precision medicine\" study, planned to begin later this year.\u003c/p>\n\u003cp>But a first step is learning what's normal for different people under different conditions.\u003c/p>\n\u003cp>The Stanford team is collecting reams of data — as many as 250,000 daily measurements — from volunteers who wear up to eight activity monitors or other sensors of varying sizes that measure heart rate, blood oxygen, skin temperature, sleep, calories expended, exercise and even exposure to radiation. That's paired with occasional laboratory tests to measure blood chemistry and some genetic information.\u003c/p>\n\u003cp>An initial finding: Blood oxygen levels decrease with rising altitudes during plane flights, in turn triggering fatigue. But toward the end of long flights, oxygen begins rising again, possibly as bodies adapt, the researchers reported.\u003c/p>\n\u003cp>It was that phenomenon that alerted Snyder, the longest-tested participant, \"that something wasn't quite right\" on one of his frequent long flights.\u003c/p>\n\u003cp>Landing in Norway for a family vacation, Snyder noticed his oxygen levels didn't return to normal like they always had before. Plus his heart rate was much higher than normal, which sometimes signals infection.\u003c/p>\n\u003cp>Sure enough, soon a low-grade fever left him dragging. He feared Lyme because two weeks before going abroad, Snyder had helped his brother build a fence in a tick-infested rural area in Massachusetts. He persuaded a Norwegian doctor to prescribe the appropriate antibiotic, and post-vacation testing back home confirmed the diagnosis.\u003c/p>\n\u003cp>Also during the study's first two years, Snyder and several other volunteers had minor cold-like illnesses that began with higher-than-normal readings for heart rate and skin temperature — and correlated with blood tests showing inflammation was on the rise before any sniffling.\u003c/p>\n\u003cp>In addition, the Stanford team detected variations in heart rate patterns that could tell the difference between study participants with what's called insulin resistance — a risk factor for Type 2 diabetes — and healthy people.\u003c/p>\n\u003cp>No, don't try to self-diagnose with your fitness tracker any time soon. The findings in Thursday's report are intriguing but the study is highly experimental, cautioned medical technology specialist Dr. Atul Butte of the University of California, San Francisco, who wasn't involved with the research.\u003c/p>\n\u003cp>\u003c/p>\n\u003cp>\"This kind of approach is going to help science more than the general public\" until there's better data about what's normal or not, Butte said. \"Remember, the baseline is always in motion. We're always getting older. We're always exposed to things. Just because there's a deviation doesn't mean it's abnormal.\"\u003c/p>\n\n\u003c/div>\u003c/p>",
"attributes": {
"named": {},
"numeric": []
}
}
],
"link": "/futureofyou/319192/wearable-sensors-help-diagnose-lyme-disease-in-stanford-study",
"authors": [
"byline_futureofyou_319192"
],
"categories": [
"futureofyou_1060",
"futureofyou_452",
"futureofyou_73"
],
"tags": [
"futureofyou_80",
"futureofyou_759",
"futureofyou_145",
"futureofyou_25"
],
"featImg": "futureofyou_319194",
"label": "source_futureofyou_319192"
},
"news_11263472": {
"type": "posts",
"id": "news_11263472",
"meta": {
"index": "posts_1716263798",
"site": "news",
"id": "11263472",
"score": null,
"sort": [
1484076595000
]
},
"parent": 0,
"labelTerm": {},
"blocks": [],
"publishDate": 1484076595,
"format": "standard",
"disqusTitle": "Yahoo Will Become 'Altaba' If Verizon Buys Its Internet Business",
"title": "Yahoo Will Become 'Altaba' If Verizon Buys Its Internet Business",
"headTitle": "The California Report | KQED News",
"content": "\u003cp>It's still unclear whether Verizon will follow through on a \u003ca href=\"http://www.npr.org/sections/thetwo-way/2016/07/25/487312798/verizon-buys-yahoo-for-4-8-billion-in-cash-touting-gains-in-mobile\">$4.8 billion deal\u003c/a> to buy Yahoo's core internet business, but if the sale is finalized, there's a name for what will be left behind.\u003c/p>\n\u003cp>For months, as the deal has made its way through negotiations and regulatory reviews, Yahoo \u003ca href=\"https://www.sec.gov/Archives/edgar/data/1011006/000119312516666712/d234178ddefa14a.htm\">referred to the hypothetical remains of its business\u003c/a> as \"RemainCo.\"\u003c/p>\n\u003cp>Now, the company has unveiled a slightly less literal name: \"Altaba.\"\u003c/p>\n\u003cp>\u003cem>The Wall Street Journal\u003c/em> explains the Altaba origin:\u003c/p>\n\u003cblockquote>\u003cp>\"Altaba's remaining assets include Yahoo's stake in \u003ca href=\"http://quotes.wsj.com/BABA\">Alibaba Group Holding\u003c/a> Ltd. and \u003ca href=\"http://quotes.wsj.com/4689.TO\">Yahoo Japan\u003c/a>. The name is a combination of the words 'alternate' and 'Alibaba,' a person familiar with the matter said.\"\u003c/p>\u003c/blockquote>\n\u003cp>As \u003ca href=\"http://www.nytimes.com/2017/01/09/business/dealbook/yahoo-would-become-altaba-after-selling-its-internet-business.html?_r=0\">the New York Times points out\u003c/a>, the name is very close to \"Al-Taba,\" a \u003ca href=\"http://www.al-taba.com/\">Pakistani scissors manufacturer\u003c/a>.\u003c/p>\n\u003cp>[ad fullwidth]\u003c/p>\n\u003cp>The sale would also bring big changes to Yahoo's current leadership. According to a \u003ca href=\"https://www.sec.gov/Archives/edgar/data/1011006/000119312517005897/d316156d8k.htm\">regulatory document\u003c/a> filed with the Securities and Exchange Commission, six members of the company's current \u003ca href=\"https://investor.yahoo.net/directors.cfm\">11-member board\u003c/a> would step down — including Marissa Mayer, Yahoo's chief executive.\u003c/p>\n\u003cfigure id=\"attachment_11263482\" class=\"wp-caption aligncenter\" style=\"max-width: 800px\">\u003cimg class=\"wp-image-11263482 size-medium\" src=\"http://ww2.kqed.org/news/wp-content/uploads/sites/10/2017/01/MarissaMayer-800x735.jpg\" alt=\"Marissa Mayer\" width=\"800\" height=\"735\" srcset=\"https://ww2.kqed.org/app/uploads/sites/10/2017/01/MarissaMayer-800x735.jpg 800w, https://ww2.kqed.org/app/uploads/sites/10/2017/01/MarissaMayer-160x147.jpg 160w, https://ww2.kqed.org/app/uploads/sites/10/2017/01/MarissaMayer-1020x938.jpg 1020w, https://ww2.kqed.org/app/uploads/sites/10/2017/01/MarissaMayer.jpg 1920w, https://ww2.kqed.org/app/uploads/sites/10/2017/01/MarissaMayer-1180x1085.jpg 1180w, https://ww2.kqed.org/app/uploads/sites/10/2017/01/MarissaMayer-960x883.jpg 960w, https://ww2.kqed.org/app/uploads/sites/10/2017/01/MarissaMayer-240x221.jpg 240w, https://ww2.kqed.org/app/uploads/sites/10/2017/01/MarissaMayer-375x345.jpg 375w, https://ww2.kqed.org/app/uploads/sites/10/2017/01/MarissaMayer-520x478.jpg 520w\" sizes=\"(max-width: 800px) 100vw, 800px\">\u003cfigcaption class=\"wp-caption-text\">If the $4.8 billion deal goes through, more than half of the company's current board members, including Yahoo's CEO, Marissa Mayer, will step down. \u003ccite>(Brad Barket/Getty Images)\u003c/cite>\u003c/figcaption>\u003c/figure>\n\u003cp>Eric Brandt, who joined Yahoo's board in March 2016, would take over as chairman of Altaba's board. He is a former executive at Broadcom, a semiconductor company.\u003c/p>\n\u003cp>As of Thursday, Brandt took over as chairman of Yahoo's board, replacing Maynard Webb, who had served in that position since 2013 and now becomes the chairman emeritus. According to the regulatory filing, the purpose of the change was \"to facilitate the transition of the Company to an investment company\" following the sale to Verizon.\u003c/p>\n\u003cp>But it's still unclear whether the sale will go forward. Following revelations of \u003ca href=\"http://www.npr.org/sections/thetwo-way/2016/12/14/505606974/yahoo-says-hackers-stole-information-from-more-than-1-billion-accounts\">multiple\u003c/a> major \u003ca href=\"http://www.npr.org/sections/thetwo-way/2016/09/22/495056961/yahoo-inc-confirms-data-from-at-least-500-million-users-was-stolen\">hacks\u003c/a> of Yahoo user accounts, Verizon said it would \"evaluate\" the potential impact on the deal.\u003c/p>\n\u003cp>[contextly_sidebar id=\"BpesfmHm7CcfEiUlntWPiml0QdpoAkNH\"]\u003c/p>\n\u003cp>Last week, AOL chief executive Tim Armstrong \u003ca href=\"http://www.cnbc.com/2017/01/05/aol-chief-tim-armstrong-says-hes-confident-vz-yhoo-deal-will-close.html\">told CNBC\u003c/a> that \"I remain hopeful the deal will close and I think we'll see what the outcomes are of the Yahoo investigations in the meantime.\"\u003c/p>\n\u003cp>Verizon \u003ca href=\"http://www.npr.org/sections/thetwo-way/2015/05/12/406115329/verizon-inks-4-4-billion-agreement-to-buy-aol\">purchased AOL\u003c/a> in 2015.\u003c/p>\n\u003cp>Also last week, a senior executive at Verizon said the company was unsure about its plan to buy Yahoo's internet business.\u003c/p>\n\u003cp>\"I can't sit here today and say with confidence one way or another because we still don't know,\" said Marni Walden, president of product innovation and new businesses at Verizon, \u003ca href=\"http://www.reuters.com/article/us-yahoo-m-a-verizon-idUSKBN14P215\">according to Reuters\u003c/a>.\u003c/p>\n\u003cp>Speaking at the Citi 2017 Internet, Media & Telecommunications Conference in Las Vegas, Walden said that if the deal does go through, \"we think it will take weeks at least. We don't have a desire to have it drag on forever. That's not our intent.\"\u003c/p>\n\u003cp>\u003c/p>\n\u003cp>Copyright 2017 NPR. To see more, visit \u003ca href=\"http://www.npr.org/\" target=\"_blank\">NPR.org\u003c/a>.\u003c/p>\n\n",
"disqusIdentifier": "11263472 http://ww2.kqed.org/news/?p=11263472",
"disqusUrl": "https://ww2.kqed.org/news/2017/01/10/yahoo-will-become-altaba-if-verizon-buys-its-internet-business/",
"stats": {
"hasVideo": false,
"hasChartOrMap": false,
"hasAudio": false,
"hasPolis": false,
"wordCount": 485,
"hasGoogleForm": false,
"hasGallery": false,
"hasHearkenModule": false,
"iframeSrcs": [],
"paragraphCount": 19
},
"modified": 1484090046,
"excerpt": "If the $4.8 billion deal goes through, more than half of the company's current board members, including Yahoo's CEO, Marissa Mayer, will step down.",
"headData": {
"twImgId": "",
"twTitle": "",
"ogTitle": "",
"ogImgId": "",
"twDescription": "",
"description": "If the $4.8 billion deal goes through, more than half of the company's current board members, including Yahoo's CEO, Marissa Mayer, will step down.",
"title": "Yahoo Will Become 'Altaba' If Verizon Buys Its Internet Business | KQED",
"ogDescription": "",
"schema": {
"@context": "https://schema.org",
"@type": "NewsArticle",
"headline": "Yahoo Will Become 'Altaba' If Verizon Buys Its Internet Business",
"datePublished": "2017-01-10T11:29:55-08:00",
"dateModified": "2017-01-10T15:14:06-08:00",
"image": "https://cdn.kqed.org/wp-content/uploads/2020/02/KQED-OG-Image@1x.png",
"isAccessibleForFree": "True",
"publisher": {
"@type": "NewsMediaOrganization",
"@id": "https://www.kqed.org/#organization",
"name": "KQED",
"logo": "https://cdn.kqed.org/wp-content/uploads/2020/02/KQED-OG-Image@1x.png",
"url": "https://www.kqed.org",
"sameAs": [
"https://www.facebook.com/KQED",
"https://twitter.com/KQED",
"https://www.instagram.com/kqed/",
"https://www.tiktok.com/@kqedofficial",
"https://www.linkedin.com/company/kqed",
"https://www.youtube.com/channel/UCeC0IOo7i1P_61zVUWbJ4nw"
]
}
}
},
"guestAuthors": [],
"slug": "yahoo-will-become-altaba-if-verizon-buys-its-internet-business",
"status": "publish",
"sourceUrl": "http://www.npr.org/",
"nprApiLink": "http://api.npr.org/query?id=509109510&apiKey=MDAxOTAwOTE4MDEyMTkxMDAzNjczZDljZA004",
"nprByline": "Rebecca Hersher",
"nprStoryDate": "Tue, 10 Jan 2017 10:11:00 -0500",
"nprLastModifiedDate": "Tue, 10 Jan 2017 10:21:10 -0500",
"nprHtmlLink": "http://www.npr.org/sections/thetwo-way/2017/01/10/509109510/yahoo-will-become-altaba-if-verizon-buys-its-internet-business?ft=nprml&f=509109510",
"nprImageAgency": "AP",
"nprImageCredit": "Marcio Jose Sanchez",
"source": "NPR",
"nprStoryId": "509109510",
"nprRetrievedStory": "1",
"nprPubDate": "Tue, 10 Jan 2017 10:13:00 -0500",
"path": "/news/11263472/yahoo-will-become-altaba-if-verizon-buys-its-internet-business",
"audioTrackLength": null,
"parsedContent": [
{
"type": "contentString",
"content": "\u003cdiv class=\"post-body\">\u003cp>\u003cp>It's still unclear whether Verizon will follow through on a \u003ca href=\"http://www.npr.org/sections/thetwo-way/2016/07/25/487312798/verizon-buys-yahoo-for-4-8-billion-in-cash-touting-gains-in-mobile\">$4.8 billion deal\u003c/a> to buy Yahoo's core internet business, but if the sale is finalized, there's a name for what will be left behind.\u003c/p>\n\u003cp>For months, as the deal has made its way through negotiations and regulatory reviews, Yahoo \u003ca href=\"https://www.sec.gov/Archives/edgar/data/1011006/000119312516666712/d234178ddefa14a.htm\">referred to the hypothetical remains of its business\u003c/a> as \"RemainCo.\"\u003c/p>\n\u003cp>Now, the company has unveiled a slightly less literal name: \"Altaba.\"\u003c/p>\n\u003cp>\u003cem>The Wall Street Journal\u003c/em> explains the Altaba origin:\u003c/p>\n\u003cblockquote>\u003cp>\"Altaba's remaining assets include Yahoo's stake in \u003ca href=\"http://quotes.wsj.com/BABA\">Alibaba Group Holding\u003c/a> Ltd. and \u003ca href=\"http://quotes.wsj.com/4689.TO\">Yahoo Japan\u003c/a>. The name is a combination of the words 'alternate' and 'Alibaba,' a person familiar with the matter said.\"\u003c/p>\u003c/blockquote>\n\u003cp>As \u003ca href=\"http://www.nytimes.com/2017/01/09/business/dealbook/yahoo-would-become-altaba-after-selling-its-internet-business.html?_r=0\">the New York Times points out\u003c/a>, the name is very close to \"Al-Taba,\" a \u003ca href=\"http://www.al-taba.com/\">Pakistani scissors manufacturer\u003c/a>.\u003c/p>\n\u003cp>\u003c/p>\u003c/div>",
"attributes": {
"named": {},
"numeric": []
}
},
{
"type": "component",
"content": "",
"name": "ad",
"attributes": {
"named": {
"label": "fullwidth"
},
"numeric": [
"fullwidth"
]
}
},
{
"type": "contentString",
"content": "\u003cdiv class=\"post-body\">\u003cp>\u003c/p>\n\u003cp>The sale would also bring big changes to Yahoo's current leadership. According to a \u003ca href=\"https://www.sec.gov/Archives/edgar/data/1011006/000119312517005897/d316156d8k.htm\">regulatory document\u003c/a> filed with the Securities and Exchange Commission, six members of the company's current \u003ca href=\"https://investor.yahoo.net/directors.cfm\">11-member board\u003c/a> would step down — including Marissa Mayer, Yahoo's chief executive.\u003c/p>\n\u003cfigure id=\"attachment_11263482\" class=\"wp-caption aligncenter\" style=\"max-width: 800px\">\u003cimg class=\"wp-image-11263482 size-medium\" src=\"http://ww2.kqed.org/news/wp-content/uploads/sites/10/2017/01/MarissaMayer-800x735.jpg\" alt=\"Marissa Mayer\" width=\"800\" height=\"735\" srcset=\"https://ww2.kqed.org/app/uploads/sites/10/2017/01/MarissaMayer-800x735.jpg 800w, https://ww2.kqed.org/app/uploads/sites/10/2017/01/MarissaMayer-160x147.jpg 160w, https://ww2.kqed.org/app/uploads/sites/10/2017/01/MarissaMayer-1020x938.jpg 1020w, https://ww2.kqed.org/app/uploads/sites/10/2017/01/MarissaMayer.jpg 1920w, https://ww2.kqed.org/app/uploads/sites/10/2017/01/MarissaMayer-1180x1085.jpg 1180w, https://ww2.kqed.org/app/uploads/sites/10/2017/01/MarissaMayer-960x883.jpg 960w, https://ww2.kqed.org/app/uploads/sites/10/2017/01/MarissaMayer-240x221.jpg 240w, https://ww2.kqed.org/app/uploads/sites/10/2017/01/MarissaMayer-375x345.jpg 375w, https://ww2.kqed.org/app/uploads/sites/10/2017/01/MarissaMayer-520x478.jpg 520w\" sizes=\"(max-width: 800px) 100vw, 800px\">\u003cfigcaption class=\"wp-caption-text\">If the $4.8 billion deal goes through, more than half of the company's current board members, including Yahoo's CEO, Marissa Mayer, will step down. \u003ccite>(Brad Barket/Getty Images)\u003c/cite>\u003c/figcaption>\u003c/figure>\n\u003cp>Eric Brandt, who joined Yahoo's board in March 2016, would take over as chairman of Altaba's board. He is a former executive at Broadcom, a semiconductor company.\u003c/p>\n\u003cp>As of Thursday, Brandt took over as chairman of Yahoo's board, replacing Maynard Webb, who had served in that position since 2013 and now becomes the chairman emeritus. According to the regulatory filing, the purpose of the change was \"to facilitate the transition of the Company to an investment company\" following the sale to Verizon.\u003c/p>\n\u003cp>But it's still unclear whether the sale will go forward. Following revelations of \u003ca href=\"http://www.npr.org/sections/thetwo-way/2016/12/14/505606974/yahoo-says-hackers-stole-information-from-more-than-1-billion-accounts\">multiple\u003c/a> major \u003ca href=\"http://www.npr.org/sections/thetwo-way/2016/09/22/495056961/yahoo-inc-confirms-data-from-at-least-500-million-users-was-stolen\">hacks\u003c/a> of Yahoo user accounts, Verizon said it would \"evaluate\" the potential impact on the deal.\u003c/p>\n\u003cp>\u003c/p>\u003cp>\u003c/p>\u003cp>\u003c/p>\n\u003cp>Last week, AOL chief executive Tim Armstrong \u003ca href=\"http://www.cnbc.com/2017/01/05/aol-chief-tim-armstrong-says-hes-confident-vz-yhoo-deal-will-close.html\">told CNBC\u003c/a> that \"I remain hopeful the deal will close and I think we'll see what the outcomes are of the Yahoo investigations in the meantime.\"\u003c/p>\n\u003cp>Verizon \u003ca href=\"http://www.npr.org/sections/thetwo-way/2015/05/12/406115329/verizon-inks-4-4-billion-agreement-to-buy-aol\">purchased AOL\u003c/a> in 2015.\u003c/p>\n\u003cp>Also last week, a senior executive at Verizon said the company was unsure about its plan to buy Yahoo's internet business.\u003c/p>\n\u003cp>\"I can't sit here today and say with confidence one way or another because we still don't know,\" said Marni Walden, president of product innovation and new businesses at Verizon, \u003ca href=\"http://www.reuters.com/article/us-yahoo-m-a-verizon-idUSKBN14P215\">according to Reuters\u003c/a>.\u003c/p>\n\u003cp>Speaking at the Citi 2017 Internet, Media & Telecommunications Conference in Las Vegas, Walden said that if the deal does go through, \"we think it will take weeks at least. We don't have a desire to have it drag on forever. That's not our intent.\"\u003c/p>\n\u003cp>\u003c/p>\n\u003cp>Copyright 2017 NPR. To see more, visit \u003ca href=\"http://www.npr.org/\" target=\"_blank\">NPR.org\u003c/a>.\u003c/p>\n\n\u003c/div>\u003c/p>",
"attributes": {
"named": {},
"numeric": []
}
}
],
"link": "/news/11263472/yahoo-will-become-altaba-if-verizon-buys-its-internet-business",
"authors": [
"byline_news_11263472"
],
"programs": [
"news_6944",
"news_72"
],
"categories": [
"news_8",
"news_248"
],
"tags": [
"news_2756",
"news_17286",
"news_20294",
"news_351"
],
"featImg": "news_11263475",
"label": "source_news_11263472"
},
"futureofyou_315372": {
"type": "posts",
"id": "futureofyou_315372",
"meta": {
"index": "posts_1716263798",
"site": "futureofyou",
"id": "315372",
"score": null,
"sort": [
1483748173000
]
},
"parent": 0,
"labelTerm": {},
"blocks": [],
"publishDate": 1483748173,
"format": "standard",
"disqusTitle": "Theranos Lays Off More Employees, Gets WSJ Reporter's Blood Test Wrong",
"title": "Theranos Lays Off More Employees, Gets WSJ Reporter's Blood Test Wrong",
"headTitle": "KQED Future of You | KQED Science",
"content": "\u003cp>In a \u003ca href=\"https://news.theranos.com/2017/01/06/company-re-engineers-operations/\" target=\"_blank\">press release\u003c/a> titled \"Company Re-engineers Operations,\" Theranos announced it has re-engineered 155 workers right out the door.\u003c/p>\n\u003cp>The layoff leaves the reeling blood-testing company, once heralded as a major innovator on the basis of its claimed ability to conduct dozens of tests from just a few drops of blood, with just 220 employees. That's down from about 850 last October, when Theranos let go of about 340 people in conjunction with shuttering its disastrous consumer blood-testing business.\u003c/p>\n\u003cp>That business, which once included dozens of blood-draw locations in Walgreen's stores, collapsed in the wake of a series of events not exactly conducive to business. Among the company's misfortunes were a Wall Street Journal investigation alleging a bevy of improprieties and inaccuracies related to the company’s secret technology; unprecedented government sanctions due to uncovered deficiencies at its main lab; and a multiplicity of lawsuits.\u003c/p>\n\u003cp>Theranos has said for months now that its main focus is on its miniLab, a printer-sized device that integrates already available technologies into one machine.\u003c/p>\n\u003cp>But some scientists who attended the unveiling of the device at a scientific conference last August were \u003ca href=\"https://ww2.kqed.org/futureofyou/2016/07/29/theranos-elizabeth-holmes-will-face-1000-scientists-monday-can-she-say-anything-to-gain-their-trust/\" target=\"_blank\">less than impressed\u003c/a>.\u003c/p>\n\u003cp>[ad fullwidth]\u003c/p>\n\u003cp>'“It’s not as if there’s something here we haven’t fundamentally seen before,\" said Dr. Stephen R. Master, one of the event’s moderators,\u003c/p>\n\u003cp>Getting FDA approval for the miniLab could also take years. How much of the $900 million that Theranos once raised from investors might be left at that point ... well, the math doesn't look good.\u003c/p>\n\u003cp>\u003cstrong>More Bad Test Results\u003c/strong>\u003c/p>\n\u003cp>Also today, The Wall Street Journal reported Theranos sent out more notices of bad test results. Last April, the company said it had voided tens of thousands of tests that may have been inaccurate.\u003c/p>\n\u003cp>From the \u003ca href=\"http://www.wsj.com/articles/theranos-cuts-40-of-remaining-workforce-1483731874\" target=\"_blank\">Journal\u003c/a>:\u003c/p>\n\u003cblockquote>\u003cp>As recently as last week the company sent out newly corrected results saying some tests done in 2015 and 2016 for hemoglobin A1c, a protein doctors measure to help diagnose diabetes, shouldn’t be relied upon, according to copies of the corrected reports.\u003c/p>\n\u003cp>In a letter sent last week, Theranos said a patient who previously had gotten a “normal to prediabetic” result should have received a result in the “prediabetic to diabetic” range.\u003c/p>\n\u003cp>Kim Toy, a house cleaner in Phoenix, also learned last week that a past Theranos lab-test result had been voided, according to her lawyer.\u003c/p>\n\u003cp>Ms. Toy had the diabetes test at a Theranos location at a Walgreens in February 2016, indicating she may be on the brink of becoming diabetic. She doubted the result then, but hadn’t received any corrected information until now.\u003c/p>\u003c/blockquote>\n\u003cp>Then, to top it all off, there's this:\u003c/p>\n\u003cp>https://twitter.com/JohnCarreyrou/status/817516317754408960\u003c/p>\n\u003cp>John Carreyrou, of course, is The Wall Street Journal reporter who started the company on its long road to ruin with his investigative reports.\u003c/p>\n\u003cp>\u003c/p>\n\u003cp>\u003ca href=\"http://www.vanityfair.com/news/2016/09/elizabeth-holmes-theranos-exclusive\" target=\"_blank\">Vanity Fair\u003c/a> reported last October that Theranos employees had chanted \"Fuck you, Carreyrou!\" during a company meeting at which founder and CEO Elizabeth Holmes had claimed the Journal's investigation was inaccurate.\u003c/p>\n\n",
"disqusIdentifier": "315372 http://ww2.kqed.org/futureofyou/?p=315372",
"disqusUrl": "https://ww2.kqed.org/futureofyou/2017/01/06/theranos-lays-off-more-employees-gets-wsj-reporters-blood-test-wrong/",
"stats": {
"hasVideo": false,
"hasChartOrMap": false,
"hasAudio": false,
"hasPolis": false,
"wordCount": 537,
"hasGoogleForm": false,
"hasGallery": false,
"hasHearkenModule": false,
"iframeSrcs": [],
"paragraphCount": 19
},
"modified": 1483756895,
"excerpt": "One hundred and fifty-five workers will lose their jobs with the company that was once a high-flying startup but is now a shell of its former self. ",
"headData": {
"twImgId": "",
"twTitle": "",
"ogTitle": "",
"ogImgId": "",
"twDescription": "",
"description": "One hundred and fifty-five workers will lose their jobs with the company that was once a high-flying startup but is now a shell of its former self. ",
"title": "Theranos Lays Off More Employees, Gets WSJ Reporter's Blood Test Wrong | KQED",
"ogDescription": "",
"schema": {
"@context": "https://schema.org",
"@type": "Article",
"headline": "Theranos Lays Off More Employees, Gets WSJ Reporter's Blood Test Wrong",
"datePublished": "2017-01-06T16:16:13-08:00",
"dateModified": "2017-01-06T18:41:35-08:00",
"image": "https://cdn.kqed.org/wp-content/uploads/2020/02/KQED-OG-Image@1x.png"
}
},
"guestAuthors": [],
"slug": "theranos-lays-off-more-employees-gets-wsj-reporters-blood-test-wrong",
"status": "publish",
"source": "KQED Future of You",
"path": "/futureofyou/315372/theranos-lays-off-more-employees-gets-wsj-reporters-blood-test-wrong",
"audioTrackLength": null,
"parsedContent": [
{
"type": "contentString",
"content": "\u003cdiv class=\"post-body\">\u003cp>\u003cp>In a \u003ca href=\"https://news.theranos.com/2017/01/06/company-re-engineers-operations/\" target=\"_blank\">press release\u003c/a> titled \"Company Re-engineers Operations,\" Theranos announced it has re-engineered 155 workers right out the door.\u003c/p>\n\u003cp>The layoff leaves the reeling blood-testing company, once heralded as a major innovator on the basis of its claimed ability to conduct dozens of tests from just a few drops of blood, with just 220 employees. That's down from about 850 last October, when Theranos let go of about 340 people in conjunction with shuttering its disastrous consumer blood-testing business.\u003c/p>\n\u003cp>That business, which once included dozens of blood-draw locations in Walgreen's stores, collapsed in the wake of a series of events not exactly conducive to business. Among the company's misfortunes were a Wall Street Journal investigation alleging a bevy of improprieties and inaccuracies related to the company’s secret technology; unprecedented government sanctions due to uncovered deficiencies at its main lab; and a multiplicity of lawsuits.\u003c/p>\n\u003cp>Theranos has said for months now that its main focus is on its miniLab, a printer-sized device that integrates already available technologies into one machine.\u003c/p>\n\u003cp>But some scientists who attended the unveiling of the device at a scientific conference last August were \u003ca href=\"https://ww2.kqed.org/futureofyou/2016/07/29/theranos-elizabeth-holmes-will-face-1000-scientists-monday-can-she-say-anything-to-gain-their-trust/\" target=\"_blank\">less than impressed\u003c/a>.\u003c/p>\n\u003cp>\u003c/p>\u003c/div>",
"attributes": {
"named": {},
"numeric": []
}
},
{
"type": "component",
"content": "",
"name": "ad",
"attributes": {
"named": {
"label": "fullwidth"
},
"numeric": [
"fullwidth"
]
}
},
{
"type": "contentString",
"content": "\u003cdiv class=\"post-body\">\u003cp>\u003c/p>\n\u003cp>'“It’s not as if there’s something here we haven’t fundamentally seen before,\" said Dr. Stephen R. Master, one of the event’s moderators,\u003c/p>\n\u003cp>Getting FDA approval for the miniLab could also take years. How much of the $900 million that Theranos once raised from investors might be left at that point ... well, the math doesn't look good.\u003c/p>\n\u003cp>\u003cstrong>More Bad Test Results\u003c/strong>\u003c/p>\n\u003cp>Also today, The Wall Street Journal reported Theranos sent out more notices of bad test results. Last April, the company said it had voided tens of thousands of tests that may have been inaccurate.\u003c/p>\n\u003cp>From the \u003ca href=\"http://www.wsj.com/articles/theranos-cuts-40-of-remaining-workforce-1483731874\" target=\"_blank\">Journal\u003c/a>:\u003c/p>\n\u003cblockquote>\u003cp>As recently as last week the company sent out newly corrected results saying some tests done in 2015 and 2016 for hemoglobin A1c, a protein doctors measure to help diagnose diabetes, shouldn’t be relied upon, according to copies of the corrected reports.\u003c/p>\n\u003cp>In a letter sent last week, Theranos said a patient who previously had gotten a “normal to prediabetic” result should have received a result in the “prediabetic to diabetic” range.\u003c/p>\n\u003cp>Kim Toy, a house cleaner in Phoenix, also learned last week that a past Theranos lab-test result had been voided, according to her lawyer.\u003c/p>\n\u003cp>Ms. Toy had the diabetes test at a Theranos location at a Walgreens in February 2016, indicating she may be on the brink of becoming diabetic. She doubted the result then, but hadn’t received any corrected information until now.\u003c/p>\u003c/blockquote>\n\u003cp>Then, to top it all off, there's this:\u003c/p>\u003c/p>\u003c/div>",
"attributes": {
"named": {},
"numeric": []
}
},
{
"type": "component",
"content": "",
"name": "singleTwitterStatus",
"attributes": {
"named": {
"id": "817516317754408960"
},
"numeric": []
}
},
{
"type": "contentString",
"content": "\u003cdiv class=\"post-body\">\u003cp>\n\u003cp>John Carreyrou, of course, is The Wall Street Journal reporter who started the company on its long road to ruin with his investigative reports.\u003c/p>\n\u003cp>\u003c/p>\n\u003cp>\u003ca href=\"http://www.vanityfair.com/news/2016/09/elizabeth-holmes-theranos-exclusive\" target=\"_blank\">Vanity Fair\u003c/a> reported last October that Theranos employees had chanted \"Fuck you, Carreyrou!\" during a company meeting at which founder and CEO Elizabeth Holmes had claimed the Journal's investigation was inaccurate.\u003c/p>\n\n\u003c/div>\u003c/p>",
"attributes": {
"named": {},
"numeric": []
}
}
],
"link": "/futureofyou/315372/theranos-lays-off-more-employees-gets-wsj-reporters-blood-test-wrong",
"authors": [
"80"
],
"categories": [
"futureofyou_1060",
"futureofyou_452",
"futureofyou_1",
"futureofyou_73"
],
"tags": [
"futureofyou_814",
"futureofyou_751",
"futureofyou_617"
],
"label": "source_futureofyou_315372"
},
"news_11257442": {
"type": "posts",
"id": "news_11257442",
"meta": {
"index": "posts_1716263798",
"site": "news",
"id": "11257442",
"score": null,
"sort": [
1483748904000
]
},
"parent": 0,
"labelTerm": {},
"blocks": [],
"publishDate": 1483748904,
"format": "standard",
"disqusTitle": "Putin Ordered 'Influence Campaign' to Help Trump, U.S. Intelligence Report Says",
"title": "Putin Ordered 'Influence Campaign' to Help Trump, U.S. Intelligence Report Says",
"headTitle": "The California Report | KQED News",
"content": "\u003cp>\u003cstrong>Updated 5:30 p.m. ET\u003c/strong>\u003c/p>\n\u003cp>The intelligence report on Russia's interference in the U.S. elections concludes that Russian President Vladimir Putin personally ordered an \"influence campaign\" that aimed to help President-elect Donald Trump.\u003c/p>\n\u003cp>\"Russia's goals were to undermine public faith in the US democratic process, denigrate Secretary Clinton, and harm her electability and potential presidency,\" the public version of the report from the FBI, the CIA and the National Security Agency states. \"We further assess Putin and the Russian Government developed a clear preference for President-elect Trump.\"\u003c/p>\n\u003cp>This is the first time the U.S. government has leveled these accusations directly at Putin, \u003ca href=\"http://www.npr.org/2017/01/06/508587538/u-s-intelligence-community-releases-public-report-on-russian-hacking\">as NPR's Mary Louise Kelly reports\u003c/a>. \"It's obviously a big deal to level that kind of charge at the head of state of a foreign country,\" she says.\u003c/p>\n\u003cp>The report does not weigh in on whether this \"influence campaign\" changed the outcome of the U.S. election.\u003c/p>\n\u003cp>[ad fullwidth]\u003c/p>\n\u003cp>Here are some of the report's key findings:\u003c/p>\n\u003cul>\n\u003cli>Putin and the Russian Government \"aspired to help President-elect Trump's election chances when possible by discrediting Secretary Clinton and publicly contrasting her unfavorably to him.\"\u003c/li>\n\u003cli>The report states that Putin's motivation to discredit Clinton was at least partially personal. It says he \"publicly blamed her since 2011 for inciting mass protests against his regime in late 2011 and early 2012, and because he holds a grudge for comments he almost certainly saw as disparaging him.\"\u003c/li>\n\u003cli>Russian intelligence \"conducted cyber operations against targets associated with the 2016 US presidential election, including targets associated with both major US political parties.\" This included primary campaigns, think tanks and lobbying groups.\u003c/li>\n\u003cli>The report asserts with \"high confidence\" that Russia's General Staff Main Intelligence Directorate \"relayed material it acquired from the [Democratic National Committee] and senior Democratic officials to Wikileaks.\"\u003c/li>\n\u003cli>\"Russian intelligence obtained and maintained access to elements of multiple US state or local electoral boards.\"\u003c/li>\n\u003cli>Taken together, these efforts \"represented a significant escalation in directness, level of activity, and scope of effort compared to previous operations aimed at US elections.\"\u003c/li>\n\u003c/ul>\n\u003cp>You can read the public version of the report here:\u003c/p>\n\u003cp>[http_redir]\u003c/p>\n\u003cp>\u003c!-- iframe plugin v.4.3 wordpress.org/plugins/iframe/ -->\u003cbr>\n\u003ciframe src=\"https://apps.npr.org/documents/document.html?embed=true&id=3254236-ICA-2017-01\" width=\"100%\" height=\"555\" scrolling=\"no\" class=\"iframe-class\" frameborder=\"0\">\u003c/iframe>\u003c/p>\n\u003cp>On Oct. 7, the U.S. first formally accused Russia of hacking the computers of the Democratic National Committee and other U.S. political organizations. \"We believe, based on the scope and sensitivity of these efforts, that only Russia's senior-most officials could have authorized these activities,\" \u003ca href=\"https://www.dhs.gov/news/2016/10/07/joint-statement-department-homeland-security-and-office-director-national\">the joint statement from\u003c/a> the Department of Homeland Security and the Office of the Director of National Intelligence said.\u003c/p>\n\u003cp>Since then, intelligence officials have doubled down and expanded upon the accusations. \"We stand more resolutely on that statement,\" Director of National Intelligence James Clapper said Thursday during a Senate Armed Services Committee hearing, \u003ca href=\"http://www.npr.org/2017/01/05/508355408/intelligence-chiefs-stand-more-resolutely-behind-finding-of-russia-election-hack\">as NPR's Brian Naylor reported\u003c/a>.\u003c/p>\n\u003cp>In December, the FBI threw its weight behind the CIA's assessment, \u003ca href=\"http://www.npr.org/2016/12/16/505890551/fbi-cia-agree-that-russia-was-trying-to-help-trump-win-the-election\">as NPR's Carrie Johnson reported\u003c/a>: \"The entire intelligence community, in fact, is now in alignment that the hacks were partly motivated to try and install Trump as president.\"\u003c/p>\n\u003cp>[contextly_sidebar id=\"bbZWV4H2X6J4mz72MNdVo074Ikr9zWsA\"]\u003c/p>\n\u003cp>President-elect Donald Trump has repeatedly dismissed the assessment. Earlier Friday afternoon, he received a briefing on the intelligence report from Clapper, CIA Director John Brennan and FBI Director James Comey at Trump Tower in New York.\u003c/p>\n\u003cp>In a statement, Trump called the meeting \"constructive\" and added that he has \"tremendous respect\" for the work of the intelligence community. He did not specifically blame Russia, saying it was one of a number of countries including China that are \"consistently trying to break through the cyber infrastructure of our government institutions, businesses and organizations.\"\u003c/p>\n\u003cp>Trump also stated that the hacks had \"absolutely no effect on the outcome of the election.\"\u003c/p>\n\u003cp>Remember, the report specifically states that it did not \"make an assessment of the impact that Russian activities had on the outcome of the 2016 election.\" It did say that the Department of Homeland Security \"assesses that the types of systems Russian actors targeted or compromised were not involved in vote tallying.\"\u003c/p>\n\u003cp>Prior to today's briefing, \u003ca href=\"http://www.nytimes.com/2017/01/06/us/politics/donald-trump-wall-hack-russia.html?hp&action=click&pgtype=Homepage&clickSource=story-heading&module=a-lede-package-region®ion=top-news&WT.nav=top-news&_r=0\">Trump told The New York Times\u003c/a> he believes the continued attention on the cyberattacks is politically motivated.\u003c/p>\n\u003cp>\"They got beaten very badly in the election. I won more counties in the election than Ronald Reagan,\" Trump told the \u003cem>Times\u003c/em>. \"They are very embarrassed about it. To some extent, it's a witch hunt. They just focus on this.\"\u003c/p>\n\u003cp>The White House \u003ca href=\"http://www.npr.org/sections/thetwo-way/2016/12/30/507525510/russia-plans-to-expel-u-s-diplomats-in-response-to-u-s-sanctions\">announced sanctions against Russia\u003c/a> last month in response to the cyberattacks. \u003c/p>\n\u003cp>\u003c/p>\n\u003cp>Copyright 2017 NPR. To see more, visit \u003ca href=\"http://www.npr.org/\" target=\"_blank\">NPR.org\u003c/a>.\u003c/p>\n\n",
"disqusIdentifier": "11257442 http://ww2.kqed.org/news/?p=11257442",
"disqusUrl": "https://ww2.kqed.org/news/2017/01/06/putin-ordered-influence-campaign-to-help-trump-u-s-intelligence-report-says/",
"stats": {
"hasVideo": false,
"hasChartOrMap": false,
"hasAudio": false,
"hasPolis": false,
"wordCount": 758,
"hasGoogleForm": false,
"hasGallery": false,
"hasHearkenModule": false,
"iframeSrcs": [],
"paragraphCount": 23
},
"modified": 1483748904,
"excerpt": "The public version of the intelligence report on the investigation into Russia's interference in the U.S. elections concludes that Russia 'aspired to help' Trump's election chances when possible.",
"headData": {
"twImgId": "",
"twTitle": "",
"ogTitle": "",
"ogImgId": "",
"twDescription": "",
"description": "The public version of the intelligence report on the investigation into Russia's interference in the U.S. elections concludes that Russia 'aspired to help' Trump's election chances when possible.",
"title": "Putin Ordered 'Influence Campaign' to Help Trump, U.S. Intelligence Report Says | KQED",
"ogDescription": "",
"schema": {
"@context": "https://schema.org",
"@type": "NewsArticle",
"headline": "Putin Ordered 'Influence Campaign' to Help Trump, U.S. Intelligence Report Says",
"datePublished": "2017-01-06T16:28:24-08:00",
"dateModified": "2017-01-06T16:28:24-08:00",
"image": "https://cdn.kqed.org/wp-content/uploads/2020/02/KQED-OG-Image@1x.png",
"isAccessibleForFree": "True",
"publisher": {
"@type": "NewsMediaOrganization",
"@id": "https://www.kqed.org/#organization",
"name": "KQED",
"logo": "https://cdn.kqed.org/wp-content/uploads/2020/02/KQED-OG-Image@1x.png",
"url": "https://www.kqed.org",
"sameAs": [
"https://www.facebook.com/KQED",
"https://twitter.com/KQED",
"https://www.instagram.com/kqed/",
"https://www.tiktok.com/@kqedofficial",
"https://www.linkedin.com/company/kqed",
"https://www.youtube.com/channel/UCeC0IOo7i1P_61zVUWbJ4nw"
]
}
}
},
"guestAuthors": [],
"slug": "putin-ordered-influence-campaign-to-help-trump-u-s-intelligence-report-says",
"status": "publish",
"sourceUrl": "http://www.npr.org/",
"nprApiLink": "http://api.npr.org/query?id=508568241&apiKey=MDAxOTAwOTE4MDEyMTkxMDAzNjczZDljZA004",
"nprByline": "Merrit Kennedy",
"nprStoryDate": "Fri, 06 Jan 2017 16:28:00 -0500",
"nprLastModifiedDate": "Fri, 06 Jan 2017 17:33:54 -0500",
"nprHtmlLink": "http://www.npr.org/sections/thetwo-way/2017/01/06/508568241/putin-ordered-influence-campaign-to-help-trump-u-s-intelligence-report-says?ft=nprml&f=508568241",
"nprImageAgency": "AP",
"nprImageCredit": "Mikhail Klimentyev",
"source": "NPR",
"nprStoryId": "508568241",
"nprRetrievedStory": "1",
"nprPubDate": "Fri, 06 Jan 2017 17:33:00 -0500",
"path": "/news/11257442/putin-ordered-influence-campaign-to-help-trump-u-s-intelligence-report-says",
"audioTrackLength": null,
"parsedContent": [
{
"type": "contentString",
"content": "\u003cdiv class=\"post-body\">\u003cp>\u003cp>\u003cstrong>Updated 5:30 p.m. ET\u003c/strong>\u003c/p>\n\u003cp>The intelligence report on Russia's interference in the U.S. elections concludes that Russian President Vladimir Putin personally ordered an \"influence campaign\" that aimed to help President-elect Donald Trump.\u003c/p>\n\u003cp>\"Russia's goals were to undermine public faith in the US democratic process, denigrate Secretary Clinton, and harm her electability and potential presidency,\" the public version of the report from the FBI, the CIA and the National Security Agency states. \"We further assess Putin and the Russian Government developed a clear preference for President-elect Trump.\"\u003c/p>\n\u003cp>This is the first time the U.S. government has leveled these accusations directly at Putin, \u003ca href=\"http://www.npr.org/2017/01/06/508587538/u-s-intelligence-community-releases-public-report-on-russian-hacking\">as NPR's Mary Louise Kelly reports\u003c/a>. \"It's obviously a big deal to level that kind of charge at the head of state of a foreign country,\" she says.\u003c/p>\n\u003cp>The report does not weigh in on whether this \"influence campaign\" changed the outcome of the U.S. election.\u003c/p>\n\u003cp>\u003c/p>\u003c/div>",
"attributes": {
"named": {},
"numeric": []
}
},
{
"type": "component",
"content": "",
"name": "ad",
"attributes": {
"named": {
"label": "fullwidth"
},
"numeric": [
"fullwidth"
]
}
},
{
"type": "contentString",
"content": "\u003cdiv class=\"post-body\">\u003cp>\u003c/p>\n\u003cp>Here are some of the report's key findings:\u003c/p>\n\u003cul>\n\u003cli>Putin and the Russian Government \"aspired to help President-elect Trump's election chances when possible by discrediting Secretary Clinton and publicly contrasting her unfavorably to him.\"\u003c/li>\n\u003cli>The report states that Putin's motivation to discredit Clinton was at least partially personal. It says he \"publicly blamed her since 2011 for inciting mass protests against his regime in late 2011 and early 2012, and because he holds a grudge for comments he almost certainly saw as disparaging him.\"\u003c/li>\n\u003cli>Russian intelligence \"conducted cyber operations against targets associated with the 2016 US presidential election, including targets associated with both major US political parties.\" This included primary campaigns, think tanks and lobbying groups.\u003c/li>\n\u003cli>The report asserts with \"high confidence\" that Russia's General Staff Main Intelligence Directorate \"relayed material it acquired from the [Democratic National Committee] and senior Democratic officials to Wikileaks.\"\u003c/li>\n\u003cli>\"Russian intelligence obtained and maintained access to elements of multiple US state or local electoral boards.\"\u003c/li>\n\u003cli>Taken together, these efforts \"represented a significant escalation in directness, level of activity, and scope of effort compared to previous operations aimed at US elections.\"\u003c/li>\n\u003c/ul>\n\u003cp>You can read the public version of the report here:\u003c/p>\n\u003cp>[http_redir]\u003c/p>\n\u003cp>\u003c!-- iframe plugin v.4.3 wordpress.org/plugins/iframe/ -->\u003cbr>\n\u003ciframe src=\"https://apps.npr.org/documents/document.html?embed=true&id=3254236-ICA-2017-01\" width=\"100%\" height=\"555\" scrolling=\"no\" class=\"iframe-class\" frameborder=\"0\">\u003c/iframe>\u003c/p>\n\u003cp>On Oct. 7, the U.S. first formally accused Russia of hacking the computers of the Democratic National Committee and other U.S. political organizations. \"We believe, based on the scope and sensitivity of these efforts, that only Russia's senior-most officials could have authorized these activities,\" \u003ca href=\"https://www.dhs.gov/news/2016/10/07/joint-statement-department-homeland-security-and-office-director-national\">the joint statement from\u003c/a> the Department of Homeland Security and the Office of the Director of National Intelligence said.\u003c/p>\n\u003cp>Since then, intelligence officials have doubled down and expanded upon the accusations. \"We stand more resolutely on that statement,\" Director of National Intelligence James Clapper said Thursday during a Senate Armed Services Committee hearing, \u003ca href=\"http://www.npr.org/2017/01/05/508355408/intelligence-chiefs-stand-more-resolutely-behind-finding-of-russia-election-hack\">as NPR's Brian Naylor reported\u003c/a>.\u003c/p>\n\u003cp>In December, the FBI threw its weight behind the CIA's assessment, \u003ca href=\"http://www.npr.org/2016/12/16/505890551/fbi-cia-agree-that-russia-was-trying-to-help-trump-win-the-election\">as NPR's Carrie Johnson reported\u003c/a>: \"The entire intelligence community, in fact, is now in alignment that the hacks were partly motivated to try and install Trump as president.\"\u003c/p>\n\u003cp>\u003c/p>\u003cp>\u003c/p>\u003cp>\u003c/p>\n\u003cp>President-elect Donald Trump has repeatedly dismissed the assessment. Earlier Friday afternoon, he received a briefing on the intelligence report from Clapper, CIA Director John Brennan and FBI Director James Comey at Trump Tower in New York.\u003c/p>\n\u003cp>In a statement, Trump called the meeting \"constructive\" and added that he has \"tremendous respect\" for the work of the intelligence community. He did not specifically blame Russia, saying it was one of a number of countries including China that are \"consistently trying to break through the cyber infrastructure of our government institutions, businesses and organizations.\"\u003c/p>\n\u003cp>Trump also stated that the hacks had \"absolutely no effect on the outcome of the election.\"\u003c/p>\n\u003cp>Remember, the report specifically states that it did not \"make an assessment of the impact that Russian activities had on the outcome of the 2016 election.\" It did say that the Department of Homeland Security \"assesses that the types of systems Russian actors targeted or compromised were not involved in vote tallying.\"\u003c/p>\n\u003cp>Prior to today's briefing, \u003ca href=\"http://www.nytimes.com/2017/01/06/us/politics/donald-trump-wall-hack-russia.html?hp&action=click&pgtype=Homepage&clickSource=story-heading&module=a-lede-package-region®ion=top-news&WT.nav=top-news&_r=0\">Trump told The New York Times\u003c/a> he believes the continued attention on the cyberattacks is politically motivated.\u003c/p>\n\u003cp>\"They got beaten very badly in the election. I won more counties in the election than Ronald Reagan,\" Trump told the \u003cem>Times\u003c/em>. \"They are very embarrassed about it. To some extent, it's a witch hunt. They just focus on this.\"\u003c/p>\n\u003cp>The White House \u003ca href=\"http://www.npr.org/sections/thetwo-way/2016/12/30/507525510/russia-plans-to-expel-u-s-diplomats-in-response-to-u-s-sanctions\">announced sanctions against Russia\u003c/a> last month in response to the cyberattacks. \u003c/p>\n\u003cp>\u003c/p>\n\u003cp>Copyright 2017 NPR. To see more, visit \u003ca href=\"http://www.npr.org/\" target=\"_blank\">NPR.org\u003c/a>.\u003c/p>\n\n\u003c/div>\u003c/p>",
"attributes": {
"named": {},
"numeric": []
}
}
],
"link": "/news/11257442/putin-ordered-influence-campaign-to-help-trump-u-s-intelligence-report-says",
"authors": [
"byline_news_11257442"
],
"programs": [
"news_6944",
"news_72"
],
"categories": [
"news_8",
"news_13",
"news_248"
],
"tags": [
"news_1323",
"news_3706",
"news_17286"
],
"affiliates": [
"news_253"
],
"featImg": "news_11257448",
"label": "source_news_11257442"
}
},
"podcastsReducer": {
"isFetching": false,
"fetchFailed": false,
"hasFetched": false,
"podcasts": {}
},
"radioProgramsReducer": {
"isFetching": false,
"fetchFailed": false,
"hasFetched": false,
"radioPrograms": {}
},
"radioSearchSegmentsReducer": {},
"programsReducer": {
"all-things-considered": {
"id": "all-things-considered",
"title": "All Things Considered",
"info": "Every weekday, \u003cem>All Things Considered\u003c/em> hosts Robert Siegel, Audie Cornish, Ari Shapiro, and Kelly McEvers present the program's trademark mix of news, interviews, commentaries, reviews, and offbeat features. Michel Martin hosts on the weekends.",
"airtime": "MON-FRI 1pm-2pm, 4:30pm-6:30pm\u003cbr />SAT-SUN 5pm-6pm",
"imageSrc": "https://cdn.kqed.org/wp-content/uploads/2024/04/All-Things-Considered-Podcast-Tile-360x360-1.jpg",
"officialWebsiteLink": "https://www.npr.org/programs/all-things-considered/",
"meta": {
"site": "news",
"source": "npr"
},
"link": "/radio/program/all-things-considered"
},
"american-suburb-podcast": {
"id": "american-suburb-podcast",
"title": "American Suburb: The Podcast",
"tagline": "The flip side of gentrification, told through one town",
"info": "Gentrification is changing cities across America, forcing people from neighborhoods they have long called home. Call them the displaced. Now those priced out of the Bay Area are looking for a better life in an unlikely place. American Suburb follows this migration to one California town along the Delta, 45 miles from San Francisco. But is this once sleepy suburb ready for them?",
"imageSrc": "https://cdn.kqed.org/wp-content/uploads/2024/04/American-Suburb-Podcast-Tile-703x703-1.jpg",
"officialWebsiteLink": "/news/series/american-suburb-podcast",
"meta": {
"site": "news",
"source": "kqed",
"order": 19
},
"link": "/news/series/american-suburb-podcast/",
"subscribe": {
"npr": "https://rpb3r.app.goo.gl/RBrW",
"apple": "https://itunes.apple.com/WebObjects/MZStore.woa/wa/viewPodcast?mt=2&id=1287748328",
"tuneIn": "https://tunein.com/radio/American-Suburb-p1086805/",
"rss": "https://ww2.kqed.org/news/series/american-suburb-podcast/feed/podcast",
"google": "https://podcasts.google.com/feed/aHR0cHM6Ly9mZWVkcy5tZWdhcGhvbmUuZm0vS1FJTkMzMDExODgxNjA5"
}
},
"baycurious": {
"id": "baycurious",
"title": "Bay Curious",
"tagline": "Exploring the Bay Area, one question at a time",
"info": "KQED’s new podcast, Bay Curious, gets to the bottom of the mysteries — both profound and peculiar — that give the Bay Area its unique identity. And we’ll do it with your help! You ask the questions. You decide what Bay Curious investigates. And you join us on the journey to find the answers.",
"imageSrc": "https://cdn.kqed.org/wp-content/uploads/2024/04/Bay-Curious-Podcast-Tile-703x703-1.jpg",
"imageAlt": "KQED Bay Curious",
"officialWebsiteLink": "/news/series/baycurious",
"meta": {
"site": "news",
"source": "kqed",
"order": 3
},
"link": "/podcasts/baycurious",
"subscribe": {
"apple": "https://podcasts.apple.com/us/podcast/bay-curious/id1172473406",
"npr": "https://www.npr.org/podcasts/500557090/bay-curious",
"rss": "https://ww2.kqed.org/news/category/bay-curious-podcast/feed/podcast",
"amazon": "https://music.amazon.com/podcasts/9a90d476-aa04-455d-9a4c-0871ed6216d4/bay-curious",
"stitcher": "https://www.stitcher.com/podcast/kqed/bay-curious",
"spotify": "https://open.spotify.com/show/6O76IdmhixfijmhTZLIJ8k"
}
},
"bbc-world-service": {
"id": "bbc-world-service",
"title": "BBC World Service",
"info": "The day's top stories from BBC News compiled twice daily in the week, once at weekends.",
"airtime": "MON-FRI 9pm-10pm, TUE-FRI 1am-2am",
"imageSrc": "https://cdn.kqed.org/wp-content/uploads/2024/04/BBC-World-Service-Podcast-Tile-360x360-1.jpg",
"officialWebsiteLink": "https://www.bbc.co.uk/sounds/play/live:bbc_world_service",
"meta": {
"site": "news",
"source": "BBC World Service"
},
"link": "/radio/program/bbc-world-service",
"subscribe": {
"apple": "https://itunes.apple.com/us/podcast/global-news-podcast/id135067274?mt=2",
"tuneIn": "https://tunein.com/radio/BBC-World-Service-p455581/",
"rss": "https://podcasts.files.bbci.co.uk/p02nq0gn.rss"
}
},
"californiareport": {
"id": "californiareport",
"title": "The California Report",
"tagline": "California, day by day",
"info": "KQED’s statewide radio news program providing daily coverage of issues, trends and public policy decisions.",
"imageSrc": "https://cdn.kqed.org/wp-content/uploads/2024/04/The-California-Report-Podcast-Tile-703x703-1.jpg",
"imageAlt": "KQED The California Report",
"officialWebsiteLink": "/californiareport",
"meta": {
"site": "news",
"source": "kqed",
"order": 8
},
"link": "/californiareport",
"subscribe": {
"apple": "https://podcasts.apple.com/us/podcast/kqeds-the-california-report/id79681292",
"amazon": "https://music.amazon.com/podcasts/26099305-72af-4542-9dde-ac1807fe36d5/kqed-s-the-california-report",
"npr": "https://www.npr.org/podcasts/432285393/the-california-report",
"stitcher": "https://www.stitcher.com/podcast/kqedfm-kqeds-the-california-report-podcast-8838",
"rss": "https://ww2.kqed.org/news/tag/tcram/feed/podcast"
}
},
"californiareportmagazine": {
"id": "californiareportmagazine",
"title": "The California Report Magazine",
"tagline": "Your state, your stories",
"info": "Every week, The California Report Magazine takes you on a road trip for the ears: to visit the places and meet the people who make California unique. The in-depth storytelling podcast from the California Report.",
"airtime": "FRI 4:30pm-5pm, 6:30pm-7pm, 11pm-11:30pm",
"imageSrc": "https://cdn.kqed.org/wp-content/uploads/2024/04/The-California-Report-Magazine-Podcast-Tile-703x703-1.jpg",
"imageAlt": "KQED The California Report Magazine",
"officialWebsiteLink": "/californiareportmagazine",
"meta": {
"site": "news",
"source": "kqed",
"order": 10
},
"link": "/californiareportmagazine",
"subscribe": {
"apple": "https://podcasts.apple.com/us/podcast/the-california-report-magazine/id1314750545",
"google": "https://podcasts.google.com/feed/aHR0cHM6Ly9mZWVkcy5tZWdhcGhvbmUuZm0vS1FJTkM3NjkwNjk1OTAz",
"npr": "https://www.npr.org/podcasts/564733126/the-california-report-magazine",
"stitcher": "https://www.stitcher.com/podcast/kqed/the-california-report-magazine",
"rss": "https://ww2.kqed.org/news/tag/tcrmag/feed/podcast"
}
},
"city-arts": {
"id": "city-arts",
"title": "City Arts & Lectures",
"info": "A one-hour radio program to hear celebrated writers, artists and thinkers address contemporary ideas and values, often discussing the creative process. Please note: tapes or transcripts are not available",
"imageSrc": "https://ww2.kqed.org/radio/wp-content/uploads/sites/50/2018/05/cityartsandlecture-300x300.jpg",
"officialWebsiteLink": "https://www.cityarts.net/",
"airtime": "SUN 1pm-2pm, TUE 10pm, WED 1am",
"meta": {
"site": "news",
"source": "City Arts & Lectures"
},
"link": "https://www.cityarts.net",
"subscribe": {
"tuneIn": "https://tunein.com/radio/City-Arts-and-Lectures-p692/",
"rss": "https://www.cityarts.net/feed/"
}
},
"closealltabs": {
"id": "closealltabs",
"title": "Close All Tabs",
"tagline": "Your irreverent guide to the trends redefining our world",
"info": "Close All Tabs breaks down how digital culture shapes our world through thoughtful insights and irreverent humor.",
"imageSrc": "https://cdn.kqed.org/wp-content/uploads/2025/02/CAT_2_Tile-scaled.jpg",
"imageAlt": "KQED Close All Tabs",
"officialWebsiteLink": "/podcasts/closealltabs",
"meta": {
"site": "news",
"source": "kqed",
"order": 1
},
"link": "/podcasts/closealltabs",
"subscribe": {
"apple": "https://podcasts.apple.com/us/podcast/close-all-tabs/id214663465",
"rss": "https://feeds.megaphone.fm/KQINC6993880386",
"amazon": "https://music.amazon.com/podcasts/92d9d4ac-67a3-4eed-b10a-fb45d45b1ef2/close-all-tabs",
"spotify": "https://open.spotify.com/show/6LAJFHnGK1pYXYzv6SIol6?si=deb0cae19813417c"
}
},
"code-switch-life-kit": {
"id": "code-switch-life-kit",
"title": "Code Switch / Life Kit",
"info": "\u003cem>Code Switch\u003c/em>, which listeners will hear in the first part of the hour, has fearless and much-needed conversations about race. Hosted by journalists of color, the show tackles the subject of race head-on, exploring how it impacts every part of society — from politics and pop culture to history, sports and more.\u003cbr />\u003cbr />\u003cem>Life Kit\u003c/em>, which will be in the second part of the hour, guides you through spaces and feelings no one prepares you for — from finances to mental health, from workplace microaggressions to imposter syndrome, from relationships to parenting. The show features experts with real world experience and shares their knowledge. Because everyone needs a little help being human.\u003cbr />\u003cbr />\u003ca href=\"https://www.npr.org/podcasts/510312/codeswitch\">\u003cem>Code Switch\u003c/em> offical site and podcast\u003c/a>\u003cbr />\u003ca href=\"https://www.npr.org/lifekit\">\u003cem>Life Kit\u003c/em> offical site and podcast\u003c/a>\u003cbr />",
"airtime": "SUN 9pm-10pm",
"imageSrc": "https://cdn.kqed.org/wp-content/uploads/2024/04/Code-Switch-Life-Kit-Podcast-Tile-360x360-1.jpg",
"meta": {
"site": "radio",
"source": "npr"
},
"link": "/radio/program/code-switch-life-kit",
"subscribe": {
"apple": "https://podcasts.apple.com/podcast/1112190608?mt=2&at=11l79Y&ct=nprdirectory",
"google": "https://podcasts.google.com/feed/aHR0cHM6Ly93d3cubnByLm9yZy9yc3MvcG9kY2FzdC5waHA_aWQ9NTEwMzEy",
"spotify": "https://open.spotify.com/show/3bExJ9JQpkwNhoHvaIIuyV",
"rss": "https://feeds.npr.org/510312/podcast.xml"
}
},
"commonwealth-club": {
"id": "commonwealth-club",
"title": "Commonwealth Club of California Podcast",
"info": "The Commonwealth Club of California is the nation's oldest and largest public affairs forum. As a non-partisan forum, The Club brings to the public airwaves diverse viewpoints on important topics. The Club's weekly radio broadcast - the oldest in the U.S., dating back to 1924 - is carried across the nation on public radio stations and is now podcasting. Our website archive features audio of our recent programs, as well as selected speeches from our long and distinguished history. This podcast feed is usually updated twice a week and is always un-edited.",
"airtime": "THU 10pm, FRI 1am",
"imageSrc": "https://cdn.kqed.org/wp-content/uploads/2024/04/Commonwealth-Club-Podcast-Tile-360x360-1.jpg",
"officialWebsiteLink": "https://www.commonwealthclub.org/podcasts",
"meta": {
"site": "news",
"source": "Commonwealth Club of California"
},
"link": "/radio/program/commonwealth-club",
"subscribe": {
"apple": "https://itunes.apple.com/us/podcast/commonwealth-club-of-california-podcast/id976334034?mt=2",
"google": "https://podcasts.google.com/feed/aHR0cDovL3d3dy5jb21tb253ZWFsdGhjbHViLm9yZy9hdWRpby9wb2RjYXN0L3dlZWtseS54bWw",
"tuneIn": "https://tunein.com/radio/Commonwealth-Club-of-California-p1060/"
}
},
"forum": {
"id": "forum",
"title": "Forum",
"tagline": "The conversation starts here",
"info": "KQED’s live call-in program discussing local, state, national and international issues, as well as in-depth interviews.",
"airtime": "MON-FRI 9am-11am, 10pm-11pm",
"imageSrc": "https://cdn.kqed.org/wp-content/uploads/2024/04/Forum-Podcast-Tile-703x703-1.jpg",
"imageAlt": "KQED Forum with Mina Kim and Alexis Madrigal",
"officialWebsiteLink": "/forum",
"meta": {
"site": "news",
"source": "kqed",
"order": 9
},
"link": "/forum",
"subscribe": {
"apple": "https://podcasts.apple.com/us/podcast/kqeds-forum/id73329719",
"google": "https://podcasts.google.com/feed/aHR0cHM6Ly9mZWVkcy5tZWdhcGhvbmUuZm0vS1FJTkM5NTU3MzgxNjMz",
"npr": "https://www.npr.org/podcasts/432307980/forum",
"stitcher": "https://www.stitcher.com/podcast/kqedfm-kqeds-forum-podcast",
"rss": "https://feeds.megaphone.fm/KQINC9557381633"
}
},
"freakonomics-radio": {
"id": "freakonomics-radio",
"title": "Freakonomics Radio",
"info": "Freakonomics Radio is a one-hour award-winning podcast and public-radio project hosted by Stephen Dubner, with co-author Steve Levitt as a regular guest. It is produced in partnership with WNYC.",
"imageSrc": "https://ww2.kqed.org/news/wp-content/uploads/sites/10/2018/05/freakonomicsRadio.png",
"officialWebsiteLink": "http://freakonomics.com/",
"airtime": "SUN 1am-2am, SAT 3pm-4pm",
"meta": {
"site": "radio",
"source": "WNYC"
},
"link": "/radio/program/freakonomics-radio",
"subscribe": {
"npr": "https://rpb3r.app.goo.gl/4s8b",
"apple": "https://itunes.apple.com/us/podcast/freakonomics-radio/id354668519",
"tuneIn": "https://tunein.com/podcasts/WNYC-Podcasts/Freakonomics-Radio-p272293/",
"rss": "https://feeds.feedburner.com/freakonomicsradio"
}
},
"fresh-air": {
"id": "fresh-air",
"title": "Fresh Air",
"info": "Hosted by Terry Gross, \u003cem>Fresh Air from WHYY\u003c/em> is the Peabody Award-winning weekday magazine of contemporary arts and issues. One of public radio's most popular programs, Fresh Air features intimate conversations with today's biggest luminaries.",
"airtime": "MON-FRI 7pm-8pm",
"imageSrc": "https://cdn.kqed.org/wp-content/uploads/2024/04/Fresh-Air-Podcast-Tile-360x360-1.jpg",
"officialWebsiteLink": "https://www.npr.org/programs/fresh-air/",
"meta": {
"site": "radio",
"source": "npr"
},
"link": "/radio/program/fresh-air",
"subscribe": {
"npr": "https://rpb3r.app.goo.gl/4s8b",
"apple": "https://itunes.apple.com/WebObjects/MZStore.woa/wa/viewPodcast?s=143441&mt=2&id=214089682&at=11l79Y&ct=nprdirectory",
"tuneIn": "https://tunein.com/radio/Fresh-Air-p17/",
"rss": "https://feeds.npr.org/381444908/podcast.xml"
}
},
"here-and-now": {
"id": "here-and-now",
"title": "Here & Now",
"info": "A live production of NPR and WBUR Boston, in collaboration with stations across the country, Here & Now reflects the fluid world of news as it's happening in the middle of the day, with timely, in-depth news, interviews and conversation. Hosted by Robin Young, Jeremy Hobson and Tonya Mosley.",
"airtime": "MON-THU 11am-12pm",
"imageSrc": "https://cdn.kqed.org/wp-content/uploads/2024/04/Here-And-Now-Podcast-Tile-360x360-1.jpg",
"officialWebsiteLink": "http://www.wbur.org/hereandnow",
"meta": {
"site": "news",
"source": "npr"
},
"link": "/radio/program/here-and-now",
"subsdcribe": {
"apple": "https://itunes.apple.com/WebObjects/MZStore.woa/wa/viewPodcast?mt=2&id=426698661",
"tuneIn": "https://tunein.com/radio/Here--Now-p211/",
"rss": "https://feeds.npr.org/510051/podcast.xml"
}
},
"hidden-brain": {
"id": "hidden-brain",
"title": "Hidden Brain",
"info": "Shankar Vedantam uses science and storytelling to reveal the unconscious patterns that drive human behavior, shape our choices and direct our relationships.",
"imageSrc": "https://ww2.kqed.org/radio/wp-content/uploads/sites/50/2018/05/hiddenbrain.jpg",
"officialWebsiteLink": "https://www.npr.org/series/423302056/hidden-brain",
"airtime": "SUN 7pm-8pm",
"meta": {
"site": "news",
"source": "NPR"
},
"link": "/radio/program/hidden-brain",
"subscribe": {
"apple": "https://itunes.apple.com/us/podcast/hidden-brain/id1028908750?mt=2",
"tuneIn": "https://tunein.com/podcasts/Science-Podcasts/Hidden-Brain-p787503/",
"rss": "https://feeds.npr.org/510308/podcast.xml"
}
},
"how-i-built-this": {
"id": "how-i-built-this",
"title": "How I Built This with Guy Raz",
"info": "Guy Raz dives into the stories behind some of the world's best known companies. How I Built This weaves a narrative journey about innovators, entrepreneurs and idealists—and the movements they built.",
"imageSrc": "https://ww2.kqed.org/news/wp-content/uploads/sites/10/2018/05/howIBuiltThis.png",
"officialWebsiteLink": "https://www.npr.org/podcasts/510313/how-i-built-this",
"airtime": "SUN 7:30pm-8pm",
"meta": {
"site": "news",
"source": "npr"
},
"link": "/radio/program/how-i-built-this",
"subscribe": {
"npr": "https://rpb3r.app.goo.gl/3zxy",
"apple": "https://itunes.apple.com/us/podcast/how-i-built-this-with-guy-raz/id1150510297?mt=2",
"tuneIn": "https://tunein.com/podcasts/Arts--Culture-Podcasts/How-I-Built-This-p910896/",
"rss": "https://feeds.npr.org/510313/podcast.xml"
}
},
"hyphenacion": {
"id": "hyphenacion",
"title": "Hyphenación",
"tagline": "Where conversation and cultura meet",
"info": "What kind of no sabo word is Hyphenación? For us, it’s about living within a hyphenation. Like being a third-gen Mexican-American from the Texas border now living that Bay Area Chicano life. Like Xorje! Each week we bring together a couple of hyphenated Latinos to talk all about personal life choices: family, careers, relationships, belonging … everything is on the table. ",
"imageSrc": "https://cdn.kqed.org/wp-content/uploads/2025/03/Hyphenacion_FinalAssets_PodcastTile.png",
"imageAlt": "KQED Hyphenación",
"officialWebsiteLink": "/podcasts/hyphenacion",
"meta": {
"site": "news",
"source": "kqed",
"order": 15
},
"link": "/podcasts/hyphenacion",
"subscribe": {
"apple": "https://podcasts.apple.com/us/podcast/hyphenaci%C3%B3n/id1191591838",
"spotify": "https://open.spotify.com/show/2p3Fifq96nw9BPcmFdIq0o?si=39209f7b25774f38",
"youtube": "https://www.youtube.com/c/kqedarts",
"amazon": "https://music.amazon.com/podcasts/6c3dd23c-93fb-4aab-97ba-1725fa6315f1/hyphenaci%C3%B3n",
"rss": "https://feeds.megaphone.fm/KQINC2275451163"
}
},
"jerrybrown": {
"id": "jerrybrown",
"title": "The Political Mind of Jerry Brown",
"tagline": "Lessons from a lifetime in politics",
"info": "The Political Mind of Jerry Brown brings listeners the wisdom of the former Governor, Mayor, and presidential candidate. Scott Shafer interviewed Brown for more than 40 hours, covering the former governor's life and half-century in the political game – and Brown has some lessons he'd like to share. ",
"imageSrc": "https://cdn.kqed.org/wp-content/uploads/2024/04/The-Political-Mind-of-Jerry-Brown-Podcast-Tile-703x703-1.jpg",
"imageAlt": "KQED The Political Mind of Jerry Brown",
"officialWebsiteLink": "/podcasts/jerrybrown",
"meta": {
"site": "news",
"source": "kqed",
"order": 18
},
"link": "/podcasts/jerrybrown",
"subscribe": {
"npr": "https://www.npr.org/podcasts/790253322/the-political-mind-of-jerry-brown",
"apple": "https://itunes.apple.com/us/podcast/id1492194549",
"rss": "https://ww2.kqed.org/news/series/jerrybrown/feed/podcast/",
"tuneIn": "http://tun.in/pjGcK",
"stitcher": "https://www.stitcher.com/podcast/kqed/the-political-mind-of-jerry-brown",
"spotify": "https://open.spotify.com/show/54C1dmuyFyKMFttY6X2j6r?si=K8SgRCoISNK6ZbjpXrX5-w",
"amazon": "https://music.amazon.com/podcasts/44420f75-3b0e-4301-ab3b-16da6b09e543/the-political-mind-of-jerry-brown"
}
},
"latino-usa": {
"id": "latino-usa",
"title": "Latino USA",
"airtime": "MON 1am-2am, SUN 6pm-7pm",
"info": "Latino USA, the radio journal of news and culture, is the only national, English-language radio program produced from a Latino perspective.",
"imageSrc": "https://ww2.kqed.org/radio/wp-content/uploads/sites/50/2018/04/latinoUsa.jpg",
"officialWebsiteLink": "http://latinousa.org/",
"meta": {
"site": "news",
"source": "npr"
},
"link": "/radio/program/latino-usa",
"subscribe": {
"npr": "https://rpb3r.app.goo.gl/xtTd",
"apple": "https://itunes.apple.com/WebObjects/MZStore.woa/wa/viewPodcast?s=143441&mt=2&id=79681317&at=11l79Y&ct=nprdirectory",
"tuneIn": "https://tunein.com/radio/Latino-USA-p621/",
"rss": "https://feeds.npr.org/510016/podcast.xml"
}
},
"marketplace": {
"id": "marketplace",
"title": "Marketplace",
"info": "Our flagship program, helmed by Kai Ryssdal, examines what the day in money delivered, through stories, conversations, newsworthy numbers and more. Updated Monday through Friday at about 3:30 p.m. PT.",
"airtime": "MON-FRI 4pm-4:30pm, MON-WED 6:30pm-7pm",
"imageSrc": "https://cdn.kqed.org/wp-content/uploads/2024/04/Marketplace-Podcast-Tile-360x360-1.jpg",
"officialWebsiteLink": "https://www.marketplace.org/",
"meta": {
"site": "news",
"source": "American Public Media"
},
"link": "/radio/program/marketplace",
"subscribe": {
"apple": "https://itunes.apple.com/WebObjects/MZStore.woa/wa/viewPodcast?s=143441&mt=2&id=201853034&at=11l79Y&ct=nprdirectory",
"tuneIn": "https://tunein.com/radio/APM-Marketplace-p88/",
"rss": "https://feeds.publicradio.org/public_feeds/marketplace-pm/rss/rss"
}
},
"masters-of-scale": {
"id": "masters-of-scale",
"title": "Masters of Scale",
"info": "Masters of Scale is an original podcast in which LinkedIn co-founder and Greylock Partner Reid Hoffman sets out to describe and prove theories that explain how great entrepreneurs take their companies from zero to a gazillion in ingenious fashion.",
"airtime": "Every other Wednesday June 12 through October 16 at 8pm (repeats Thursdays at 2am)",
"imageSrc": "https://cdn.kqed.org/wp-content/uploads/2024/04/Masters-of-Scale-Podcast-Tile-360x360-1.jpg",
"officialWebsiteLink": "https://mastersofscale.com/",
"meta": {
"site": "radio",
"source": "WaitWhat"
},
"link": "/radio/program/masters-of-scale",
"subscribe": {
"apple": "http://mastersofscale.app.link/",
"rss": "https://rss.art19.com/masters-of-scale"
}
},
"mindshift": {
"id": "mindshift",
"title": "MindShift",
"tagline": "A podcast about the future of learning and how we raise our kids",
"info": "The MindShift podcast explores the innovations in education that are shaping how kids learn. Hosts Ki Sung and Katrina Schwartz introduce listeners to educators, researchers, parents and students who are developing effective ways to improve how kids learn. We cover topics like how fed-up administrators are developing surprising tactics to deal with classroom disruptions; how listening to podcasts are helping kids develop reading skills; the consequences of overparenting; and why interdisciplinary learning can engage students on all ends of the traditional achievement spectrum. This podcast is part of the MindShift education site, a division of KQED News. KQED is an NPR/PBS member station based in San Francisco. You can also visit the MindShift website for episodes and supplemental blog posts or tweet us \u003ca href=\"https://twitter.com/MindShiftKQED\">@MindShiftKQED\u003c/a> or visit us at \u003ca href=\"/mindshift\">MindShift.KQED.org\u003c/a>",
"imageSrc": "https://cdn.kqed.org/wp-content/uploads/2024/04/Mindshift-Podcast-Tile-703x703-1.jpg",
"imageAlt": "KQED MindShift: How We Will Learn",
"officialWebsiteLink": "/mindshift/",
"meta": {
"site": "news",
"source": "kqed",
"order": 12
},
"link": "/podcasts/mindshift",
"subscribe": {
"apple": "https://podcasts.apple.com/us/podcast/mindshift-podcast/id1078765985",
"google": "https://podcasts.google.com/feed/aHR0cHM6Ly9mZWVkcy5tZWdhcGhvbmUuZm0vS1FJTkM1NzY0NjAwNDI5",
"npr": "https://www.npr.org/podcasts/464615685/mind-shift-podcast",
"stitcher": "https://www.stitcher.com/podcast/kqed/stories-teachers-share",
"spotify": "https://open.spotify.com/show/0MxSpNYZKNprFLCl7eEtyx"
}
},
"morning-edition": {
"id": "morning-edition",
"title": "Morning Edition",
"info": "\u003cem>Morning Edition\u003c/em> takes listeners around the country and the world with multi-faceted stories and commentaries every weekday. Hosts Steve Inskeep, David Greene and Rachel Martin bring you the latest breaking news and features to prepare you for the day.",
"airtime": "MON-FRI 3am-9am",
"imageSrc": "https://cdn.kqed.org/wp-content/uploads/2024/04/Morning-Edition-Podcast-Tile-360x360-1.jpg",
"officialWebsiteLink": "https://www.npr.org/programs/morning-edition/",
"meta": {
"site": "news",
"source": "npr"
},
"link": "/radio/program/morning-edition"
},
"onourwatch": {
"id": "onourwatch",
"title": "On Our Watch",
"tagline": "Deeply-reported investigative journalism",
"info": "For decades, the process for how police police themselves has been inconsistent – if not opaque. In some states, like California, these proceedings were completely hidden. After a new police transparency law unsealed scores of internal affairs files, our reporters set out to examine these cases and the shadow world of police discipline. On Our Watch brings listeners into the rooms where officers are questioned and witnesses are interrogated to find out who this system is really protecting. Is it the officers, or the public they've sworn to serve?",
"imageSrc": "https://cdn.kqed.org/wp-content/uploads/2024/04/On-Our-Watch-Podcast-Tile-703x703-1.jpg",
"imageAlt": "On Our Watch from NPR and KQED",
"officialWebsiteLink": "/podcasts/onourwatch",
"meta": {
"site": "news",
"source": "kqed",
"order": 11
},
"link": "/podcasts/onourwatch",
"subscribe": {
"apple": "https://podcasts.apple.com/podcast/id1567098962",
"google": "https://podcasts.google.com/feed/aHR0cHM6Ly9mZWVkcy5ucHIub3JnLzUxMDM2MC9wb2RjYXN0LnhtbD9zYz1nb29nbGVwb2RjYXN0cw",
"npr": "https://rpb3r.app.goo.gl/onourwatch",
"spotify": "https://open.spotify.com/show/0OLWoyizopu6tY1XiuX70x",
"tuneIn": "https://tunein.com/radio/On-Our-Watch-p1436229/",
"stitcher": "https://www.stitcher.com/show/on-our-watch",
"rss": "https://feeds.npr.org/510360/podcast.xml"
}
},
"on-the-media": {
"id": "on-the-media",
"title": "On The Media",
"info": "Our weekly podcast explores how the media 'sausage' is made, casts an incisive eye on fluctuations in the marketplace of ideas, and examines threats to the freedom of information and expression in America and abroad. For one hour a week, the show tries to lift the veil from the process of \"making media,\" especially news media, because it's through that lens that we see the world and the world sees us",
"airtime": "SUN 2pm-3pm, MON 12am-1am",
"imageSrc": "https://ww2.kqed.org/radio/wp-content/uploads/sites/50/2018/04/onTheMedia.png",
"officialWebsiteLink": "https://www.wnycstudios.org/shows/otm",
"meta": {
"site": "news",
"source": "wnyc"
},
"link": "/radio/program/on-the-media",
"subscribe": {
"apple": "https://itunes.apple.com/us/podcast/on-the-media/id73330715?mt=2",
"tuneIn": "https://tunein.com/radio/On-the-Media-p69/",
"rss": "http://feeds.wnyc.org/onthemedia"
}
},
"pbs-newshour": {
"id": "pbs-newshour",
"title": "PBS NewsHour",
"info": "Analysis, background reports and updates from the PBS NewsHour putting today's news in context.",
"airtime": "MON-FRI 3pm-4pm",
"imageSrc": "https://cdn.kqed.org/wp-content/uploads/2024/04/PBS-News-Hour-Podcast-Tile-360x360-1.jpg",
"officialWebsiteLink": "https://www.pbs.org/newshour/",
"meta": {
"site": "news",
"source": "pbs"
},
"link": "/radio/program/pbs-newshour",
"subscribe": {
"apple": "https://itunes.apple.com/us/podcast/pbs-newshour-full-show/id394432287?mt=2",
"tuneIn": "https://tunein.com/radio/PBS-NewsHour---Full-Show-p425698/",
"rss": "https://www.pbs.org/newshour/feeds/rss/podcasts/show"
}
},
"perspectives": {
"id": "perspectives",
"title": "Perspectives",
"tagline": "KQED's series of daily listener commentaries since 1991",
"info": "KQED's series of daily listener commentaries since 1991.",
"imageSrc": "https://cdn.kqed.org/wp-content/uploads/2025/01/Perspectives_Tile_Final.jpg",
"imageAlt": "KQED Perspectives",
"officialWebsiteLink": "/perspectives/",
"meta": {
"site": "radio",
"source": "kqed",
"order": 14
},
"link": "/perspectives",
"subscribe": {
"apple": "https://podcasts.apple.com/us/podcast/id73801135",
"npr": "https://www.npr.org/podcasts/432309616/perspectives",
"rss": "https://ww2.kqed.org/perspectives/category/perspectives/feed/",
"google": "https://podcasts.google.com/feed/aHR0cHM6Ly93dzIua3FlZC5vcmcvcGVyc3BlY3RpdmVzL2NhdGVnb3J5L3BlcnNwZWN0aXZlcy9mZWVkLw"
}
},
"planet-money": {
"id": "planet-money",
"title": "Planet Money",
"info": "The economy explained. Imagine you could call up a friend and say, Meet me at the bar and tell me what's going on with the economy. Now imagine that's actually a fun evening.",
"airtime": "SUN 3pm-4pm",
"imageSrc": "https://ww2.kqed.org/radio/wp-content/uploads/sites/50/2018/04/planetmoney.jpg",
"officialWebsiteLink": "https://www.npr.org/sections/money/",
"meta": {
"site": "news",
"source": "npr"
},
"link": "/radio/program/planet-money",
"subscribe": {
"npr": "https://rpb3r.app.goo.gl/M4f5",
"apple": "https://itunes.apple.com/us/podcast/planet-money/id290783428?mt=2",
"tuneIn": "https://tunein.com/podcasts/Business--Economics-Podcasts/Planet-Money-p164680/",
"rss": "https://feeds.npr.org/510289/podcast.xml"
}
},
"politicalbreakdown": {
"id": "politicalbreakdown",
"title": "Political Breakdown",
"tagline": "Politics from a personal perspective",
"info": "Political Breakdown is a new series that explores the political intersection of California and the nation. Each week hosts Scott Shafer and Marisa Lagos are joined with a new special guest to unpack politics -- with personality — and offer an insider’s glimpse at how politics happens.",
"airtime": "THU 6:30pm-7pm",
"imageSrc": "https://cdn.kqed.org/wp-content/uploads/2024/04/Political-Breakdown-2024-Podcast-Tile-703x703-1.jpg",
"imageAlt": "KQED Political Breakdown",
"officialWebsiteLink": "/podcasts/politicalbreakdown",
"meta": {
"site": "radio",
"source": "kqed",
"order": 5
},
"link": "/podcasts/politicalbreakdown",
"subscribe": {
"apple": "https://podcasts.apple.com/us/podcast/political-breakdown/id1327641087",
"amazon": "https://music.amazon.com/podcasts/e0c2d153-ad36-4c8d-901d-f1da6a724824/political-breakdown",
"npr": "https://www.npr.org/podcasts/572155894/political-breakdown",
"stitcher": "https://www.stitcher.com/podcast/kqed/political-breakdown",
"spotify": "https://open.spotify.com/show/07RVyIjIdk2WDuVehvBMoN",
"rss": "https://ww2.kqed.org/news/tag/political-breakdown/feed/podcast"
}
},
"possible": {
"id": "possible",
"title": "Possible",
"info": "Possible is hosted by entrepreneur Reid Hoffman and writer Aria Finger. Together in Possible, Hoffman and Finger lead enlightening discussions about building a brighter collective future. The show features interviews with visionary guests like Trevor Noah, Sam Altman and Janette Sadik-Khan. Possible paints an optimistic portrait of the world we can create through science, policy, business, art and our shared humanity. It asks: What if everything goes right for once? How can we get there? Each episode also includes a short fiction story generated by advanced AI GPT-4, serving as a thought-provoking springboard to speculate how humanity could leverage technology for good.",
"airtime": "SUN 2pm",
"imageSrc": "https://cdn.kqed.org/wp-content/uploads/2024/04/Possible-Podcast-Tile-360x360-1.jpg",
"officialWebsiteLink": "https://www.possible.fm/",
"meta": {
"site": "news",
"source": "Possible"
},
"link": "/radio/program/possible",
"subscribe": {
"apple": "https://podcasts.apple.com/us/podcast/possible/id1677184070",
"spotify": "https://open.spotify.com/show/730YpdUSNlMyPQwNnyjp4k"
}
},
"pri-the-world": {
"id": "pri-the-world",
"title": "PRI's The World: Latest Edition",
"info": "Each weekday, host Marco Werman and his team of producers bring you the world's most interesting stories in an hour of radio that reminds us just how small our planet really is.",
"airtime": "MON-FRI 2pm-3pm",
"imageSrc": "https://cdn.kqed.org/wp-content/uploads/2024/04/The-World-Podcast-Tile-360x360-1.jpg",
"officialWebsiteLink": "https://www.pri.org/programs/the-world",
"meta": {
"site": "news",
"source": "PRI"
},
"link": "/radio/program/pri-the-world",
"subscribe": {
"apple": "https://itunes.apple.com/us/podcast/pris-the-world-latest-edition/id278196007?mt=2",
"tuneIn": "https://tunein.com/podcasts/News--Politics-Podcasts/PRIs-The-World-p24/",
"rss": "http://feeds.feedburner.com/pri/theworld"
}
},
"radiolab": {
"id": "radiolab",
"title": "Radiolab",
"info": "A two-time Peabody Award-winner, Radiolab is an investigation told through sounds and stories, and centered around one big idea. In the Radiolab world, information sounds like music and science and culture collide. Hosted by Jad Abumrad and Robert Krulwich, the show is designed for listeners who demand skepticism, but appreciate wonder. WNYC Studios is the producer of other leading podcasts including Freakonomics Radio, Death, Sex & Money, On the Media and many more.",
"airtime": "SUN 12am-1am, SAT 2pm-3pm",
"imageSrc": "https://ww2.kqed.org/radio/wp-content/uploads/sites/50/2018/04/radiolab1400.png",
"officialWebsiteLink": "https://www.wnycstudios.org/shows/radiolab/",
"meta": {
"site": "science",
"source": "WNYC"
},
"link": "/radio/program/radiolab",
"subscribe": {
"apple": "https://itunes.apple.com/us/podcast/radiolab/id152249110?mt=2",
"tuneIn": "https://tunein.com/radio/RadioLab-p68032/",
"rss": "https://feeds.wnyc.org/radiolab"
}
},
"reveal": {
"id": "reveal",
"title": "Reveal",
"info": "Created by The Center for Investigative Reporting and PRX, Reveal is public radios first one-hour weekly radio show and podcast dedicated to investigative reporting. Credible, fact based and without a partisan agenda, Reveal combines the power and artistry of driveway moment storytelling with data-rich reporting on critically important issues. The result is stories that inform and inspire, arming our listeners with information to right injustices, hold the powerful accountable and improve lives.Reveal is hosted by Al Letson and showcases the award-winning work of CIR and newsrooms large and small across the nation. In a radio and podcast market crowded with choices, Reveal focuses on important and often surprising stories that illuminate the world for our listeners.",
"airtime": "SAT 4pm-5pm",
"imageSrc": "https://ww2.kqed.org/radio/wp-content/uploads/sites/50/2018/04/reveal300px.png",
"officialWebsiteLink": "https://www.revealnews.org/episodes/",
"meta": {
"site": "news",
"source": "npr"
},
"link": "/radio/program/reveal",
"subscribe": {
"apple": "https://itunes.apple.com/us/podcast/reveal/id886009669",
"tuneIn": "https://tunein.com/radio/Reveal-p679597/",
"rss": "http://feeds.revealradio.org/revealpodcast"
}
},
"rightnowish": {
"id": "rightnowish",
"title": "Rightnowish",
"tagline": "Art is where you find it",
"info": "Rightnowish digs into life in the Bay Area right now… ish. Journalist Pendarvis Harshaw takes us to galleries painted on the sides of liquor stores in West Oakland. We'll dance in warehouses in the Bayview, make smoothies with kids in South Berkeley, and listen to classical music in a 1984 Cutlass Supreme in Richmond. Every week, Pen talks to movers and shakers about how the Bay Area shapes what they create, and how they shape the place we call home.",
"imageSrc": "https://cdn.kqed.org/wp-content/uploads/2024/04/Rightnowish-Podcast-Tile-500x500-1.jpg",
"imageAlt": "KQED Rightnowish with Pendarvis Harshaw",
"officialWebsiteLink": "/podcasts/rightnowish",
"meta": {
"site": "arts",
"source": "kqed",
"order": 16
},
"link": "/podcasts/rightnowish",
"subscribe": {
"npr": "https://www.npr.org/podcasts/721590300/rightnowish",
"rss": "https://ww2.kqed.org/arts/programs/rightnowish/feed/podcast",
"apple": "https://podcasts.apple.com/us/podcast/rightnowish/id1482187648",
"stitcher": "https://www.stitcher.com/podcast/kqed/rightnowish",
"google": "https://podcasts.google.com/feed/aHR0cHM6Ly9mZWVkcy5tZWdhcGhvbmUuZm0vS1FJTkMxMjU5MTY3NDc4",
"spotify": "https://open.spotify.com/show/7kEJuafTzTVan7B78ttz1I"
}
},
"science-friday": {
"id": "science-friday",
"title": "Science Friday",
"info": "Science Friday is a weekly science talk show, broadcast live over public radio stations nationwide. Each week, the show focuses on science topics that are in the news and tries to bring an educated, balanced discussion to bear on the scientific issues at hand. Panels of expert guests join host Ira Flatow, a veteran science journalist, to discuss science and to take questions from listeners during the call-in portion of the program.",
"airtime": "FRI 11am-1pm",
"imageSrc": "https://cdn.kqed.org/wp-content/uploads/2024/04/Science-Friday-Podcast-Tile-360x360-1.jpg",
"officialWebsiteLink": "https://www.wnycstudios.org/shows/science-friday",
"meta": {
"site": "news",
"source": "npr"
},
"link": "/radio/program/science-friday",
"subscribe": {
"apple": "https://itunes.apple.com/WebObjects/MZStore.woa/wa/viewPodcast?s=143441&mt=2&id=73329284&at=11l79Y&ct=nprdirectory",
"tuneIn": "https://tunein.com/radio/Science-Friday-p394/",
"rss": "http://feeds.wnyc.org/science-friday"
}
},
"snap-judgment": {
"id": "snap-judgment",
"title": "Snap Judgment",
"tagline": "Real stories with killer beats",
"info": "The Snap Judgment radio show and podcast mixes real stories with killer beats to produce cinematic, dramatic radio. Snap's musical brand of storytelling dares listeners to see the world through the eyes of another. This is storytelling... with a BEAT!! Snap first aired on public radio stations nationwide in July 2010. Today, Snap Judgment airs on over 450 public radio stations and is brought to the airwaves by KQED & PRX.",
"airtime": "SAT 1pm-2pm, 9pm-10pm",
"imageSrc": "https://cdn.kqed.org/wp-content/uploads/2024/05/Snap-Judgment-Podcast-Tile-703x703-1.jpg",
"imageAlt": "KQED Snap Judgment",
"officialWebsiteLink": "https://snapjudgment.org",
"meta": {
"site": "arts",
"source": "kqed",
"order": 4
},
"link": "https://snapjudgment.org",
"subscribe": {
"apple": "https://podcasts.apple.com/us/podcast/snap-judgment/id283657561",
"npr": "https://www.npr.org/podcasts/449018144/snap-judgment",
"stitcher": "https://www.pandora.com/podcast/snap-judgment/PC:241?source=stitcher-sunset",
"spotify": "https://open.spotify.com/show/3Cct7ZWmxHNAtLgBTqjC5v",
"rss": "https://snap.feed.snapjudgment.org/"
}
},
"soldout": {
"id": "soldout",
"title": "SOLD OUT: Rethinking Housing in America",
"tagline": "A new future for housing",
"info": "Sold Out: Rethinking Housing in America",
"imageSrc": "https://cdn.kqed.org/wp-content/uploads/2024/04/Sold-Out-Podcast-Tile-703x703-1.jpg",
"imageAlt": "KQED Sold Out: Rethinking Housing in America",
"officialWebsiteLink": "/podcasts/soldout",
"meta": {
"site": "news",
"source": "kqed",
"order": 13
},
"link": "/podcasts/soldout",
"subscribe": {
"npr": "https://www.npr.org/podcasts/911586047/s-o-l-d-o-u-t-a-new-future-for-housing",
"apple": "https://podcasts.apple.com/us/podcast/introducing-sold-out-rethinking-housing-in-america/id1531354937",
"rss": "https://feeds.megaphone.fm/soldout",
"spotify": "https://open.spotify.com/show/38dTBSk2ISFoPiyYNoKn1X",
"stitcher": "https://www.stitcher.com/podcast/kqed/sold-out-rethinking-housing-in-america",
"tunein": "https://tunein.com/radio/SOLD-OUT-Rethinking-Housing-in-America-p1365871/"
}
},
"spooked": {
"id": "spooked",
"title": "Spooked",
"tagline": "True-life supernatural stories",
"info": "",
"imageSrc": "https://cdn.kqed.org/wp-content/uploads/2024/10/Spooked-Podcast-Tile-703x703-1.jpg",
"imageAlt": "KQED Spooked",
"officialWebsiteLink": "https://spookedpodcast.org/",
"meta": {
"site": "news",
"source": "kqed",
"order": 7
},
"link": "https://spookedpodcast.org/",
"subscribe": {
"apple": "https://podcasts.apple.com/us/podcast/spooked/id1279361017",
"npr": "https://www.npr.org/podcasts/549547848/snap-judgment-presents-spooked",
"spotify": "https://open.spotify.com/show/76571Rfl3m7PLJQZKQIGCT",
"rss": "https://feeds.simplecast.com/TBotaapn"
}
},
"tech-nation": {
"id": "tech-nation",
"title": "Tech Nation Radio Podcast",
"info": "Tech Nation is a weekly public radio program, hosted by Dr. Moira Gunn. Founded in 1993, it has grown from a simple interview show to a multi-faceted production, featuring conversations with noted technology and science leaders, and a weekly science and technology-related commentary.",
"airtime": "FRI 10pm",
"imageSrc": "https://cdn.kqed.org/wp-content/uploads/2024/04/Tech-Nation-Radio-Podcast-Tile-360x360-1.jpg",
"officialWebsiteLink": "http://technation.podomatic.com/",
"meta": {
"site": "science",
"source": "Tech Nation Media"
},
"link": "/radio/program/tech-nation",
"subscribe": {
"rss": "https://technation.podomatic.com/rss2.xml"
}
},
"ted-radio-hour": {
"id": "ted-radio-hour",
"title": "TED Radio Hour",
"info": "The TED Radio Hour is a journey through fascinating ideas, astonishing inventions, fresh approaches to old problems, and new ways to think and create.",
"airtime": "SUN 3pm-4pm, SAT 10pm-11pm",
"imageSrc": "https://ww2.kqed.org/radio/wp-content/uploads/sites/50/2018/04/tedRadioHour.jpg",
"officialWebsiteLink": "https://www.npr.org/programs/ted-radio-hour/?showDate=2018-06-22",
"meta": {
"site": "news",
"source": "npr"
},
"link": "/radio/program/ted-radio-hour",
"subscribe": {
"npr": "https://rpb3r.app.goo.gl/8vsS",
"apple": "https://itunes.apple.com/WebObjects/MZStore.woa/wa/viewPodcast?s=143441&mt=2&id=523121474&at=11l79Y&ct=nprdirectory",
"tuneIn": "https://tunein.com/radio/TED-Radio-Hour-p418021/",
"rss": "https://feeds.npr.org/510298/podcast.xml"
}
},
"thebay": {
"id": "thebay",
"title": "The Bay",
"tagline": "Local news to keep you rooted",
"info": "Host Devin Katayama walks you through the biggest story of the day with reporters and newsmakers.",
"imageSrc": "https://cdn.kqed.org/wp-content/uploads/2024/04/The-Bay-Podcast-Tile-703x703-1.jpg",
"imageAlt": "KQED The Bay",
"officialWebsiteLink": "/podcasts/thebay",
"meta": {
"site": "radio",
"source": "kqed",
"order": 2
},
"link": "/podcasts/thebay",
"subscribe": {
"apple": "https://podcasts.apple.com/us/podcast/the-bay/id1350043452",
"amazon": "https://music.amazon.com/podcasts/d800ea4c-7a2c-42f2-b861-edaf78a5db0b/the-bay",
"npr": "https://www.npr.org/podcasts/586725995/the-bay",
"stitcher": "https://www.stitcher.com/podcast/kqed/the-bay",
"spotify": "https://open.spotify.com/show/4BIKBKIujizLHlIlBNaAqQ",
"rss": "https://feeds.megaphone.fm/KQINC8259786327"
}
},
"thelatest": {
"id": "thelatest",
"title": "The Latest",
"tagline": "Trusted local news in real time",
"info": "",
"imageSrc": "https://cdn.kqed.org/wp-content/uploads/2025/05/The-Latest-2025-Podcast-Tile-703x703-1.jpg",
"imageAlt": "KQED The Latest",
"officialWebsiteLink": "/thelatest",
"meta": {
"site": "news",
"source": "kqed",
"order": 6
},
"link": "/thelatest",
"subscribe": {
"apple": "https://podcasts.apple.com/us/podcast/the-latest-from-kqed/id1197721799",
"npr": "https://www.npr.org/podcasts/1257949365/the-latest-from-k-q-e-d",
"spotify": "https://open.spotify.com/show/5KIIXMgM9GTi5AepwOYvIZ?si=bd3053fec7244dba",
"rss": "https://feeds.megaphone.fm/KQINC9137121918"
}
},
"theleap": {
"id": "theleap",
"title": "The Leap",
"tagline": "What if you closed your eyes, and jumped?",
"info": "Stories about people making dramatic, risky changes, told by award-winning public radio reporter Judy Campbell.",
"imageSrc": "https://cdn.kqed.org/wp-content/uploads/2024/04/The-Leap-Podcast-Tile-703x703-1.jpg",
"imageAlt": "KQED The Leap",
"officialWebsiteLink": "/podcasts/theleap",
"meta": {
"site": "news",
"source": "kqed",
"order": 17
},
"link": "/podcasts/theleap",
"subscribe": {
"apple": "https://podcasts.apple.com/us/podcast/the-leap/id1046668171",
"npr": "https://www.npr.org/podcasts/447248267/the-leap",
"stitcher": "https://www.stitcher.com/podcast/kqed/the-leap",
"spotify": "https://open.spotify.com/show/3sSlVHHzU0ytLwuGs1SD1U",
"rss": "https://ww2.kqed.org/news/programs/the-leap/feed/podcast"
}
},
"the-moth-radio-hour": {
"id": "the-moth-radio-hour",
"title": "The Moth Radio Hour",
"info": "Since its launch in 1997, The Moth has presented thousands of true stories, told live and without notes, to standing-room-only crowds worldwide. Moth storytellers stand alone, under a spotlight, with only a microphone and a roomful of strangers. The storyteller and the audience embark on a high-wire act of shared experience which is both terrifying and exhilarating. Since 2008, The Moth podcast has featured many of our favorite stories told live on Moth stages around the country. For information on all of our programs and live events, visit themoth.org.",
"airtime": "SAT 8pm-9pm and SUN 11am-12pm",
"imageSrc": "https://ww2.kqed.org/radio/wp-content/uploads/sites/50/2018/04/theMoth.jpg",
"officialWebsiteLink": "https://themoth.org/",
"meta": {
"site": "arts",
"source": "prx"
},
"link": "/radio/program/the-moth-radio-hour",
"subscribe": {
"apple": "https://itunes.apple.com/us/podcast/the-moth-podcast/id275699983?mt=2",
"tuneIn": "https://tunein.com/radio/The-Moth-p273888/",
"rss": "http://feeds.themoth.org/themothpodcast"
}
},
"the-new-yorker-radio-hour": {
"id": "the-new-yorker-radio-hour",
"title": "The New Yorker Radio Hour",
"info": "The New Yorker Radio Hour is a weekly program presented by the magazine's editor, David Remnick, and produced by WNYC Studios and The New Yorker. Each episode features a diverse mix of interviews, profiles, storytelling, and an occasional burst of humor inspired by the magazine, and shaped by its writers, artists, and editors. This isn't a radio version of a magazine, but something all its own, reflecting the rich possibilities of audio storytelling and conversation. Theme music for the show was composed and performed by Merrill Garbus of tUnE-YArDs.",
"airtime": "SAT 10am-11am",
"imageSrc": "https://cdn.kqed.org/wp-content/uploads/2024/04/The-New-Yorker-Podcast-Tile-360x360-1.jpg",
"officialWebsiteLink": "https://www.wnycstudios.org/shows/tnyradiohour",
"meta": {
"site": "arts",
"source": "WNYC"
},
"link": "/radio/program/the-new-yorker-radio-hour",
"subscribe": {
"apple": "https://itunes.apple.com/us/podcast/id1050430296",
"tuneIn": "https://tunein.com/podcasts/WNYC-Podcasts/New-Yorker-Radio-Hour-p803804/",
"rss": "https://feeds.feedburner.com/newyorkerradiohour"
}
},
"the-sam-sanders-show": {
"id": "the-sam-sanders-show",
"title": "The Sam Sanders Show",
"info": "One of public radio's most dynamic voices, Sam Sanders helped launch The NPR Politics Podcast and hosted NPR's hit show It's Been A Minute. Now, the award-winning host returns with something brand new, The Sam Sanders Show. Every week, Sam Sanders and friends dig into the culture that shapes our lives: what's driving the biggest trends, how artists really think, and even the memes you can't stop scrolling past. Sam is beloved for his way of unpacking the world and bringing you up close to fresh currents and engaging conversations. The Sam Sanders Show is smart, funny and always a good time.",
"airtime": "FRI 12-1pm AND SAT 11am-12pm",
"imageSrc": "https://cdn.kqed.org/wp-content/uploads/2025/11/The-Sam-Sanders-Show-Podcast-Tile-400x400-1.jpg",
"officialWebsiteLink": "https://www.kcrw.com/shows/the-sam-sanders-show/latest",
"meta": {
"site": "arts",
"source": "KCRW"
},
"link": "https://www.kcrw.com/shows/the-sam-sanders-show/latest",
"subscribe": {
"rss": "https://feed.cdnstream1.com/zjb/feed/download/ac/28/59/ac28594c-e1d0-4231-8728-61865cdc80e8.xml"
}
},
"the-splendid-table": {
"id": "the-splendid-table",
"title": "The Splendid Table",
"info": "\u003cem>The Splendid Table\u003c/em> hosts our nation's conversations about cooking, sustainability and food culture.",
"imageSrc": "https://cdn.kqed.org/wp-content/uploads/2024/04/The-Splendid-Table-Podcast-Tile-360x360-1.jpg",
"officialWebsiteLink": "https://www.splendidtable.org/",
"airtime": "SUN 10-11 pm",
"meta": {
"site": "radio",
"source": "npr"
},
"link": "/radio/program/the-splendid-table"
},
"this-american-life": {
"id": "this-american-life",
"title": "This American Life",
"info": "This American Life is a weekly public radio show, heard by 2.2 million people on more than 500 stations. Another 2.5 million people download the weekly podcast. It is hosted by Ira Glass, produced in collaboration with Chicago Public Media, delivered to stations by PRX The Public Radio Exchange, and has won all of the major broadcasting awards.",
"airtime": "SAT 12pm-1pm, 7pm-8pm",
"imageSrc": "https://ww2.kqed.org/radio/wp-content/uploads/sites/50/2018/04/thisAmericanLife.png",
"officialWebsiteLink": "https://www.thisamericanlife.org/",
"meta": {
"site": "news",
"source": "wbez"
},
"link": "/radio/program/this-american-life",
"subscribe": {
"apple": "https://itunes.apple.com/WebObjects/MZStore.woa/wa/viewPodcast?s=143441&mt=2&id=201671138&at=11l79Y&ct=nprdirectory",
"rss": "https://www.thisamericanlife.org/podcast/rss.xml"
}
},
"tinydeskradio": {
"id": "tinydeskradio",
"title": "Tiny Desk Radio",
"info": "We're bringing the best of Tiny Desk to the airwaves, only on public radio.",
"airtime": "SUN 8pm and SAT 9pm",
"imageSrc": "https://cdn.kqed.org/wp-content/uploads/2025/04/300x300-For-Member-Station-Logo-Tiny-Desk-Radio-@2x.png",
"officialWebsiteLink": "https://www.npr.org/series/g-s1-52030/tiny-desk-radio",
"meta": {
"site": "news",
"source": "npr"
},
"link": "/radio/program/tinydeskradio",
"subscribe": {
"rss": "https://feeds.npr.org/g-s1-52030/rss.xml"
}
},
"wait-wait-dont-tell-me": {
"id": "wait-wait-dont-tell-me",
"title": "Wait Wait... Don't Tell Me!",
"info": "Peter Sagal and Bill Kurtis host the weekly NPR News quiz show alongside some of the best and brightest news and entertainment personalities.",
"airtime": "SUN 10am-11am, SAT 11am-12pm, SAT 6pm-7pm",
"imageSrc": "https://cdn.kqed.org/wp-content/uploads/2024/04/Wait-Wait-Podcast-Tile-300x300-1.jpg",
"officialWebsiteLink": "https://www.npr.org/programs/wait-wait-dont-tell-me/",
"meta": {
"site": "news",
"source": "npr"
},
"link": "/radio/program/wait-wait-dont-tell-me",
"subscribe": {
"npr": "https://rpb3r.app.goo.gl/Xogv",
"apple": "https://itunes.apple.com/WebObjects/MZStore.woa/wa/viewPodcast?s=143441&mt=2&id=121493804&at=11l79Y&ct=nprdirectory",
"tuneIn": "https://tunein.com/radio/Wait-Wait-Dont-Tell-Me-p46/",
"rss": "https://feeds.npr.org/344098539/podcast.xml"
}
},
"weekend-edition-saturday": {
"id": "weekend-edition-saturday",
"title": "Weekend Edition Saturday",
"info": "Weekend Edition Saturday wraps up the week's news and offers a mix of analysis and features on a wide range of topics, including arts, sports, entertainment, and human interest stories. The two-hour program is hosted by NPR's Peabody Award-winning Scott Simon.",
"airtime": "SAT 5am-10am",
"imageSrc": "https://cdn.kqed.org/wp-content/uploads/2024/04/Weekend-Edition-Podcast-Tile-360x360-1.jpg",
"officialWebsiteLink": "https://www.npr.org/programs/weekend-edition-saturday/",
"meta": {
"site": "news",
"source": "npr"
},
"link": "/radio/program/weekend-edition-saturday"
},
"weekend-edition-sunday": {
"id": "weekend-edition-sunday",
"title": "Weekend Edition Sunday",
"info": "Weekend Edition Sunday features interviews with newsmakers, artists, scientists, politicians, musicians, writers, theologians and historians. The program has covered news events from Nelson Mandela's 1990 release from a South African prison to the capture of Saddam Hussein.",
"airtime": "SUN 5am-10am",
"imageSrc": "https://cdn.kqed.org/wp-content/uploads/2024/04/Weekend-Edition-Podcast-Tile-360x360-1.jpg",
"officialWebsiteLink": "https://www.npr.org/programs/weekend-edition-sunday/",
"meta": {
"site": "news",
"source": "npr"
},
"link": "/radio/program/weekend-edition-sunday"
}
},
"racesReducer": {},
"racesGenElectionReducer": {},
"racesGenElection2026Reducer": {},
"radioSchedulesReducer": {},
"listsReducer": {
"posts/news?category=technology": {
"isFetching": false,
"latestQuery": {
"from": 1440,
"size": 12
},
"vitalsOnly": false,
"totalRequested": 12,
"isLoading": false,
"isLoadingMore": true,
"total": {
"value": 2410,
"relation": "eq"
},
"items": [
"news_11291235",
"news_11286563",
"futureofyou_322609",
"futureofyou_323092",
"futureofyou_322634",
"science_1338482",
"news_11276919",
"news_11275664",
"futureofyou_319192",
"news_11263472",
"futureofyou_315372",
"news_11257442"
],
"complete": true
}
},
"recallGuideReducer": {
"intros": {},
"policy": {},
"candidates": {}
},
"savedArticleReducer": {
"articles": [],
"status": {}
},
"newslettersReducer": {
"isFetching": false,
"fetchFailed": false,
"hasFetched": false,
"newsletters": {},
"isSubscribing": false,
"isUnsubscribing": false,
"subscribedNewsletters": {}
},
"termsReducer": {
"about": {
"name": "About",
"type": "terms",
"id": "about",
"slug": "about",
"link": "/about",
"taxonomy": "site"
},
"arts": {
"name": "Arts & Culture",
"grouping": [
"arts",
"pop",
"trulyca"
],
"description": "KQED Arts provides daily in-depth coverage of the Bay Area's music, art, film, performing arts, literature and arts news, as well as cultural commentary and criticism.",
"type": "terms",
"id": "arts",
"slug": "arts",
"link": "/arts",
"taxonomy": "site"
},
"artschool": {
"name": "Art School",
"parent": "arts",
"type": "terms",
"id": "artschool",
"slug": "artschool",
"link": "/artschool",
"taxonomy": "site"
},
"bayareabites": {
"name": "KQED food",
"grouping": [
"food",
"bayareabites",
"checkplease"
],
"parent": "food",
"type": "terms",
"id": "bayareabites",
"slug": "bayareabites",
"link": "/food",
"taxonomy": "site"
},
"bayareahiphop": {
"name": "Bay Area Hiphop",
"type": "terms",
"id": "bayareahiphop",
"slug": "bayareahiphop",
"link": "/bayareahiphop",
"taxonomy": "site"
},
"campaign21": {
"name": "Campaign 21",
"type": "terms",
"id": "campaign21",
"slug": "campaign21",
"link": "/campaign21",
"taxonomy": "site"
},
"careers": {
"name": "Careers",
"type": "terms",
"id": "careers",
"slug": "careers",
"link": "/careers",
"taxonomy": "site"
},
"checkplease": {
"name": "KQED food",
"grouping": [
"food",
"bayareabites",
"checkplease"
],
"parent": "food",
"type": "terms",
"id": "checkplease",
"slug": "checkplease",
"link": "/food",
"taxonomy": "site"
},
"education": {
"name": "Education",
"grouping": [
"education"
],
"type": "terms",
"id": "education",
"slug": "education",
"link": "/education",
"taxonomy": "site"
},
"elections": {
"name": "Elections",
"type": "terms",
"id": "elections",
"slug": "elections",
"link": "/elections",
"taxonomy": "site"
},
"events": {
"name": "Events",
"type": "terms",
"id": "events",
"slug": "events",
"link": "/events",
"taxonomy": "site"
},
"event": {
"name": "Event",
"alias": "events",
"type": "terms",
"id": "event",
"slug": "event",
"link": "/event",
"taxonomy": "site"
},
"filmschoolshorts": {
"name": "Film School Shorts",
"type": "terms",
"id": "filmschoolshorts",
"slug": "filmschoolshorts",
"link": "/filmschoolshorts",
"taxonomy": "site"
},
"food": {
"name": "KQED food",
"grouping": [
"food",
"bayareabites",
"checkplease"
],
"type": "terms",
"id": "food",
"slug": "food",
"link": "/food",
"taxonomy": "site"
},
"forum": {
"name": "Forum",
"relatedContentQuery": "posts/forum?",
"parent": "news",
"type": "terms",
"id": "forum",
"slug": "forum",
"link": "/forum",
"taxonomy": "site"
},
"futureofyou": {
"name": "Future of You",
"grouping": [
"science",
"futureofyou"
],
"parent": "science",
"type": "terms",
"id": "futureofyou",
"slug": "futureofyou",
"link": "/futureofyou",
"taxonomy": "site"
},
"jpepinheart": {
"name": "KQED food",
"relatedContentQuery": "posts/food,bayareabites,checkplease",
"parent": "food",
"type": "terms",
"id": "jpepinheart",
"slug": "jpepinheart",
"link": "/food",
"taxonomy": "site"
},
"liveblog": {
"name": "Live Blog",
"type": "terms",
"id": "liveblog",
"slug": "liveblog",
"link": "/liveblog",
"taxonomy": "site"
},
"livetv": {
"name": "Live TV",
"parent": "tv",
"type": "terms",
"id": "livetv",
"slug": "livetv",
"link": "/livetv",
"taxonomy": "site"
},
"lowdown": {
"name": "The Lowdown",
"relatedContentQuery": "posts/lowdown?",
"parent": "news",
"type": "terms",
"id": "lowdown",
"slug": "lowdown",
"link": "/lowdown",
"taxonomy": "site"
},
"mindshift": {
"name": "Mindshift",
"parent": "news",
"description": "MindShift explores the future of education by highlighting the innovative – and sometimes counterintuitive – ways educators and parents are helping all children succeed.",
"type": "terms",
"id": "mindshift",
"slug": "mindshift",
"link": "/mindshift",
"taxonomy": "site"
},
"news": {
"name": "News",
"grouping": [
"news",
"forum"
],
"type": "terms",
"id": "news",
"slug": "news",
"link": "/news",
"taxonomy": "site"
},
"newsletters": {
"name": "newsletters",
"type": "terms",
"id": "newsletters",
"slug": "newsletters",
"link": "/newsletters",
"taxonomy": "site"
},
"perspectives": {
"name": "Perspectives",
"parent": "radio",
"type": "terms",
"id": "perspectives",
"slug": "perspectives",
"link": "/perspectives",
"taxonomy": "site"
},
"podcasts": {
"name": "Podcasts",
"type": "terms",
"id": "podcasts",
"slug": "podcasts",
"link": "/podcasts",
"taxonomy": "site"
},
"pop": {
"name": "Pop",
"parent": "arts",
"type": "terms",
"id": "pop",
"slug": "pop",
"link": "/pop",
"taxonomy": "site"
},
"pressroom": {
"name": "Pressroom",
"type": "terms",
"id": "pressroom",
"slug": "pressroom",
"link": "/pressroom",
"taxonomy": "site"
},
"quest": {
"name": "Quest",
"parent": "science",
"type": "terms",
"id": "quest",
"slug": "quest",
"link": "/quest",
"taxonomy": "site"
},
"radio": {
"name": "Radio",
"grouping": [
"forum",
"perspectives"
],
"description": "Listen to KQED Public Radio – home of Forum and The California Report – on 88.5 FM in San Francisco, 89.3 FM in Sacramento, 88.3 FM in Santa Rosa and 88.1 FM in Martinez.",
"type": "terms",
"id": "radio",
"slug": "radio",
"link": "/radio",
"taxonomy": "site"
},
"root": {
"name": "KQED",
"image": "https://ww2.kqed.org/app/uploads/2020/02/KQED-OG-Image@1x.png",
"imageWidth": 1200,
"imageHeight": 630,
"headData": {
"title": "KQED | News, Radio, Podcasts, TV | Public Media for Northern California",
"description": "KQED provides public radio, television, and independent reporting on issues that matter to the Bay Area. We’re the NPR and PBS member station for Northern California."
},
"type": "terms",
"id": "root",
"slug": "root",
"link": "/root",
"taxonomy": "site"
},
"science": {
"name": "Science",
"grouping": [
"science",
"futureofyou"
],
"description": "KQED Science brings you award-winning science and environment coverage from the Bay Area and beyond.",
"type": "terms",
"id": "science",
"slug": "science",
"link": "/science",
"taxonomy": "site"
},
"stateofhealth": {
"name": "State of Health",
"parent": "science",
"type": "terms",
"id": "stateofhealth",
"slug": "stateofhealth",
"link": "/stateofhealth",
"taxonomy": "site"
},
"support": {
"name": "Support",
"type": "terms",
"id": "support",
"slug": "support",
"link": "/support",
"taxonomy": "site"
},
"thedolist": {
"name": "The Do List",
"parent": "arts",
"type": "terms",
"id": "thedolist",
"slug": "thedolist",
"link": "/thedolist",
"taxonomy": "site"
},
"trulyca": {
"name": "Truly CA",
"grouping": [
"arts",
"pop",
"trulyca"
],
"parent": "arts",
"type": "terms",
"id": "trulyca",
"slug": "trulyca",
"link": "/trulyca",
"taxonomy": "site"
},
"tv": {
"name": "TV",
"type": "terms",
"id": "tv",
"slug": "tv",
"link": "/tv",
"taxonomy": "site"
},
"voterguide": {
"name": "Voter Guide",
"parent": "elections",
"alias": "elections",
"type": "terms",
"id": "voterguide",
"slug": "voterguide",
"link": "/voterguide",
"taxonomy": "site"
},
"guiaelectoral": {
"name": "Guia Electoral",
"parent": "elections",
"alias": "elections",
"type": "terms",
"id": "guiaelectoral",
"slug": "guiaelectoral",
"link": "/guiaelectoral",
"taxonomy": "site"
},
"news_category_technology": {
"isLoading": true
},
"news_248": {
"type": "terms",
"id": "news_248",
"meta": {
"index": "terms_1716263798",
"site": "news",
"id": "248",
"found": true
},
"relationships": {},
"featImg": null,
"name": "Technology",
"description": null,
"taxonomy": "category",
"headData": {
"twImgId": null,
"twTitle": null,
"ogTitle": null,
"ogImgId": null,
"twDescription": null,
"description": null,
"title": "Technology Archives | KQED News",
"ogDescription": null
},
"ttid": 256,
"slug": "technology",
"isLoading": false,
"link": "/news/category/technology"
},
"source_futureofyou_322609": {
"type": "terms",
"id": "source_futureofyou_322609",
"meta": {
"override": true
},
"name": "KQED Future of You",
"isLoading": false
},
"source_futureofyou_322634": {
"type": "terms",
"id": "source_futureofyou_322634",
"meta": {
"override": true
},
"name": "\u003ca href=\"https://www.statnews.com/2017/01/19/california-stem-cell-agency-cirm/\">STAT\u003c/a>",
"isLoading": false
},
"source_futureofyou_319192": {
"type": "terms",
"id": "source_futureofyou_319192",
"meta": {
"override": true
},
"name": "KQED Future of You",
"isLoading": false
},
"source_news_11263472": {
"type": "terms",
"id": "source_news_11263472",
"meta": {
"override": true
},
"name": "NPR",
"link": "http://www.npr.org/",
"isLoading": false
},
"source_futureofyou_315372": {
"type": "terms",
"id": "source_futureofyou_315372",
"meta": {
"override": true
},
"name": "KQED Future of You",
"isLoading": false
},
"source_news_11257442": {
"type": "terms",
"id": "source_news_11257442",
"meta": {
"override": true
},
"name": "NPR",
"link": "http://www.npr.org/",
"isLoading": false
},
"news_6944": {
"type": "terms",
"id": "news_6944",
"meta": {
"index": "terms_1716263798",
"site": "news",
"id": "6944",
"found": true
},
"relationships": {},
"featImg": "https://ww2.kqed.org/app/uploads/sites/10/2014/10/News-Fix-Logo-Web-Banners-04.png",
"name": "News Fix",
"description": null,
"taxonomy": "program",
"headData": {
"twImgId": null,
"twTitle": null,
"ogTitle": null,
"ogImgId": null,
"twDescription": null,
"description": "The News Fix is a daily news podcast from KQED that breaks down the latest headlines and provides in-depth analysis of the stories that matter to the Bay Area.",
"title": "News Fix - Daily Dose of Bay Area News | KQED",
"ogDescription": null
},
"ttid": 6968,
"slug": "news-fix",
"isLoading": false,
"link": "/news/program/news-fix"
},
"news_72": {
"type": "terms",
"id": "news_72",
"meta": {
"index": "terms_1716263798",
"site": "news",
"id": "72",
"found": true
},
"relationships": {},
"featImg": "https://ww2.kqed.org/app/uploads/sites/10/2014/10/TCR-2-Logo-Web-Banners-03.png",
"name": "The California Report",
"description": null,
"taxonomy": "program",
"headData": {
"twImgId": null,
"twTitle": null,
"ogTitle": null,
"ogImgId": null,
"twDescription": null,
"description": null,
"title": "The California Report Archives | KQED News",
"ogDescription": null
},
"ttid": 6969,
"slug": "the-california-report",
"isLoading": false,
"link": "/news/program/the-california-report"
},
"news_1169": {
"type": "terms",
"id": "news_1169",
"meta": {
"index": "terms_1716263798",
"site": "news",
"id": "1169",
"found": true
},
"relationships": {},
"featImg": null,
"name": "Immigration",
"description": null,
"taxonomy": "category",
"headData": {
"twImgId": null,
"twTitle": null,
"ogTitle": null,
"ogImgId": null,
"twDescription": null,
"description": null,
"title": "Immigration Archives | KQED News",
"ogDescription": null
},
"ttid": 1180,
"slug": "immigration",
"isLoading": false,
"link": "/news/category/immigration"
},
"news_6188": {
"type": "terms",
"id": "news_6188",
"meta": {
"index": "terms_1716263798",
"site": "news",
"id": "6188",
"found": true
},
"relationships": {},
"featImg": null,
"name": "Law and Justice",
"description": null,
"taxonomy": "category",
"headData": {
"twImgId": null,
"twTitle": null,
"ogTitle": null,
"ogImgId": null,
"twDescription": null,
"description": null,
"title": "Law and Justice Archives | KQED News",
"ogDescription": null
},
"ttid": 6212,
"slug": "law-and-justice",
"isLoading": false,
"link": "/news/category/law-and-justice"
},
"news_33520": {
"type": "terms",
"id": "news_33520",
"meta": {
"index": "terms_1716263798",
"site": "news",
"id": "33520",
"found": true
},
"relationships": {},
"featImg": null,
"name": "Podcast",
"description": null,
"taxonomy": "category",
"headData": {
"twImgId": null,
"twTitle": null,
"ogTitle": null,
"ogImgId": null,
"twDescription": null,
"description": null,
"title": "Podcast Archives | KQED News",
"ogDescription": null
},
"ttid": 33537,
"slug": "podcast",
"isLoading": false,
"link": "/news/category/podcast"
},
"news_13": {
"type": "terms",
"id": "news_13",
"meta": {
"index": "terms_1716263798",
"site": "news",
"id": "13",
"found": true
},
"relationships": {},
"name": "Politics",
"slug": "politics",
"taxonomy": "category",
"description": null,
"featImg": null,
"headData": {
"title": "Politics | KQED News",
"description": null,
"ogTitle": null,
"ogDescription": null,
"ogImgId": null,
"twTitle": null,
"twDescription": null,
"twImgId": null
},
"ttid": 13,
"isLoading": false,
"link": "/news/category/politics"
},
"news_356": {
"type": "terms",
"id": "news_356",
"meta": {
"index": "terms_1716263798",
"site": "news",
"id": "356",
"found": true
},
"relationships": {},
"featImg": null,
"name": "Science",
"description": null,
"taxonomy": "category",
"headData": {
"twImgId": null,
"twTitle": null,
"ogTitle": null,
"ogImgId": null,
"twDescription": null,
"description": null,
"title": "Science Archives | KQED News",
"ogDescription": null
},
"ttid": 364,
"slug": "science",
"isLoading": false,
"link": "/news/category/science"
},
"news_1323": {
"type": "terms",
"id": "news_1323",
"meta": {
"index": "terms_1716263798",
"site": "news",
"id": "1323",
"found": true
},
"relationships": {},
"featImg": null,
"name": "Donald Trump",
"description": null,
"taxonomy": "tag",
"headData": {
"twImgId": null,
"twTitle": null,
"ogTitle": null,
"ogImgId": null,
"twDescription": null,
"description": null,
"title": "Donald Trump Archives | KQED News",
"ogDescription": null
},
"ttid": 1335,
"slug": "donald-trump",
"isLoading": false,
"link": "/news/tag/donald-trump"
},
"news_17286": {
"type": "terms",
"id": "news_17286",
"meta": {
"index": "terms_1716263798",
"site": "news",
"id": "17286",
"found": true
},
"relationships": {},
"featImg": null,
"name": "tcr",
"description": null,
"taxonomy": "tag",
"headData": {
"twImgId": null,
"twTitle": null,
"ogTitle": null,
"ogImgId": null,
"twDescription": null,
"description": null,
"title": "tcr Archives | KQED News",
"ogDescription": null
},
"ttid": 17318,
"slug": "tcr",
"isLoading": false,
"link": "/news/tag/tcr"
},
"news_1631": {
"type": "terms",
"id": "news_1631",
"meta": {
"index": "terms_1716263798",
"site": "news",
"id": "1631",
"found": true
},
"relationships": {},
"name": "Technology",
"slug": "technology",
"taxonomy": "tag",
"description": null,
"featImg": null,
"headData": {
"title": "Technology | KQED News",
"description": null,
"ogTitle": null,
"ogDescription": null,
"ogImgId": null,
"twTitle": null,
"twDescription": null,
"twImgId": null
},
"ttid": 1643,
"isLoading": false,
"link": "/news/tag/technology"
},
"news_18540": {
"type": "terms",
"id": "news_18540",
"meta": {
"index": "terms_1716263798",
"site": "news",
"id": "18540",
"found": true
},
"relationships": {},
"featImg": null,
"name": "Education",
"description": null,
"taxonomy": "category",
"headData": {
"twImgId": null,
"twTitle": null,
"ogTitle": null,
"ogImgId": null,
"twDescription": null,
"description": null,
"title": "Education Archives | KQED News",
"ogDescription": null
},
"ttid": 2595,
"slug": "education",
"isLoading": false,
"link": "/news/category/education"
},
"news_8": {
"type": "terms",
"id": "news_8",
"meta": {
"index": "terms_1716263798",
"site": "news",
"id": "8",
"found": true
},
"relationships": {},
"featImg": null,
"name": "News",
"description": null,
"taxonomy": "category",
"headData": {
"twImgId": null,
"twTitle": null,
"ogTitle": null,
"ogImgId": null,
"twDescription": null,
"description": null,
"title": "News Archives | KQED News",
"ogDescription": null
},
"ttid": 8,
"slug": "news",
"isLoading": false,
"link": "/news/category/news"
},
"news_206": {
"type": "terms",
"id": "news_206",
"meta": {
"index": "terms_1716263798",
"site": "news",
"id": "206",
"found": true
},
"relationships": {},
"featImg": null,
"name": "University of California",
"description": null,
"taxonomy": "tag",
"headData": {
"twImgId": null,
"twTitle": null,
"ogTitle": null,
"ogImgId": null,
"twDescription": null,
"description": null,
"title": "University of California Archives | KQED News",
"ogDescription": null
},
"ttid": 214,
"slug": "university-of-california",
"isLoading": false,
"link": "/news/tag/university-of-california"
},
"futureofyou_1060": {
"type": "terms",
"id": "futureofyou_1060",
"meta": {
"index": "terms_1716263798",
"site": "futureofyou",
"id": "1060",
"found": true
},
"relationships": {},
"featImg": null,
"name": "DIY Health",
"description": null,
"taxonomy": "category",
"headData": {
"twImgId": null,
"twTitle": null,
"ogTitle": null,
"ogImgId": null,
"twDescription": null,
"description": null,
"title": "DIY Health Archives | KQED Arts",
"ogDescription": null
},
"ttid": 1060,
"slug": "diy-health",
"isLoading": false,
"link": "/futureofyou/category/diy-health"
},
"futureofyou_452": {
"type": "terms",
"id": "futureofyou_452",
"meta": {
"index": "terms_1716263798",
"site": "futureofyou",
"id": "452",
"found": true
},
"relationships": {},
"featImg": null,
"name": "Health Policy",
"description": null,
"taxonomy": "category",
"headData": {
"twImgId": null,
"twTitle": null,
"ogTitle": null,
"ogImgId": null,
"twDescription": null,
"description": null,
"title": "Health Policy Archives | KQED Arts",
"ogDescription": null
},
"ttid": 452,
"slug": "health-policy",
"isLoading": false,
"link": "/futureofyou/category/health-policy"
},
"futureofyou_1062": {
"type": "terms",
"id": "futureofyou_1062",
"meta": {
"index": "terms_1716263798",
"site": "futureofyou",
"id": "1062",
"found": true
},
"relationships": {},
"featImg": null,
"name": "Hope/Hype",
"description": null,
"taxonomy": "category",
"headData": {
"twImgId": null,
"twTitle": null,
"ogTitle": null,
"ogImgId": null,
"twDescription": null,
"description": null,
"title": "Hope/Hype Archives | KQED Arts",
"ogDescription": null
},
"ttid": 1062,
"slug": "hopehype",
"isLoading": false,
"link": "/futureofyou/category/hopehype"
},
"futureofyou_1": {
"type": "terms",
"id": "futureofyou_1",
"meta": {
"index": "terms_1716263798",
"site": "futureofyou",
"id": "1",
"found": true
},
"relationships": {},
"featImg": null,
"name": "KQED Future Of You",
"description": null,
"taxonomy": "category",
"headData": {
"twImgId": null,
"twTitle": null,
"ogTitle": null,
"ogImgId": null,
"twDescription": null,
"description": null,
"title": "KQED Future Of You Archives | KQED Arts",
"ogDescription": null
},
"ttid": 1,
"slug": "future-of-you",
"isLoading": false,
"link": "/futureofyou/category/future-of-you"
},
"futureofyou_73": {
"type": "terms",
"id": "futureofyou_73",
"meta": {
"index": "terms_1716263798",
"site": "futureofyou",
"id": "73",
"found": true
},
"relationships": {},
"featImg": null,
"name": "KQED News",
"description": null,
"taxonomy": "category",
"headData": {
"twImgId": null,
"twTitle": null,
"ogTitle": null,
"ogImgId": null,
"twDescription": null,
"description": null,
"title": "KQED News Archives | KQED Arts",
"ogDescription": null
},
"ttid": 73,
"slug": "kqed-news",
"isLoading": false,
"link": "/futureofyou/category/kqed-news"
},
"futureofyou_1171": {
"type": "terms",
"id": "futureofyou_1171",
"meta": {
"index": "terms_1716263798",
"site": "futureofyou",
"id": "1171",
"found": true
},
"relationships": {},
"featImg": null,
"name": "ACA",
"description": null,
"taxonomy": "tag",
"headData": {
"twImgId": null,
"twTitle": null,
"ogTitle": null,
"ogImgId": null,
"twDescription": null,
"description": null,
"title": "ACA Archives | KQED Arts",
"ogDescription": null
},
"ttid": 1171,
"slug": "aca",
"isLoading": false,
"link": "/futureofyou/tag/aca"
},
"futureofyou_1173": {
"type": "terms",
"id": "futureofyou_1173",
"meta": {
"index": "terms_1716263798",
"site": "futureofyou",
"id": "1173",
"found": true
},
"relationships": {},
"featImg": null,
"name": "Ezekiel Emanuel",
"description": null,
"taxonomy": "tag",
"headData": {
"twImgId": null,
"twTitle": null,
"ogTitle": null,
"ogImgId": null,
"twDescription": null,
"description": null,
"title": "Ezekiel Emanuel Archives | KQED Arts",
"ogDescription": null
},
"ttid": 1173,
"slug": "ezekiel-emanuel",
"isLoading": false,
"link": "/futureofyou/tag/ezekiel-emanuel"
},
"futureofyou_1172": {
"type": "terms",
"id": "futureofyou_1172",
"meta": {
"index": "terms_1716263798",
"site": "futureofyou",
"id": "1172",
"found": true
},
"relationships": {},
"featImg": null,
"name": "Obamacare",
"description": null,
"taxonomy": "tag",
"headData": {
"twImgId": null,
"twTitle": null,
"ogTitle": null,
"ogImgId": null,
"twDescription": null,
"description": null,
"title": "Obamacare Archives | KQED Arts",
"ogDescription": null
},
"ttid": 1172,
"slug": "obamacare",
"isLoading": false,
"link": "/futureofyou/tag/obamacare"
},
"futureofyou_680": {
"type": "terms",
"id": "futureofyou_680",
"meta": {
"index": "terms_1716263798",
"site": "futureofyou",
"id": "680",
"found": true
},
"relationships": {},
"featImg": null,
"name": "stem cells",
"description": null,
"taxonomy": "tag",
"headData": {
"twImgId": null,
"twTitle": null,
"ogTitle": null,
"ogImgId": null,
"twDescription": null,
"description": null,
"title": "stem cells Archives | KQED Arts",
"ogDescription": null
},
"ttid": 680,
"slug": "stem-cells",
"isLoading": false,
"link": "/futureofyou/tag/stem-cells"
},
"futureofyou_1167": {
"type": "terms",
"id": "futureofyou_1167",
"meta": {
"index": "terms_1716263798",
"site": "futureofyou",
"id": "1167",
"found": true
},
"relationships": {},
"featImg": null,
"name": "DIY",
"description": null,
"taxonomy": "tag",
"headData": {
"twImgId": null,
"twTitle": null,
"ogTitle": null,
"ogImgId": null,
"twDescription": null,
"description": null,
"title": "DIY Archives | KQED Arts",
"ogDescription": null
},
"ttid": 1167,
"slug": "diy",
"isLoading": false,
"link": "/futureofyou/tag/diy"
},
"futureofyou_1164": {
"type": "terms",
"id": "futureofyou_1164",
"meta": {
"index": "terms_1716263798",
"site": "futureofyou",
"id": "1164",
"found": true
},
"relationships": {},
"featImg": null,
"name": "EpiPen",
"description": null,
"taxonomy": "tag",
"headData": {
"twImgId": null,
"twTitle": null,
"ogTitle": null,
"ogImgId": null,
"twDescription": null,
"description": null,
"title": "EpiPen Archives | KQED Arts",
"ogDescription": null
},
"ttid": 1164,
"slug": "epipen",
"isLoading": false,
"link": "/futureofyou/tag/epipen"
},
"futureofyou_38": {
"type": "terms",
"id": "futureofyou_38",
"meta": {
"index": "terms_1716263798",
"site": "futureofyou",
"id": "38",
"found": true
},
"relationships": {},
"featImg": null,
"name": "FDA",
"description": null,
"taxonomy": "tag",
"headData": {
"twImgId": null,
"twTitle": null,
"ogTitle": null,
"ogImgId": null,
"twDescription": null,
"description": null,
"title": "FDA Archives | KQED Arts",
"ogDescription": null
},
"ttid": 38,
"slug": "fda",
"isLoading": false,
"link": "/futureofyou/tag/fda"
},
"futureofyou_1275": {
"type": "terms",
"id": "futureofyou_1275",
"meta": {
"index": "terms_1716263798",
"site": "futureofyou",
"id": "1275",
"found": true
},
"relationships": {},
"featImg": null,
"name": "featured",
"description": null,
"taxonomy": "tag",
"headData": {
"twImgId": null,
"twTitle": null,
"ogTitle": null,
"ogImgId": null,
"twDescription": null,
"description": null,
"title": "featured Archives | KQED Arts",
"ogDescription": null
},
"ttid": 1275,
"slug": "featured",
"isLoading": false,
"link": "/futureofyou/tag/featured"
},
"futureofyou_1168": {
"type": "terms",
"id": "futureofyou_1168",
"meta": {
"index": "terms_1716263798",
"site": "futureofyou",
"id": "1168",
"found": true
},
"relationships": {},
"featImg": null,
"name": "Michael Laufer",
"description": null,
"taxonomy": "tag",
"headData": {
"twImgId": null,
"twTitle": null,
"ogTitle": null,
"ogImgId": null,
"twDescription": null,
"description": null,
"title": "Michael Laufer Archives | KQED Arts",
"ogDescription": null
},
"ttid": 1168,
"slug": "michael-laufer",
"isLoading": false,
"link": "/futureofyou/tag/michael-laufer"
},
"futureofyou_1093": {
"type": "terms",
"id": "futureofyou_1093",
"meta": {
"index": "terms_1716263798",
"site": "futureofyou",
"id": "1093",
"found": true
},
"relationships": {},
"featImg": null,
"name": "DIY Health",
"description": null,
"taxonomy": "collection",
"headData": {
"twImgId": null,
"twTitle": null,
"ogTitle": null,
"ogImgId": null,
"twDescription": null,
"description": null,
"title": "DIY Health Archives | KQED Arts",
"ogDescription": null
},
"ttid": 1093,
"slug": "diy-health",
"isLoading": false,
"link": "/futureofyou/collection/diy-health"
},
"futureofyou_961": {
"type": "terms",
"id": "futureofyou_961",
"meta": {
"index": "terms_1716263798",
"site": "futureofyou",
"id": "961",
"found": true
},
"relationships": {},
"featImg": null,
"name": "CIRM",
"description": null,
"taxonomy": "tag",
"headData": {
"twImgId": null,
"twTitle": null,
"ogTitle": null,
"ogImgId": null,
"twDescription": null,
"description": null,
"title": "CIRM Archives | KQED Arts",
"ogDescription": null
},
"ttid": 961,
"slug": "cirm",
"isLoading": false,
"link": "/futureofyou/tag/cirm"
},
"futureofyou_80": {
"type": "terms",
"id": "futureofyou_80",
"meta": {
"index": "terms_1716263798",
"site": "futureofyou",
"id": "80",
"found": true
},
"relationships": {},
"featImg": null,
"name": "kqedscience",
"description": null,
"taxonomy": "tag",
"headData": {
"twImgId": null,
"twTitle": null,
"ogTitle": null,
"ogImgId": null,
"twDescription": null,
"description": null,
"title": "kqedscience Archives | KQED Arts",
"ogDescription": null
},
"ttid": 80,
"slug": "kqedscience",
"isLoading": false,
"link": "/futureofyou/tag/kqedscience"
},
"science_31": {
"type": "terms",
"id": "science_31",
"meta": {
"index": "terms_1716263798",
"site": "science",
"id": "31",
"found": true
},
"relationships": {},
"featImg": null,
"name": "Climate",
"description": null,
"taxonomy": "category",
"headData": {
"twImgId": null,
"twTitle": null,
"ogTitle": null,
"ogImgId": null,
"twDescription": null,
"description": null,
"title": "Climate Archives | KQED Science",
"ogDescription": null
},
"ttid": 33,
"slug": "climate",
"isLoading": false,
"link": "/science/category/climate"
},
"science_40": {
"type": "terms",
"id": "science_40",
"meta": {
"index": "terms_1716263798",
"site": "science",
"id": "40",
"found": true
},
"relationships": {},
"featImg": null,
"name": "News",
"description": null,
"taxonomy": "category",
"headData": {
"twImgId": null,
"twTitle": null,
"ogTitle": null,
"ogImgId": null,
"twDescription": null,
"description": null,
"title": "News Archives | KQED Science",
"ogDescription": null
},
"ttid": 42,
"slug": "news",
"isLoading": false,
"link": "/science/category/news"
},
"news_21114": {
"type": "terms",
"id": "news_21114",
"meta": {
"index": "terms_1716263798",
"site": "news",
"id": "21114",
"found": true
},
"relationships": {},
"featImg": null,
"name": "Changing Workplace",
"description": null,
"taxonomy": "tag",
"headData": {
"twImgId": null,
"twTitle": null,
"ogTitle": null,
"ogImgId": null,
"twDescription": null,
"description": null,
"title": "Changing Workplace Archives | KQED News",
"ogDescription": null
},
"ttid": 21131,
"slug": "changing-workplace",
"isLoading": false,
"link": "/news/tag/changing-workplace"
},
"news_17687": {
"type": "terms",
"id": "news_17687",
"meta": {
"index": "terms_1716263798",
"site": "news",
"id": "17687",
"found": true
},
"relationships": {},
"featImg": null,
"name": "diversity",
"description": null,
"taxonomy": "tag",
"headData": {
"twImgId": null,
"twTitle": null,
"ogTitle": null,
"ogImgId": null,
"twDescription": null,
"description": null,
"title": "diversity Archives | KQED News",
"ogDescription": null
},
"ttid": 17721,
"slug": "diversity",
"isLoading": false,
"link": "/news/tag/diversity"
},
"news_21405": {
"type": "terms",
"id": "news_21405",
"meta": {
"index": "terms_1716263798",
"site": "news",
"id": "21405",
"found": true
},
"relationships": {},
"featImg": null,
"name": "equity",
"description": null,
"taxonomy": "tag",
"headData": {
"twImgId": null,
"twTitle": null,
"ogTitle": null,
"ogImgId": null,
"twDescription": null,
"description": null,
"title": "equity Archives | KQED News",
"ogDescription": null
},
"ttid": 21422,
"slug": "equity",
"isLoading": false,
"link": "/news/tag/equity"
},
"news_17041": {
"type": "terms",
"id": "news_17041",
"meta": {
"index": "terms_1716263798",
"site": "news",
"id": "17041",
"found": true
},
"relationships": {},
"featImg": null,
"name": "the-california-report-featured",
"description": null,
"taxonomy": "tag",
"headData": {
"twImgId": null,
"twTitle": null,
"ogTitle": null,
"ogImgId": null,
"twDescription": null,
"description": null,
"title": "the-california-report-featured Archives | KQED News",
"ogDescription": null
},
"ttid": 17067,
"slug": "the-california-report-featured",
"isLoading": false,
"link": "/news/tag/the-california-report-featured"
},
"news_1397": {
"type": "terms",
"id": "news_1397",
"meta": {
"index": "terms_1716263798",
"site": "news",
"id": "1397",
"found": true
},
"relationships": {},
"featImg": null,
"name": "Transportation",
"description": null,
"taxonomy": "category",
"headData": {
"twImgId": null,
"twTitle": null,
"ogTitle": null,
"ogImgId": null,
"twDescription": null,
"description": null,
"title": "Transportation Archives | KQED News",
"ogDescription": null
},
"ttid": 1409,
"slug": "transportation",
"isLoading": false,
"link": "/news/category/transportation"
},
"news_578": {
"type": "terms",
"id": "news_578",
"meta": {
"index": "terms_1716263798",
"site": "news",
"id": "578",
"found": true
},
"relationships": {},
"featImg": null,
"name": "bicycles",
"description": null,
"taxonomy": "tag",
"headData": {
"twImgId": null,
"twTitle": null,
"ogTitle": null,
"ogImgId": null,
"twDescription": null,
"description": null,
"title": "bicycles Archives | KQED News",
"ogDescription": null
},
"ttid": 587,
"slug": "bicycles",
"isLoading": false,
"link": "/news/tag/bicycles"
},
"news_18555": {
"type": "terms",
"id": "news_18555",
"meta": {
"index": "terms_1716263798",
"site": "news",
"id": "18555",
"found": true
},
"relationships": {},
"featImg": null,
"name": "cycling",
"description": null,
"taxonomy": "tag",
"headData": {
"twImgId": null,
"twTitle": null,
"ogTitle": null,
"ogImgId": null,
"twDescription": null,
"description": null,
"title": "cycling Archives | KQED News",
"ogDescription": null
},
"ttid": 18572,
"slug": "cycling",
"isLoading": false,
"link": "/news/tag/cycling"
},
"news_38": {
"type": "terms",
"id": "news_38",
"meta": {
"index": "terms_1716263798",
"site": "news",
"id": "38",
"found": true
},
"relationships": {},
"featImg": null,
"name": "San Francisco",
"description": null,
"taxonomy": "tag",
"headData": {
"twImgId": null,
"twTitle": null,
"ogTitle": null,
"ogImgId": null,
"twDescription": null,
"description": null,
"title": "San Francisco Archives | KQED News",
"ogDescription": null
},
"ttid": 58,
"slug": "san-francisco",
"isLoading": false,
"link": "/news/tag/san-francisco"
},
"futureofyou_759": {
"type": "terms",
"id": "futureofyou_759",
"meta": {
"index": "terms_1716263798",
"site": "futureofyou",
"id": "759",
"found": true
},
"relationships": {},
"featImg": null,
"name": "lyme disease",
"description": null,
"taxonomy": "tag",
"headData": {
"twImgId": null,
"twTitle": null,
"ogTitle": null,
"ogImgId": null,
"twDescription": null,
"description": null,
"title": "lyme disease Archives | KQED Arts",
"ogDescription": null
},
"ttid": 759,
"slug": "lyme-disease",
"isLoading": false,
"link": "/futureofyou/tag/lyme-disease"
},
"futureofyou_145": {
"type": "terms",
"id": "futureofyou_145",
"meta": {
"index": "terms_1716263798",
"site": "futureofyou",
"id": "145",
"found": true
},
"relationships": {},
"featImg": null,
"name": "sensors",
"description": null,
"taxonomy": "tag",
"headData": {
"twImgId": null,
"twTitle": null,
"ogTitle": null,
"ogImgId": null,
"twDescription": null,
"description": null,
"title": "sensors Archives | KQED Arts",
"ogDescription": null
},
"ttid": 145,
"slug": "sensors",
"isLoading": false,
"link": "/futureofyou/tag/sensors"
},
"futureofyou_25": {
"type": "terms",
"id": "futureofyou_25",
"meta": {
"index": "terms_1716263798",
"site": "futureofyou",
"id": "25",
"found": true
},
"relationships": {},
"featImg": null,
"name": "wearables",
"description": null,
"taxonomy": "tag",
"headData": {
"twImgId": null,
"twTitle": null,
"ogTitle": null,
"ogImgId": null,
"twDescription": null,
"description": null,
"title": "wearables Archives | KQED Arts",
"ogDescription": null
},
"ttid": 25,
"slug": "wearables",
"isLoading": false,
"link": "/futureofyou/tag/wearables"
},
"news_2756": {
"type": "terms",
"id": "news_2756",
"meta": {
"index": "terms_1716263798",
"site": "news",
"id": "2756",
"found": true
},
"relationships": {},
"featImg": null,
"name": "Marissa Mayer",
"description": null,
"taxonomy": "tag",
"headData": {
"twImgId": null,
"twTitle": null,
"ogTitle": null,
"ogImgId": null,
"twDescription": null,
"description": null,
"title": "Marissa Mayer Archives | KQED News",
"ogDescription": null
},
"ttid": 2774,
"slug": "marissa-mayer",
"isLoading": false,
"link": "/news/tag/marissa-mayer"
},
"news_20294": {
"type": "terms",
"id": "news_20294",
"meta": {
"index": "terms_1716263798",
"site": "news",
"id": "20294",
"found": true
},
"relationships": {},
"featImg": null,
"name": "Verizon",
"description": null,
"taxonomy": "tag",
"headData": {
"twImgId": null,
"twTitle": null,
"ogTitle": null,
"ogImgId": null,
"twDescription": null,
"description": null,
"title": "Verizon Archives | KQED News",
"ogDescription": null
},
"ttid": 20311,
"slug": "verizon",
"isLoading": false,
"link": "/news/tag/verizon"
},
"news_351": {
"type": "terms",
"id": "news_351",
"meta": {
"index": "terms_1716263798",
"site": "news",
"id": "351",
"found": true
},
"relationships": {},
"featImg": null,
"name": "Yahoo!",
"description": null,
"taxonomy": "tag",
"headData": {
"twImgId": null,
"twTitle": null,
"ogTitle": null,
"ogImgId": null,
"twDescription": null,
"description": null,
"title": "Yahoo! Archives | KQED News",
"ogDescription": null
},
"ttid": 359,
"slug": "yahoo",
"isLoading": false,
"link": "/news/tag/yahoo"
},
"futureofyou_814": {
"type": "terms",
"id": "futureofyou_814",
"meta": {
"index": "terms_1716263798",
"site": "futureofyou",
"id": "814",
"found": true
},
"relationships": {},
"featImg": null,
"name": "Elizabeth Holmes",
"description": null,
"taxonomy": "tag",
"headData": {
"twImgId": null,
"twTitle": null,
"ogTitle": null,
"ogImgId": null,
"twDescription": null,
"description": null,
"title": "Elizabeth Holmes Archives | KQED Arts",
"ogDescription": null
},
"ttid": 814,
"slug": "elizabeth-holmes",
"isLoading": false,
"link": "/futureofyou/tag/elizabeth-holmes"
},
"futureofyou_751": {
"type": "terms",
"id": "futureofyou_751",
"meta": {
"index": "terms_1716263798",
"site": "futureofyou",
"id": "751",
"found": true
},
"relationships": {},
"featImg": null,
"name": "John Carreyrou",
"description": null,
"taxonomy": "tag",
"headData": {
"twImgId": null,
"twTitle": null,
"ogTitle": null,
"ogImgId": null,
"twDescription": null,
"description": null,
"title": "John Carreyrou Archives | KQED Arts",
"ogDescription": null
},
"ttid": 751,
"slug": "john-carreyrou",
"isLoading": false,
"link": "/futureofyou/tag/john-carreyrou"
},
"futureofyou_617": {
"type": "terms",
"id": "futureofyou_617",
"meta": {
"index": "terms_1716263798",
"site": "futureofyou",
"id": "617",
"found": true
},
"relationships": {},
"featImg": null,
"name": "theranos",
"description": null,
"taxonomy": "tag",
"headData": {
"twImgId": null,
"twTitle": null,
"ogTitle": null,
"ogImgId": null,
"twDescription": null,
"description": null,
"title": "theranos Archives | KQED Arts",
"ogDescription": null
},
"ttid": 617,
"slug": "theranos",
"isLoading": false,
"link": "/futureofyou/tag/theranos"
},
"news_3706": {
"type": "terms",
"id": "news_3706",
"meta": {
"index": "terms_1716263798",
"site": "news",
"id": "3706",
"found": true
},
"relationships": {},
"featImg": null,
"name": "hacking",
"description": null,
"taxonomy": "tag",
"headData": {
"twImgId": null,
"twTitle": null,
"ogTitle": null,
"ogImgId": null,
"twDescription": null,
"description": null,
"title": "hacking Archives | KQED News",
"ogDescription": null
},
"ttid": 3724,
"slug": "hacking",
"isLoading": false,
"link": "/news/tag/hacking"
},
"news_253": {
"type": "terms",
"id": "news_253",
"meta": {
"index": "terms_1716263798",
"site": "news",
"id": "253",
"found": true
},
"relationships": {},
"featImg": null,
"name": "NPR",
"description": null,
"taxonomy": "affiliate",
"headData": {
"twImgId": null,
"twTitle": null,
"ogTitle": null,
"ogImgId": null,
"twDescription": null,
"description": "KQED is the NPR station for the Bay Area, providing award-winning news, programming, and community engagement.",
"title": "NPR Archives - Get the Latest News and Reports from California | KQED",
"ogDescription": null
},
"ttid": 7083,
"slug": "npr",
"isLoading": false,
"link": "/news/affiliate/npr"
}
},
"userPermissionsReducer": {
"wpLoggedIn": false
},
"eventsReducer": {},
"fssReducer": {},
"tvDailyScheduleReducer": {},
"tvWeeklyScheduleReducer": {},
"tvPrimetimeScheduleReducer": {},
"tvMonthlyScheduleReducer": {},
"userAccountReducer": {
"user": {
"email": null,
"emailStatus": "EMAIL_UNVALIDATED",
"loggedStatus": "LOGGED_OUT",
"loggingChecked": false,
"articles": [],
"firstName": null,
"lastName": null,
"phoneNumber": null,
"fetchingMembership": false,
"membershipError": false,
"memberships": [
{
"id": null,
"startDate": null,
"firstName": null,
"lastName": null,
"familyNumber": null,
"memberNumber": null,
"memberSince": null,
"expirationDate": null,
"pfsEligible": false,
"isSustaining": false,
"membershipLevel": "Prospect",
"membershipStatus": "Non Member",
"lastGiftDate": null,
"renewalDate": null,
"lastDonationAmount": null
}
]
},
"authModal": {
"isOpen": false,
"view": "LANDING_VIEW"
},
"error": null
},
"youthMediaReducer": {},
"checkPleaseReducer": {
"filterData": {
"region": {
"key": "Restaurant Region",
"filters": [
"Any Region"
]
},
"cuisine": {
"key": "Restaurant Cuisine",
"filters": [
"Any Cuisine"
]
}
},
"restaurantDataById": {},
"restaurantIdsSorted": [],
"error": null
},
"userAgentReducer": {
"userAgent": "Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)",
"isBot": true
}
}
